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Abstract
Protein sequencing has produced overwhelming amount of protein sequences, espe-
cially in the last decade. Nevertheless, the majority of the proteins’ functional and
structural classes are still unknown, and experimental methods currently used to de-
termine these properties are very expensive, laborious and time consuming. Therefore,
automated computational methods are urgently required to accurately and reliably pre-
dict functional and structural classes of the proteins. Several bioinformatics methods
have been developed to determine such properties of the proteins directly from their
sequence information. Such methods that involve signal processing methods have
recently become popular in the bioinformatics area and been investigated for the anal-
ysis of DNA and protein sequences and shown to be useful and generally help better
characterise the sequences. However, there are various technical issues that need to
be addressed in order to overcome problems associated with the signal processing
methods for the analysis of the proteins sequences.
Amino acid indices that are used to transform the protein sequences into signals have
various applications and can represent diverse features of the protein sequences and
amino acids. As the majority of indices have similar features, this project proposes
a new set of computationally derived indices that better represent the original group
of indices. A study is also carried out that resulted in finding a unique and universal
set of best discriminating amino acid indices for the characterisation of allergenic
proteins. This analysis extracts features directly from the protein sequences by using
Discrete Fourier Transform (DFT) to build a classification model based on Support
Vector Machines (SVM) for the allergenic proteins. The proposed predictive model
yields a higher and more reliable accuracy than those of the existing methods.
A new method is proposed for performing a multiple sequence alignment. For this
method, DFT-based method is used to construct a new distance matrix in combination
with multiple amino acid indices that were used to encode protein sequences into nu-
merical sequences. Additionally, a new type of substitution matrix is proposed where
the physicochemical similarities between any given amino acids is calculated. These
similarities were calculated based on the 25 amino acids indices selected, where each
one represents a unique biological protein feature. The proposed multiple sequence
alignment method yields a better and more reliable alignment than the existing meth-
ods.
In order to evaluate complex information that is generated as a result of DFT, Com-
plex Informational Spectrum Analysis (CISA) is developed and presented. As the
results show, when protein classes present similarities or differences according to the
Common Frequency Peak (CFP) in specific amino acid indices, then it is probable
that these classes are related to the protein feature that the specific amino acid rep-
resents. By using only the absolute spectrum in the analysis of protein sequences
using the informational spectrum analysis is proven to be insufficient, as biologically
related features can appear individually either in the real or the imaginary spectrum.
This is successfully demonstrated over the analysis of influenza neuraminidase protein
sequences.
Upon identification of a new protein, it is important to single out amino acid responsi-
ble for the structural and functional classification of the protein, as well as the amino
acids contributing to the protein’s specific biological characterisation. In this work, a
novel approach is presented to identify and quantify the relationship between individ-
ual amino acids and the protein. This is successfully demonstrated over the analysis
of influenza neuraminidase protein sequences.
Characterisation and identification problem of the Influenza A virus protein sequences
is tackled through a Subgroup Discovery (SD) algorithm, which can provide ancillary
knowledge to the experts. The main objective of the case study was to derive in-
terpretable knowledge for the influenza A virus problem and to consequently better
describe the relationships between subtypes of this virus. Finally, by using DFT-based
sequence-driven features a Support Vector Machine (SVM)-based classification model
was built and tested, that yields higher predictive accuracy than that of SD.
The methods developed and presented in this study yield promising results and can be
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In the recent years, biology has been revolutionised from being a completely lab-based
science to becoming an information science. Bioinformatics is the area of science in which
computer science, information technology and biology are combined to establish a new
discipline. In this chapter, an introduction to Bioinformatics will be given as well as pro-
tein sequences and amino acids that are the main focus of the thesis. Furthermore, signal
processing as a bioinformatics method will be briefly introduced, and its applicability in
bioinformatics will be discussed. Finally, the thesis aims and contributions will also be
provided.
1.1 What Is Bioinformatics?
The main aim of the bioinformatics research area is to enable the discovery of new biolog-
ical insights, as well as to create a global set of rules that govern biology [1; 2]. Originally,
this area was associated with the creation and maintenance of databases for storing bio-
logical information such as DNA [3] and protein sequences [4]. These types of databases
would usually be associated with complex user-interfaces that would enable researchers to
access and update as well as append biological information. As the number and quality
of biological data gathered in these databases increased, this information could be used to
create a complete description of cellular activities and their associations with distinct disor-
der conditions. Therefore, the field of bioinformatics has evolved [1; 2] to analyse various
types of data including DNA and protein sequences, protein domains, and protein struc-
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tures. The research area in which biological data are analysed and interpreted is referred
to as computational biology. Some of the significant fields of study within bioinformatics
and computational biology as follows
• The development of tools and databases for managing biologically related informa-
tion, such as
– Swiss-Prot & TrEMBL [5], high quality annotated and non-redundant protein
sequence databases.
– UniProt [4] (Universal Protein Resource), an information database on protein
sequences.
• The development of statistical and mathematical algorithms to analyse biological
databases like the prediction of structural and functional class of protein sequences
[6] and the protein sequences clustering into groups of associated sequences [7].
One of the aims of bioinformatics is to identify, understand and model the driving forces
of the biological processes. In order to accomplish this goal this research area uses compu-
tational methods such as machine learning, data mining and pattern recognition techniques.
To name research areas where these computational methods are successfully implemented
are drug design and discovery [8], DNA and protein sequence alignment [9; 10], protein
structure alignment [11] and gene prediction and identification [12].
Bioinformatics is considered to be an important research area as it can be used to help
improve our understanding of the biological processes where the collection of further in-
formation is difficult or challenging. For example, in a specific biological process that can
cause a disease in humans and the collection of further information is ethically challenging
[13; 14] or forbidden by the current laws [13; 14], various models of the same process
within other organisms can be used to gain further knowledge.
The reason for applying computational methods in order to understand different bi-
ological processes is that by using these methods a generalised model of the biological
processes can be constructed. Additionally, by using these models, a hypothesis can be
constructed regarding a specific biological process, which can be validated with lab-based
experiments. By using this practice, money and time can be saved as lab-based experiments
are expensive and highly time-consuming [15; 16].
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Bioinformatic-based methods have been developed, studied and applied for various
areas. As the work presented in this research project focuses mainly upon the analysis of
protein sequences a brief description of proteins will be given in the following section.
1.2 Proteins
A protein is a biomodule that generally consists of 20 smaller components called amino
acids, which are linked together [17]. They are connected with strong bonds creating a one-
dimensional chain, in a similar way of DNA single strands. By using the 20 amino acid
representation, each protein can be represented mathematically by a character string. The
length of this string is relatively small, a few hundreds or thousands, relative to the DNA
representation which is usually in millions or hundred of millions [17]. Protein functions
are usually determined by their complex three-dimensional (3-D) structures in which they
usually tend to fold. The 3-D structure determines where a protein can bind with other
modules in a process that resemble a hand fitting into a glove [18]. Although all proteins
in living cells are determined by character sequences, there is not yet a method to predict
the 3-D structures.
The genetic code controls the protein synthesis by mapping each of the 64 possible
triplets of DNA characters into the 20 amino acids [17], as shown in Table 1.1. A particular
codon, the M amino acid (methionine), serves as a START codon but also appears in other
locations in the sequence. Additionally, there are also three amino acids that serve as STOP
codons, as Table 1.1 shows. There are two ways to code the nucleotides into amino acids
depending on the direction the DNA strands (forward or reverse) [19].
One of the most important and unsolved problems in bioinformatics is to automatically
identify which proteins serve a particular function. The sequence is coded in nucleotides
of three (codons), so the sequence needs to be a multiple of three, starting with a START
codon and ending with a STOP codon. The STOP codon cannot appear in any other loca-
tion in the sequence, contrary to the START codon that can appear as the M amino acid. In
the next section a more detailed description of the amino acids will be given.
3
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Table 1.1: Amino Acids
Name Abbreviation Codons
Alanine Ala/A GCU, GCC, GCA, GCG
Arginine Arg/R CGU, CGC, CGA, CGG, AGA, AGG
Asparagine Asn/N AAU, AAC
Aspartic Acid Asp/D GAU, GAC
Cysteine Cys/C UGU, UGC
Glutamic Acid Gln/Q CAA, CAG
Glutamine Glu/E GAA, GAG
Glycine Gly/G GGU, GGC, GGA, GGG
Histidine His/H CAU, CAC
Isoleucine Ile/I AUU, AUC, AUA
START AUG
STOP UAG, UGA, UAA
Leucine Leu/L UUA, UUG, CUU, CUC, CUA, CUG
Lysine Lys/K AAA, AAG
Methionine Met/M AUG
Phenylalanine Phe/F UUU, UUC
Proline Pro/P CCU, CCC, CCA, CCG
Serine Ser/S UCU, UCC, UCA, UCG, AGU, AGC
Threonine Thr/T ACU, ACC, ACA, ACG
Tryptophan Trp/W UGG
Tyrosine Tyr/Y UAU, UAC
Valine Val/V GUU, GUC, GUA, GUG
1.3 Amino acids
An amino acid has an average molecular weight of 135 daltons [20], and is one of the small-
est bio-molecules that exist in nature. These bio-molecules exist naturally in a zwitterion
state [20] (zwitterion-state exist when an amino acid has zero net charge but carries posi-
tive and negative charges on different atoms) where the carboxylic acid part is ionized and
the basic amino group is protonated [20]. The common structure of the class of amino acid
is an organic carboxylic acid group with an amino group attached to the saturated carbon
atom [20]. The simplest amino acid is glycine, which is the only one that is optically inac-
tive as its saturated carbon atom is unsubstituted. The remaining of the 20 most common
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amino acids used are optically active in both dextrorotary and levorotary stereoisomers
[20]. These amino acids are listed in Table 1.2 along with relevant biological information.
In nature, the groups of proteins that are studied, are levorotary isomers. On the saturated
carbon atom of the amino acid various substituents can connect from lower alkyl groups
to aromatic amines and, alcohols and there are also acidic and basic side chains as well as
thiol chains that can be oxidized to dithiol linkages between two similar amino acids [20].
All proteins and enzymes that exist in nature are the product of amino acid combina-
tions and so they are considered to be principal building blocks. Ribonucleic Acid (RNA)
unites these amino acids into proteins according to the genetic code, while ribosomes de-
code messenger RNA. The content of the amino acids that are used to assemble the protein
or enzyme determines the spatial and biochemical properties of this protein or enzyme.
The primary sequence of the protein may be determined by the amino acid backbone, and
the nature of this chain can specify the properties of the protein. These chains can be polar,
non-polar or even neutral [21]. The polar side chains of the protein usually appear on the
surface, where they can interact with the water based environment found in cells [22]. The
non-polar side chains tend to appear in the center of the protein, where they can interact
with other non-polar amino acids [22]. These interactions can create a hydrophobic region
in an enzyme in a non-polar atmosphere. Additionally, substituents can exist in the active
side of enzymes, where they can provide a polar region in which to be able to conduct
biochemical synthesis [23].
The twenty amino acids are obtained from different sources and used differently as
listed in Table 1.2 [20; 22].
1.4 Amino Acid Indices
An amino acid index is a fixed length vector containing twenty numerical values repre-
senting a protein’s physiochemical or biochemical property. Amino acid indices have been
developed and extensively investigated since the early sixties and derived by means of lab-
oratory experiments on biological specimens (e.g., hydrophobicity [24], polarity [25], size
[26] or volume [25]) and/or computational experiments on laboratory-derived indices (e.g.,
principal components extracted from relations between chemical structure and biological
activity in peptides [27]).
The largest database of amino acid indices is the AAindex1 database [28] that is located
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Table 1.2: Biological Information About Amino Acids
Amino Acid Biological Information
Alanine Used in most of the proteins and it is the second simplest amino acid
Arginine Usually used at the active sites of enzymes
Asparagine Obtained from aspartic acid
Aspartic Acid Intermediate in the citric acid cycle
Cysteine Involved in active sites and protein tertiary structure determination
Glutamic Acid Negatively charged and found on the surface of proteins
Glutamine Can easily cross the barrier between blood and brain tissue
Glycine Simplest amino acid - acts as neurotransmitter antagonist
Histidine Responsible for histamine biosynthesis
Isoleucine Exclusively used in protein and enzyme construction
Leucine Exclusively used in protein and enzyme construction also
Lysine Essential with a positive charge on the aliphatic side chain
Methionine Essential and initiate protein synthesis
Phenylalanine Most common aromatic amino acid in proteins
Proline Used in the synthesis of collagen
Serine Found in the active site of serine proteases
Threonine Involved in porphyrin metabolism
Tryptophan Used the least frequently in proteins
Tyrosine Used to build neurotransmitters and hormones
Valine Used to hold proteins together
at the GenomeNet. The latest update of this database was in March 2008 and contained
544 amino acid indices collected from various published literatures dating between 1964
and 2005.
Amino acid indices represent distinctive physicochemical and biochemical properties
of a protein, and can be used in a variety of bioinformatics problems where different protein
characteristics play a key role. In the literature, various studies have utilised amino acid
indices in identification of protein structural class [29; 30; 31], protein subcellular location
[32], secondary structure [33; 34], transmembrane sequences [35], predicting chemical
structure and biological function [36], surface prediction [37; 38] and prediction of disor-
dered regions [39]. As amino acid indices are assigned to amino acids in a protein sequence
the protein can then become a discrete sequence or signal by which signal processing meth-
ods can then be used to analyse.
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1.5 Signal Processing Methods
In recent years, signal-processing techniques have been used in bioinformatics to extract
information that is expected to reveal a protein’s biological function [40; 41; 42]. Signal
processing can be defined as the research area that deals with the analysis of discrete and
continuous signals. A signal can be described as a mathematical relation that shows how
the signal magnitude varies over time. Signal processing is applied in many research areas,
such as engineering and applied mathematics and the involved signals can be in the format
of images, sound and any type of measurement from sensors. One of the most common
signal analysis techniques is the Fourier transform, in which a signal can be converted into
a series of frequencies. This expresses a range over which some measurements produced by
a physical phenomenon, such as sound, electromagnetic radiation, or the mass of specific
kinds of particles, can vary [43].
There are various research areas where signal processing is successfully applied such
as audio signal processing [44], image processing [45], speech processing [46; 47], digital
communications [48], and biomedicine [49]. For a variety of applications [50; 51] it is
important to characterise a signal for the frequency and time domain at the same time.
In application to biology, such signal processing methods can point to the existence of
important characteristics in the data that the signal represents. Regarding the analysis of
protein sequences, representing them as numerical signals should be expected to reveal
specific biological characteristics such as the binding sites.
1.6 Thesis Aim
Protein sequencing has produced overwhelming amounts of protein sequences especially
in the last decade [52; 53; 54; 55]. Nevertheless, functional and structural classes of the
majority of the protein sequences are still unknown, and experimental methods currently
used to determine these properties are very expensive, laborious and time consuming [15].
Therefore, automated computational methods are urgently required to accurately and reli-
ably predict functional and structural classes of the proteins. Several bioinformatics meth-
ods have been developed to determine such properties of proteins directly from their se-
quence information [56]. Such methods involving signal processing methods, which are
discussed and analysed in the literature review, have recently become popular throughout
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the bioinformatics area and have been investigated for the analysis of DNA and protein
sequences and are shown to be useful and generally help better characterise the sequences
[41; 57]. The following research question arises: How can signal processing techniques
be utilised in order to improve already existing bioinformatics approaches, or used
to extract novel features that can be used for characterisation and classification of
protein sequences?
In order to address the research question, the outcome of this study will be a series of
bioinformatics systems that consider signal-processing techniques for the analysis of the
protein sequences as a signal and hence are expected to be capable of better characterising
the proteins. This will also be further improved by fusing multiple protein characteristics
and pattern recognition methods. This research study will bring a novel concept to charac-
terising the proteins, and will help predict structural and functional classes of the proteins
from primary sequence information with greater reliability and accuracy. In addition, this
will be the most comprehensive and consistent study that considers the use of amino acid
indices. It is also expected that this work will provide guidelines to other areas of study
in proteomics, in which automated prediction of a protein characteristic can achieved by
using only the primary structure of this protein. It is anticipated that the outcome of the
research has great potential in commercialisation and patent application.
1.7 Thesis Contributions
The main contributions of this thesis are
• As different groups of amino acid indices included in the database have similar fea-
tures, a hybrid computational method is developed by using hierarchical cluster-
ing and principal component analysis. The hybrid method helped to summarise the
groups of the indices and derive a small representative set of the amino acid indices.
A new Database is also developed and presented in the Amino Acid Index Database
(AAID) web-server (http://cisaps.com/indices), containing all the latest published
amino acid indices as well as new indices.
• A comprehensive study is carried out that resulted in finding a unique and universal
set of best discriminating amino acid indices for the characterisation of the aller-
genic proteins. This was achieved by extracting features from protein sequences by
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using Discrete Fourier Transform (DFT) and building a classification model based
on Support Vector Machines (SVM), for allergenic proteins.
• A new method is proposed for performing a multiple sequence alignment. For this
method, Discrete Fourier Transform-based signal processing method is used to con-
struct the distance matrix in combination with multiple amino acid indices that were
used to encode protein sequences into numerical sequences. Additionally in this
work, a new type of substitution matrix is proposed where the physicochemical sim-
ilarities between any given amino acids is calculated. These similarities were cal-
culated based on the 25 amino acids indices selected, where each one represents a
unique biological protein feature.
• Complex Informational Spectrum Analysis (CISA) is developed to analyse protein
sequences using the information captured in the real and imaginary spectrum in ad-
dition to the absolute spectrum. A web-based server is also developed and presented,
named CISAPS, which provides CISA for the analysis of protein sequences.
• A novel approach is developed and presented to identify and quantify the relationship
between amino acids and proteins by using signal processing methods. Two methods
are presented in this analysis based on DFT to calculate the effect of the individual
amino acid to the protein sequence. The first takes into consideration of the Common
Frequency Peak (CFP) that is calculated from the Informational Spectrum Analysis
(ISA), and the second considers the entire absolute spectrum generated by DFT.
• Characterisation and classification problem of the influenza A virus is tackled through
a Sub-group Discovery (SD) algorithm and compared with Support Vector Machines
(SVM), in order to accurately predict the subtype class.
1.8 Thesis Organisation
Having given a brief introduction to the research study, its contributions and achievements,




• Chapter 2 reviews the literature regarding the sequence-driven features that can be
extracted from protein sequences as well as signal processing methods used in the
analysis of proteins.
• Chapter 3 presents the Amino Acid Index Database web-server, which contains the
largest up to date database with all the latest published amino acid indices. Addition-
ally, this chapter introduces a new set of computationally derived indices that better
represent the original group of indices.
• Chapter 4 presents a study that tries to discover a unique and universal set of best dis-
criminating amino acid indices for the characterisation and prediction of allergenic
proteins.
• In Chapter 5, a new method is proposed for performing multiple sequence alignment
based on Discrete Fourier Transform.
• In Chapter 6, the Complex Resonant Recognition Model, based on the Discrete
Fourier Transform, is developed and its robustness is demonstrated by applying in the
influenza A subtypes Neuraminidase gene. Additionally, the Complex Informational
Spectrum Analysis of Protein Sequences (CISAPS) web-server is presented.
• In Chapter 7, a novel approach is presented for identifying and quantifying the re-
lationship between amino acid and protein by firstly considering the characteristic
frequency peak that is obtained from the Resonant Recognition Model, and secondly
by considering the entire absolute frequency spectrum.
• In Chapter 8, characterisation and classification of the influenza A virus is tackled
through a Subgroup Discovery algorithm, namely Non-dominated Multi-objective
Evolutionary algorithm for Extracting Fuzzy rules in Subgroup Discovery (NMEEF-
SD), and SVM that resulted in higher predictive accuracy than that of NMEEF-SD
.




If it is considered that proteins’ biological functions are controlled by the selective ability
of the protein to interact with specific elements in the environment an argument can arise:
How is this selected ability achieved and what is its physical basis? Several attempts have
been made to decode the rules that drive biological functions of the proteins, which mainly
deal with secondary and tertiary structures, but not directly from the amino acid sequences.
In recent years, different models have been developed for prediction of biological prop-
erties (e.g. functional or structural classes) of proteins or peptides. These models usually
use physicochemical properties and sequence-derived structural information that can be
extracted directly from protein sequences’ primary structures. These sequence-driven fea-
tures are generally found to be capable of representing and classifying protein sequences
with distinctive functional and structural classes. They are further combined with statisti-
cal and computational learning methods in order to classify protein sequences regardless
of their sequence similarity [58; 59].
2.1 Sequence-Driven Features for Proteins
A list of features that can be extracted directly from the primary structure of protein se-
quences, and are widely accepted and used in the literature can be found in Table 2.1.
One of the first and most widely used features of protein sequences is Amino Acid
Composition (AAC) that can be represented using a vector of 20 dimensions. The percent-
age of representation of all the 20 natural amino acids can be calculated by using Equation
11
2. LITERATURE REVIEW









Amino acid composition 1 20 [60]
Pseudo-amino acid composition a a [61]
Dipeptide composition 1 400 [62]
Moreau-Broto autocorrelation 8 240 [63]
Moran autocorrelation 8 240 [63]
Geary autocorrelation 8 240 [63]
Sequence-order-coupling number 2 60 [64]




Topological atom model - 405 [58]
Total amino acid properties a a [58]
a - The number of features depends on the λ parameter and the length
of the protein sequences
2.1.
AAC(i) =
total number of amino acids i
total number of amino acids
(2.1)
where i is a specific amino acid in a protein. From the literature, AAC has been success-
fully used in a variety of applications such as predicting protein structural classes [67] and
subcellular localisation of proteins [68].
Another important set of the features is the pseudo amino acid composition (PseAA)
[61]. This feature was proposed in order to take in consideration of sequence-order infor-
mation that would otherwise be lost with alternative approaches [61]. PseAA composition
consists of a set of 20 or greater discrete factors where the first 20 factors are the con-
ventional composition amino acid indices; the supplemental factors are calculated with
additional algorithms using sequence-order information. These additional factors can be
any combination of other factors, including the traditional 20 amino acid indices or a series
of rank-different correlation factors throughout a protein chain. Hence the significance of
PseAA composition is to include the amino acid composition, and maintain all the infor-
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mation beyond the AA composition that might be lost in using alternative procedures, and
reveal the characteristics of a protein sequence through a discrete model. Many different
models exist that can formulate a PseAA composition. The algorithm for the PseAA [61]
is as follows:
P = R1R2R3R4R5R6R7 · · ·RL (2.2)
P =
[
f1 f2 · · · f20
]T
(2.3)
P = [p1, p2, · · · , p20, p20+1, · · · , p20+λ]T, (λ < L) (2.4)
where P represents the protein sequence, L the amino acid residues, fu(u = 1, 2, ...20) the
normalised occurrence frequency of the 20 amino acids and T the transposing operator.




i=1 fi + w
∑λ
k=1 τk
, (1 ≤ u ≤ 20)
wτu−20∑20
i=1 fi + w
∑λ
k=1 τk
, (20 + 1 ≤ u ≤ 20 + λ)
(2.5)
where the weight factor is w, and k is the k-th correlation factor. The sequence order













[Φξ (Ri+k)− Φξ (Ri)]2 (2.7)
where Φξ (Ri) is the ξ − th function of the AA Ri and Γ the total number of the
functions taken into consideration.
Physical characteristics of the protein sequences which can be used in the PseAA com-
position, Φ1 (Ri) ,Ψ2 (Ri) and Ψ3 (Ri) can be the hydrophobicity, hydrophilicity, and side
13
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chain mass values respectively for the amino acid Ri [61]. The total number of func-
tions considered for this example is Γ = 3 . From Equation 2.4, the first 20 compo-
nents (p1, · · · , p20) show the conversional amino acid composition of the protein while
the remaining components (p20+1, · · · , p20+λ) are the correlation factors. These additional
correlation factors are thought to hold information about the protein is sequence order.
By changing the integer parameter λ in Equation 2.4, the PseAA composition will lead
to a dimension-difference. Other models can be used in addition to the example given
(Equation 2.7) such as physicochemical distance or amphiphilic pattern mode to calculate
different types of PseAA compositions.
In line with the development of such sequence-driven features Protein Feature Server
(PROFEAT) [56; 58] has been developed for researchers to be able to calculate the afore-
mentioned physicochemical and structural features of the amino acid sequences. PRO-
FEAT can be accessed and used freely at: http://jing.cz3.nus.edu.sg/cgi-bin/prof/prof.cgi.
Applications areas where the above-mentioned features can be used for predicting are given
in Table 2.2.
Table 2.2: Examples of the Predictive Models Developed Using the Sequence-Driven Fea-
tures
Application Area Reference
Protein structural classes [69; 70]
Functional families [71]
Sub-nuclear location of proteins [72]
Protein-protein interactions [73; 74]
Sub-cellular locations [75; 76]
Outer membrane proteins [77]
Transmembrane regions in protein [78]
Lipase types [79]
Protein folding [80; 81]
Protease types [82]
DNA-binding proteins [83; 84]
Protein secondary structural contents [85]
Regardless of the various uses and applications of non-signal processing-based tech-
niques, currently the area of signal processing within bioinformatics has became highly
motivational in the recent years while studying protein sequences, with diverse applica-
tions emerging. One of the main use of signal processing-based techniques is to be able to
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capture sequence order information, which will be discussed in the next section.
2.2 Signal Processing Methods
By using signal processing techniques the biological function of each sequence should be
able to be extracted without the secondary and tertiary structures being known [18; 86]. Ev-
ery macro-module, amino acid or nucleotide, can be represented by a corresponding value.
This value can be any of the biochemical properties like electron-ion interaction potential
[87; 88], hydrophobicity [88; 89], solubility [88; 89] or molecular weight [88; 89]. By
applying existing signal processing techniques it is possible to extract information that will
match sequence biological functions. A very common method used for analysing macro-
module sequences to extract biological functions is based on the search for similarities in
the arrangements between the groups of sequences. To be able to proceed with current
signal processing techniques a set of numerical values needs to be assigned to nucleotides
or amino acids [17; 87; 88; 89]. These values should be, by nature, representative of some
of the characteristics of the macro-modules with which they pair, and be relevant to the
biological activity of each module. By using this technique a module in the sequence is
represented by the same number despite its position. The final goal of the use of these
discrete signals is to determine biological functions of amino acid or nucleotide sequences
by extracting related parameters. So, any signal processing method can then be applied to
separate these unique parameters from the sequences.
For each group of proteins analysed [87; 89], there is a group of proteins that corre-
sponds to specific frequency in the spectrum. Every biological function corresponds to one
unique frequency or a set of unique frequencies. The importance of this conclusion is that
specific biological functions can be recognised from macro-modules by using signal pro-
cessing methods by extracting significant features of the frequencies, which are not found
in unrelated frequencies. There are various types of signal processing techniques that can
be used in the analysis of protein sequences, like Frequency Analysis (Discrete Fourier
Transform) and Space-Frequency Analysis (short-space Fourier Transform and Wavelet).
These types of transform will be discussed in more detail in the following sections.
15
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2.2.1 Frequency Analysis Using Discrete Fourier Transform




x(m)e−j(2pi/N)nm n = 0, 1, ..., N − 1 (2.8)
where x(m) is the mth member of the numerical series, N is the total number of points in
the series, and X(n) are coefficients of the DFT. As the DFT coefficients consisted of two
mirror parts, only the first half of the series (N/2) points) will be hereafter considered. The





where F is the maximal frequency of all signals and d is the distance between points of the
sequence. If it is assumed that distance d = 1 then the maximum frequency in the spectrum
can be found as F = 1/2(1) = 0.5. The output of DFT is a complex sequence and can be
characterized as follows
X(n) = (R(n) + jI(n)), n = 0, 1, ..., (N − 1)/2 (2.10)
where R(n) is the Real part of the sequence and I(n) the Imaginary part.
The absolute spectrum can be formulated as follows
S(n) = X(n)X
∗(n) = |X(n)|2 , n = 0, 1, ..., (N − 1)/2 (2.11)
where S(n) is the absolute spectrum for a specific protein, X(n) are the DFT coefficients
of the series x(n) and X∗(n) are the complex conjugate.
2.2.2 Informational Spectrum Analysis
The Informational Spectrum Analysis (ISA) [40; 90; 91; 92] is a physicomathematical
model that analyses the interaction of a protein and its target by using Discrete Fourier
Transform. One application of this model involves prediction of a protein’s biological
function [31; 93]. In this technique, Discrete Fourier transform is applied to a numerical
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representation of a protein sequence, and a frequency is determined for a protein’s partic-
ular function. The aim of ISA is therefore to determine a Characteristic Frequency Peak
(CFP) in the absolute spectrum that correlates with a biological function expressed by a set
of protein sequences by using the informational spectrum.





where C(n) is the informational spectrum and M is the number of protein sequences used








where L is the number of points in the Informational Spectrum (C).
After obtaining the Informational Spectrum the CFP can then be determined by select-
ing a frequency, or set of frequencies that present higher values of peaks. CFP pursuant
to the absolute informational spectrum analysis can be used for characterising and distin-
guishing the proteins. However, the following conditions should be fulfilled for the CFP to
be related to a biological function:
1. For diverse biological functions, CFP is expected to be dissimilar.
2. For biologically dissimilar protein sequences, CFP should not exist.
3. For a collection of protein sequences that allocate the same biological function a
single CFP should exist.
A special case of ISA is Resonant Recognition Model (RRM) [40; 91; 92] where the
Electro-ion Interaction Potential (EIIP) index [87] is used to encode protein sequences to
numerical sequences. The EIIP index values can be found in Table 2.3. In order to show
how the method can be applied in practice, an example is given below [94]. This is a case
study where Acid and Basic fibroblast growth factor (FGF) protein sequences were anal-











Table 2.3: EIIP Values
Amino acid EIIP Amino acid EIIP
Leu 0.0000 Tyr 0.0516
Ile 0.0000 Trp 0.0548
Asn 0.0036 Gln 0.0761
Gly 0.0050 Met 0.0823
Glu 0.0057 Ser 0.0829
Val 0.0058 Cys 0.0829
Pro 0.0198 Thr 0.0941
His 0.0242 Phe 0.0946
Lys 0.0371 Arg 0.0959
Ala 0.0373 Asp 0.1263
These sequences can be converted into numerical sequences using the EIIP index. They
are presented in signal in Figures 2.1 and 2.2, respectively. The next step in RRM process
is to apply DFT to the numerical representations of FGF protein sequences. The frequency
spectrum’s results are shown in Figures 2.3 and 2.4, respectively. Finally, the informational
spectrum of the two bovine FGF proteins is calculated as shown in Figure 2.5.
18
Figure 2.1: Acidic Bovine FGF With EIIP Index Values
Figure 2.2: Basic Bovine FGF With EIIP Index Values
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Figure 2.3: Absolute Frequency Spectrum of Acidic Bovine FGF
Figure 2.4: Absolute Frequency Spectrum of Basic Bovine FGF
20
Figure 2.5: Absolute Informational Spectrum of the Two Bovine FGF Proteins Shown in
Figures 2.3 and 2.4
2.2.3 Space-Frequency Analysis
Time-Frequency analysis (TFA) [95] is the simultaneous analysis of signals in both the time
and frequency domains, by using time-frequency representation (TFR). For the analysis of
protein sequences as signals, the concept of time is not applicable. Thus, space-frequency
representation (SFR) is used a signal is represented over both space and frequency. By
using SFR, non-stationary signals can be examined, as this representation can show how
the frequency component of a signal changes over space. Additionally, using frequency
analysis methods only with non-stationary signals can be inadequate for providing useful
information. Space-Frequency Analysis (SFA) studies a two-dimensional signal, instead of
analysing a single dimensional signal using a particular transformation (like Fourier Trans-
form). Furthermore, a space-frequency transform is used to analyse this signal with the
domain of a two-dimensional real plane acquired from the signal. Some of the applications
where SFA is used are prediction of Hydrophobic Cores of Proteins [96], predicting aller-
genic proteins using wavelet transform [97], prediction of protein structural classes [70],
identification of drug binding sites [98] and predicting protein coding regions [99]. In this
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section two popular methods, the short-space Fourier transform and wavelet transform will
be discussed.
2.2.3.1 Short-Space Fourier Transform
The short-time Fourier Transform (STFT) [95], is a Fourier-related transform used to deter-
mine the sinusoidal frequency and phase content of local sections of a signal as it changes
over time. As mentioned in the previous section the concept of analysis of protein se-
quences over time and frequency is not applicable. Therefore in this Chapter the concept
of time is replaced by space. The concept of short-time Fourier Transform is described as
short-Space Fourier Transform (SSFF). In the discrete case, which is useful in the analy-
sis of molecules, the signal that is going to be transformed can be divided into windows
(chunks). These windows usually overlap to reduce errors at the boundary. Thereafter, in
the next step of the transform each window of the divided data is transformed and the result,
which is complex numbers, is added to the matrix. This matrix stores information about
the magnitude and phase for every point of the input sequence in space and frequency. This
can be defined as:




where the x[n] is the input signal and w[n] is the window. In the above equation, m is
discrete and ω is continuous. In most typical applications, including bioinformatics, the
short-space Fourier transform is performed using the Discrete Fourier Transform, so both
variables are discrete and quantised.
The magnitudes squared of the short-space Fourier transform generate the spectrogram
as the following function shows:
Spectrogram = {x(t)} ≡ |X(τ, ω)|2 (2.15)
An example of short-space Fourier transformation using the Acid Bovine FGF and
Bovine FGF is presented in this chapter. Different window sizes and overlap sizes were
tested for this analysis and presented in Figures 2.6 and 2.7 for window = 28% and overlap
= 99%. In order to show the effect of these parameters, further experiments were carried
out and their results are presented in Appendix A as Figures A.1 and A.2 for window = 10%
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and overlap = 25%, Figures A.3 and A.4 for window = 10% and overlap = 50%, Figures
A.5 and A.6 for window = 10% and overlap = 99%, Figures A.7 and A.8 for window =
28% and overlap = 50%, Figures A.9 and A.10 for window = 40% and overlap = 50%, and
Figures A.11 and A.12 for window = 40% and overlap = 99% for Acid bovine FGF and
Basic bovine FGF protein sequences, respectively. Furthermore, Figures 2.6 and 2.7 with
the parameter set to window = 28% of the protein sequence and overlap = 99% of the
window present a clearer indication regarding the hotspot locations. As the results show,
a hotspot is detected at 0.48 and 0.49 for Acid bovine FGF and Basic bovine FGF protein
sequences, respectively.
Figure 2.6: Short-Space Fourier Transform of Acid Bovine FGF Protein (Window: 28% -
Overlap: 99%)
2.2.3.2 Wavelet Transform
As discussed in the previous section, Fourier transform can only derive spectral information
in contrast to the wavelet transform (WT), which can acquire both spectral and temporal
information. The main disadvantage of Fourier transform is that Fourier’s coefficients
simply include universal average space-domain information resulting from the location
23
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Figure 2.7: Short-Space Fourier Transform of Basic Bovine FGF Protein (Window: 28% -
Overlap: 99%)
specific features being lost, in contrast to the wavelet transform.
A continuous wavelet transform can be characterised as the projection of a signal f(t)
on the wavelet function ψ [100]. The projection of a signal x onto the subspace of scale a




WTψ{x}(a, b) · ψa,b(t) db (2.16)
where a determine the positive scale and b defines the shift and it can be any real number;
(a, b) describes a point in the right half-plane R+ × R. The subspace of scale a (where










the wavelet coefficients ban is described as:





The wavelet coefficients can be congregate into a scaleogram, for the analysis of a given
signal.
From a computational perspective it is impossible to calculate all wavelet coefficient for
the analysis of a signal, but it is adequate to select a discrete subset in order to reconstruct
a signal from the corresponding wavelet coefficient. The corresponding discrete subset of











subject to (ψm,n : m,n ∈ Z).
For the analysis of protein sequences using the wavelet transform, three main steps
need to be followed:
• Convert protein sequences to numerical sequences
• Selection of wavelet function
• Decompose the sequences by wavelet transform
• Use cross-correlation analysis to identify similar sequences
A method for protein analysis proposed by Fang and Cosic [50] uses a WT to analyse
a protein sequence that was converted into a signal using the EIIP values. In addition, as
the WT provides the same time-space resolution for each scale, the WT can be chosen to
localise individual events, such as active site identification. The amino acids that comprise
the active sites are identified as the set of local extrema of the coefficients in the wavelet
transform domain. The energy concentrated in the regional extrema represent the locations
of sharp variation points of the EIIP, which are proposed as the most critical locations of a
protein’s biological function [50].
In the experiment with Bovine FGF protein sequences, and by using the Morlet WT
[51] the potential cell attachment sites are identified between the residues 46-48 and 88-90
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as shown in Figures 2.8 and 2.9 for acid and basic bovine FGF protein, respectively. In
this example, it can be observed that there are two bright regions in the spectrogram that
correspond to the amino acids at the active sites. As the paper [50] proposes, WTs show
promise for identifying amino acids at (potential) biologically active sites when used, but
do not reveal the characteristic frequency component of the Resonant Recognition Model.
Furthermore, it can be very difficult to explain the spectrogram of the continuous WT, and
different space-frequency transforms can be used.
In order to show the effect of the use of different wavelet function, further experiments
were carried out and their results are presented in Appendix A as Figures A.13 and A.14
shows the Paul WT [101], Figures A.15 and A.16 shows the Mexican Hat WT [101],
Figures A.17 and A.18 shows the Derivative of Gaussian WT [101], and Figures A.19
and A.20 shows the Haar WT [101] for Acid and Basic Bovine FGF protein sequences,
respectively.
Figure 2.8: Morlet Wavelet Transform of Acid Bovine FGF Protein
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Figure 2.9: Morlet Wavelet Transform of Basic Bovine FGF Protein
2.3 Summary
In this Chapter, a literature review regarding existing sequence-driven features and signal
processing techniques that are used are presented. For the first section, two main commonly
used techniques, AAC and PseAA, are described. For the second section various signal
processing methods used throughout the literature are given. For the first part, Frequency
Analysis and DFT are presented. For the second part, Space-Frequency analysis, with
SSFT and Wavelet Transform analysis are described.
In the next chapter, a description of amino acid indices is given which they represent
unique physiochemical protein features. These amino acid indices are used to convert pro-
tein sequences to numerical sequences for further analysis. Furthermore, different methods






Description of Amino Acid Indices
3.1 Introduction
In the literature, a protein sequence contains important information regarding many protein
properties such as protein structural classes [102; 103], protein-protein interactions [104]
and protein function [105] can be derived from the amino acid composition [60] and fur-
ther improved by including amino acid index values that can be assigned to each amino
acid [61]. An amino acid index is a fixed length vector containing twenty values repre-
senting a protein’s physiochemical or biochemical property. Amino acid indices have been
developed and extensively investigated since the early sixties and derived by mainly labo-
ratory experiments such as hydrophobicity [24], polarity [25], size [26] or volume [25] on
biological specimens as well as computational experiments, ( e.g. electron-ion interaction
potential (EIIP) [87] and Amino Acid Composition [106] (AAC)) on laboratory-derived
indices. The largest database of amino acid indices is the AAindex1 database which is
located at the GenomeNet [28]. The latest update of this database was in March 2008 and
contained 544 amino acid indices from various published literature’s dating between 1964
and 2005.
Amino acid indices represent distinctive physicochemical and biochemical properties
of a protein, and can be used in a variety of bioinformatics problems where different pro-
tein characteristics play a key role. In the literature, various studies have utilised amino
acid indices in identification of protein structural classes [29; 30; 31], protein subcellu-
lar location [32], secondary structure [33; 34], transmembrane sequences [35], predicting
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chemical structure and biological function [36], surface prediction [37; 38] and prediction
of disordered regions [39].
Closer investigation of the AAindex database reveals that many of these deposited in-
dices have similar or identical sets of index values. In order to increase the robustness of
this dataset these indices need to be removed or merged. In addition, the areas of bioinfor-
matics and proteomics are highly active and new amino acid indices that represent novel
protein features or characteristics are bound to be constantly generated. As the AAindex
database was last updated [28] in 2008 any amino acid indices generated beyond this date
are not included.
Recent studies [107; 108] have used the AAindex database and did not consider remov-
ing or combining the duplicate or highly similar entries within the dataset or to include any
newly published indices in order to expand the dataset. The aim of the research to be
presented in this chapter is therefore to add recently presented amino acid indices in the
literature, remove any duplicate indices from the existing databases and to reduce the re-
dundancy of the remaining indices in regard to the features they represent. In order to
reduce the redundancy of groups of highly similar indices, which represent the same or
related protein features they need to be combined into a computationally generated index.
This new amino acid index can then be used as a representative of the entire group from
which it was generated. As the similarity of the entire set of amino acids is low, a method
is needed to group indices with high similarity. In order to achieve it, hierarchical cluster-
ing is used to create clusters of amino acid indices that represent similar features. Using
principal component analysis to generate one single index that can represent these indices
can then combine the clustered indices.
The chapter covers the methodology used for this analysis and it is organised as follows:
Section 3.2 presents the methods (hierarchical clustering and principal component analysis)
and materials (amino acid indices) used in this chapter for the analysis. Section 3.3 presents
the results obtained from this analysis. Finally, concluding remarks are outlined in Section
3.4.
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3.2 Methods and Materials
3.2.1 Amino Acid Indices
One of the largest sets of amino acid indices were published in the amino acid index
database AAIndex [28]. The database consists of 544 indices, each of which is assigned
a unique identification code. From this database, 13 amino acid indices were found to
have missing index values. The identification codes of these indices are: AVBF000101,
AVBF000102, AVBF000103, AVBF000104, AVBF000105, AVBF000106, AVBF000107,
AVBF000108, AVBF000109, YANJ020101, GUYH850103, ROSM880104 and ROSM880105.
In addition, three indices, namely RICJ880102, PRAM900102 and LEVM780102, have
identical index values with RICJ880101, LEVM780101 and PRAM900101, respectively,
but come under a unique accession ID.
From the literature, 83 recently published amino acid indices [29; 31; 34; 109; 110;
111; 112; 113] were discovered and added in the database and consequently brought the to-
tal number of unique indices to 611, which is one of the largest collection of non-redundant
and unique datasets of amino acid indices. These are all listed in Appendix B.
3.2.2 Normalisation
As amino acid indices originated from different sources each amino acid index is nor-





where E, µ and σ correspond to index value, mean value and standard deviation for a
particular amino acid index, respectively. By using z-score the comparison two or more
amino acid indices is possible from different normal distributions.
3.2.3 Hierarchical Clustering Analysis
Cluster analysis is the method for allocating a set of objects into groups, called clusters.
The included objects of each cluster would be more similar, in a measurable way, to each
other than objects that belong to a different cluster. Hierarchical clustering is a statistical
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method that tries to build clustered structures based on distances. In this chapter, the ag-
glomerative hierarchical clustering method is used where each member of the dataset is
assigned to a cluster. This method joins clusters pairwise as it moves one step in the hier-
archy. The distance between clusters is measured between data points using the Euclidean
distance as shown in Equation 3.2.
d =
√
(A12 − A11)2 + · · ·+ (A202 − A201)2 (3.2)
where A1-A20 represents values of the 20 amino acids for each amino acid index.
The advantages of using hierarchical clustering in the analysis of amino acid indices
are: 1) non-parametric method, 2) calculates a comprehensive hierarchy of clusters and 3)
does not require for the number of clusters to be identified before the analysis. For this
analysis three types of agglomerative hierarchical clustering, namely single, complete and
average linkage, are considered and described below
1. Single linkage: The smallest distance (D) in objects (x) in clusters (r and s) is used.
D(r, s) = min(dist(xri, xsj)) (3.3)
where i ∈ (i, · · · , nr), j ∈ (1, · · · , ns), nr and sn are the number of objects in
cluster r and s, respectively. xri is the ith object in cluster r and xsj is the jth object
in cluster s.
2. Complete linkage: the largest distance (D) in objects (x) in clusters (r and s) is used.
D(r, s) = max(dist(xri, xsj)) (3.4)
where i ∈ (i, · · · , nr), j ∈ (1, · · · , ns), nr and sn are the number of objects in
cluster r and s, respectively. xri is the ith object in cluster r and xsj is the jth object
in cluster s.










where i ∈ (i, · · · , nr), j ∈ (1, · · · , ns), nr and sn are the number of objects in
cluster r and s, respectively. xri is the ith object in cluster r and xsj is the jth object
in cluster s.
The main difference between single and complete linkage is that the single linkage
approach takes the minimum distance value whereas the complete linkage method takes
the maximum distance value. The average linkage takes the average between all the pairs
of objects between clusters. Furthermore, in order for the hierarchical clustering to be used
a threshold (cut-off point) needs to be used to determine the minimum distance clusters
should have from each other. For the analysis presented in this chapter, an optimal cut-
off point will be determined by observing the dendrograms produced by the hierarchical
cluster method.
3.2.4 Principal Component Analysis
Principal component analysis (PCA) [115] was originally introduced in 1901 by Karl Pear-
son [116]. PCA is a mathematical process that converts a set of related measurements into
principal components, which is a set of linearly uncorrelated values, by utilising the or-
thogonal transformation. The amount of principal components produced by the PCA are
equal to or less than the amount of the original measurements.
In this chapter, PCA is used to reduce the high dimensionality of the amino acid indices
dataset to develop a smaller set of computational indices. These indices will inherit the
biological features of the majority of the indices from the original set of amino acid indices.
Using the hierarchical clustering techniques, the amino acid indices will be arranged into
clusters, where their members will exhibit high similarity. PCA is then applied to each
cluster of amino acids separately. For each cluster, the number of principal components
extracted is equal to the number of variables being analysed where they represent a certain
variance of the original set. The first principal component represents the highest variance
in percentage and thus only this principal component is retained.
The set of values represented in the first component can be considered as a new compu-
tationally generated amino acid index that represents the original set of indices that exist in
the cluster under investigation. By using a threshold value for the variance a set of compu-
tationally generated indices will be selected. An example of the process is the following:
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• Based on the hierarchical clustering techniques a cluster of N amino acid indices is
selected.
• By using these amino acid indices a matrix of 20xN is created.
• PCA is applied to the 20xN matrix, which will be converted into principal compo-
nents.
• The first principal component of the generated matrix will contain a set of 20 values,
which are the linear combination for theN given amino acid indices, and the variance
value which represents the percentage of representation.
• If the variance is equal to or higher than a pre-set threshold, this computationally
generated index is selected.
3.3 Results
Results obtained through the analyses of amino acid indices by Hierarchical clustering and
principal component analysis are presented. In addition, in order to show robustness of
the newly discovered AAI results of the hybrid approach obtained through a case study is
presented and discussed.
3.3.1 Hierarchical Clustering Analysis
By using the hierarchical clustering methods described in section 3.2.3, five different
datasets of amino acid indices were produced. By the applying of a cut-off point to the
hierarchical procedure, it can be defined how similar or dissimilar the amino acid indices
would be in the generated clusters. The optimal cut-off point was derived by observing the
dendrograms produced by the hierarchical clustering method. The optimal cut-off points
for single and complete linkage were found to be 1.0 and 0.65, respectively; any higher
cut-off point resulted in the majority of indices gathered in a single cluster, and any lower
cut-off point a high percentage of clusters created contained only one amino acid index.
Furthermore, the optimal cut-off point for average linkage was 1.0. For this case, the use
of 0.65 as a cut-off point was considered but the clusters created were identical to the 1.0
cut-off point. In this case, the number of clusters produced are 107, 181 and 155 for single,
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complete and average linkage, respectively. In the case where the cut-off point equals 0.65,
134 and 216 clusters were created for single and complete linkage, respectively. Figures
3.4, 3.5 and 3.6 shows the dendrograms produced by the hierarchical clustering techniques.
In this study, by looking into the clusters of amino acid indices, it can be observed
that the arrangements within the clusters match the cross-correlation values between these
indices; where two or more indices are clustered together the correlation between them
is high. For example, amino acid indices 1 and 17 were clustered together using single
linkage (1.0), single linkage (0.65) and complete linkage (0.65). Both index 1 and 17 relate
to alpha-CH chemical shifts and have a correlation coefficient of 0.949. The maximum
correlation coefficient between two amino acid indices is 1.
3.3.2 Principal Component Analysis Results
PCA was applied to create a computationally generated index to summarise each cluster.
To evaluate if the computationally generated index retains the biological information from
the individual the variance is utilised. By using the variance, which is calculated by PCA,
the value of representation can be determined for the computationally generated index to
the original set of indices in that cluster. The acceptance threshold for the variance is
set to 99%, anything lower is discarded. The results in Table 3.1 show the number of
computationally generated indices with variance ≥0.99. Furthermore, the discussion of
the results will focus on the number of computationally generated indices where variance
≥0.99. The full set of results are available in the Amino Acid Index Database (AAID) web
server as discussed in section 3.3.3.
3.3.3 Web-Server Access
In order to make the amino acid indices publicly available the Amino Acid Index Database
(AAID) web-server is developed and publicly made available at
http://cisaps.com/indices/. The user can search throughout the database using a unique ID
assigned to each amino acid index and search for specific amino acid indices. Additionally,
the user can enter a feature-related keyword to find all the related indices. An example can
be observed in Figures 3.1, 3.2 and 3.3 for stability amino acid indices. Figure 3.1 shows
the initialised web-server. Figure 3.2 shows an example where the user requires amino
indices for feature stability. In this case, the search term ”Stability” needs to be entered to
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Table 3.1: PCA General Results
No. of No. of
Computationally Computationally
Linkage Cluster Threshold Generated Generated
Indices Indices










the web-server as a query. As Figure 3.2 shows the AAID server returns three amino acid
indices with identification numbers 441, 497 and 498. If a more detailed description of a
selected amino acid index is required the user can search the amino acid index database
using the identification number provided. An example is given in Figure 3.3 where a
more comprehensive description is provided for the 441 amino acid index that represents
side-chain contribution to protein stability (kJ/mol). Another feature of the web-server is
that the user can retrieve the computationally generated indices from this investigation for
each clustering method. Results for single linkage hierarchical clustering (Figures B.2 and
B.3), complete linkage hierarchical clustering (Figures B.4 and B.5) and average linkage
hierarchical clustering (Figure B.6) can be found in Appendix B.
Figure 3.1: Amino Acid Index Database (AAID) Web Server
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Figure 3.2: AAID Web Server Search for ”Stability”
3.4 Conclusions
Amino acid indices have various applications and can represent diverse features of the
protein sequences and amino acids. In this chapter, the largest up to date database is devel-
oped, which contains all the latest published amino acid indices and presented in the AAID
web-server.
As the majority of indices included in the database have similar features, this chapter
proposes a set of computationally derived indices that better represent the original group
of indices. For this analysis hierarchical clustering and PCA is used. By using hierarchical
clustering methods the amino acid indices with similar features are clustered together. The
next step is to use PCA on these clusters to computationally derive an amino acid index
that would be able to represent the original amino acid indices included in the cluster. In
the original AAID database, 611 AAI exist. By using the computational generated AAI the
search space can be reduced without losing any valuable information. The search space can
be reduced to 542, 478, 521, 395 and 544 by using single linkage hierarchical clustering
(1.0 and 0.65), complete linkage hierarchical clustering (1.0, 0.65) and average linkage
hierarchical clustering (1.0 and 0.4) linkage, respectively.
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Approach to Predict Protein
Allergenicity.
4.1 Introduction
An allergy is a disorder, where a persons immune system reacts to substances from the
environment that normally is considered as harmless [117]. An allergy is one of the four
types of immune system hypersensitivity called Type I. In an allergic reaction, excessive
activation of white blood cells are activated by an antibody called Immunoglobulin E (IgE).
This reaction results in an inflammatory response from mild to life-threading symptoms.
Our current knowledge suggests that allergenic proteins constitute a very limited set
of protein families (130 protein families of 9318 total protein sequences) inside the vastly
diverse protein kingdom [118]. However, unifying features responsible for the allergenic-
ity of such proteins have not been clearly determined yet [119; 120] despite numerous
attempts dating back to the early 1970s [121]. Most recent studies aim to decipher the
code of allergenicity, narrowing down to characteristic molecular features such as con-
served physicochemical property motifs [118], enzymatic activity [119], IgE-binding sites
[118; 122; 123; 124], T cell epitopes [125], receptor binding sites [126; 127; 128] or unique
carbohydrates on the surface of allergenic proteins [129; 130; 131].
In an earlier study [132] it was proposed that hydrophobicity could be a characteristic
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feature required to unleash the allergenic potential of a protein molecule, but the conclu-
sions were drawn from a very limited set of allergenic and non-allergenic proteins, where
there were only 37 allergens and 46 non-allergens in the 3NUL group, 9 allergens and 162
non-allergens in the 2ACT group, 27 allergens and 19 non-allergens in the 1BV1 group,
and 22 allergens and 51 non-allergens in the 1QNX group, limiting the study to just 95
allergens from four protein families in total. They reported that study limitations were both
due to a small set of known allergen sequences and homologous structures, as well as some
technical limitations such as manual sequence input into the server and the computational
capabilities of the ConSurf server [133].
In recent years, intelligent tools have been developed for detecting patterns and extract-
ing features that can be used to describe allergenic protein sequences. Some of these tools
use methods such as sequence similarity search [134; 135], allergen representative pep-
tides (ARPs) [136], wavelet transforms [97], Support Vector Machines (SVM) [134; 137],
k-Nearest-Neighbor (kNN) classifiers [138] and Gaussian classifiers [139]. These meth-
ods perform very accurately for high homology allergen sequences, whereas their perfor-
mance is considerably weaker for low homology allergen sequences. Furthermore, addi-
tional studies showed that high homology between proteins is not directly linked to cross-
reactivity [140; 141; 142] and to distinguish allergens from non allergen sequences that
have the characteristics along with high homology remain challenging. Therefore, a new
homology independent method is needed to be developed to determine if a protein is an
allergen or not.
The aim of this study is therefore to differentiate sets of allergenic and non-allergenic
proteins using a signal-processing based bioinformatics approach. In order to consider
variations over the databases, three different databases of allergenic proteins, namely al-
lergenonline [143], AllerHunter [134], and UniProt [4] are used to retrieve the allergen and
non-allergen sequences. More importantly, unique sets of amino acid indices are identified
that discriminate allergenic proteins from the non-allergenic ones by comparing diverse
characteristics of constituting amino acids. In this analysis, it has been determined that
relative partition energies [144], mean fraction area loss [145], and hydrophobicity [112]
amino acid indices, can be used to discriminate allergenic proteins from the non-allergenic
ones more accurately. Additionally, this study confirmed the results presented in previous
studies [132], that suggest that hydrophobicity might be important for the overall aller-
genicity of a protein. The findings suggest novel characteristics of allergenic proteins, in
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addition to the method of investigation that offers the advantages of supreme computa-
tional simplicity and greater computational power of evaluation in comparison with previ-
ous studies in this field.
4.2 Materials and Methods
In this chapter, a novel method is presented which uses Discrete Fourier Transform to
extract information from protein sequences and Support Vector machines as a predic-
tive tool for allergenic protein sequences. Additionally, the collection of allergenic and
non-allergenic protein sequences from three online databases (allergenonline [143], Aller-
Hunter [134], and UniProt [4]), will be discussed.
4.2.1 Discrete Fourier Transform




x(m)e−j(2pi/N)nm n = 0, 1, ..., N − 1 (4.1)
where x(m) is the mth member of the numerical series, N is the total number of points in
the series, and X(n) are coefficients of the DFT. As the DFT coefficients consisted of two
mirror parts, only the first half of the series (N/2) points) will be hereafter considered. The





where d is the distance between points of the sequence. If it is assumed that distance d = 1
then the maximum frequency in the spectrum can be found as F = 1/2(1) = 0.5.
The output of DFT is a complex sequence and can be characterised as
X(n) = (R(n) + jI(n)), n = 0, 1, ..., (N − 1)/2 (4.3)
where R(n) and I(n) are the Real and Imaginary parts of the sequence, respectively.
The absolute spectrum can be formulated as
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S(n) = X(n)X
∗(n) = |X(n)|2 , n = 0, 1, ..., (N − 1)/2 (4.4)
where S(n) is the absolute spectrum for a specific protein, X(n) are the DFT coefficients
of the series x(n) and X ∗ (n) are the complex conjugates.
To be able to apply DFT, protein sequences need to be encoded into numerical se-
quences by using an amino acid index as described in Chapter 3. By using the amino acid
indices, the protein sequences can be encoded into numerical sequences in order for DFT
to be applied. DFT coefficients can then be used to represent feature characteristics of the
allergen and non-allergen protein sequences.
4.2.2 Preprocessing the Protein Sequences
Studies have shown that preprocessing of the signals by using zero-padding and window-
ing is generally necessary and can influence the features extracted from signal processing
techniques [146]. Before applying DFT to the protein sequences, these two techniques
(zero-padding and windowing) used in signal processing therefore need to be considered.
The first technique is the windowing where the encoded numerical sequences are mul-
tiplied by a pre-calculated window to reduce spectral leakage. In this case, the Hamming
window [147] is used, and can be calculated using Equation 4.5.





n = 0 ≤ n ≤ N − 1 (4.5)
The second technique is the zero-padding where a specified number of zero elements
is added to the end of each sequence to increase signal length. This technique is essential
as the given protein sequences may not be of the same length.
4.2.3 Support Vector Machine as a Predictive Tool
In the literature, Support Vector Machines (SVM) have been shown to be a valuable pre-
dictive tool in the analysis of protein sequences. Some examples of research areas that
SVM was used with promising predictive results are the prediction of protein secondary
structure [85], prediction of protein-protein interactions [148], prediction of RNA-binding
proteins from primary sequence [149], prediction of protein subcellular localisation [150],
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classification of enzyme family [151], and classification of G-protein coupled receptors
[152].
A support vector machine (SVM) [153; 154], is a supervised statistical learning method
that analyses data and recognises patterns for classification, which makes SVM a non-
probabilistic linear classifier [153; 154]. The SVM finds the solutions for the optimisation
problem as defined in Equation 4.6 by constructing hyperplanes into a higher or infinite
dimensional space by the function φ.








Tφ(xi) + b) ≥ 1− ξi
ξi ≥ 0, i = 1, ..., l
where xi is a training set which is associated with labels yi where xi ∈ Rn, y ∈ {−1, 1}l
and C is the penalisation constant of the error term.
The goal of SVM is to find a linear separating hyperplane, maximum-margin hyper-
plane, that has the greater distance to the closest training point, the maximal margin, of all
the given classes in this higher dimensional space. To construct a nonlinear classifier using
SVM, a kernel function [155] needs to be applied to maximum-margin hyperplanes to fit
in a transformed feature space. For this analysis, radial basis function (RBF) based kernel
function was used as shown in Equation 4.7.
K(xi, xj) = e
−γ||xi−xy ||2 γ > 0 (4.7)
where γ, r and d are kernel parameters. For this analysis, LIBSVM [156] is used to con-
struct the SVM-based classifier and grid search is applied to find the optimal values of the
kernel C and γ parameters.
This type of kernel function is used because in many applications, RBF has been shown
to be the simplest to adapt and the most generally applicable [157; 158].
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4.2.4 Evaluating the Performance of the Predictive Models
For this analysis, the K-fold cross-validation technique [159] is used for measuring the
performance of the allergen classifier as cross-validation is important for independently
testing and validating different theories on existing data, where collecting additional data
is impossible, costly or time consuming. This technique usually is used to approximate
how these predictive models will behave and perform in practice. The first step of the
cross-validation procedure involves dividing randomly the data into subsets [159]. The
second step involves performing the analysis on one subset called the training set [159],
and validate the analysis on the remaining subset(s) called the testing set. To decrease
inconsistency the cross-validation technique is performed for multiple times using different
partitions of the data for training and testing subsets. The final results are then calculated
using the averaged performance of all the testing subsets [159].
In the literature, different cross validation methods exist. Three of the most common
and widely used methods are K-fold cross-validation [160], repeated random sub-sampling
validation [159], and leave-one-out cross-validation [159]. In this analysis, K-fold cross-
validation is going to be used.
In K-fold cross-validation [160], the collected samples are randomly partitioned into K
subsets, each one called a ”fold”. After partitioning the samples one subset is used as the
testing set for validating the predictive model and the remaining (K-1) subsets are used as
training sets. This process is repeated for K times until each fold is tested. The predictive
accuracy for the K-fold cross-validation is calculated from the average result of the folds.
For this analysis, two different K-fold cross validation analyses were taken into con-
sideration. For the first analysis, a 2-fold cross validation is performed for all amino acid
indices that exist in the database, to be able to determine the most related features in clas-
sification of allergenic protein sequences. For the second analysis, for the highest rated
feature an additional 5-fold cross-validation is performed, in order to determine accuracy
of the SVM classifier .
The performance of the allergen classifier was evaluated based on sensitivity (SE),
specificity (SP), geometric mean (G-mean) [161], F-measure [162], Matthews correlation
coefficient (MCC) [163] and total accuracy (TACC). SP and SE correspond to the percent-
age of the correctly classified allergen and non-allergen proteins, respectively and TACC of
the classifier represents the percentage of the correctly classified protein sequences. They
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TP + TN + FP + FN
∗ 100 (4.10)
where true positives (TP) and true negatives (TN) represent the correctly identified allergen
and non-allergen protein sequences, respectively. In addition, false negatives (FN) and false
positives (FP) represents the misidentified allergen and non-allergen protein sequences,
respectively.
Assessment of the performance of the classifiers by using SE, SP and TACC is not
reliable due to the nature of imbalanced data sets [164]. Therefore, MCC, G-Means and
F-measure are used additionally, which have been shown to provide more reliable compar-
ison.
The MCC [163] is a measurement used in machine learning to validate a binary clas-
sifier and can successfully be used in validating imbalanced data sets. It can be calculated
by using Equation 4.11
MCC =
(TP ∗ TN)− (FN ∗ FP )√
(TN + FN)(TP + FN)(TN + FP )(TP + FP )
(4.11)
The output of MCC is a value between [-1,1] where 1 represents 100% correct clas-
sification and -1 represents 100% misclassification. and 0 indicates random classification
[163].
G-mean [161], another metric that uses SE and SP as given in Equation 4.12
GMean =
√
SE ∗ SP (4.12)
Finally, another measurement used to test the accuracy of the classifier is F-measure
[162], as shown in Equation 4.13
F −Measure = 2 ∗ TP
2 ∗ TP + FN + FP (4.13)
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The output of the F-measure is a value between [0,1] where 1 represents 100% correct
classification and 0 represents 100% misclassification.
4.2.5 Allergenic Protein Databases
For this analysis, in order to address and investigate diversity over allergenic proteins data
were collected from three online databases, allergenonline [143] (http://www.allergenonline.org),
AllerHunter [134] (http://tiger.dbs.nus.edu.sg/AllerHunter), and UniProt [4]
(http://www.uniprot.org). From UniProt, only the verified Allergens were considered as
opposed to the allergenonline and AllerHunter database where all allergenic proteins avail-
able were considered. Table 4.1 lists the number of allergen and non-allergen proteins
collected from each database. For the allergen dataset, 857, 1489 and 1416 protein se-
quences were retrieved from Uniprot, allergenonline and AllerHunter, respectively. For
the non-allergen dataset, 1000 and 12474 protein sequences were retrieved from Uniprot
and AllerHunter, respectively. In addition, Table 4.1 shows the maximum, minimum, and
average length of the protein sequences for each dataset.
Table 4.1: Allergen and Non-Allergen Online Databases used in this study
Allergen Proteins Non Allergen Proteins
UniProt AllergenOnline AllerHunter UniProt AllerHunter
No. Proteins 857 1489 1416 1000 12474
Max. Length 1558 1662 1662 5890 7390
Min. Length 5 8 3 78 6
Avg. Length 235.65 227.06 221.67 752.56 380.52
Closer investigation was carried out to examine how these databases differ and thus to
reveal diversity over different databases. The following list shows the number of overlap-
ping protein sequences pairwise for all the Allergen databases as also shown in Figure 4.1.
The complete list of protein sequences used in this study can be found in Appendix E.
• allergenonline versus AllerHunter: 886 common protein sequences
• allergenonline versus UniProt: 416 common protein sequences
• AllerHunter versus UniProt: 411 common protein sequences
• The common proteins for all three databases are 360.
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Figure 4.1: Allergen Databases and Number of Proteins
This result clearly shows the diversity of allergenic protein sequences and the inconsis-
tency of allergenic databases. Therefore, the use of one database to construct a universal
predictive model that predicts allergenic protein sequences may not be reliable. From the
latest literature, AllerHunter is the most precise available online tool for classification of
Allergenic protein sequences [134].
4.3 Results and Discussion
In this chapter, a study is performed in order to differentiate sets of allergenic and non-
allergenic proteins using a signal-processing based bioinformatics approach. For this anal-
ysis, DFT coefficients were used to characterise protein sequences as well as multiple
amino acid indices in order to encode protein sequences to numerical sequences. Finally,
support vector machines were utilised as a predictive tool. In order to test how different
databases affect the prediction of allergenic proteins, the following two main analyses were
carried out.
Analysis 1: Allergenonline database that consists of 1404 allergen protein was used for
training. For this analysis, 85 allergen proteins were found to overlap with the proteins
in AllerHunter as an independent test set and therefore removed. Additionally, from the
AllerHunter database, 9979 non-allergen proteins were used for training.
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Analysis 2: UniProt database that consist of 817 allergen proteins was used for training.
Additionally, from the UniProt database, 996 non-allergen proteins were used for training.
For this analysis, 40 allergen proteins and 4 non-allergen proteins were found to overlap
with validation proteins in the AllerHunter were used as an independent test and therefore
removed.
To be able to have a truly accurate comparison between AllerHunter and the method
proposed in this chapter, allergen and non-allergen protein sequences given by AllerHunter
were used as an independent set. For this analysis, 139 allergen protein sequences and 1245
non allergen protein sequences provided by the AllerHunter web-server [134] were taken
into consideration.
By using SVM and the 2-fold cross validation, ten amino acid indices that scored higher
in relation to the classification accuracy are identified, as shown presented in Table 4.2. As
the results show, hydrophobicity related amino acid indices appears multiple times in these
higher related features. Although the hydrophobicity feature has been shown to be related
to allergenic proteins [132; 165; 166; 167] which is further supported by this study, other
protein features that are represented in amino acid indices, such as the relative partition
energies and fractional area loss have equal or greater importance in classification of al-
lergens. For the comprehensive analysis of allergenic protein sequences the highest rated
amino acid index (optimised relative partition energies - method C) additional analysis by
using SVM and 5-fold cross-validation was performed.
As Table 4.2 suggests that allergenic proteins seem to have distinct amino acid profiles,
namely relative partition energies [144], mean fraction area loss [145], hydrophobicity
[112; 112; 169], hydrophathy [168], relative amino acid closeness [29], medium-range
nonbonded energy [111] and relative connectivity [29]. The results also reveal a novel list
of amino acid indices that better discriminate allergenic proteins.
The results suggests that allergenic proteins are best characterised by distinct pattern of
relative partition energies, i.e. allergens seem to have distinct conformational energy at the
residue level determined by the amino acid indices [144], where inter-residue protein con-
tact energies were estimated based on an equilibrium mixture approximation of residues.
Pairwise contact energies for 20 types of residues have been determined from the observed
frequencies of contacts with regression coefficients that were obtained by comparing ”in-
put” and predicted values with the Bethe approximation [170] for the equilibrium mixtures
of interacting residues. Optimised relative partition energies - method B involved deter-
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mination of contact energies only, and Optimised relative partition energies - method C
included the estimation of repulsive interaction energies in addition to contact energies.
The next best set of amino acid indices for discriminating allergens is found to be the
mean fraction area loss [145]. For this protein feature, proteins of known structures were
used to measure the average area that each residue buries upon protein folding; this area
buried is correlated with residue hydrophobicity. For medium-range non-bonded energy
[111] amino acid indices, studies were based on correlations of free energy change with
sequence information and amino acid properties, including hydrophobicity [171], by us-
ing Bayesian-regularised genetic neural networks for creating predictive models for the
conformational stability, (i.e. protein stability prediction). For relative connectivity amino
acid indices exploits new residue networks [29] which have been constructed from the PDB
structures of 640 representative proteins; the new indices have been derived from the amino
acids in residue networks and were related to hydrophobicity and beta propensity. The hy-
drophathy index reposted by [168] was used for prediction of protein surface accessibility,
based on information obtained from a single amino acid position or pair-information for a
window of seventeen amino acids around the test residue. The hydrophobic free energies
are directly related to the accessible surface area of both polar and nonpolar groups.
For this case study, two sets of independent test sets were created. For the first set,
262 allergen protein sequences were used. These sequences were obtained by adding the
testing sequences of Analysis 1 (fold 5), and Analysis 2 (fold 2). Furthermore, any se-
quences existing in AllerHunter training data and the remaining folds of Analysis 1 and
2 were removed along with any duplicate proteins. For non-allergen protein sequences in
the testing protein sequences of Analysis 1 (fold 5) was used by removing any duplicate
protein sequences existing in AllerHunter, totaling 193 protein sequences. For the second
independent test set, AllerHunter set was used.
For Analysis 1, using 5-folds cross validation and by using the independent test, the best
results were obtained in fold 5. The results are, 0.9534, 0.9424, 0.9479, 0.7988, 0.7842 and
95.23% for sensitivity, specificity, G-Mean, F-measure, MCC and total accuracy, respec-
tively. The average results of Analysis 1 are, 0.9436 ± 0.0080, 0.9381 ± 0.0064, 0.9409
± 0.0048, 0.7685 ± 0.0224, 0.7535 ± 0.0223 and 94.31 ± 0.71%
for sensitivity, specificity, G-Mean, F-measure, MCC and total accuracy, respectively. For
Analysis 2, the best results were obtained in fold 2. The results are, 0.9065, 0.9534, 0.9296,
0.7802, 0.7613 and 94.87% for sensitivity, specificity, G-Mean, F-measure, MCC and total
53
4. SIGNAL PROCESSING-BASED BIOINFORMATICS APPROACH TO
PREDICT PROTEIN ALLERGENICITY.
accuracy, respectively. The average results of Analysis 2 are, 0.8734 ± 0.0207, 0.9541
± 0.0038, 0.9128 ± 0.0107, 0.7645 ± 0.0147, 0.7420 ± 0.0166 and 94.60 ± 0.38% for
sensitivity, specificity, G-Mean, F-measure, MCC and total accuracy, respectively. The
complete set of the results for Analysis 1 and 2 can be found in Tables 4.3 and 4.4, respec-
tively. The results obtained from AllerHunter are, 0.8561, 0.9446, 0.8993, 0.7278, 0.7024
and 93.57% for sensitivity, specificity, G-Mean, F-measure, MCC and total accuracy, re-
spectively. A summary of the first independent test set results, can be found at Figure
4.5.
The results using AllerHunter independent set are the following: for AllerHunter,
0.8264, 1.0, 0.9091, 0.9050, 0.8169 and 89.96 %, for Analysis 1, 0.8943, 0.9482, 0.99,
0.9258, 0.8346 and 91.70% and for Analysis 2, 0.9170, 0.9741, 0.9451, 0.9474, 0.8830
and 94.10% obtained for sensitivity, specificity, G-Mean, F-measure, MCC and total accu-
racy, respectively. The results can also be obtained from Table 4.6. As the results show
Analysis 2 performs significantly better than AllerHunter and Analysis 1.
This analysis extracts features from DFT to build a classification model for allergenic
proteins, and performs better in comparison to the AllerHunter classification model. As the
results show, AllerHunter is more biased to non-allergen protein sequences as sensitivity,
specificity and MCC values show. This method of classification of allergenic and non-
allergenic protein sequence is more balanced, and it is better for creating a generalised
classification model.
4.4 Conclusions
Although some homologous regions explained Immunoglobulin E (IgE) cross-reactivity
in groups of allergens [165], no universal molecular structure could be associated with
allergenicity as reported in previous studies [132; 165; 166; 167]. The study resulted
in finding a unique and universal set of best discriminating amino acid indices for the
characterisation of allergenic proteins. In summary, all amino acid indices identified from
the study characterises different aspects of hydrophobicity of allergenic proteins (Table
4.2) with high sensitivity and specificity.
The results presented in this chapter support previous study [132], and earlier reports
by others [165; 166; 167]. Some allergens have been reported previously as hydrophobic
proteins, e.g. hydrophobic allergens from Hevea brasiliensis [166], soybean hydrophobic
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protein [167] and certain hydrophobic lipid-binding lipocalins [165].
Hydrophobic substances have the tendency to form aggregates. Many allergens have
been reported to have hydrophobic epitopes responsible for polymerisation, e.g. Ara h 1
was shown to form a highly stable homotrimer [172]. Interestingly, the majority of the
IgE-binding epitopes are also located in the same hydrophobic regions at the distal ends
of the three-dimensional structure where monomer-monomer contacts occur. This may
suggest that further studies should be carried out to explore the role of the hydrophobic
epitopes in polymerisation and the importance of quaternary protein structure in the overall
allergenicity.
Mite allergen Der p 2, has structural homology with MD-2 protein, which is the lipopolysac-
charide (LPS)-binding component of the Toll-like receptor 4 signalling complex [173]. The
data further supports the suggestion of the study that allergens may possess intrinsic adju-
vant activity due to their hydrophobicity and hence the ability to bind lipid entities, which
could be a general functional property responsible for allergenicity.
Bioinformatics provides a powerful means of exploring protein structure and func-
tion from the data derived from topological properties of amino acids. Protein primary
structure-based methods are less computationally intense and do not require X-ray crystal
structure of proteins to be available, which makes such tools very suitable for the explo-
ration of allergenic proteins with a still limited number of structures accessible.
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Table 4.5: Predictive Accuracy Results Based on Independent Dataset 1
Analysis Sensitivity Specificity G-Mean F-measure MCC Total Accuracy
AllerHunter 0.8561 0.9446 0.8993 0.7278 0.7024 93.57%
Analysis 1 0.9534 0.9424 0.9479 0.7988 0.7842 95.23%
Analysis 2 0.9065 0.9534 0.9296 0.7802 0.7613 94.87%
Table 4.6: Predictive Accuracy Results Based on Independent Dataset 2
Analysis Sensitivity Specificity G-Mean F-measure MCC Total Accuracy
AllerHunter 0.8264 1.0000 0.9091 0.9050 0.8169 89.96 %
Analysis 1 0.8943 0.9482 0.9209 0.9258 0.8346 91.70%
Analysis 2 0.9170 0.9741 0.9451 0.9474 0.8830 94.10%
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Multiple Protein Sequence Alignment
Based on Multiple Amino Acid Indices
and Discrete Fourier Transform
5.1 Introduction
In bioinformatics, a protein sequence alignment is a procedure that tries to arrange the
sequences of proteins in order to identify high similarity regions that may be attributed to
functional, structural, or evolutionary relationships between the sequences [16].
In recent years, Multiple Sequence Alignment (MSA) in protein sequences has become
an important tool in bioinformatics and has successfully been applied in various fields such
as pattern identification [174], domain identification [175], secondary structure prediction
[11] and phylogenetic analysis [176]. Most of the algorithms developed to perform MSA
generally use progressive alignment based on the Feng and Doolittle algorithm [177]. This
type of algorithm is based on dynamic programming [178] to perform the sequence align-
ment.
Although there are various methods and tools that have been developed to perform
MSA the dynamic programming is one of the most common methods [179; 180; 181;
182; 183; 184; 185; 186] for pairwise protein sequence alignments [178]. By using the
dynamic programming, the optimal alignment is guaranteed. However, the use of dy-
namic programming for MSA is limited to a few small protein sequences [187; 188] due
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to present limitations of processing power. To overcome these limitations, current methods
use heuristics to process large sets of protein sequences [189]. Such methods are called
progressive alignment algorithms and have been shown to perform MSA with adequate
speed and higher accuracy [16; 190] in comparison to other MSA methods such as it-
erative methods [191] or Hidden Markov models [192]. By making the assumption that
high homology between two protein sequences indicates that these sequences are evolu-
tionarily related, MSA can be constructed using a series of pairwise alignments. The order
of these alignments can be established by constructing and following a phylogenetic tree
[177]. This algorithm initially aligns high related protein sequences using the dynamic
programming and progressively includes less homologically related proteins. Progressive
algorithms can perform better with protein sequence sets that have high overall similarity;
an example is the alignment of protein sequences with known structure [11] to retrieve
their related domains. However, for each MSA performed using the progressive methods,
two issues need to be addressed to in order to improve the quality of the results:
• By using the progressive methods for MSA, there is no guarantee that the global
optimal alignment will be found [193; 194]. Commonly, this issue is either raised
when the relationships of protein sequences in the phylogenetic tree are not in the
correct order or if errors occur in the early pairwise alignments and by adding less
related proteins, these errors will increase. There is a close relationship between the
homology percentage of sequence sets and these alignment errors. The higher the
homology, the lower the MSA error congregated will be.
• For the progressive methods, substitution matrix and gap penalties are important
parameters that play an important role [195]. In high homology protein sets, the use
of these parameters will find the optimal or close to desirable alignment. Contrarily,
with low homology protein sets, these parameters are very important as they will
affect critically the MSA result. In order to obtain the highest accurate result a wide
range of these parameters needs to be tested.
In order to overcome these two algorithmic problems a novel approach that utilises
signal-processing techniques and multiple amino acid indices will be described in this
chapter. The chapter is organised as follows: Section 5.2 presents briefly the existing
methods that implement MSA along with their main differences. Additionally, section 5.2
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describes the most commonly used substitution matrices along with the techniques used to
construct them. Section 5.3 presents the methods and materials developed and used in this
chapter, while Section 5.4 presents the results obtained. Finally, concluding remarks are
outlined in Section 5.5.
5.2 Background
This section describes existing methods in the literature that implement progressive multi-
ple sequence alignment techniques while focusing on their main differences. The methods
described are FASTA [183], Clustal [184; 196], MAFFT [186] and T-Coffee [185].
5.2.1 Progressive Alignment Method
In order to use progressive alignment, a series of multiple pairwise alignments needs to be
performed. The basic process of progressive alignment is the following:
• Step 1: Select two protein sequences by using a guide tree.
• Step 2: Align the two selected protein sequences by using a pairwise alignment
method.
• Step 3: By using the guide tree, select another protein sequence and align it to the
aligned sequence generated in Step 2.
• Step 4: Repeat Step 3 until all the protein sequences in the set are covered.
In the literature, their are various progressive alignment schemes, such as FASTA [183],
Clustal [184; 196] and T-coffee [185]. These methods can differ in the way the guide tree
is constructed, which gives the order of the pairwise alignments.
Progressive alignment method is a heuristic method and has the following characteris-
tics:
• The function used to rate each pairwise alignment is the same as the function used
for optimisation of MSA.
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• The global optimal score of MSA is indirectly calculated only after a series of pair-
wise alignment score calculations.
• It does not directly optimise any global scoring function of alignment correctness.
• It can produce accurate results comparatively faster [16; 190] than other MSA meth-
ods like iterative methods [191] or Hidden Markov Models [192].
For the progressive alignment methods, one of the most essential heuristic properties
is the selection and alignment of protein sequences with high homology first. These initial
alignments produce the most reliable results. One of the most common algorithms used for
progressive alignment is the Feng-Doolittle algorithm [177].
5.2.2 Multiple Sequence Alignment Methods
5.2.2.1 FASTA
FASTA is one of the earliest and simplest protein and DNA multiple sequence alignment
algorithm. This method was originally developed in 1985 by David Lipman and William
Pearson [183] in the FASTP software package. In order to calculate similarity scores be-
tween protein sequences, FASTA uses the following steps to perform the protein sequence
alignment:
• Step 1, the mutual regions with two-consecutive identities or regions with high con-
centration of single residue identities will be determined from pairwise protein se-
quences.
• Step 2, by using the Point accepted mutation (PAM250) substitution matrix [197],
the shared regions identified in Step 1 will be re-evaluated. The region with the best
score will be saved for future reference in a library.
• Step 3, the re-evaluated regions from Step 2 can be combined by using gaps. The
aligned gapped protein sequences can be used to calculate a similarity score.
• Step 4, by using the Smith-Waterman algorithm [198] an optimum alignment score
of the individual protein sequence with the library sequence will be constructed.
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• Step 5, the algorithm returns the pairwise alignment and the optimal alignment score
for each protein sequence.
5.2.2.2 Clustal
Initially, in Clustal [184; 196] alignment algorithm, fast approximate methods [199] were
used to calculate the pairwise distances and align a large number of proteins. The similarity
scores for each protein sequence under investigation are calculated as the number of k-tuple
matches. This is usually performed by calculating the identical amino acids from the best
pairwise alignment between proteins and subtraction of a pre-determined penalty value for
each gap.
In later years, more sophisticated versions of the program were developed. They are
ClustalW [200], ClustalX [201] and ClustalΩ [202] that have been shown to calculate
similarity scores for protein sequences more accurately. These programs utilise dynamic
programming for protein sequence alignments. In addition, two separate gap penalties were
used, for opening and extending gaps, and a full amino acid weight matrix. These similarity
scores are estimated as the number of identities based on the best alignment divided by the
number of residues compared and excluding the gap positions. These values are in the
format of the similarity score’s in percentage and can be converted into distances by using
Equation 5.1. The distance can be used to construct the guide tree.
distance = 1− (similarity score/100) (5.1)
5.2.2.3 T-Coffee
The T-Coffee (Tree-based Consistency Objective Function For alignment Evaluation) [185]
algorithm has two main features for performing multiple sequence alignments; the first is
the use of integrated data sources, and the second is the optimisation method. For the
first attribute, the data sources used by T-Coffee are generated by a series of pairwise
alignments. These data sources can contain both local and global pairwise alignments. For
the second attribute, which is the optimisation method, attempts to discover the multiple
alignment that fits better with the pairwise alignments in the data sources used.
This scheme implemented by T-Coffee resembles the progressive alignments methods
used by other methods like ClustalW, which generally have the advantage of speed relative
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to other methods (iterative methods or Hidden Markov models), and the results are com-
paratively robust [16; 190]. The main difference of T-Coffee with the other progressive
alignment methods is that it does not follow a pre-constructed guide-tree to perform the
pairwise alignments. T-Coffee utilises the information presented in the data sources to pro-
ceed with progressive alignment in a way that all the alignments between all the pairs of
protein sequences are considered in each step of the multiple alignment. This process com-
bines the advantages that progressive alignment methods have to offer, which is simplicity
and speed, but with smaller probability to make errors.
5.2.2.4 MAFFT
The MAFFT (Multiple Alignment using Fast Fourier Transform) method [186] performs
multiple sequence alignments by using Fast Fourier transform (FFT). For this algorithm,
the scoring system, which includes substitution matrix and gap penalties, was modified to
increase accuracy. In a previous study [203] it is suggested that the Needleman-Wunsch
(NW) algorithm [178], as used in ClustalW [200] and T-Coffee [185] performs well with
all-positive distance matrices. In addition, when the efficiency of such a matrix was ex-
amined, only proteins with similar lengths were considered. For the alignment problems
for protein sequences with different lengths, it is still not clear if all-positive substitution
matrices are suitable. For MAFFT application, a new substitution matrix was used so that












where a and b represent amino acids, Mab is the original all-positive substitution matrix, fa
is the rate of occurrence of amino acid a, and Sa is the gap extension penalty parameter. By
using this new Mab substitution matrix, the value between two identical protein sequences
is 1.0 + Sa whereas the similarity score between two unrelated protein sequences is Sa.
MAFFT performs multiple sequence alignments by using progressive alignment tech-
niques. In order to improve the speed of the progressing algorithm in relation to other meth-
ods it uses Fast Fourier Transform to identify homologous regions in protein sequences. If
the protein sequences under study have homologous regions, these regions will appear in
several peaks in the correlation. As these peaks will only indicate the existence of homol-
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ogous regions and not their location, a sliding window is used. The level of similarity of
each region is measured based on the 20 highest peaks in the correlation. If consecutive
homologous regions are identified, they are jointed into one region.
5.2.3 Substitution Matrix
In bioinformatics, a substitution matrix [197] expresses the rate at which one member in a
sequence changes to another over time. Substitution matrices are generally used in protein
or DNA sequence alignments, where the similarity between sequences relies upon their
mutation rates as characterised in the matrix. There are various types of substitution matri-
ces. Some of widely used and accepted matrices such as, PAM, BLOSUM, and GONNET
are described below.
5.2.3.1 Point Accepted Mutation (PAM)
Originally, Point Accepted Mutation (PAM) matrices [197] were introduced in the late
1970s and used in protein sequence alignments. In order to create the PAM matrix of
protein mutation [204; 205], a Markov chain model [206] was utilised. These original
PAM matrices were calculated based on 1572 measurements on mutation of 71 families
with high similarity protein sequences.
For practical uses and to be able to compare different PAM matrices extracted from pro-
tein sequences with various lengths, PAM matrices are normalised. Therefore, the PAM
matrix that is calculated from protein sequences with only one mutation occurring for ev-
ery 100 amino acids will be called PAM1. Another example of the PAM matrix, PAM30,
which is given in Table 5.1, is normally used in the literature for a protein sequence’s align-
ment [197]. The PAM30 matrix supplies substitution probabilities for sequences where 30
mutations occur for every 100 amino acids. A substitution matrix can also be created by
using the 20 standard amino acid indices, generating a 20 x 20 matrix where each position
represents the probability of a given amino acid to be substituted by one of the remaining.
5.2.3.2 Blocks of Amino Acid Substitution (BLOSUM)
The Blocks of Amino Acid Substitution (BLOSUM) matrix that is a substitution matrix
used for protein sequence alignments was introduced in the early 90s [207]. In contrast
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to other substitution matrices like PAM, which are generated from comparisons of high
similarity protein sequences, BLOSUM matrices are supported on observed alignments.
In the literature, BLOSUM matrices are commonly used in multiple alignments between
biological diverging protein sequences [208].
For building BLOSUM matrices, the BLOCKS database [209] was used to extract pro-
tein families with preserved regions. By using these protein sequences the relative fre-
quencies of amino acids and their substitution probabilities were calculated. Furthermore,
for the 210 possible substitutions of the 20 standard amino acids, the log-odds score was






qi ∗ qj ) (5.3)
where i and j are any two given amino acids, pij is the probability of these two amino
acids substituting each other in a sequence and λ is a scaling factor. Finally, qi and qj
represent the probability of arbitrarily finding amino acids i and j, respectively, in any
protein sequence.
Various BLOSUM matrices were constructed by using different protein families in
recent years, and a numeric system based on protein similarity is used to differentiate these
matrices. A high number attached to BLOSUM matrix, like BLOSUM80 will indicate that
this matrix was designed for aligning protein sequences with high similarity, in contrast to a
low number, like BLOSUM45 that will indicate being designed for aligning low similarity
protein sequences. Table 5.2 shows a commonly used matrix, BLOSUM62 [210] as it
has been shown to give a better representation, and improve the performance of protein
multiple sequence alignments [211].
5.2.3.3 GONNET
The GONNET matrix was introduced in 1992 by Gonnet, Cohen and Benner [212]. This
type of matrix calculates the differences between amino acids by using exhaustive protein
pairwise alignments. The first step to derive the GONNET matrix is to align the given
protein sequences by using other substitution matrices like PAM or BLOSUM. The next
step is to estimate the distance matrix by using the alignment, and interactively refine the
alignment to calculate a new distance matrix. All the resulting matrices are normalised to
250 PAMs.
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As the authors indicated in the original description of the algorithm [212] the resulted
matrix is affected by the homology of the proteins used. For this reason it is proposed
for the initial alignment, the PAM250 substitution matrix to be used, and for the iterative
alignment refinements, a PAM matrix to be used that is appropriate to the homology of the
protein sequences used.
5.3 Methods and Materials
In this chapter a novel method is presented, which uses signal processing techniques, and
more specifically Discrete Fourier Transform (DFT) along with multiple amino acid indices
to perform MSA in protein sequences.
5.3.1 Feng-Doolittle Algorithm
In this chapter the Feng-Doolittle algorithm will be used in order to perform MSA. In order
to apply this algorithm the following steps needs to be completed:
• By using DFT, as described in Section 5.3.3, a matrix N(N-1)/2 can be calculated
which represents all the pairwise similarity scores between protein sequences.
• By using these distance values a guide tree can be constructed using the Unweighted
Pair Group Method with Arithmetic Mean (UPGMA) clustering method [213] as
shown in Section 5.3.4.
• By using the guide tree the child nodes that present higher similarity are aligned first.
By adding protein sequences to the alignment in the order they were appended to the
guide tree a final alignment that covers all sequences can be obtained.
Each pairwise alignment is performed using dynamic programming, specifically Needle-
man - Wunsch (NW) algorithm [178]. A pseudo-code of the NW algorithm is given in the
following algorithm.
1 Alignment A = ’ ’
2 Al ignment B = ’ ’
3 s i z e A = l e n g t h (A)
4 s i z e B = l e n g t h (B)
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5
6 whi le ( s i z e A > 0 and s i z e B > 0)
7
8 Score = S c o r e f u n c t i o n ( s i ze A , s i z e B )
9 D i a g o n a l S c o r e = S c o r e f u n c t i o n ( s i ze A −1, s i z e B −1)
10 Upper Score = S c o r e f u n c t i o n ( s i ze A , s i z e B −1)
11 L e f t S c o r e = S c o r e f u n c t i o n ( s i ze A −1, s i z e B )
12
13 i f ( Sco re == D i a g o n a l S c o r e + S (A( s i z e A ) , B( s i z e B ) ) )
14 Alignment A = A( s i z e A ) + Alignment A
15 Alignment B = B( s i z e B ) + Alignment B
16 s i z e A = s ize A−1
17 s i z e B = s i z e B−1
18
19 e l i f ( Sco re == L e f t S c o r e + d )
20 Alignment A = A( s i z e A ) + Alignment A
21 Alignment B = ’− ’ + Al ignment B
22 s i z e A = s ize A−1
23
24 e l i f ( Sco re == Upper Score + d )
25 Alignment A = ’− ’ + Alignment A
26 Alignment B = B( s i z e B ) + Alignment B
27 s i z e B = s i z e B−1
28
29 whi le ( s i z e A > 0)
30 Alignment A = A( s i z e A ) + Alignment A
31 Alignment B = ’− ’ + Al ignment B
32 s i z e A = s ize A−1
33
34 whi le ( s i z e B > 0)
35 Alignment A = ’− ’ + Alignment A
36 Alignment B = B( s i z e B ) + Alignment B
37 s i z e B = s i z e B−1
After each pairwise alignment, each gap in the aligned sequences, which is denoted
with the symbol ’-’ is replaced with the amino acid symbol ’X’. This action is performed
to distinguish gaps inserted in previews alignments with current alignments and to ensure
consistency. The algorithm time complexity is O(nk) [214] for k sequence alignments,
where each sequence length is n.
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5.3.2 Amino Acid Indices
In order to encode protein sequences to numerical sequences, amino acid indices need to
be selected. In the literature, 611 amino acid indices exist, each one representing a unique
biological protein feature. For this study, 25 amino acid indices were selected as shown
in Table 5.3. These amino acid indices represent general and widely accepted features
[22; 215; 216; 217] of the amino acids, like size [26], volume [25], molecular weight [24]
and hydrophobicity [24; 218; 219; 220]. The complete list of the amino acid indices used
for this analysis is presented in Table 5.3 and Table 5.4.
Table 5.3: Amino Acid Indices Used For The Alignment
ID Name Description Reference
1 ZIMJ680102 Bulkiness [221]
2 ZIMJ680104 Isoelectric point [221]
3 HUTJ700102 Absolute entropy [222]
4 DAWD720101 Size [26]
5 GRAR740102 Polarity [25]
6 GRAR740103 Volume [25]
7 FASG760101 Molecular weight [24]
8 FASG760102 Melting point [24]
9 FASG890101 Hydrophobicity index [24]
10 ZHOH040101 The stability scale from the knowledge-based
atom-atom potential
[223]
11 OOBM770103 Long range non-bonded energy per atom [224]
12 MANP780101 Average surrounding hydrophobicity [218]
13 WOLR790101 Hydrophobicity index [219]
14 FAUJ880101 Hydration potential [225]
15 FAUJ880102 Smoothed upsilon steric parameter [226]
16 ARGP820101 Hydrophobicity index [220]
17 VELV850101 Electron-ion interaction potential [87]
18 FAUJ880111 Positive charge [226]
19 FAUJ880112 Negative charge [226]
20 FAUJ880109 Number of hydrogen bond donors [226]
21 KYTJ820101 Hydropathy index [227]
22 BHAR880101 Average flexibility indices [228]
23 Proscale 4 Recognition factors [112]
24 Nl Long-range contacts [111]
25 Rk Relative connectivity [29]
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In literature, as described in section 5.2.3, three substitution matrices are commonly used,
PAM, BLOSUM and GONNET.
Important limitations have been observe in recent works [109; 229; 230; 231] such as
• PAM Matrix Disadvantages
– Assumes uniform distribution of all mutation types.
– Uses high homology proteins in order to deduce relationships in diverse pro-
teins.
• BLOSUM Matrix Disadvantages
– Limited to a subset of conserved domains.
– Ignores the closeness of relationship between proteins.
In order for GONNET matrix to be constructed, PAM and BLOSUM matrices are used
along with exhaustive pairwise sequence alignments, thus it will inherit the same general
disadvantages as the substitution matrix it uses.
In recent years, numerous substitution matrices have been developed that include phys-
ical characteristics of proteins, such as local sequence-structure information [232], alpha-
helix information, secondary structure information [233] and solvent accessibility states
[234; 235]. These substitution matrices are shown to have generally improved protein
sequence alignments.
In this chapter, a novel similarity (or substitution) matrix constructed and presented.
This substitution matrix is not considered based on the mutation rate, like PAM [197] or
BLOSUM [207] matrices, but on the physicochemical properties of each amino acid. In
order to calculate the substitution matrix, the amino acids need to be converted to numerical
values. These values can be derive from the amino acid indices.
As detailed in Chapter 3, 611 amino acid indices exist in the literature, each represent-
ing a unique biological feature, which can encode amino acids. By using the numerical
representation of the amino acids the pairwise Euclidean distance between all the amino
acids can be calculated. The Euclidean distance between two amino acids x and y where
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x = (x1, x2, ..., xn) and y = (y1, y2, ..., yn) and n is the number of features, can be calcu-




(yi − xi)2 (5.4)
Further information regarding the amino acid indices used to calculate the substitution
matrix can be found in Section 5.3.2.
By using the proposed substitution matrix the following advantages can be obtained
compared to the classical substitution matrices such as PAM, BLOSUM and GONNET:
• The proposed substitution matrix is not biased to specific groups of protein sequences
[236] as the values are calculated from the amino acid indices, and not from the
protein sequences.
• By using the classical substitution matrix, the use of a different matrix can have
a major impact on the alignment [236]. For the proposed substitution matrix, the
same matrix can be considered regardless of the protein sequence’s homology to be
aligned or the mutation rate presented.
• A correlation to the physical characterisations of the amino acids that the substitution
matrix derived from can be achieved.
• Different similarity matrices can be generated when different physical characterisa-
tions of amino acids are considered. These characteristics are represented by the
amino acid indices.
5.3.4 Construction of Dendrogram
The first step in constructing a dendrogram, which is used as a guide tree for MSA, is to
calculate the distance matrix between all the protein sequences. The following steps need
to be completed in order to calculate the distance matrix.
• Each protein sequence in the dataset is converted to 25 numerical sequences using
the amino acid indices shown in Table 5.3.
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• As different protein sequences are likely to have distinct lengths, each numerical
sequence is zero-padded to match the length of the longest protein sequence in the
dataset. This step is essential for comparing multiple proteins with different lengths.
• By using DFT as described in Equations 5.5 and 5.6, the absolute frequency spectra
is calculated for each of the 25 numerical sequences for all the protein sequences.
• For each protein sequence, the 25 absolute frequency spectra is combined into one
vector. By using the correlation distance, as Equation 5.7 shows, the distance matrix




x(m)e−j(2pi/N)nm n = 0, 1, ..., N − 1 (5.5)
where x(m) is the mth member of the numerical series, N is the total number of points in
the series, and X(n) are coefficients of the DFT. As the DFT coefficients consisted of two
mirror parts, only the first half of the series (N/2) points) will be hereafter considered. The
following formula determines the absolute frequency spectrum
S(n) = X(n)X
∗(n) = |X(n)|2 , n = 0, 1, ..., (N − 1)/2 (5.6)
where S(n) is the absolute spectrum for a specific protein, X(n) are the DFT coefficients
of the series x(n) and X∗(n) are the complex conjugate.
The correlation distance can be calculated as follows
D(X, Y ) = 1− (X − X¯) · (Y − Y¯ )‖ (X − X¯) ‖2 ‖ (Y − Y¯ ) ‖2 (5.7)
where X¯ and Y¯ represent the mean values of vectors X and Y , respectively.
After calculating the distance matrix, the guide tree can be constructed. The method
used to build the guide tree is the Unweighted Pair Group Method with Arithmetic Mean
(UPGMA). Moreover, UPGMA is a hierarchical clustering method created by Sokal and
Michener [213] and used in bioinformatics for the creation of phenetic trees. Initially, the
UPGMA method was used in protein electrophoresis studies, but currently it is a common
practice to use it in complex protein or DNA phylogenetic analyses, or in MSA to built the
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guide trees. A detailed description of the procedure that the UPGMA algorithm follows to
create a rooted dendrogram is given below:
1. Calculate the distance matrix D (Eq. 5.7) for all the protein sequences.
2. Initialise the dendrogram by creating one leaf node for each protein sequence in the
dataset.
3. Find X and Y protein sequences that have the smallest distance DX,Y between them.
4. Create a new node XY.
5. Connect X and Y, and give the two branches connecting X and Y to XY with the
length DX,Y /2.
6. Compute the distance from the new node to all the remaining nodes of the dendro-








7. Append the distances calculated above in D matrix and delete the distances that
correspond to the nodes X and Y.
8. Repeat Steps 3-7 until all the protein sequences are covered.
5.3.5 Case Study: Multiple Sequence Alignment of Cluster of Differ-
entiation 4 Proteins
The Cluster of Differentiation 4 (CD4) [237] is a glycoprotein and was discovered in late
1970. CD4 is expressed on the surface of T helper cells, monocytes, macrophages, and
dendritic cells. The main function of CD4 is to act as a co-receptor that supports the T-
cell receptor with an antigen-presenting cell. In recent years, CD4 has become subject
to an intense research towards finding a cure for Human immunodeficiency virus (HIV).
Protein sequence alignment is important as it can identify regions of similarity that can be
considered significant in regards to the functional, structural or evolutionary relationships
between the protein sequences. HIV-1 uses CD4 to infect a host T-cell and accomplishes
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this by binding gp120, a known viral envelope protein with CD4 [238]. In this study, 32
CD4 protein sequences, as listed in Table 5.5, will be used. These protein sequences were
collected from UniProt [4] for various animal species.
Table 5.5: CD4 Proteins
ID Uniprot ID Organism Protein Length
1 P01730 Human 458
2 P16004 Chimpanzee 458
3 P79185 Crab-eating Macaque 458
4 P79184 Japanese Macaque 458
5 P16003 Rhesus Macaque 458
6 Q08340 Pig-tailed Macaque 458
7 Q29037 Common Squirrel Monkey 457
8 Q08338 Green Monkey 458
9 P06332 Mouse 457
10 P46630 Rabbit 459
11 P05540 Rat 457
12 Q6R3N3 Pig 417
13 A7YY52 Bovine 395
14 NP 001123374 Sheep 455
15 ACG76115 Goat 455
16 Q8HZT8 White-tufted-ear Marmoset 457
17 P33705 Dog 463
18 AAB24450 Cat 474
19 Q9XS78 Beluga Whale 455
20 Q71QE2 Bottle-nosed Dolphin 455
21 NP 001092760 Gray short-tailed Opossum 461
22 ABR22561 Tammar Wallaby 464
23 AAS67020 Chicken 487
24 CAP04927 Turkey 487
25 B8YEL3 Domestic Duck 482
26 AAW63065 Muscovy Duck 482
27 BAD37153 Fugu Rubripes 463
28 B5D5T7 European Seabass 480
29 ADM47441 Orange-spotted Grouper 469
30 ADV78594 Mandarin Fish 549
31 ABU95653 Spotted-green Pufferfish 466
32 ACM50926 Atlantic Halibut 461
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5.4 Results and Discussions
Two sets of results are obtained and presented. The first set of results presents the generated
dendrograms for the protein sequences. These dendrograms (figures 5.1, 5.2 and 5.3) are
essential in current MSA methods as they can be used as guide trees for the order in which
protein sequences are to be aligned. The second set of results refers to application of MSA
for protein sequences using the modified Feng-Doolittle algorithm as described in section
5.2.1.
5.4.1 Dendrogram
Figures 5.1, 5.2 and 5.3 show the dendrograms generated by using MAFFT, ClustalW2
and T-Coffee, respectively. The online European Molecular Biology Laboratory - Eu-
ropean Bioinformatics Institute (EMBL-EBI) webserver [239] was used to construct the
dendrograms for MAFFT, ClustalW2 and T-Coffee. The dendrogram generated by using
UPGMA method presented in this chapter is given in Figure 5.4.
By using the algorithm as described in Section 5.3.4, distance matrices and dendrogram
can be generated by using any given set of amino acid indices, each one of which represents
a unique biological feature of protein sequences. In this section, the results are based on the
combination of 25 widely accepted amino acid indices [22; 215; 216; 217], which produced
the best results, according to the biological relationships between proteins, for constructing
dendrograms and performing MSA for protein sequences. These amino acid indices can be
used to construct a dendrogram based on a specific individual protein feature. An example
of these dendrograms can be seen in Appendix C.
By using Table 5.6, which represents the pairwise percent identity of the protein se-
quences used, and considering the assumption that a high-quality guide tree joins the first
sequences that present the highest similarity, the algorithm presented in this chapter gen-
erated the best dendrogram according to the biological relationships between proteins. A
good example can be seen with CD4 protein sequence extracted from rabbit, which belongs
to glires. Glires is a clade consisting of rodents (mice and rat) and lagomorphs (rabbits and
hares). As Table 5.6 shows, by using only the percent identity, the biological similarity of
two protein sequences is not directly observable. By using the percent identity, the CD4
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tity is calculated to be 74%, 54% and 52% between rabbit - pig, rabbit - mouse and rabbit -
rat CD4 protein sequences, respectively. In addition, by using the dendrograms generated
from MAFFT 5.1, ClustalW 5.2, and T-Coffee 5.3 methods, there is no direct association
connecting all three CD4 proteins (rabbit, mouse and rat). By using the method proposed
in this chapter, there is a clearer indication as seen in Figure 5.4, associating rabbit, mouse
and rat CD4 proteins. As the dendrogram show, for the proposed method mouse and rat
CD4 protein sequences will be aligned first, and thereafter, the aligned protein sequence
will be aligned to rabbit CD4 protein sequences.
As stated in the previous sections, by making the assumption that high similarity be-
tween protein sequences indicates that these sequences are evolutionarily related, MSA
can be constructed by using a series of pairwise alignments. For illustration and validation
purposes, two sections of the guide tree are selected to be aligned in which all the pro-
tein sequence present high similarity according to the distance matrix. The first subgroup
selected as seen in Figure 5.5, represents all the CD4 protein sequences extracted from
primates [240]. The second group selected as shown in Figure 5.6 represent all the CD4
protein sequences extracted from animals that belong to the Artiodactyla order [240].
5.4.2 Multiple Sequence Alignment
The first step in MSA, after constructing the guide tree, is to calculate the substitution
matrix. In order to calculate the substitution matrix, the amino acids need to be converted to
numerical sequences. By using Table 5.3 that lists the selected 25 amino acid indices, each
amino acid was converted into 25 numerical values. By using the numerical representation
of the amino acids, the pairwise Euclidean distance between all amino acids was calculated.
Table 5.8 shows the generated substitution matrix. For the gap penalty, the value -16 was
used, and it was calculated by 4 ∗min(SM), where SM represents the substitution matrix
values, given in Table 5.8. The formula for the gap penalty value was obtained throughout
extensive experimental testing that was performed for this case study.
By using the Feng-Doolittle algorithm as described in section 5.3.1, MSA was per-
formed for the two subgroups of protein sequences that were selected. By using the EMBL-
EBI webserver, MSA for these selected subgroups was performed by using MAFFT, ClustalW2
and T-Coffee methods with their default parameters, which produced the MSA with the
higher percent identity. The results for the first MSA, which includes the protein sequences
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Figure 5.1: Dendrogram Constructed By Using MAFFT Method
84
Figure 5.2: Dendrogram Constructed By Using ClustalW2 Method
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Figure 5.3: Dendrogram Constructed By Using T-Coffee Method
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Figure 5.4: Dendrogram Constructed By Using The DFT and 25 Amino Acid Indices
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Figure 5.5: Guide-Tree Selected for Multiple Sequence Alignment 1
Figure 5.6: Guide-Tree Selected For Multiple Sequence Alignment 2
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from primates, are given in Figure 5.4.2. For this analysis, the method described in this
chapter and the methods used for comparison (MAFFT, ClustalW2 and T-Coffee), pro-
duced identical alignments.
The results for the second MSA, which includes the protein sequences from the order
Artiodactyla, are given in Figures 5.4.2, 5.4.2, 5.4.2 and 5.4.2, which correspond to the
results obtained from the proposed algorithm, ClustalW2, MAFFT and T-Coffee methods,
respectively. For this analysis, the pairwise percent identity of all the protein sequences
used was calculated. As the results show, the proposed method performs better compared
to the other three MSA methods studied. Table 5.9 presents an overview of the results
obtained. By using the percent identity of two aligned protein sequences, a single value
can be obtained that represents the percentage of identical residues in relation to the length
of the alignment.
For the results presented in Table 5.9, each pairwise percent identity of the proposed
method is compared to the Clustal, MAFFT and T-Coffee results. The results are high-
lighted with red and yellow colours, where red indicates that the proposed method performs
better than the percent identity, whereas the results that performed worse are highlighted
in yellow. The unhighlighted results indicate identical results to the proposed method.
For the first comparison with Clustal, the results show that for the alignment of pig
and bovine CD4 protein sequences, the proposed method performed better than the pair-
wise percent identity. For the remaining of the results, the two methods produced identical
results. For the second and third comparisons with MAFFT and T-Coffee, the proposed
method performed better in all the pairwise percent identity comparisons except the com-
parisons between pig - whale CD4 and pig CD4 - dolphin CD4 protein sequences.
For the average percentage identity of all the protein sequences used is calculated and
presented in Table 5.9. As the results show the proposed method has the highest average
percent identity of 70.830% in comparison to 70.29%, 70.443% and 70.443% for Clustal,
MAFFT and T-Coffee, respectively.
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Figure 5.7: Results for the Proposed MSA Method, Clustalw2, MAFFT and T-COFFEE
for Alignment 1
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Figure 5.9: Results for the ClustalW2 MSA Method for Alignment 2
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Figure 5.11: Results for the T-COFFEE MSA Method for Alignment 2
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Table 5.9: Pairwise Percent Identity of CD4 Aligned Protein Sequences For Analysis 2
Proposed Algorithm
Bovine Sheep Goat Whale Dolphin API*
Pig 55.677% 62.445% 62.445% 66.376% 65.939%
70.830%
Bovine 73.362% 72.926% 59.389% 60.044%




Bovine Sheep Goat Whale Dolphin API*
Pig 54.585% 61.354% 61.354% 65.721% 65.284%
70.29%
Bovine 72.926% 72.489% 58.079% 58.734%




Bovine Sheep Goat Whale Dolphin API*
Pig 55.120% 61.874% 61.874% 66.449% 66.013%
70.443%
Bovine 72.985% 72.549% 58.170% 58.824%




Bovine Sheep Goat Whale Dolphin API*
Pig 55.120% 61.874% 61.874% 66.449% 66.013%
70.443%
Bovine 72.985% 72.549% 58.170% 58.824%
Sheep 96.296% 72.549% 72.549%
Goat 72.331% 72.331%
Beluga Whale 96.732%
Red indicates lower values in comparison to the proposed method.
Yellow indicates higher values in comparison to the proposed method.
*API - Average Percent Identity
5.5 Conclusions
In this chapter, a new method was proposed for performing protein multiple sequence
alignment. For this method Discrete Fourier Transform, was used to construct the dis-
tance matrix in combination with the multiple amino acid indices that were used to encode
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protein sequences into numerical sequences. The distance matrix is important as it can
be used to construct a dendrogram that will act as a guide for MSA in which the global
alignment is estimated by a series of pairwise alignments. The amino acid indices selected
for this analysis are based on general and widely accepted features of the amino acids.
Additionally, these indices are used to construct a substitution matrix. In the literature,
this similarity or substitution matrix states the rate at which one amino acid is replaced by
another over time. In this chapter, a new type of substitution matrix is proposed where the
physicochemical similarities between any pair of given amino acids is calculated. These
similarities were calculated based on the 25 amino acids indices selected, where each one
represents a unique biological protein feature.
In order to show the applicability and robustness of the proposed method, a case study
was presented by using 32 CD4 protein sequences extracted from the UniProt online
database. For this study, two sets of results were presented, one for constructing a rooted
dendrogram that is used as a guide tree for multiple sequence alignments. The results sug-
gests that the proposed method for constructing guide trees can identify hidden similarities
between the protein sequences which are not directly observable using only the homology
information. By using this guide tree, two subgroups were selected, one representing all
the primates presented in the protein dataset and one that include all the protein sequences
extracted from the animals that belong to the Artiodactyla order. The second set was gen-
erated by applying MSA to the selected subgroups and comparing the results with other
MSA methods in the literature like ClustalW2, MAFFT and T-Coffee MSA methods.
The results show that the proposed method yields a more reliable MSA for the protein
sequences can be performed. For the Alignment 1, the proposed method as well as the
CLUSTALW, MAFFT, and T-COFFEE produced identical MSAs. For Alignment 2, the
MSAs produced from all the methods were highly similar, with the proposed method hav-
ing the highest pairwise percent identity of CD4 aligned protein sequences in comparison
to ClustalW2, MAFFT and T-Coffee MSA methods. Additionally, as the results show the
proposed method has the highest average percent identity.
In conclusion, the proposed MSA method is not biased to specific groups of protein
sequences [236] as the values for the substitution matrix are calculated from the amino acid
indices, and not from the protein sequences. Additionally, for the proposed MSA, the same
substitution matrix can be considered regarding the protein sequence’s homology to be
aligned or the mutation rate presented. A correlation to the physical characterisations of the
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amino acids the substitution matrix derived from can be achieved, while different similarity
matrices can be generated by considering different amino acids physical characterisations,
that each amino acid indices represents.
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Chapter 6
Complex Informational Spectrum for
the Analysis of Protein Sequences
6.1 Introduction
If it is considered that a protein’s biological function is controlled by the selective ability
of the protein to interact with selected elements in the environment the following argument
arises: how is this selective ability achieved? Several attempts have been made to decode
the rules that help drive biological functions of the proteins directly from the primary struc-
ture of a protein sequence. One common method used for analysing protein sequences to
determine biological functions is based on the search for similarities in the arrangements
between the groups of sequences. One example is the Basic Local Alignment Search Tool
(BLAST) [241]. Another method for analysing macro-module sequences is to extract struc-
tural and physicochemical features such as amino acid and dipeptide composition derived
from primary structure of a protein sequence [62; 242]. These features can be used for
prediction of protein structural classes [31; 93], functional classes [149; 151; 152; 243]
and protein-protein interactions [73; 148; 244].
In recent years, signal processing techniques have been used in bioinformatics to ex-
tract information that is expected to reveal a protein’s biological function [40; 41; 42].
One of the methods that uses Discrete Fourier Transform (DFT) is Informational Spectrum
Analysis (ISA) [40; 91; 92]. In previous applications where ISA was used for each group
of proteins analysed [40; 91; 92] there was a group of proteins that corresponds to specific
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peaks in the frequency spectrum. Therefore, the method suggests [87; 92; 146; 245] that
every biological function corresponds to one unique or a set of unique peaks. The impor-
tance of this general conclusion is that specific biological functions can be extracted from
protein sequences using the signal processing techniques by identifying significant features
of the frequencies, which are not found in unrelated frequencies.
Complementary information such as real and imaginary frequency spectra can be de-
rived from DFT, which has successfully been used in various areas, including biomedicine
[246]. However, complex SP concept was not previously explored in the analysis of pro-
tein sequences. A new method, the complex informational spectrum [245], was developed
to explore results obtained from all three frequency spectra for the analysis of protein se-
quences.
In the traditional approach, due to the complex nature of proteins and their functional
groups, the use of only the absolute spectrum in the analysis of protein sequences can be
insufficient. Biologically related features of protein sequences can be more distinct either
in the real or the imaginary spectrum. Various applications, such as, development of new
drugs [247], identification of important protein sequence’s domains [42; 248] and inves-
tigation of protein sequences interaction [249], where ISA and RRM are already applied
in the literature, CISA will also be applicable and will be able to contribute additional
information.
To be able to proceed with current signal processing techniques a set of numerical
values must be assigned to nucleotides or amino acids [28] in order to transform protein
sequences into signals. These values should generally represent natural biological charac-
teristics of the macro-modules with which they are paired and be relevant to the biological
activity of each module. These properties are taken as any of the amino acid indices de-
posited in the AAIndex database such as electron-ion interaction potential (EIIP) [87; 88],
hydrophobicity [88; 89], solubility [88; 89] or molecular weight [88; 89]. Additional amino
acid indices were included in the analysis that were not included in AAIndex. Such indices
include long-range contacts [111] and relative connectivity [29].
In this chapter, Complex Informational Spectrum Analysis (CISA) was introduced.
Application of the CISA in the influenza virus is also presented in order to show usefulness
and robustness of the method developed. Using an expanded set of amino acid indices
further supports this. Additionally, the Complex Informational Spectrum for Analysis of
Protein Sequences (CISAPS) web server is presented, which can be freely accessed to
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extract features of proteins from their amino acid sequences.
6.2 Methods And Materials
6.2.1 Signal Processing-Based for the Analysis of Protein Sequence
By using digital signal processing techniques the goal is to extract information that can
be related to biological functions of proteins. Various signal processing methods have
been used in bioinformatics for analysing protein sequences in recent years; one of the
most common methods is the informational spectrum analysis (ISA) [40; 91; 92]. For
the ISA method to be implemented for the analysis of protein sequences, Discrete Fourier
Transform (DFT) is applied after each amino acid of the protein sequences is expressed
as numerical sequences by using various amino acid indices. A special case of ISA is the
Resonant Recognition Model [40; 87; 91; 92] where the EIIP amino acid index [87] is
used to encode alphabetical protein sequences into numerical sequences. ISA reveals that
functionally related protein sequences common peaks appear in the informational spectrum
whereas they do not appear in functionally unrelated sequences. This is directly related to
the biological property of the amino acid index used. In previous studies, ISA uses DFT
to extract parameters using the absolute spectrum. However, DFT that generates com-
plex output (imaginary and real frequency spectra) has shown to produce complementary
information in various fields such as Doppler ultrasound in medicine [246], polar solva-
tion dynamics in the femtosecond evolution [250], time-domain sum-frequency generation
spectroscopy using mid-infrared pulse shaping [251], hydrophobic oil droplet-water inter-
face for the orientation and charge of water [252] and noisy speech enhancement [253].
To the best of our knowledge, complex signal processing concept has not been ex-
plored for the analysis of protein sequences. Therefore, for the first time, this chapter is
concerned with the development of the complex informational spectrum (CISA) for the
analysis of groups of proteins using their sequence information. This study therefore aims
at deriving absolute, real and imaginary spectra from DFT for a given set of proteins. They
will then be used to extract characteristic frequency parameters for the group of proteins
under study. This piece of information can be used to characterise and classify protein
sequences. In order for researchers to apply the method in their own set of proteins with-
out any knowledge of SP or complex SP concept, a freely accessible web server (CISAPS
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web-server) is also developed and presented in this chapter.
6.2.2 Preprocessing of Protein Sequences
Previous studies [146] have shown that techniques such as zero-padding and windowing
may affect the analysis and the features extracted from proteins sequences. Before applying
the informational spectrum analysis to protein sequences, these techniques used in signal
processing needs to be considered.
6.2.2.1 Windowing
The first technique considered is windowing, which tries to reduce spectral leakage [254]
by multiplying a pre-calculated window with the encoded numerical sequences. Spectral
leakage is caused when processing finite-length signals using frequency analysis of infinite
signals in which it appears that some energy has leaked out of the primary signal spectrum
into neighboring frequencies. As the literature shows in other applications [255; 256] that
windowing can reduce or even eliminate spectral leakage when frequency analysis and
DFT are used. Various different types of windows exist in the literature like Hamming
[147; 257], Hanning [257] and Rectangular [257] window. In this case, the Hamming
window is used and can be defined in Equation 6.1 and presented in Fiq. 6.1.





n = 0 ≤ n ≤ N − 1 (6.1)
where N is the total amino acids in a protein sequence.
6.2.2.2 Zero-padding
The second technique used is zero-padding [258; 259] in which a specified number of zero
elements is added to the end of each sequence in order to increase signal length before
DFT is applied to the signals. This technique is essential for CISA as the given protein
sequences may not be of the same length thus making CISA unrealisable. Seven different
resolutions were used for the analysis of influenza A neuraminidase proteins. The first
signal length used is 470, which is the maximum protein length of the influenza A protein
subtypes. The remaining six signal lengths used are 512 (29), 1024 (210), 2048 (211), 4096
(212), 8192 (213) and 16384 (214).
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Figure 6.1: Hamming Window
6.2.3 Complex Informational Spectrum Analysis




x(m)e−j(2pi/N)nm n = 0, 1, ..., N − 1 (6.2)
where x(m) is the mth member of the numerical series, N is the total number of points
in the series, and X(n) are coefficients of the DFT. As the DFT coefficients consisted of
two mirror parts, only the first half of the series (N/2) points) will be hereafter considered.






where d is the distance between points of the sequence.
If it is assumed that all points of the sequence are equidistant with distance d = 1 then
the maximum frequency in the spectrum can be found to be F = 1/2(1) = 0.5. This shows
that the frequency range does not depend on the number of points in the sequence but only
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the resolution of the spectrum.
As the definition of DFT is complex which is shown in Eq. 6.2, the output of DFT also
yields a complex sequence and can be represented as follows
X(n) = (R(n) + jI(n)), n = 0, 1, ..., (N − 1)/2 (6.4)
where R(n) and I(n) are the Real and Imaginary parts of the sequence, respectively.
They produce real and imaginary spectra results of which can be separately explored,
and when combined, generate absolute spectrum. The absolute, real imaginary spectrum
and complex informational spectrum can be formulated as follows
Absolute Spectrum:
Sa(n) = X(n)X
∗(n) = |X(n)|2 , n = 0, 1, ..., (N − 1)/2 (6.5)
where Sa is the absolute spectrum for a specific protein, X(n) are the DFT coefficients of
the series x(n) and X ∗ (n) are the complex conjugate.
Real Spectrum:
Sr(n) = |R(n)|2 , n = 0, 1, ..., (N − 1)/2 (6.6)
where Sr is the real spectrum for a specific protein, R(n) are the real parts of DFT coeffi-
cients X(n)
Imaginary Spectrum:
Si(n) = |I(n)|2 , n = 0, 1, ..., (N − 1)/2 (6.7)
















where Ca, Cr and Ci are the absolute, real and imaginary informational spectrum, respec-
tively, and M is the number of protein sequences used for a specific class of proteins.








where L is the number of points in the Absolute (Ca), Real (Cr) and Imaginary Informa-
tional Spectrum (Ci).
The aim of this method is to determine a Characteristic Frequency Peak (CFP) using the
informational spectrum for each spectrum (absolute, real and imaginary) that is expected
to correlate with a biological function expressed by a group of protein sequences. To
determine such a parameter, it is necessary to find common characteristics of the sequences
with the same biological function.
CFP as a result of the CISA can be used to characterise and distinguish them from
another group of proteins. However, the following conditions should be fulfilled for the
CFP to be related to a biological function:
1. Only one CFP should exist for a group of protein sequences that share the same
biological function.
2. For different biological functions the CFP is expected to be different.
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6.3 Web Server Access
The CISAPS web server is available at http://cisaps.com/main/. As seen in Figure 6.2, the
user can input the required information for the analysis using the input form.
Figure 6.2: CISAPS Web Server Input Form
The mandatory information required is a valid email and protein sequences saved in
FASTA format. The CISAPS web server can process up to 1000 protein sequences per
analysis, where the length of any given protein should be between 8 and 4096. After a
successful submission to the CISAPS web server, an email will be sent to the user with
a description of the submitted data including number of proteins, unknown amino acids
found in protein sequences and signal length used DFT. After the submission, protein se-
quences will be processed and an email will be sent to the user with the generated reports
of the analysis. The email includes:
• A report of the CISA results grouped by CFP.
• A report of the CISA results listed by amino acid Index ID.
• Summary report of the occurrences of CFP.
6.4 Case Study: Analysing Influenza Neuraminidase Pro-
tein Sequences
During the twentieth century three major influenza A pandemics were recorded which were
caused by H1N1, H2N2, and H3N2 viruses in this chronological order. In addition, H5N1
and H1N2 viruses are considered as current pandemic threats [260; 261]. Previous studies
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[42] used influenza A subtypes to analyse the hemagglutinin (HA) gene with the RRM,
aiming to identify new therapeutic targets for drug development by better understanding
the interaction between the influenza virus and its receptors. For this analysis, the Neu-
raminidase (NA) gene of these five different subtypes of Influenza A virus was used, as it
is the target for current antiviral drugs called neuraminidase inhibitors [262]. All data were
collected from the Influenza Virus Resource database [263].
Influenza A H1N1 subtype virus is a subtype of influenza A virus and the most com-
mon cause of influenza in humans [264]. H1N1 first emerged in 1918 and was responsible
for Spanish flu that killed 50 to 100 million people worldwide within a year (1918-1919)
[265]. In 1947, a new H1N1 virus emerged through intrasubtype reassortment while the
neuraminidase (NA) gene was preserved, which may have prevented the advancing of a
new pandemic [266]. In 1957, H1N1 suddenly became extinct in humans and the reason is
still not clear today. One probable explanation is that the development of high immunity to
the H1N1 virus in conjunction with the development of immunity to the H2N2 Influenza
virus led to the extinction of the virus. In 1977, the H1N1 virus reappeared in the for-
mer Soviet Union, Hong Kong, and north-eastern China [266]. Genetic analysis of the
re-emerged H1N1 virus suggests that the strain had been conserved since 1950, and acci-
dentally released from a laboratory facility. In April 2009, a new strain of H1N1 (S-OIV)
was identified in the United States [264]. This new strain emerged from reassortment of
NA and matrix genes from the Eurasian H1N1 influenza A swine virus and the remaining
six gene segments from the H1N2 swine virus. For this subtype, four different groups of
proteins were retrieved from the Influenza Virus Resource database, summarised in Table
6.4 and listed in Appendix D.
For the Influenza A H2N2 subtype, 76 proteins were sequenced before the period 1957 -
1968 from the Influenza Virus Resource database. H2N2 influenza viruses that could affect
humans appeared in 1957; these were the result of antigenic shift from reassortment be-
tween already existing human H1N1 and avian H2N2 viruses [264]. H2N2 viruses possess
the HA, NA, and PB1 gene fragments of an avian H2N2 virus whereas the remaining five
gene fragments originated from the human H1N1 virus. H1N1 viruses were displaced by
H2N2 viruses that were spreading quickly among humans, causing the Asian flu pandemic
(1956-1958) which killed an estimated two million people worldwide [264].
For Influenza A H3N2 subtype, 200 proteins sequenced from the period 1968 - 2000
were retrieved from the Virus Resource database. H3N2 viruses emerged in 1968 by re-
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Influenza Subtype Period Number of Proteins
H1N1 27 1933 - 1946
H1N1 12 1947 - 1957
H1N1 48 1979 - 1989
H1N1 200 2009
H2N2 76 1957 - 1968
H3N2 200 1968 - 2000
H1N2 27 2001 - 2004
H5N1 70 2005 - 2009
Table 6.1: Influenza Protein Sequences
assortment between circulating human H2N2 and avian H3 viruses [264]. These viruses
adapted from H3 avian virus HA and PB1 genes and the six genes, including NA and, frag-
ments of the already circulating human H2N2 viruses. H3N2 was responsible for the Hong
Kong pandemic (1968-1969) which killed an estimated one million people worldwide.
For Influenza A H1N2 subtype, 27 proteins sequenced from the period 2001 - 2004
were retrieved from the Virus Resource database. The results of the genetically charac-
terised H1N2 subtype [261] to determine the origin of all the eight gene segments showed
that all H1N2 isolates were reassortants of classical swine H1N1 and triple reassortant
H3N2 viruses. The neuraminidase (NA) and PB1 genes of the H1N2 isolates were of hu-
man origin, while the hemagglutinin (HA), nucleoprotein (NP), matrix (M), non-structural
(NS), PA and PB2 polymerase genes were of avian or swine origin.
For Influenza A H5N1 subtype, 70 proteins sequenced from the period 2005 - 2009
in Asia were retrieved from the Virus Resource database. The H5N1 virus was created
by combining various influenza A subtype virus [260]. Avian H3N8 contributes to H5N1
the PB2, PB1, NP and NS genes, while Avian H7N1 contributes to the M gene. H5N3
has the highest nucleotide similarity to H5N1 for the PA gene, which suggests that it has
contributed to the PA and HA gene. Finally, avian H1N1 supplied the NA gene [260].
6.5 Results and Discussion
In this chapter, three sets of results were presented. The first set of results shows the effect
of windowing and zero-padding on the results extracted from the complex informational
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spectrum analysis. The second set of results refers to the analysis of the influenza neu-
raminidase protein sequences. For this case study, each H1N1, H5N1, H2N2, H3N2 and
H1N2 NA protein file was submitted independently to the CISAPS server, and their results
were retrieved by using the reports generated for absolute, real and imaginary informational
spectrum CFPs. For the third analysis, computationally generated amino acid indices as
presented in Chapter 3, were compared with original amino acid indices in relation to the
CISA. The results for the third analysis were obtained using the acid and basic bovine
growth factor protein sequences as presented in Chapter 2.
6.5.1 Effects of Windowing and Zero-Padding
For each of the Influenza A subtypes, two CFP are extracted for each signal length used;
one where the windowing is applied (w) and one where windowing is suppressed (/w). The
results for the Influenza A neuraminidase subtypes are presented in Tables 6.3, 6.4 and 6.5
for CISA, AIS, RIS and IIS respectively and show that windowing and zero-padding have
key impacts on CFP extracted.
Significant changes in the AIS, RIS and IIS have been observed for all the Influenza
A NA subtypes when signal length is increased from 470 to 16384 through zero-padding.
For example, in the case of subtype H1N1, in AIS was found to be 0.1681 when the signal
length was 470, but it shifted to 0.0730 when the signal length was increased to 16384.
Similar results for other subtypes are also observed in subtype H5N1 (0.1681 to 0.4839),
H1N2 (0.3170 to 0.3970) and H3N2 (0.3170 to 0.3970). For RIS, in subtype H1N1 the
CFP shifted from 0.4106 to 0.1687, H5N1 from 0.4830 to 0.3181, H1N2 from 0.3170 to
0.3965 and H2N2 from 0.3170 to 0.4091. For IIS the CFP shifted in subtype H5N1 from
0.3170 to 0.4844 and H3N2 from 0.3447 to 0.3972.
Additionally, significant changes in the AIS, RIS, and IIS can be observed for all In-
fluenza A NA subtypes by applying the hamming window to the encoded protein sequences
before CISA. For CFP in AIS where windowing is applied, significant changes are ob-
served in subtype H1N1 (0.1687 to 0.0732), H5N1 (0.4839 to 0.0739), H1N2 (0.3970
to 0.4584), H2N2 (0.3972 to 0.4859), and H3N2 (0.3970 to 0.4586). For RIS the CFP
shifted in subtype H5N1 from 0.3181 to 0.0731, H1N2 from 0.3965 to 0.4587, H2N2 from
0.4091 to 0.4863 and H3N2 from 0.3171 to 0.4586. For IIS the CFP shifted in subtype
H5N1 (0.4844 to 0.0742), H1N2 (0.3973 to 0.4577), H2N2 (0.3973 to 0.4852) and H3N2
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(0.3972 to 0.1889).
By considering the average percentage identity shown in Table 6.2 and the information
retrieved from the literature regarding the Influenza A NA proteins the best match with CFP
extracted from influenza A subtypes using CISA as shown in Tables 6.3-6.5 is obtained
when the signal length of 4096 and windowing are both applied.
Table 6.2: Average Percent Identity
H1N1 H1N2 H2N2 H3N2 H5N1
H1N1 93% - - - -
H1N2 40% 98% - - -
H2N2 42% 86% 96% - -
H3N2 40% 88% 86% 94% -
H5N1 83% 41% 43% 41% 96%
6.5.2 Case study Results
By submitting each H1N1, H5N1, H2N2, H3N2 and H1N2 NA protein file independently
to the CISAPS server, and using the reports generated for absolute, real and imaginary
informational spectrum CFPs, results were retrieved. All the results obtained and reports
generated can be found in Supplement 3. For the analysis, methods used in signal process-
ing to extract better results were considered. As the Influenza A protein sequences have
different lengths, maximum DFT resolution as well as windowing was also applied to the
signals (protein sequences) in order to reduce spectral leakage as discussed in sub-section
6.2.2. A similar CFP between influenza A subtypes would suggest a close relationship
between two protein classes for the particular feature that the amino acid index represents.
By using minimum and maximum thresholds two sets of amino acid indices were retrieved.
The first set represents amino acid indices with identical or closely related CFPs while the
second set retrieved represent amino acids with more distributed CFPs. Two sets of tables
are created to illustrate these results; Tables 6.10, 6.11 and 6.12 show amino acid indices
that present highly similar cases, where Tables 6.13, 6.14 and 6.15 show amino acid in-
dices that present the most distinct cases according to CFPs. Further information regarding
amino acid indices shown in Tables 6.10 to 6.15 can be retrieved from the web server by
using the assigned ID number.
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Figure 6.3: H1N1 2009 Absolute Report sample obtained from the CISAPS web server
After extracting the results from the CISAPS web server, the next step in the analysis is
to discover if any of the biological features represented in amino acid indices from Tables
6.10 - 6.15 can be related to previous work in the literature. The following associations
were achieved:
• The results indicate that Hydrophobicity plays an important role for the neuraminidase
gene, as it appears multiple times with different amino acid indices. Identification
numbers of these amino acid indices that represent hydrophobicity are 56, 57, 58,
242 and 513. The literature supports [267; 268; 269] that the hydrophobic region
of the influenza neuraminidase gene plays an important role informing the function-
ality of the gene [268; 269] and that it is a potential target for new antiviral drugs
[268; 269].
• According to the literature, Protein Kinase C (PK-C) that is represented in amino
acid 76, appears to play an important role in distinguishing various H5N1 subtypes
[270].
• Another protein feature that is utilised from H1N1 subtype mutants [271] is linker
propensity, which is represented in amino acid indices 434 and 496.
• Finally, as previous work shows, neuraminidase active sites present high polarity
[272] that is represented in amino acid index 111.
As the importance of the amino acid indices that represent hydrophobicity, PK-C and
linker propensity to the neuraminidase gene is established it can be concluded that the
rest of the amino acid indices which appear in Tables 6.10 - 6.15 have a higher degree of
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association than the rest of the amino acid indices in the database. Further investigation
is required regarding the biological relationship of these indices to the influenza A NA
gene. One of the promising results is indices 557 that represent short- and medium-range
non-bonded energy [111], which only appears in the imaginary spectrum.
In the literature, when informational spectrum analysis is used [40; 91; 92] only the
absolute spectrum is considered. As the results show, only the use of the absolute spectrum
to determine how two or more protein classes are related according to CFP is not sufficient.
Several amino acid indices do not appear in the absolute spectrum and have significant bio-
logical importance to the influenza A NA gene. One example are indices 111 and 513 that
represent polarity and hydrophobicity respectively. Additionally, amino acid indices for
the real informational spectrum are 154, 242 and 427 and for the imaginary informational
spectrum are 403, 421, 463 and 557, which do not appear in the absolute spectrum and
may also be biologically significant.
Table 6.3: Absolute Spectra Results
N H1N1 H5N1 H1N2 H2N2 H3N2
/w w /w w /w w /w w /w w
470 0.1681 0.0745 0.1681 0.0745 0.3170 0.4574 0.4085 0.1894 0.3170 0.1894
512 0.0742 0.0742 0.4844 0.0742 0.3965 0.4590 0.4082 0.1504 0.3965 0.4590
1024 0.1689 0.0732 0.4844 0.0742 0.3975 0.458 0.3975 0.1504 0.3975 0.4590
2048 0.0737 0.0737 0.4839 0.0737 0.3970 0.4585 0.3970 0.4858 0.3970 0.4585
4096 0.0737 0.0735 0.4839 0.0740 0.3970 0.4585 0.3972 0.4858 0.3970 0.4585
8192 0.0737 0.0735 0.4839 0.0739 0.3970 0.4584 0.3972 0.4860 0.3971 0.4585
16384 0.0737 0.0735 0.4839 0.0739 0.3970 0.4584 0.3972 0.4859 0.3970 0.4586
Table 6.4: Real Spectra Results
N H1N1 H5N1 H1N2 H2N2 H3N2
/w w /w w /w w /w w /w w
470 0.4106 0.4915 0.4830 0.4872 0.3170 0.5000 0.3170 0.5000 0.3170 0.3170
512 0.2188 0.2188 0.3184 0.3184 0.3965 0.4590 0.3926 0.4863 0.3965 0.4590
1024 0.0732 0.0732 0.4834 0.0732 0.3965 0.4590 0.4092 0.4863 0.3174 0.4590
2048 0.0732 0.0732 0.4834 0.0732 0.3965 0.4585 0.4092 0.4863 0.3169 0.4585
4096 0.1687 0.0732 0.3181 0.0732 0.3965 0.4587 0.4092 0.4863 0.3171 0.4585
8192 0.1687 0.0731 0.3181 0.0731 0.3965 0.4587 0.4091 0.4863 0.3171 0.4586
16384 0.1687 0.0732 0.3181 0.0731 0.3965 0.4587 0.4091 0.4863 0.3171 0.4586
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Table 6.5: Imaginary Spectra Results
N H1N1 H5N1 H1N2 H2N2 H3N2
/w w /w w /w w /w w /w w
470 0.0745 0.0745 0.3170 0.0745 0.4085 0.4574 0.4085 0.4851 0.3447 0.4596
512 0.0742 0.0742 0.4844 0.0742 0.4082 0.2227 0.4082 0.1777 0.4082 0.2109
1024 0.0742 0.0742 0.4844 0.0742 0.3975 0.4580 0.3975 0.4854 0.3975 0.3975
2048 0.0742 0.0742 0.4844 0.0742 0.3975 0.4575 0.3975 0.4854 0.3975 0.1890
4096 0.0742 0.0742 0.4844 0.0742 0.3972 0.4578 0.3972 0.4854 0.3972 0.1890
8192 0.0741 0.0741 0.4844 0.0742 0.3973 0.4578 0.3972 0.4852 0.3972 0.1890
16384 0.0741 0.0741 0.4844 0.0742 0.3973 0.4577 0.3973 0.4852 0.3972 0.1889
6.5.3 Comparison of Generated and Original Amino Acid Indices in
respect to Complex informational Spectrum Analysis
To compare the computationally generated Amino Acid indices (AAI) with the original
AAI, CISA [146; 245] was applied to extract biologically related features. To demonstrate
the application of CISA two protein sequences and four computationally generated AAI
were used in the analysis. The protein sequences selected are (1) acid bovine fibroblast
growth factor (AAA66188) [94] and (2) bovine fibroblast growth factor (AAA30517) [94].
The four computationally generated AAI that yielded a variance of 1.0 and appeared
in all five clustering methods are selected, as shown in Table 6.6. All the AAI within the
selected clusters represents the same or similar biological feature of the protein sequences.
The original AAIs that were used to generate the four new computationally generated AAI
are summarised as follows:
• Cluster 1
– BROC820101: Retention coefficient in TFA [273]
– BROC820102: Retention coefficient in HFBA [273]
• Cluster 2
– PRAM820102: Slope in regression analysis x 1.0E1 [274]
– PRAM820103: Correlation coefficient in regression analysis [274]
• Cluster 3
– MIYS990101: Relative partition energies derived by the Bethe approximation
[144]
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– MIYS990102: Optimized relative partition energies - method A [144]
• Cluster 4
– MIYS990103: Optimized relative partition energies - method B [144]
– MIYS990104: Optimized relative partition energies - method C [144]
In order for the CISA method to be applied, the protein sequences used must have the
same length. Zero-padding is used to increase the length of the proteins to 512. Addition-
ally, the Hamming windowing was applied to the protein sequences used. Characteristic
Frequency Peak (CFP) is obtained for each AAI, including the original and computation-
ally generated AAI. Tables 6.7, 6.8 and 6.9 show the extracted CFP values from the protein
sequences. Results show, that for each of the original AAIs, which belongs to the same
cluster, the extracted CFP value is similar or identical to the other AAIs that belong to the
same cluster. However, results in tables 6.7, 6.8 and 6.9 shows AAI that belong to another
cluster and represent a different biological feature can result to the same CFP. For exam-
ple, cluster 1, 3 and 4 resulted to an approximate identical CFP in AIS, RIS and IIS, only
cluster 2 can be distinguished. By using computationally generated AAI for CIS analysis,
a clear separation of the CFP extracted values for the clusters can be achieved. In addition,
clusters that represent each class with variance 1.0 the CFP extracted in all three possible
spectra are distinct (Table 6.6).
Table 6.7: Absolute Informational Spectrum Results
Generated Index Name Original Index CFP Generated
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Table 6.8: Real Informational Spectrum Results
Generated Index Name Original Index CFP Generated













Table 6.9: Imaginary Informational Spectrum Results
Generated Index Name Original Index CFP Generated














In this chapter a web-based server is developed and presented , named CISAPS, which
provides complex informational spectrum analysis for protein sequences. As the results
show protein classes that present similarities or differences according to the CFP in specific
amino acid indices, then it is probable that these classes are related with the protein feature
that the specific amino acid represents. Furthermore, the use of only the absolute spectrum
in the analysis of protein sequences using the informational spectrum analysis is proven
to be insufficient, as biologically related features to the analysis of influenza A subtypes
appear individually either in the real or the imaginary spectrum.
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In the literature, various areas exist where ISA and RRM have been successfully ap-
plied. For these areas, CISA will also be applicable, and will be able to contribute addi-
tional information as discussed below.
Development of New Drugs:
Bioinformatics has become an important component in drug discovery in the recent years,
by accelerating this complex, expensive and time-consuming process. ISA, in combination
with the EIIP scale index can successfully be applied in the bioinformatics model for the
discovery and development of new drugs. As the EIIP scale index represents the interaction
potential of amino acids, the development time of a new drug can considerably decrease
by applying ISA or CISA in the following ways:
1. By extracting key features such as the CFP of compounds that have shown activity
against the target disease and comparing them against molecular databases.
2. By using ISA and CISA, the selected compounds can be modified to increase the
desire biological activity.
3. Additionally potential target areas can be identified by selecting protein or nucleotide
sequences domains.
An example of applying ISA in the area of drug discovery can be found in [247] where this
technique was applied in development of HIV entry inhibitors.
Identification of important protein sequence’s domains:
In biology, similar or identical nucleotide or protein sequences are called conserved se-
quences that can occur across different species or are presented in different molecules
within the same organism. In influenza research area, the identification of such as a con-
served domain is essential, especially any receptor binding related domain to the devel-
opment of influenza inhibitors. By using ISA, the informational [42; 248] and structural
[42; 248] features as well multiple conserved domain [275] of HA with receptor-virus in-
teraction were investigated that related with receptor-virus interaction. These studies were
intended to expand the collection of key regions by discovering multiple domains of H1N1
and H5N1 HA subtype 1 that can alter the receptor binding model. Using the same ap-
proach, mutations F71S, T128S, E302K and M314L, in the H1N1 HA gene are recognised
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necessary for the human interaction. Additionally, positions 94D, 196D and 274D in the
H1N1 HA were marked as important hot-spots for mutations. One of these mutations hot-
spots, D274E, is already identified in H1N1 isolates and its contribution to the human host
adaptation is identified. Furthermore, the results in these studies propose that the Influenza
subtype H1N1 HA gene will persist in mutating, which could further promote the human
interaction. These results were extracted using CFP at frequencies 0.055 and 0.295. An-
other study that uses ISA aims to predict amino acid residues in highly conserved domains
of the hormone prolactin (PRL) [276]. In this study, ISA was implemented with the EIIP
scale index to extract the CFP of the PRL hormone and to determine which amino acids
contribute more to these frequencies, and therefore to the PRL biological function. By
using ISA, the highly conserved regions by using ISA were determined in amino-terminal
and C-terminus regions of PRL. As the paper [276] proposes, predictions correspond with
experimentally tested residues using site-direct mutagenesis and photoaffinity labeling.
Investigation of Protein Sequences Interaction:
Another bioinformatics area in which ISA is applied is the analysis of protein sequence in-
teraction. By using ISA with EIIP index scale’s interactions between oncogene, IL-2, and
p53 tumor suppressor proteins were analysed [249]. In order to investigate the common
interactions of these protein sequences, CFP needs to be determined. As the results of this
study had showed, ISA can be effectively used to extract features from protein sequences
related to their common biological function. All three interactive protein sequences used
share the CFP at frequency 0.0322. This identified feature is a distinguishing feature of
oncogene proteins and can be used to characterise promotion of uncontrolled cell growth.
Furthermore, anti-cancerous properties can be identified using CFP features and peptides
can be designed to exhibit only these characteristics. As these results [249] show, ISA
and CISA can provide a new method to understand information presented in a protein se-
quence’s primary structure. Finally, these results can be used to contribute significantly in
the development of new biomaterials by accelerating complex costly and time consuming
procedures.
Additionally, an example is given where CIS analysis is applied to the generated amino
acid indices in comparison to the original amino acid indices, as described in chapter 3.
The results indicate that a clear separation of the CFP extracted for each of the clusters
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can be achieved, in which distinctive protein features are represented. In contrast, in the
individual amino acid indices, different protein features may result in the same or similar
CFP.
This web-based server enables researchers with little knowledge of signal processing
methods to apply and include complex informational spectrum analysis to their work. Fur-
thermore, CISAPS uses a collection of 611 unique amino acid indices, each one repre-
senting a different property, to perform the analysis. Moreover, in this chapter, various
technical issues such as signal length and windowing that may affect the analysis are also
addressed.
Finally, a comparison is given between the original and generated amino acid indices
in regard to the CISA. As the results show by using CISA and the generated amino acid
indices, CFP extracted in all three possible spectra are more distinct in relation to the bio-
logical features the amino acid indices represent, in comparison to the original amino acid
indices. More experimental study is required for the use of CISA with the generated amino
acid indices as presented in Chapter 3, and their practical applications in classification and
characterisation of protein sequences.
Table 6.10: Characteristic Frequency Peak Similarities in Absolute Informational Spec-
trum
ID H1N1 1933 H1N1 1947 H1N1 1979 H1N1 2009 H5N1 H1N2 H2N2 H3N2
56 0.142 0.1418 0.1418 0.1276 0.1423 0.122 0.1218 0.122
57 0.1276 0.1276 0.1276 0.1276 0.1274 0.122 0.1218 0.122
58 0.142 0.142 0.142 0.1276 0.1425 0.122 0.122 0.122
84 0.082 0.0817 0.082 0.0815 0.0817 0.081 0.0813 0.081
113 0.1208 0.1208 0.1208 0.1205 0.1208 0.122 0.122 0.122
126 0.082 0.0817 0.0817 0.0817 0.0815 0.081 0.0813 0.081
173 0.082 0.0817 0.082 0.0817 0.0815 0.0808 0.0813 0.081
333 0.0817 0.0815 0.0817 0.0815 0.0813 0.0805 0.081 0.0808
369 0.082 0.0817 0.082 0.0817 0.0815 0.081 0.0813 0.0813
416 0.0815 0.0815 0.0815 0.0813 0.081 0.0803 0.0808 0.0805
436 0.1271 0.1271 0.1271 0.1271 0.1269 0.122 0.122 0.122
544 0.1274 0.1274 0.1274 0.1274 0.1271 0.1218 0.1218 0.1218
589 0.0822 0.082 0.082 0.0817 0.082 0.0815 0.0815 0.0815
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Table 6.11: Characteristic Frequency Peak Similarities in Real Informational Spectrum
ID H1N1 1933 H1N1 1947 H1N1 1979 H1N1 2009 H5N1 H1N2 H2N2 H3N2
56 0.1269 0.1271 0.1423 0.1271 0.1418 0.1218 0.1218 0.1218
57 0.1269 0.1271 0.1271 0.1271 0.1274 0.1218 0.1218 0.1218
58 0.1269 0.1425 0.1423 0.1425 0.1418 0.1218 0.1218 0.1218
84 0.0827 0.0813 0.0813 0.0813 0.0817 0.0813 0.0813 0.0813
111 0.1269 0.1271 0.1271 0.1271 0.1274 0.1218 0.1218 0.122
113 0.121 0.1213 0.1213 0.1213 0.121 0.1218 0.1218 0.1218
126 0.0827 0.0813 0.0813 0.0813 0.0817 0.0813 0.0815 0.0815
173 0.0827 0.0813 0.0813 0.0813 0.0817 0.0813 0.0815 0.0815
242 0.1269 0.1271 0.1271 0.1271 0.1271 0.1218 0.1218 0.1218
333 0.0827 0.081 0.0813 0.0813 0.0817 0.0813 0.0813 0.0813
369 0.0827 0.0813 0.0813 0.0813 0.0817 0.0813 0.0815 0.0815
416 0.0825 0.081 0.0813 0.0813 0.0817 0.0813 0.0813 0.0813
436 0.1269 0.1271 0.1271 0.1271 0.1274 0.1215 0.1215 0.1215
513 0.1269 0.1271 0.1271 0.1271 0.1274 0.1218 0.1218 0.1218
544 0.1269 0.1271 0.1271 0.1271 0.1274 0.1218 0.1218 0.1218
589 0.0827 0.0813 0.0813 0.0813 0.082 0.0815 0.0815 0.0815
Table 6.12: Characteristic Frequency Peak Similarities in Imaginary Informational Spec-
trum
ID H1N1 1933 H1N1 1947 H1N1 1979 H1N1 2009 H5N1 H1N2 H2N2 H3N2
56 0.1279 0.1415 0.1415 0.1281 0.1428 0.1227 0.1225 0.1227
57 0.1281 0.1281 0.1281 0.1281 0.1428 0.1227 0.1227 0.1225
58 0.1281 0.1415 0.1415 0.1281 0.1428 0.1227 0.1225 0.1227
84 0.0817 0.082 0.0822 0.0822 0.0827 0.0803 0.0803 0.0803
113 0.1201 0.1203 0.1203 0.1203 0.1201 0.1227 0.1227 0.1225
126 0.0817 0.0822 0.0822 0.0822 0.0808 0.0805 0.0805 0.0805
173 0.0817 0.0822 0.0825 0.0822 0.0808 0.0803 0.0805 0.0805
333 0.0817 0.0822 0.0822 0.0822 0.0808 0.0803 0.0805 0.0803
369 0.0817 0.0822 0.0822 0.0822 0.0808 0.0803 0.0805 0.0803
403 0.0378 0.0698 0.0698 0.0698 0.0713 0.0698 0.0698 0.0698
416 0.0815 0.082 0.082 0.082 0.0805 0.0803 0.0803 0.0803
436 0.1281 0.1281 0.1281 0.1281 0.1262 0.1225 0.1225 0.1225
463 0.4846 0.4832 0.4832 0.4832 0.4841 0.4851 0.4849 0.4851
544 0.1281 0.1281 0.1281 0.1281 0.1428 0.1227 0.1227 0.1225
589 0.0817 0.0822 0.0825 0.0822 0.083 0.0805 0.0825 0.0825
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Table 6.13: Characteristic Frequency Peak Differences in Absolute Informational Spec-
trum
ID H1N1 1933 H1N1 1947 H1N1 1979 H1N1 2009 H5N1 H1N2 H2N2 H3N2
73 0.4885 0.4712 0.471 0.471 0.4707 0.02 0.02 0.0203
81 0.4837 0.4839 0.0251 0.0576 0.0588 0.4861 0.4861 0.4861
110 0.4605 0.4605 0.4607 0.0203 0.02 0.0205 0.0203 0.0205
285 0.0586 0.0586 0.4341 0.4344 0.4346 0.0207 0.4363 0.0205
359 0.4888 0.4888 0.4885 0.0188 0.4885 0.0215 0.458 0.0215
373 0.4893 0.4898 0.49 0.4893 0.489 0.0769 0.0761 0.0764
375 0.4297 0.4292 0.4283 0.4305 0.43 0.0381 0.0378 0.0378
496 0.4463 0.4463 0.4466 0.3902 0.0234 0.0683 0.0686 0.0686
536 0.4602 0.4602 0.4605 0.4602 0.4602 0.0203 0.0207 0.0205
574 0.0395 0.0395 0.0395 0.0393 0.3502 0.4863 0.4858 0.4861
588 0.0576 0.0573 0.0573 0.0576 0.0583 0.4863 0.4861 0.4863
Table 6.14: Characteristic Frequency Peak Differences in Real Informational Spectrum
ID H1N1 1933 H1N1 1947 H1N1 1979 H1N1 2009 H5N1 H1N2 H2N2 H3N2
73 0.4641 0.4702 0.4705 0.4705 0.4824 0.0195 0.0195 0.0195
76 0.4702 0.4841 0.4841 0.0859 0.0727 0.409 0.021 0.021
81 0.0246 0.4841 0.0249 0.1796 0.0591 0.4858 0.4858 0.4858
110 0.4602 0.4605 0.4605 0.0193 0.021 0.4566 0.0195 0.4566
154 0.0581 0.4841 0.0561 0.0561 0.0591 0.3773 0.4858 0.4858
343 0.4902 0.1083 0.1083 0.0815 0.49 0.1088 0.4339 0.4339
359 0.4883 0.4888 0.4885 0.0193 0.0188 0.0215 0.4585 0.0215
373 0.491 0.4888 0.489 0.4888 0.4905 0.0781 0.0761 0.0761
375 0.43 0.428 0.4278 0.43 0.4305 0.0371 0.0371 0.0371
427 0.0224 0.0227 0.0227 0.3895 0.0224 0.4366 0.4366 0.3199
536 0.4605 0.4605 0.4607 0.0212 0.4595 0.0193 0.0212 0.0212
574 0.0403 0.04 0.04 0.0398 0.039 0.4863 0.4861 0.4861
588 0.0581 0.0581 0.0581 0.0581 0.0588 0.4861 0.4858 0.4858
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Table 6.15: Characteristic Frequency Peak Differences in Imaginary Informational Spec-
trum
ID H1N1 1933 H1N1 1947 H1N1 1979 H1N1 2009 H5N1 H1N2 H2N2 H3N2
73 0.4632 0.4714 0.4714 0.4714 0.4837 0.0205 0.0203 0.0205
76 0.0722 0.4832 0.4832 0.0717 0.4839 0.408 0.0754 0.0754
81 0.0259 0.4834 0.0261 0.0571 0.0578 0.4871 0.4868 0.4868
359 0.4893 0.4898 0.4898 0.0183 0.4888 0.0224 0.0205 0.0205
375 0.4307 0.429 0.429 0.4309 0.4295 0.0381 0.0381 0.0381
285 0.4334 0.1096 0.4336 0.4336 0.4346 0.0203 0.4356 0.0205
343 0.4893 0.1074 0.1074 0.0825 0.489 0.0637 0.4351 0.4348
421 0.0232 0.0237 0.0237 0.3902 0.0234 0.4358 0.4356 0.4356
434 0.4653 0.0237 0.0237 0.4653 0.0234 0.4356 0.4356 0.4356
536 0.4649 0.185 0.4597 0.4597 0.4605 0.0203 0.0203 0.0203
557 0.0569 0.02 0.02 0.0571 0.0195 0.4085 0.4361 0.4361
574 0.0393 0.039 0.039 0.0388 0.0403 0.4873 0.4851 0.4854
588 0.0569 0.4029 0.0571 0.0571 0.0578 0.4868 0.4868 0.4868
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Chapter 7
Investigation into the Effects of an
Individual Amino Acid on Protein
Function by Means of Discrete Fourier
Transform
7.1 Introduction
In recent years, a number of tools that are capable of directly identifying the mechanism
by which proteins interact with their environment have been developed. Several of these
tools are able to directly identify rules from primary protein structures. Two popular tools
are the Basic Local Alignment Search Tool (BLAST) [241] and Protein Feature Server
(PROFEAT) [56]. The former searches for similarities in the arrangements of amino acids
in proteins while the latter extracts structural and physicochemical features from protein
sequences, which can then be combined with statistical and/or machine learning methods
for prediction of properties of proteins [79; 277; 278; 279]. Capturing sequence order is an
important but challenging problem, for which there have been various methods developed
[280; 281; 282].
Matching biological functions to features that are extracted by signal processing is an-
other technique that is available in order to deal with capturing sequence order information.
An example of this is the Resonant Recognition Model (RRM) [91; 92] that uses Discrete
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Fourier Transform (DFT) and electron-ion interaction potential (EIIP) amino acid scale
[87]. By using this method, characteristic features of proteins or families of proteins, can
be identified which can be related to a specific protein function. With RRM each of the
protein classes under study can be related to the biological function that they represent,
by identifying a unique peak or set of peaks extracted from the frequency spectrum. Each
unique peak extracted using RRM is called a Characteristic Frequency Peak (CFP). Further
information regarding the RRM and Complex Resonant Recognition Model (CRRM) can
be found in Chapters 2 and 6, respectively.
After identifying a unique peak or set of peaks which can be related to specific biolog-
ical function by using signal processing techniques, a question that arises is which amino
acid of the protein sequences contributes most to the specific feature extracted? One ap-
proach [42; 247] in the literature uses RRM to determine which section of protein is a
dominant contributor to CFP. This section can be identified by measuring the magnitude of
DFT at the CFP position, and selecting the window with the highest value. In this study,
a new approach that measures the effect of individual amino acids of protein sequences
upon CFP extracted from RRM is developed and presented. For this analysis, five different
protein classes of influenza A virus Neuraminidase (NA) protein, which includes H1N1,
H1N2, H2N2, H3N2 and H5N1 subtypes, are used to show applicability and robustness of
the method developed.
7.2 Methodology
In this section, the influence of individual amino acid on the common frequency peak and
on the absolute spectrum is described [283]. The difference between these methods is
on the selection of the frequency. The former method selects the frequency based on the
common frequency peak that is calculated by using the RRM. The latter method calculates
the effect of individual amino acids from the entire frequency spectrum and selects the
frequency that presents the highest change.
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7.2.1 Influence of Individual Amino Acid on the Common Frequency
Peak
The following algorithm must be followed to determine how individual amino acid can
affect the magnitude of DFT at the CFP position.
STEP 1: Calculate the CFP position for given protein sequences using Informational
Spectrum Analysis.
STEP 2: Calculate the magnitude of DFT at the CFP position for all original protein
sequences.
STEP 3: Remove single amino acid at position X from original protein sequences with
length N.
STEP 4: Recalculate the magnitude of DFT at the CFP position for all modified protein
sequences.
STEP 5: Compare DFT at the CFP position between original and modified protein
sequences.
STEP 6: Repeat STEP 3 to 5 for all N amino acids in protein sequences.
After all the six steps are completed the outcome is a measurement for all individual
amino acids of all given protein sequences.
7.2.2 Influence of Individual Amino Acid on the Absolute Spectrum
In the previous section an algorithm is described to determine the effects of individual
amino acids on the CFP in the spectrum determined by RRM. In this section an additional
algorithm will be described on how individual amino acid can affect the entire absolute
spectrum in different locations and at different magnitude.
STEP 1: Calculate the absolute spectrum for given protein sequences.
STEP 2: Remove single amino acid at position X from original protein sequences with
length N.
STEP 3: Recalculate the absolute spectrum for all modified protein sequences.
STEP 4: Compare the absolute spectrum between original and modified protein se-
quences.
STEP 5: Repeat STEP 2 to 4 for all N amino acids in protein sequences.
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STEP 6: Select the frequency with the maximum value which represent the maximum
effect in the absolute spectrum
After all five steps are completed the outcome is a measurement for all individual amino
acids of all given protein sequences.
7.3 Case Study: Analysing Influenza A NA protein Se-
quences
7.3.1 Protein Sequences
For the analysis five Influenza A Neuraminidase (NA) proteins were retrieved from the In-
fluenza Virus Resource data set [263]. Further information regarding the protein sequences
used can be found in Table 7.1. A pairwise percent identity for all the proteins that belong
to the family of influenza NA proteins was calculated by using CLUSTALW [200] and
is given in Table 7.2. A high pairwise percent identity is observed between H1N1 and
H5N1 (87%), H1N2 and H2N2 (85%) and H1N2 and H3N2 (87%) NA proteins. Low per-
cent identity is observed between H1N1 and H1N2 (40%), H1N1 and H2N2 (42%), H1N1
and H3N2 (39%), H5N1 and H1N2 (41%), H5N1 and H2N2 (42%) and H5N1 and H3N2
(41%).
Table 7.1: Influenza A NA protein Sequences Used for the Case Study
ID Name Length Reference
ADK33724 A/Aarhus/INS242/2009(H1N1) 469 [284]
ADG59213 A/Anhui/1/2005(H5N1) 449 [285]
CAD29972 A/Egypt/84/2001(H1N2) 469 [286]
ABO52305 A/Albany/3/1958(H2N2) 469 [284]
ACF22356 A/Hong Kong/1-2-MA21-2/1968(H3N2) 469 [284]
7.3.2 Results
In this section, the results produced the influence of individual amino acid on the common
frequency peak and on the absolute spectrum will be presented and discussed.
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Table 7.2: Pairwise Percent Identity
H1N1 H1N2 H2N2 H3N2
H1N2 40% - - -
H2N2 42% 85% - -
H3N2 39% 87% 94% -
H5N1 87% 41% 42% 41%
7.3.2.1 Influence of Individual Amino Acid on The Common Frequency Peak
By following the method described in Section 7.2.1 the following results are obtained for
the five influenza A NA proteins. Step 1 requires that the CFP position for the protein
sequences is calculated. For the five influenza A NA proteins, Figure 7.1 shows the CFP
was found to be 0.4583. By following the remaining Steps 2 to 6, the influence of all amino
acids of Influenza NA proteins is calculated. Figures 7.2, 7.3, 7.4, 7.5 and 7.6 show the
results for H1N1, H5N1, H1N2, H2N2 and H3N2 NA proteins respectively. Each point
in the figures gives the impact of a particular amino acid on DFT at the CFP position. All
the results are presented in percentage to the original value of DFT at the CFP position.
A threshold can be used to adjust the identified location according to the individual amino
acid impact. For this analysis, a 60% threshold is applied to the results in order to obtain
a sufficient area from the protein sequences. Four key areas are identified by applying the
60% threshold to the results.
These areas present the highest impact on DFT at CFP position. The key areas are A, B
and C as displayed in Figures 7.2 and 7.3 between H1N1 and H5N1 NA proteins. Area D is
displayed in figures 7.4, 7.5 and 7.6 is also identified between H1N2, H2N2 and H3N2 NA
proteins. All amino acids that correspond to areas A, B, C and D can be found in Tables
7.3, 7.4, 7.5, 7.6 and 7.7 for H1N1, H5N1, H1N2, H2N2 and H3N2, respectively .
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Figure 7.1: Informational Spectrum Analysis Results
By using the identified areas as shown in Tables 7.3-7.7 three segments that exist un-
changed in influenza A proteins between H1N1 and H5N1 and two segments between
H1N2, H2N2 and H3N2 NA proteins are identified. For H1N1 and H5N1 NA proteins the
following segments are identified
• PSPYNSRFESVAWS from A area,
• IGISGPDNGAVAVLKYNGIITDTIKSWRNNILRTQESECACVNGSCFTVMTS
from B1 area and
• EITCVCRDNWHGSN from B2 area.
For H1N2, H2N2 and H3N2 NA proteins the following segments are identified
• GRLVDSIGSWS and
• ILRTQESECVCINGTC from area D.
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Figure 7.2: H1N1 Results
7.3.2.2 Influence of Individual Amino Acid to Absolute Spectrum
For this analysis, one H1N1 NA protein is selected, A/Brevig Mission/1/1918 H1N1 (3BEQ)
[287], for which extensive information exists in the literature regarding the primary, sec-
ondary and tertiary structures, as well as the binding site with NA inhibitors. By following
the method described in Section 7.2.2 the following results are obtained for the five in-
fluenza A NA proteins. Step 1 requires that the absolute spectrum for the protein sequences
is calculated. As steps 2 and 3 describe, by removing single amino acid from the H1N1
NA protein, the absolute spectrum is recalculated for the modified sequence. The subse-
quent step is to compare these spectra calculated, as Figure 7.7 shows where the X axis
represents frequencies and the Y axis represents the amino acids of the protein sequence.
The next step in the analysis is to select the frequency with the maximum value, which
represents the maximum effect of individual amino acids in the absolute spectrum. This
frequency is 0.3735 as it is highlighted in Figure 7.7 and can be observed in more detail in
Figure 7.8. Furthermore, by using Figure 7.8, three consecutive areas, S1, S2 and S3, are
identified. Additionally, the identified areas, S1, S2 and S3, correspond to specific amino
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Figure 7.3: H5N1 Results
acids on the protein sequence under investigation. Figure 7.9 highlights these amino acids
selected with colour coding on the tertiary structure of H1N1 NA as Figures 7.10 and 7.11
show. As the results indicate, the identified areas S1, S2 and S3 converge in an active site
within the structure that appears in the tertiary structure of H1N1 NA as Figure 7.10 shows.
From the literature [287], zanamivir, which is an antiviral, binds to this location as Figure
7.11 shows.
7.4 Conclusions and Discussions
Upon identification of a new protein, it is important to single out these amino acids respon-
sible for the structural classification of the protein, as well as the amino acids contributing
to the protein’s specific biological characterisation. In this chapter, a novel approach is
presented to identify and quantify this cause and effect relationship between amino acid
and protein. Two methods are presented in this chapter; the first method takes into con-
sideration the frequency peak, CFP, which it calculated by using the RRM, and the sec-
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Figure 7.4: H1N2 Results
ond technique considers the entire absolute spectrum. Applicability and robustness of the
methods are shown on a case study where five different protein families of the influenza
A virus NA proteins, which includes H1N1, H1N2, H2N2, H3N2 and H5N1 NA proteins,
are studied.
For the first method described, which studies the influence of individual amino acid to
CFP for each of the Influenza A NA proteins studied, areas A, B, C and D that have a high
impact on DFT at CFP position as shown in Figures 7.2 to 7.6, are identified. The analyses
identified five segments, three between H1N1 and H5N1 and two between H1N2, H2N2
and H3N2 and suggested that they play a key role in Influenza A NA protein functionality
and can potentially be considered as target areas for future antiviral drugs and vaccines such
as neuraminidase inhibitors [262]. For the second method, which studies the influence of
individual amino acid, the frequency 0.3735 is highlighted to present the highest impact to
absolute spectrum. Furthermore, by using this distinguished frequency three consecutive
areas, S1, S2 and S3 are identified. As the results show the identified areas S1, S2 and
S3 converge in an active site within the structure that appears in the tertiary structure of
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Figure 7.5: H2N2 Results
H1N1 NA as shown in Figures 7.10, where according to the literature [287], the antiviral
zanamivir binds to this location as shown in Figure 7.11.
The biological functionality, represented by the amino acid index used to encode pro-
tein sequences to numerical sequences, can directly be linked to the identified segments
of the protein sequences. In this study, EIIP was used, but more than 611 unique amino
acid indices exist as discussed in in Chapter 3. These amino acid indices can be used to en-
code protein sequences and thus utilised for further analysis that may help reveal additional
important segments of the protein sequences under study.
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Figure 7.6: H3N2 Results
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Figure 7.7: Effects of single amino acid on absolute spectrum for H1N1 NA protein
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Figure 7.8: Results for frequency 0.3735 for H1N1 NA protein
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Figure 7.10: H1N1 NA protein active site within the structure
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approach for Subgroup Discovery and
Classification of Protein Sequences
8.1 Introduction
In recent years, decoding the rules that drive biological functions of proteins directly from
their primary structures, has become a subject of intensive research with one example being
the Basic Local Alignment Search Tool (BLAST) [241]. Signal processing-base techniques
such as Resonant Recognition Model (RRM) [40; 91; 92] and Complex Resonant Recog-
nition Model (CRRM) [245] have been introduced in bioinformatics to extract information
that is expected to match protein biological functions. The study is performed using the
algorithms that help derive meaningful knowledge from the proteins based on features ex-
tracted from the signal processing techniques. One such example is the examination of the
relationship between a different protein sequences subgroups. These results can then help
develop therapy and/or vaccines.
Signal processing techniques can generate a large amount of information, which can
be related to a protein’s biological function. The RRM and CRRM are only two of the
techniques that try to identify which of the features extracted are related to the protein
biological function. New methods are required to be able to identify all the important
features that can be related to the bioinformatics problem, and to discard any ineffective or
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noisy data. In this chapter, two algorithms will be used to be able to determine if a feature,
or a set of features, extracted from protein sequences using signal-processing techniques
can be used to characterise different protein classes. The algorithms used are the Subgroup
Discovery (SD) [288; 289] and Support Vector Machine (SVM) [153; 154].
SD can have both predictive and descriptive orientation, and its objective is to find in-
terpretable rules to describe relationships in the data. SD algorithms have been applied to
bioinformatics problems such as cancer diagnosis [290; 291; 292; 293; 294]. These types
of bioinformatics problems can be characterised as complex, in respect to the number of
variables (between 7000 and 22,000), and with a low number of cases (not more than 200
cases). In various applications [290; 291; 292; 293; 294], good results of the SD algo-
rithms in solving bioinformatics problems were presented, where novelty and interpretable
models were obtained. The Non-dominated Multiobjective Evolutionary Algorithm for
Extracting Fuzzy Rules in Subgroup Discovery (NMEEF-SD) [295] is employed as it is a
novel approach which has been shown to yield more accurate results [295]. These proper-
ties have been considered by the experts in applying NMEEF-SD to the influenza A virus
problem with several objectives, for obtaining a model, which can describe relationships
in an interpretable way, and for predicting the type of the virus for new proteins introduced
in the data set.
Additionally, SVM [153; 154] is implemented to create a classification model, which
can be used to model relationships between protein sequences. SVM is a supervised sta-
tistical learning method that analyses data and recognises patterns for classification. The
SVM takes a set of input data and predicts to which of two or more possible classes each
given input belongs. SVM is selected as it can produce accurate and robust classification
results on a established theoretical basis even when input data are noisy or non-linearly
separable [296; 297].
Therefore, an exhaustive experimental study with the NMEEF-SD algorithm and SVM
is presented for the problem, where different configurations of the algorithms are used
to find the best model. By using the NMEEF-SD algorithm, the study is tackled from two
different perspectives. On the one hand, a complete study from the point of view of SD task
is performed to find the best parameters employed for the algorithm to solve the problem
with respect to interpretability, novelty and precision. On the other hand, a predictive
analysis is performed to show the ability of the NMEEF-SD algorithm to classify new
proteins in the different virus studied. By using the SVM algorithm, the study tries to find
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the best parameters to build the most accurate classification model. Furthermore, F-score
is used in combination with SVM to select the top-related features for the classification
model.
Finally, the predictive models obtained by the NMEEF-SD and SVM with the complete
data set is presented to show the more representative subgroups and classification models
created for the influenza A virus problem. An exhaustive study of different neuraminidase
genes of influenza A virus subtypes is presented in this chapter: H1N1, H2N2, H3N2 and
H5N1 NA subtypes are used in this analysis. These protein sequences were chosen for the
high percentage identity they demonstrate within individual influenza subtype classes and
the high variation they display in percent identity.
The chapter is organised as follows: Section 8.2 presents the methods and materials
used in this chapter. Section 8.2.1 describes the signal processing methods used to extract
protein related features. Sections 8.2.2 and 8.2.4 describes the methods used in this anal-
ysis, NMEEF-SD and SVM respectively. Section 8.3 presents a case study with influenza
subtypes sequences and the results obtained by employing NMEEF-SD and SVM. Finally,
conclusions are discussed in Section 8.4.
8.2 Methods and Materials
8.2.1 Signal Processing For Protein Sequence Analysis
By using digital signal processing techniques, the goal is to extract information that can
be related to biological functions of proteins. Various methods have been used in bioin-
formatics for analysing protein sequences in recent years, and one of the most common
methods is the RRM [40; 91; 92] and CRRM [245]. Previous studies [42] used influenza A
subtypes to analyse the hemagglutinin (HA) gene, with RRM aiming to identify new thera-
peutic targets for drug development by better understanding the interaction of the influenza
virus and its receptors.
In contrast to previous studies, the analysis was performed directly to absolute spec-
trum, which is derived by applying Discrete Fourier Transform (DFT) to each numerical
encoded protein sequence. Electron-ion interaction potential (EIIP) [87; 88] amino acid
index, as shown in Table 2.3, is used as express protein sequences to numerical sequences
in order to be able to apply DFT. For the analysis of influenza A virus proteins, as the
141
8. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
SUBGROUP DISCOVERY AND CLASSIFICATION OF PROTEIN SEQUENCES
sequences have different lengths, zero-padding was used to extend all protein sequences
to N = 512 thus the output of the absolute spectrum is 256 features. Further information
regarding RRM, CRRM can be found in Chapters 2 and 6, respectively.
8.2.2 Subgroup Discovery Technique 1
The concept of Subgroup Discovery Technique (SD) was initially introduced by Kloesgen
[288] and Wrobel [289]. SD [288; 289] is a data mining technique that aims at discovering
relationships between properties of a given data set in respect to a specific property defined
by the user. An induced subgroup can be represented by a rule (R) [298; 299]:
R : Cond → Class
where Class represents the target variable for SD, and Cond is a combination of attribute-
value features that describe a statistical distribution in respect to the Class.
SD has a combination of predictive and descriptive orientation, and it is differentiated
from classification techniques because SD attempts to describe knowledge for the data
while a classifier attempts to predict it. Furthermore, the model obtained by a SD algo-
rithm is usually simple and interpretable, while that obtained by a classifier is complex and
precise.
As Figure 8.1 shows, the model obtained from the classifier (Fig. 8.1(a)) is more com-
plex than the model obtained from the SD technique (Fig. 8.1(b)). In addition, the accuracy
of the classification model is greater than the accuracy obtained by the SD model, but, with
respect to the interpretability the best results are obtained from the SD model. In conclu-
sion, the SD algorithm obtains simple models to describe behaviour of the data with a good
level of accuracy.
Despite the lack of consistency of the quality measures utilised in SD methods, dif-
ferent studies [295; 300; 301; 302; 303] propose measures like sensitivity, unusualness,
confidence and significance as the most important measurements of the quality of the sub-
groups.
• Sensitivity [288] is used to quantify the quality of individual rules according to the
individual patterns of interest covered. It is a measure with precision and generality
characteristics and it can be computed as:
1This section is mainly covered in a collaboration with Cristbal Jos Carmona del Jesus to investigate
applications of Signal Processing and Subgroup Discovery Techniques in analysis of protein sequences.
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(a) Classification Model (b) Subgroup Discovery Model





where tp are the examples correctly classified, and Pos are the examples of the class.
• Unusualness [304] attempts to obtain a trade-off between generality, interest and












where fp are the examples incorrectly classified, and ns are the examples of the data
set.
• Confidence [305] measures the relative frequency of examples satisfying the com-





• Significance [288] indicates the significance of a finding, if measured by the likeli-
hood ratio of a rule, and it can be computed as:
Sign(R) = 2 ·
nc∑
k=1
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where nc is the number of classes to study. It must be noted that, although each
rule is for a specific Class, the significance measures the novelty in the distribution
impartially for all the values of the class, hence the use of the summation.
With this set of quality measurements the subgroups obtained by the SD model are
evaluated in a correct and quantifiable way.
8.2.3 NMEEF-SD: Non-dominated Multi-objective Evolutionary Al-
gorithm For Extracting Fuzzy Rules in Subgroup Discovery 2
In the literature different Evolutionary Fuzzy Systems (EFSs) can be found, such as SDIGA
[306], MESDIF [307] and NMEEF-SD [295] in solving SD problems. Despite the good
behaviour of this group of algorithms to solve the SD problem, in this chapter the NMEEF-
SD algorithm is employed because it is a novelty approach which obtains significant and
accurate results as can be observed in [295].
The NMEEF-SD [295] is an EFS whose objective is to extract descriptive fuzzy and/or
crisp rules for the SD task, depending on the type of variables presented in the given prob-
lem. This technique is based on a multi-objective approach, the Nondominated Sorting
Genetic Algorithm II (NSGA-II) [308] algorithm, which is a computationally fast multi-
objective evolutionary algorithm based on a non-dominated sorting approach, and on the
use of elitism.
The fuzzy logic is used to represent the continuous features, by using linguistic vari-
ables, which allow data mining processes to use numerical features without the need of
incensement of the interpretability of the extracted knowledge by their discretisation. A
linguistic variable such as temperature may have a value such as low, medium or high. The
import aspect of linguistic variables is that they can be modified via linguistic boundaries
associated with certain functions. The continuous variables are considered linguistic, and
the fuzzy sets corresponding to the linguistic labels can be specified by the user or defined
by means of a uniform partition, if knowledge from experts is not available.
With respect to the representation of the rules, NMEEF-SD employs the “Chromosome
= Rule” approach, where only the antecedent is represented in the chromosome and the
consequent is prefixed to one of the possible values of the target feature in the evolution.
2This section is mainly covered in a collaboration with Cristbal Jos Carmona del Jesus to investigate
applications of Signal Processing and Subgroup Discovery Techniques in analysis of protein sequences.
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Therefore, the algorithm must be executed as many times as the number of different values
the target variable contains. It uses an integer representation model with as many genes as
variables contained in the original data set without considering the target variable. Thus,
the set of possible values for the categorical features is indicated by the problem, and for
numerical variables it is the set of linguistic terms determined heuristically, or with expert
information.
The quality measures considered as objectives in the evolutionary process are selected
depending on the nature of the problem. In this chapter, NMEEF-SD uses Sensitivity and
Unusualness as objectives for the multi-objective approach. The set of rules extracted
for the algorithm are filtered with respect to a minimum confidence threshold, which is
defined as a parameter of the algorithm. This confidence is a variation of the Confidence
presented in this chapter, which is the Fuzzy Confidence [306]. A single operation
scheme of NMEEF-SD algorithm can be observed in Algorithm 1.
Algorithm 1 NMEEF-SD Algorithm
Generate the initial (parents) population
while (number of evaluations) is not reached do
Generate offspring population
Join the parent and offspring population in a combined one
Generate all non-dominated fronts of the combined population
if Pareto front (Front 1) evolves then
Apply NSGA-II evolution
else
Apply Re-initialisation Based On Coverage
end if
end while
Return the individuals of the Pareto front which reach a fuzzy confidence threshold
The main disadvantage of the classifiers in bioinformatics problems is the general lack
of interpretability for the models obtained. These models that are obtained from classifiers
have, as the main objective, accuracy. Additionally, in the majority of situations, these
models are complex and they use a wide number of variables to describe different classes
of the data set. In this way, it is very difficult for the experts to analyse and understand the
behaviour of the different classes under investigation.
However, by the use of SD techniques simple and interpretable models can be ex-
tracted, where only some rules with a low number of variables representing each class are
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obtained. The use of the NMEEF-SD algorithm in bioinformatics problems also facilitates
the analysis by the experts because it uses linguistic labels in all the variables of the data
set.
The search of interesting rules for the SD algorithms is another advantage provided by
the NMEEF-SD algorithm. The use of unusualness and sensitivity as objective vectors
in the multi-objective approach also provides a maximisation, not only for these measures
but also for other measures in SD, as significance and confidence, because the unusualness
and sensitivity have precision, novelty and coverage properties in their definitions.
Finally, the NMEEF-SD algorithm can be also studied like a classifier to see the be-
haviour of the algorithm to predict new data introduced. Thus, the experts can distinguish
different groups of data with simple rules, which were obtained, and allow experts to have
a clearer understanding of the given problem
8.2.4 Support Vector Machines
A support vector machine, (SVM) [153; 154] is a supervised statistical learning method
that analyses data and recognises patterns for classification. The SVM takes a set of input
data and predicts in which of two possible classes each given input belongs. A more
detailed description of SVM can be found in Section 4.2.3. SVM is used in this analysis as
it can produce accurate and robust classification results on a established theoretical basis
even when input data are noisy or non-linearly separable [296; 297]. For this analysis the
LIBSVM [156] tool was used to build a classification model. Furthermore, a 5-fold cross-
validation was used in combination with F-score to find the optimum number of useful
features that can be used to predict Influenza A neuraminidase subtypes without sacrificing
any accuracy. In addition, grid search was used which is provided by LIBSVM to find the
optimal parameters for the predictive model.
8.2.5 Feature Selection Using F-score
Feature selection [309; 310] is the technique of selecting relevant features for building
robust classification models. Furthermore, feature selection is a particularly important step
in analysing the data from many experimental techniques as they often include a large
number of variables but low number of samples. By removing redundant features from the
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data, feature selection can improve the performance of classification techniques like SVM
in the following ways:
• Reduce data dimensionality.
• Improve the generalisation capability of the classification model.
• Speed up learning process.
• Improve model interpretability.
F-score [311] is one of the simplest but effective techniques, which measures the sep-
aration of two sets of real numbers. By using vectors xk , k = 1, ...,m, as input data,
the number of positive and negative samples are n+ and n− , respectively. F-score can be
defined as follows for the ith feature:
F (i) ≡ (x
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i are the averages of the ith feature of the positive and negative data
sets. The ith feature of the kth positive instance is x(+)k,i , and x
(−)
k,i is the ith feature of the
kth negative instance. In Equation 8.5 the numerator reveals the separation between the
positive and negative sets, while the denominator points to the one within each of the two
sets. The higher the F-score is, the higher the probability the feature under investigation
is more separable using the given classes. Therefore, F-score is used as a feature selection
criterion with SVM.
8.3 Case Study - Influenza A Neuraminidase Protein Se-
quence
8.3.1 Protein Sequences
Influenza A virus belongs to the orthomyxoviridae family of viruses and can affect mainly
birds and some mammals. The Influenza A virus genome consists of eight single genes; the
hemagglutinin (HA) gene, the neuraminidase (NA) gene, the nucleoprotein (NP) gene, the
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matrix proteins (M) gene, the non-structural proteins (NS) gene and three RNA polymerase
(PA, PB1, PB2) genes. Rarely do human pandemic outbreaks arise when the influenza A
virus is transmitted from wild birds to domestic poultry. During the twentieth century, three
major influenza pandemics were recorded, which were caused by H1N1, H2N2, and H3N2
viruses. In addition, the H5N1 virus is considered as a current pandemic thread. For this
analysis, as Table 8.1 shows, four different subtypes of Influenza A virus Neuraminidase
(NA) gene were used, as it is the target for current antiviral drugs, called neuraminidase
inhibitors [262]. The complete list of protein sequences used in this study can be found in
Appendix D.
Table 8.1: Influenza A Virus Neuraminidase Proteins





For influenza A subtypes 200 H1N1 NA proteins from 2009, 76 H2N2 NA proteins
from the period 1957-1968, 200 H3N2 NA proteins from the period 1968-2000 and 70
H5N1 NA proteins from the period 2005-2009 were collected from the Influenza Virus
Resource data set [263]. The relationship of influenza subtypes in respect of NA gene is
shown in the following:
• H1N1 from 2009 is the result of reassortment between Eurasian H1N1 influenza A
swine virus and H1N2 swine virus [264]. H1N1 retains the NA gene from Eurasian
H1N1 influenza A swine virus.
• H2N2 from the period 1957-1968 is the result of reassortment between existing hu-
man H1N1 and avian H2N2 viruses [264]. H2N2 retains the NA gene from the avian
H2N2 virus.
• H3N2 from the period 1968-2000 is the result of reassortment between circulating
human H2N2 and avian H3 viruses [264]. H3N2 retains the NA gene from human
H2N2 virus.
• H5N1 from the period 2005-2009 was created by combining various influenza A
subtype viruses [260] where H5N1 retains the NA gene from avian H1N1 virus.
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Percentage identity is a measurement used to determine the similarity between protein
sequences. By using CLUSTALW, a freely available online tool [264], the pairwise percent
identity of all the influenza A NA genes was calculated. Table 8.2 shows the average
percent identity between all the classes.
Table 8.2: Average Pairwise Percent Identity
H1N1 H2N2 H3N2 H5N1
H1N1 93% - - -
H2N2 42% 96% - -
H3N2 40% 86% 94% -
H5N1 83% 43% 41% 96%
As Table 8.2 shows, the percent identity within each individual influenza subtype class
is very high with 93%, 96%, 94% and 96% for H1N1 NA, H2N2 NA, H3N2 NA and H5N1
NA influenza A subtypes In contrast to the individual class, percent identity from different
classes may vary significantly, with high average percent identity of 83% between H1N1
and H5N1 and 86% between H2N2. Very low average percent identity was determined
between H1N1 and H2N2 with 42%, H1N1 and H3N2 with 40%, H5N1 and H2N2 with
43%, and finally H5N1 and H3N2 with 41% average percent identity.
The main objective of this chapter is to find relationships between different proteins
in the influenza A virus problem, with respect to different classes of these viruses. To
follow this objective the problem is analysed and studied with a SD approach, the NMEEF-
SD algorithm. In addition, a classification model is built based on SVM with features
selections based on F-score. The problem has a high dimensionality, and it is composed for
256 features and 546 proteins sequences, where the proteins are distributed in the classes
with 200 for class H1N1, 76 for H2N2, 200 for H3N2 and 70 for class H5N1.
All features used have a real domain, and therefore, they are continuous features, i.e.
256 continuous variables. The NMEEF-SD algorithm considers the continuous variables
as linguistic fuzzy variables with fuzzy logic. More specifically, in this chapter, uniform
partitions with triangular membership functions are used, as shown in Figure 8.2 for a
variable with three linguistic labels {Low, Medium, High}. The parameters employed
by NMEEF-SD are presented in Table 8.3.
Due to the non-deterministic nature of the NMEEF-SD, 5-fold cross validation is used
to verify the results. In this way, the results shown are the averages of the results ob-
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Figure 8.2: Example of Fuzzy Partition For A Continuous Variable With Three Labels
Table 8.3: Parameters For The NMEEF-SD Algorithm




Linguistic Labels 3, 5, 7 and 9
Mutation probability 0.1
Re-initialisation based on coverage (50% of biased)
Minimum confidence 0.2, 0.4 and 0.6
Representation of the rule Canonical
tained for each fold. Therefore, the following average results in the experimental study
in the tables can be observed: the number of linguistic labels employed (LLs), the mini-
mum confidence threshold used (MinCnf ), number of rules (]Rules), number of variables
(]V ar), significance (SIGN ), unusualness (UNUS), sensitivity (SENS) and confidence
(CONF ).
8.3.2 Analysis of The Results Obtained For The NMEEF-SD Algo-
rithm
Due to the complexity of the problem, it is necessary to use a diverse number of linguistic
labels to find the best results. The algorithm can use different minimum confidence thresh-
old to return rules that are fairly accurate. Therefore, for this study, 3, 5, 7 and 9 linguistic
labels were used, with a minimum confidence threshold of 0.2, 0.4 and 0.6 for each one,
as mentioned in Table 8.3. In this way, the NMEEF-SD algorithm is executed 25 times for
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Table 8.4: Results Obtained For The NMEEF-SD Algorithm in The Experimental Study
For The Influenza A Virus Problem
LLs MinCnf ]Rules ]V ar SIGN UNUS SENS CONF
3
0.2 4.60 2.79 57.945 0.153 1.000 0.747
0.4 3.80 2.65 61.653 0.174 1.000 0.811
0.6 2.60 2.73 66.967 0.190 1.000 0.849
5
0.2 3.40 2.13 47.628 0.125 0.990 0.708
0.4 3.00 2.17 50.925 0.134 0.992 0.767
0.6 2.20 2.10 54.155 0.148 1.000 0.807
7
0.2 3.00 2.28 47.832 0.110 0.963 0.760
0.4 2.40 2.42 47.094 0.113 0.939 0.854
0.6 1.60 2.37 52.038 0.127 0.938 0.911
9
0.2 1.60 2.00 40.257 0.092 0.952 0.585
0.4 1.40 2.00 39.211 0.099 0.944 0.631
0.6 0.60 0.80 17.191 0.048 0.378 0.394
each combination of parameters, and the average is shown for each row in Table 8.4. The
best result for each quality measure is highlighted.
As Table 8.4 shows, the best results are obtained by using 3 linguistic labels. Table 8.5
shows the results obtained for each class in the experimental study for the influenza A virus
problem with 3 linguistic labels. The results presented in this table are obtained using 5-
fold cross validation for each class. For the subgroups obtained for a minimum confidence
threshold of 0.6 the results indicate that there are not subgroups to describe all the classes.
This is because the confidence threshold is too high in order to obtain good results in all
the classes. Therefore, the results obtained in this configuration must be discarded. The
best results obtained for the NMEEF-SD algorithm are obtained with 3 linguistic labels
and minimum confidence of 0.2 and 0.4. Additionally, analyses related to the SD task for
each class 3 linguistic labels and minimum confidence of 0.4 are presented below:
• The subgroups obtained for the H1N1 subtype have a high interpretability due to
the low number of variables, where, in general, the subgroups obtained have less
than 3 variables. The values for the significance and unusualness are the highest in
respect to the values obtained from the remaining subtypes. The results obtained
for this subtype are 69.9%, 19.9%, 100% and 84.5% for significance, unusualness,
sensitivity and confidence respectively. Furthermore, the relation between sensitivity
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Table 8.5: Results Obtained For The NMEEF-SD Algorithm For Each Class in The Exper-
imental Study For The Influenza A Virus Problem With 3 Linguistic Labels
MinCnf Class ]Rules ]V ar SIGN UNUS SENS CONF
0.2
H1N1 8.00 2.88 69.868 0.199 1.000 0.849
H2N2 5.00 3.20 44.562 0.101 1.000 0.543
H3N2 6.00 2.50 64.036 0.178 1.000 0.812
H5N1 5.00 2.60 44.907 0.102 1.000 0.717
0.4
H1N1 8.00 2.88 69.868 0.199 1.000 0.849
H2N2 3.00 2.33 41.860 0.107 1.000 0.601
H3N2 5.00 2.40 67.831 0.193 1.000 0.835
H5N1 3.00 3.00 45.190 0.104 1.000 0.768
0.6
H1N1 7.00 3.00 70.349 0.202 1.000 0.867
H2N2 0.00 0.00 0.000 0.000 0.000 0.000
H3N2 5.00 2.40 67.831 0.193 1.000 0.835
H5N1 1.00 3.00 44.923 0.101 1.000 0.867
and confidence is very good as the algorithm obtains subgroups where all the protein
sequences for the class are covered.
• For the H2N2 subtype, the subgroups obtained are with the lower number of vari-
ables, and the interpretability is excellent. The values of significance and unusual-
ness are also high considering that this class has a low number of protein sequences.
The results obtained for this subtype are 41.9%, 10.7%, 100% and 60.1% for signif-
icance, unusualness, sensitivity and confidence, respectively.
• For the H3N2 subgroup the best subgroups are obtained along with the H1N1 sub-
type. The results obtained for this subtype are 67.8%, 19.3%, 100% and 83.5% for
significance, unusualness, sensitivity and confidence, respectively.
• H5N1 is the class with the lowest number of protein sequences. Despite this fact,
the results of sensitivity and confidence are very interesting as the subgroups cover
protein sequences of the subtype with high confidence. The results obtained for this
subtype are 45.2%, 10.4%, 100% and 76.8% for significance, unusualness, sensitiv-
ity and confidence, respectively.
Despite the objective of the NMEEF-SD algorithm being to obtain general and unusual
rules to describe relations between the properties of the proteins with respect to different
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Table 8.6: Predictive Results Obtained By NMEEF-SD Algorithm With 3 Linguistic La-
bels And A Minimum Confidence of 0.2 For The Influenza A Virus Problem
Class H1N1 H2N2 H3N2 H5N1
H1N1 0.965±0.055 0.000±0.000 0.000±0.000 0.025±0.055
H2N2 0.000±0.000 0.799±0.413 0.201±0.413 0.000±0.000
H3N2 0.000±0.000 0.132±0.086 0.868±0.086 0.000±0.000
H5N1 0.217±0.424 0.000±0.000 0.000±0.000 0.729±0.424
Table 8.7: Predictive Results Obtained By NMEEF-SD Algorithm With 3 Linguistic La-
bels And A Minimum Confidence of 0.4 For The Influenza A Virus Problem
Class H1N1 H2N2 H3N2 H5N1
H1N1 0.975±0.056 0.000±0.000 0.000±0.000 0.025±0.056
H2N2 0.107±0.174 0.413±0.537 0.481±0.457 0.000±0.000
H3N2 0.000±0.025 0.043±0.112 0.925±0.106 0.000±0.000
H5N1 0.629±0.458 0.000±0.000 0.029±0.064 0.343±0.480
type of virus, the algorithm has also a good behaviour as a classifier, as can be observed in
the following analysis. Table 8.6 shows the confusion matrix for the accuracy of the model
extracted by NMEEF-SD with three linguistic labels and a minimum confidence threshold
of 0.2, and Table 8.7 shows the confusion matrix of the model with the same linguistic
labels and 0.4 of minimum confidence. The results presented in both tables are the average
of the 5-fold cross validation and the standard deviation for each one.
The total accuracy for the complete data set is 0.872±0.051 for Table 8.6, and 0.797±
0.069 for Table 8.7. As can be observed in this study, for the model extracted by NMEEF-
SD algorithm good precision in classifying new examples can be obtained. The best results
are obtained with the minimum confidence threshold set to 0.2. In conclusion, NMEEF-SD
shows good behaviour of the SD algorithms in discovering relationships in the analysis and
classification of influenza A NA subtypes. An analysis for each subtype of virus can be
observed below:
• For the H1N1 subtype class the average accuracy is 0.965±0.055, where the mis-
classified proteins were as H5N1.
• For the H2N2 subtype class the average accuracy is 0.799±0.413, where the mis-
classified proteins were as H3N2.
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Table 8.8: Results of Subgroups Obtained For Each Class Using The NMEEF-SD Algo-
rithm
Subgroup SIGN UNUS SENS CONF
IF (f44 = Low AND f97 = Low) THEN Cl = H1N1 363.485 0.224 1.000 0.966
IF (f9 = Low AND f54 = Low f153 = Low AND f217 =
Low) THEN Cl = H2N2
227.960 0.105 1.000 0.600
IF (f8 = Low) THEN Cl = H3N2 373.894 0.182 1.000 0.730
IF (f141 = Low AND f207 = Low AND f219 =
Low) THEN Cl = H3N2
309.357 0.196 0.995 0.966
IF (f115 = Low) THEN Cl = H5N1 188.813 0.097 1.000 0.677
• For the H3N2 subtype class the average accuracy is 0.868±0.086, where the mis-
classified proteins were as H2N2.
• For the H5N1 subtype class the average accuracy is 0.729±0.424, where the mis-
classified proteins were as H1N1.
This analysis shows a strong correlation between the features extracted from the pro-
tein sequences using absolute spectrum and proteins percentage identity between classes
as shown in Table 8.2. Only subtype classes that present high percentage identity between
them as H1N1 with H5N1 subtype (83%) and H2N2 with H3N2 subtype (86%) were par-
tially misclassification.
8.3.3 Fuzzy Subgroups Extracted By NMEEF-SD
Once determined that NMEEF-SD with 3 linguistic labels and a minimum confidence
threshold of 0.2 obtains the best results for the influenza A virus problem, a new experiment
was performed using the complete data set in order to analyse the subgroups obtained by
NMEEF-SD. A detailed description of the NMEEF-SD algorithm can be found in [295].
Table 8.8 shows the subgroups obtained for the NMEEF-SD algorithm for each class with
3 linguistic labels and a minimum confidence of 0.2, where the variable fx corresponds
with the feature number x. The number of features that are included in the rules produced
by the NMEEF-SD algorithm are limited to 11. In Figure 8.3, the linguistic representations
for each variable found in the subgroups extracted by the algorithm can be observed. In
addition, the table presents the results associated for each subgroup.
As it can be observed in Table 8.8, from the results of unusualness and significance,
innovative information regarding the classification of NA subtypes introduced can be in-
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(a) Feature 8 (b) Feature 9 (c) Feature 44 (d) Feature 54
(e) Feature 97 (f) Feature 115 (g) Feature 141 (h) Feature 153
(i) Feature 207 (j) Feature 217 (k) Feature 219
Figure 8.3: Linguistic Representations of The Continuous Feature of The Model Extracted
By The NMEEF-SD Algorithm
troduced. Furthermore, the sensitivity obtained for the majority of the subgroups is the
maximum level, and the confidence is very high with values higher than 0.6 and some very
close to the maximum level. These good relations between the values of sensitivity and
confidence present subgroups with high quality. In addition, the interpretability of these
rules is excellent with subgroups, which in any case do not exceed of the four features.
Other methods that use signal processing techniques to extract biologically related
features in order to characterise protein sequences, like Resonant Recognition Model in
Hemagglutinin gene [42], and Complex Resonant Recognition for Neuraminidase gene
[245] use informational spectrum analysis to retrieve these features. The extracted features
are then used to characterise a specific class or compare it with another protein class based
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on the common frequency peak [245]. By using NMEEF-SD algorithm simple rules, as
Table 8.8 shows, can be extracted based on the features retrieve from the absolute spec-
trum. By using these features life-saving knowledge can be extracted and associated with
the Influenza protein’s sequences. These rules, created based on the features extracted, can
then help develop therapy and/or vaccines. For the influenza problem, the rules created
are based on 11 features extracted using DFT for all subtype classes. For example, for an
unknown protein sequence, to be able to determine in which subgroup it belongs only 11
features of the absolute spectrum need to be considered and not the whole spectrum, where
for the influenza A problem it consists of 256 variables. The importance of this outcome
is that by using the NMEEF-SD algorithm biologically related positions are selected in the
absolute spectrum for a problem, and a model is constructed with simple rules to charac-
terise all protein classes. A detailed analysis for the subgroups extracted for each subtype
of virus is shown below:
• For the H1N1 NA gene one rule with two features is obtained to describe this sub-
type, features 44 and 97. For feature 44, as Figure 8.3(c) shows, the interval for
Low is from 0.0 to 0.0125, and for feature 97, as Figure 8.3(e) shows, the interval
for Low is from 0.0006 to 0.0791. The SD results obtained for this subtype are very
good with all the examples covered with 96.6% accuracy. In addition, the unusu-
alness and significance values are very high, which shows an unusual behaviour of
these properties to characterise this subtype of virus.
• For the H2N2 NA gene, one rule with four features is obtained to describe this sub-
type, features 9, 54, 153 and 217. For feature 9, as Figure 8.3(b) shows, the interval
for Low is from 0.0015 to 0.0348, for feature 54, as Figure 8.3(d) shows, the interval
for Low is from 0.0068 to 0.0619, for feature 153, as Figure 8.3(h) shows, the inter-
val for Low is from 0.0002 to 0.0426, and finally, for feature 217, as Figure 8.3(j)
shows, the interval for Low is from 0.0 to 0.0334. All the protein sequences for this
subtype of virus are covered as the sensitivity is equal to 100.0%, with a 60.0% of
success. The value of significance indicates a relative significance of this subtype
of virus with respect to the others. Despite this subtype having a low number of
instances the unusualness value is important. The interpretability of this subgroup is
excellent with one subgroup represented with only one variable.
• For the H3N2 NA gene two rules are obtained to describe this subtype. For the
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first rule, feature 8 is used and for the second rule features 141, 207 and 219 are
used. For feature 8, as Figure 8.3(a) shows, the interval for Low is from 0.006 to
0.0386, for feature 141, as Figure 8.3(g) shows, the interval for Low is from 0.0 to
0.0243, for feature 207, as Figure 8.3(i) shows, the interval for Low is from 0.0021
to 0.0430, and finally, for feature 219, as Figure 8.3(k) shows, the interval for Low is
from 0.0 to 0.04. To represent this subtype two different subgroups can be observed.
For the first rule, a general subgroup is obtained with only one feature where all the
examples for the subtypes are covered with 73.0% of proteins predicted correctly.
For the second rule, a more specific subgroup is obtained with three features where
99.5% of proteins are covered with a 96.6% success. These relations between the
sensitivity and confidence show a good rule to describe and classify new instances
for this type of subtype.
• For the H5N1 NA gene, one feature, feature 115 of the absolute spectra was created
to classify this subtype. For feature 115, as Figure 8.3(f) shows, the interval for Low
is from 0.0006 to 0.0428. This subgroup covers all the proteins of this subtype with
a success of 67.7%, and the results for significance and unusualness are interesting,
considering that this subtype has the lower number of instances of the data set. The
interpretability of this subgroup is excellent, with one subgroup extracted with only
one variable.
8.3.4 Classification Models Based on Support Vector Machines
By using SVM and F-score, a classification model was constructed for the Influenza A
neuraminidase gene subtypes. By using F-score the goal is to select the most separable
features extracted from influenza subtypes and create a predictive model without sacrificing
any of the accuracy obtained by using all the features extracted. Figure 8.4 shows F-score
value for all the features extracted from the protein sequences.
In order to build an accurate and generalised predictive model, 5-fold cross-validation
was used. In combination with F-score, the minimum number of useful features that can
be used to predict Influenza A neuraminidase subtypes without sacrificing any accuracy
was set to 20. This number of features was discovered by manually eliminating features
and repeating the analysis. Table 8.9 shows the best 20 features used with their calculated
F-score. Figures 8.5 and 8.6 shows a plot of the best 20 features. In each subplot 8.5(a) -
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Figure 8.4: Feature Scores Based on F-score
8.5(h) a clear separation for most of the influenza subtypes can be observed.
The total accuracy for the complete data set is 0.983 ± 0.006. As the results show,
good precision in classifying new protein sequences can be obtained. In addition, it can
be observed in this study, the results obtained for the SVM based classification model as
expected, have higher accuracy in comparison to the results obtained from the NMEEF-SD
algorithm. An analysis for each influenza subtype can be observed below:
• For the H1N1 subtype class the average accuracy is 1.0±0.0.
• For the H2N2 subtype class the average accuracy is 0.92 ± 0.05, where the misclas-
sified proteins were as H3N2.
• For the H3N2 subtype class the average accuracy is 0.99 ± 0.01, where the misclas-
sified proteins were as H2N2.
• For the H5N1 subtype class the average accuracy is 0.96 ± 0.04, where the misclas-
sified proteins were as H1N1.
This analysis shows a strong correlation between the features extracted from the protein
sequences and refined using F-score, with protein percentage identity between classes as
158
Table 8.9: Top 20 Features In Order of Importance Based on F-score
Feature Score Feature Score
1 39 25.0333 11 116 12.1021
2 9 20.8762 12 136 11.8541
3 97 20.8564 13 79 11.6046
4 8 20.7845 14 90 11.4991
5 38 15.2451 15 192 10.3009
6 98 15.0310 16 117 9.9620
7 209 13.9315 17 234 9.8864
8 7 13.1166 18 252 9.1989
9 197 12.9016 19 236 9.1070
10 111 12.6627 20 113 8.9069
Table 8.10: Classification Results For SVM Predictive Model
Class H1N1 H2N2 H3N2 H5N1
H1N1 1.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
H2N2 0.00 ± 0.00 0.92 ± 0.05 0.08 ± 0.05 0.00 ± 0.00
H3N2 0.00 ± 0.00 0.01 ± 0.01 0.99 ± 0.01 0.00 ± 0.00
H5N1 0.04 ± 0.04 0.00 ± 0.00 0.00 ± 0.00 0.96 ± 0.04
shown in Table 8.2. As in the case with the analysis with the NMEEF-SD algorithm, the
most challenging part is to separate subtypes that present high percentage identity between
them. As the bibliography indicates [260; 264], there is a clear biological connection
between these influenza subtypes.
8.4 Conclusions
In this chapter, the influenza A virus characterisation problem is tackled through a SD
algorithm, which can provide ancillary knowledge to the experts. The main objective of
the case study was to find interpretable knowledge within the influenza A virus problem
to describe the relationships between subtypes of this virus. For this purpose, one of the
most representative SD algorithms was applied, the NMEEF-SD algorithm. NMEEF-SD is
based on an EFS which is suitable for extracting rules with few features, i.e. interpretable,
in order to facilitate the comprehensibility of the subgroups by the experts.
NMEEF-SD obtains representative subgroups for each subtype of virus of the problem.
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These subgroups show an unusual and significant behaviour, and they also represent the
total examples for each class with good confidence. The NMEEF-SD algorithm obtains a
good level of precision when classifying new proteins to include in the data set. Further-
more, the rules extracted in order to classify new examples are interpretable because the
algorithm employs linguistic labels to represent the continuous features, and because the
number of features for each subgroup is very low.
This case study offers the community a new point of view in the analysis of the in-
fluenza A virus with a novelty technique characterised by its interpretability, which obtains
simple rules to represent different subtypes of virus. In this way, the model can classify
an unknown protein sequence in a subtype of virus with only 11 features by using the
NMEEF-SD and 20 features using SVM of the absolute spectrum instead of the whole
spectrum, which consists of 256 features.
Additionally, in this chapter, an SVM classification model was built and tested with
very high predictive accuracy. Furthermore, it has been demonstrated that by using signal
processing techniques, in this case DFT, useful features can be extracted from protein se-
quences. By using F-score to refine these features and select the most appropriate, with the
combination of SVM, an excellent classifier can be obtained for protein sequences.
Finally in this chapter, the influenza A problem EIIP amino acid index (Table 2.3)
is used to determine the absolute spectrum for each protein sequence. However, in the
literature, 611 amino acid indices [312] exist to represent different biological features,
and they can be used to construct different models in future works. Further information
regarding the amino acid indices can be found in Chapter 3.
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(a) Feature 39 (b) Feature 9
(c) Feature 97 (d) Feature 8
(e) Feature 38 (f) Feature 98
(g) Feature 209 (h) Feature 7
(i) Feature 197 (j) Feature 111
Figure 8.5: Top 20 Features In Order of Importance Based on F-score (1-10)
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(a) Feature 116 (b) Feature 136
(c) Feature 79 (d) Feature 90
(e) Feature 192 (f) Feature 117
(g) Feature 234 (h) Feature 252
(i) Feature 236 (j) Feature 113
Figure 8.6: Top 20 Features In Order of Importance Based on F-score (10-20)
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Chapter 9
Conclusions and Future Work
9.1 Research Summary
Protein sequencing has produced overwhelming amounts of protein sequences especially in
the last decade [52; 53; 54; 55]. Nevertheless, the majority of the proteins’ functional and
structural classes sequenced are still unknown, and experimental methods currently used
to determine these properties are very expensive, laborious and time consuming [15; 16].
Consequently, automated computational methods are urgently required to accurately and
reliably predict functional and structural classes of the proteins. Several bioinformatics
methods have been developed to determine such properties of proteins directly from their
sequence information [56]. These involve signal processing methods, which are discussed
and analysed in the literature review and have recently become popular in the bioinformat-
ics area. They have been investigated for the analysis of DNA and protein sequences, and
are shown to be useful and generally help better characterise the sequences [41; 57].
The outcome of this study is a series of bioinformatics systems that considers signal
processing techniques for the analysis of protein sequences as a signal, and hence are ex-
pected to be capable of better characterising the proteins. This is also further improved
by fusing multiple protein characteristics and pattern recognition methods. This research
study, brought a novel concept to characterising the proteins and helped to predict structural
and functional classes of the proteins from primary sequence information with greater reli-
ability and accuracy. In addition, this is the most comprehensive and consistent study that
considers the use of amino acid indices. It is expected that this work will provide guide-
lines to other areas of study in proteomics the main aim of which is automated prediction
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of a protein’s properties by using its primary structure.
9.2 Contribution to Knowledge
This thesis makes the following main original contributions:
• Amino acid indices have various applications and can represent diverse features of
the protein sequences and amino acids. As the majority of indices included in the
database have similar features, Chapter 3 proposes a set of computationally derived
indices that summarise and better represent the original group of the indices. For this
analysis, the hierarchical clustering and principal component analysis (PCA) were
used. By using the hierarchical clustering methods the amino acid indices with sim-
ilar features are clustered together. The next step is to use PCA on these clusters to
computationally derive an amino acid index that should be able to represent the origi-
nal amino acid indices included in the cluster. In the AAID database, 611 amino acid
indices exist. By using the computational generated amino acid indices the search
space can be reduced without losing any valuable information. The search space can
be reduced to 542, 478, 521, 395 and 544 amino acid indices, by using single (1.0),
single (0.65), complete (1.0), complete (0.65) and average (1.0 and 0.4) linkage, re-
spectively. Additionally, in Chapter 3, the largest database of amino acid indices is
developed, which contains all the latest published amino acid indices and presented
in the Amino Acid Index Database (AAID) web-server (http://cisaps.com/indices).
• In Chapter 4, a study is carried out in order to find a unique and universal set of best
discriminating amino acid indices for the characterisation of allergenic proteins. This
analysis extracts features directly from protein sequences by using Discrete Fourier
Transform (DFT) to build a classification model based on Support Vector Machines
(SVM), for allergenic proteins. In summary, all the amino acid indices identified
from the study characterises different aspects of hydrophobicity of allergenic pro-
teins (Table 4.2).
An extensive analysis was performed by using the Optimised relative partition ener-
gies - method C [144] amino acid index which is found to be the best amino acid in-
dex for characterising the allergen protein sequences. The classification model devel-
oped performs better in comparison to the AllerHunter classification model, which is
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considered to be the latest and most precise available online tool for classification of
Allergenic protein sequences [134]. As the results show, AllerHunter is more biased
to non-allergen protein sequences as sensitivity, specificity and Matthews correlation
coefficient (MCC) values show. This method of classification of allergenic and non-
allergenic protein sequence is more reliable, and it is better for creating a generalised
classification model.
• In chapter 5, a new method was proposed for performing protein multiple sequence
alignments. For this method, Discrete Fourier Transform was used to construct a
new distance matrix in combination with the multiple amino acid indices that were
used to encode protein sequences into numerical sequences. The distance matrix is
important as it can be used to construct a dendrogram that will act as a guide for
Multiple Sequence Alignment (MSA) in which the global alignment is estimated by
a series of pairwise alignments. The amino acid indices selected for this analysis
are based on general and widely accepted features of the amino acids. Additionally,
these indices are used to construct a similarity matrix. In this chapter, a new type of
substitution matrix is proposed where the physicochemical similarities between any
given amino acids is calculated. These similarities were calculated based on the 25
amino acids indices selected, where each one represents a unique biological protein
feature.
Additionally, in this Chapter, a case study was presented by using 32 CD4 protein
sequences extracted from the UniProt database. The results show that the proposed
method yields a more reliable alignment in comparison to the state-of-art MSA pro-
grams, like CLUSTALW, MAFFT, and T-COFFEE. Furthermore, the proposed MSA
method is not biased to specific groups of protein sequences [236] as the values for
the similarity matrix are calculated from the amino acid indices, and not from the
protein sequences. Finally, for the proposed MSA, the same similarity matrix can be
considered regarding the protein sequence’s homology to be aligned or the mutation
rate presented. A correlation to the physical characterisations of the amino acids the
similarity matrix derived from can be achieved, while different similarity matrices
can be generated by considering distinctive amino acids physical characterisations,
that each amino acid index represents.
• In chapter 6, Complex Informational Spectrum Analysis (CISA) is developed and
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presented. As the results show, when protein classes present similarities or differ-
ences according to the Common Frequency Peak (CFP) in specific amino acid in-
dices, then it is probable that these classes are related to the protein feature that the
specific amino acid represents. Furthermore, the use of only the absolute spectrum in
the analysis of protein sequences using the informational spectrum analysis is proven
to be insufficient, as biologically related features within the analysis of influenza A
subtypes appear individually either in the real or the imaginary spectrum. Some of
the applications of Informational Spectrum Analysis (ISA) and Resonant Recogni-
tion Model (RRM) that are already applied in the literature and CISA will also be
applicable, and will be able to contribute additional information to the development
of new drugs [247], identification of important protein sequences’ domains and in-
vestigation of protein sequence interactions.
In this Chapter, a web-based server is also developed and presented, named CIS-
APS, which provides CISA for protein sequences. This web-based server enables
researchers with little knowledge of signal processing methods to apply CISA to
their work. Furthermore, CISAPS uses a collection of 611 unique amino acid in-
dices, each one representing a different property, to perform the analysis. Moreover,
in this chapter, various technical issues such as signal length and windowing that
may affect the analysis are also addressed.
• Upon identification of a new protein, it is important to single out amino acid responsi-
ble for the structural and functional classification of the protein, as well as the amino
acids contributing to the protein’s specific biological characterisation. In Chapter 7,
a novel approach is presented to identify and quantify the relationship between in-
dividual amino acids and the protein. Two methods are presented in this Chapter;
the first takes into consideration the frequency peak, CFP, which it calculated from
the RRM, and the second considers the entire absolute spectrum. Applicability and
robustness of the methods are shown on a case study where five different protein
families of the influenza A virus NA genes, which includes H1N1, H1N2, H2N2,
H3N2 and H5N1 NA genes, are studied.
• In chapter 8, the influenza A virus problem is tackled through a Subgroup Discovery
(SD) algorithm, which can provide ancillary knowledge to the experts. The main
objective of the case study was to derive interpretable knowledge for the influenza
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A virus problem and to consequently better describe the relationships between sub-
types of this virus. For this purpose, one of the most representative SD algorithms
was applied, namely the Non-dominated Multiobjective Evolutionary Algorithm for
Extracting Fuzzy Rules in Subgroup Discovery (NMEEF-SD) algorithm. NMEEF-
SD is based on Evolutionary Fuzzy System (EFS), which is suitable for extracting
rules with small number of features, in order to facilitate the comprehensibility of
the subgroups by the experts. The NMEEF-SD algorithm obtains a good level of
precision when classifying new proteins to include in the data set. Furthermore, the
rules extracted in order to classify new examples are interpretable because the algo-
rithm employs linguistic labels to represent the continuous features, and the number
of features for each subgroup is very low.
Additionally, in this chapter, an SVM classification model was built and tested with
very high predictive accuracy. Furthermore, it has been demonstrated that by using
signal processing techniques, in this case DFT, useful features can be extracted from
protein sequences. By using F-score to refine these features and select the most
appropriate, with the combination of SVM, an excellent classifier can be obtained
for protein sequences. This case study offers the community a new point of view
in the analysis of the influenza A virus with a novelty technique characterised by its
interpretability, which obtains simple rules to represent different subtypes of virus.
In this way, the model can classify an unknown protein sequence in a subtype of
virus with only 11 features by using the NMEEF-SD and 20 features using SVM of
the absolute spectrum instead of the whole spectrum, which consists of 256 features.
9.3 Future Work
So far, a series of bioinformatics systems that considers signal-processing techniques for
analysis of the protein sequence have been discussed. In this section, the possible directions
for future research are going to be discussed.
• As presented in Chapter 3, 611 amino acid indices exist to represent distinctive bio-
logical features, and they can be used in the development of different models in future
works. In various methods developed and presented in this thesis, such as Chapter
5, for performing multiple protein sequence alignments, Chapter 7 for investigat-
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ing the effects of an individual amino acid on protein function based on Discrete
Fourier Transform or Chapter 8 for subgroup discovery and classification of protein
sequences, a limited set of the available amino acid indices was used. Further in-
vestigation regarding the effects of the complete set of amino acid indices should be
carried out.
• In Chapter 3 novel amino acid indices were produced and presented by using the
hierarchical cluster analysis and principal component analysis. Further evaluation
needs to be contacted regarding the quality of these generated amino acid indices.
Finally the effect of these generated amino acid indices on existing methods needs
to be investigated.
• Further research regarding the formulation of the gap penalties in multiple sequence
alignments is required. In the analysis presented in chapter 5 gap penalties are as-
signed to the value 4∗(min(similarityscore)). In future works, as the gap penalties
are the only variables in the proposed approach that can be taken into consideration
for the homological similarity to the protein sequences to be aligned, a new adaptive
model needs to be constructed that considers the protein sequences’ homology.
Additionally, for the alignment of protein sequences, 25 amino acid indices were
used to construct the similarity matrix. In Chapter 3, 611 amino acid indices are
described that represent a specific protein feature. In future works, the effect of indi-
vidual amino acid index to the alignment of protein sequences needs to be studied.
• The Complex Resonant Recognition Model [245] can generate the real and imag-
inary spectrum in addition to the absolute spectrum was developed. As indicated
in Chapter 6, these additional spectrum’s can also be used to contribute supplemen-
tal information to the analysis of protein sequences. Additional work needs to be
contacted regarding the contribution of these frequency spectrums to other meth-
ods where signal-processing methods are used to classify or characterise protein se-
quences.
• Finally, other signal processing techniques as presented in Chapter 2, can be utilise
for characterisation and classification of protein sequences.
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Figure A.1: Short-Space Fourier of Acid Bovine FGF Protein (Window: 10% - Overlap:
25%)
Figure A.2: Short-Space Fourier of Basic Bovine FGF Protein (Window:10% - Overlap:
25%)
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Figure A.3: Short-Space Fourier of Acid Bovine FGF Protein (Window: 10% - Overlap:
50%)




Figure A.5: Short-Space Fourier of Acid Bovine FGF Protein (Window: 10% - Overlap:
99%)
Figure A.6: Short-Space Fourier of Basic Bovine FGF Protein (Window: 10% - Overlap:
99%)
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Figure A.7: Short-Space Fourier of Acid Bovine FGF Protein (Window: 28% - Overlap:
50%)




Figure A.9: Short-Space Fourier of Acid Bovine FGF Protein (Window: 40% - Overlap:
50%)
Figure A.10: Short-Space Fourier of Basic Bovine FGF Protein (Window: 40% - Overlap:
50%)
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Figure A.11: Short-Space Fourier of Acid Bovine FGF Protein (Window: 40% - Overlap:
99%)




Figure A.13: Paul Wavelet Transform of Acid Bovine FGF Protein
Figure A.14: Paul Wavelet Transform of Basic Bovine FGF Protein
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Figure A.15: Mexican Hat Wavelet Transform of Acid Bovine FGF Protein
Figure A.16: Mexican Hat Wavelet Transform of Basic Bovine FGF Protein
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Figure A.17: Derivative of Gaussian Wavelet Transform of Acid Bovine FGF Protein
Figure A.18: Derivative of Gaussian Wavelet Transform of Basic Bovine FGF Protein
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Figure A.19: Haar Wavelet Transform of Acid Bovine FGF Protein







B. AMINO ACID INDICES
Table B.1: Amino Acid Indices from the Literature that were not in-
cluded in the AAIndex database.
ID Description Reference ID Description Reference
529 Factor 1 [109] 571 Solvent-accessible surface
area for denatured
[111]
530 Factor 2 [109] 572 Solvent-accessible surface
area for native
[111]
531 Factor 3 [109] 573 Solvent-accessible surface
area for unfolding
[111]
532 Factor 4 [109] 574 Gibbs free energy change of
hydration for unfolding
[111]
533 Factor 5 [109] 575 Gibbs free energy change of
hydration for denatured
[111]
534 Hydrophobicity [31] 576 Gibbs free energy change of
hydration for native protein
[111]
535 Mass [31] 577 Unfolding enthalpy change
of hydration
[111]
536 pK1(a-CO2H [31] 578 Unfolding entropy change
of hydration
[111]
537 pK2(NH3 [31] 579 Unfolding hydration heat
capacity change
[111]
538 pI(NH3 [31] 580 Unfolding Gibbs free energy [111]
539 Goldman-Engelman-Steitz
scale
[110] 581 Unfolding enthalpy [111]
540 GA set 1 [110] 582 Unfolding entropy changes
of side-chain
[111]
541 GA set 2 [110] 583 Unfolding Gibbs free energy
change
[111]
542 GA set 3 [110] 584 Unfolding enthalpy change [111]
543 Relative connectivity [29] 585 Unfolding entropy change
of protein
[111]
544 Relative Clustering Coeffi-
cient
[29] 586 Volume [111]
545 Relative Closeness [29] 587 Shape [111]
546 Relative Betweenness [29] 588 Flexibility [111]
547 Compressibility [111] 589 Pf-s [111]
548 Surrounding hydrophobicity [111] 590 Hydrophobic Parameter [34]
549 Polarity [111] 591 Recognition factors [112]
550 Isoelectric point [111] 592 Hydrophobicity [112]
551 Equilibrium constant [111] 593 Hydrophobicity [112]
552 Molecular weight [111] 594 Hydrophobicity [112]
553 Bulkiness [111] 595 Hydrophobic [112]
554 Chromatographic index [111] 596 Mobilities chromatography
paper (RF
[112]





556 Normalized consensus hy-
drophobicity
[111] 598 Average flexibility index [112]
557 Short- and medium-range
nonbonded energy





[111] 600 Conformational parameter
beta turn
[112]
559 Total nonbonded energy [111] 601 overall amino acid composi-
tion
[112]
560 Coil tendencies [111] 602 Number of codon coding [112]
561 Helical contact area [111] 603 Membrane buried helix pa-
rameter
[112]
562 Mean RMS fluctuational
displacement
[111] 604 Antigenicity value X 10. [112]
563 Buriedness [111] 605 Hydrophobicity indices ph
7.5
[112]
564 N-terminal of a-helix [111] 606 Transmembrane tendency [112]
565 C-terminal of a-helix [111] 607 Molar fraction accessible
residues
[112]
566 Middle of a-helix [111] 608 Conformational parameter
beta sheet
[112]
567 Partial specific volume [111] 609 Conformational parameter
coil
[112]
568 Average medium contacts [111] 610 Amino acid composition [112]
569 Long-range contacts [111] 611 Characterizing distribution
of allergen-unique segments
[113]

















Table B.2: PCA Generated Amino Acid Indices With Single Linkage 1
Variance Indices A R N D C Q E G H I L K M F P S T W Y V
1 1 17 -0.19 -0.11 0.08 0.09 0.13 -0.16 -0.20 -0.41 -0.01 0.51 0.44 -0.18 -0.10 0.02 -0.02 -0.10 -0.20 0.04 -0.01 0.37
1 3 4 -0.33 -0.16 0.05 0.01 0.66 0.27 -0.03 -0.05 0.10 -0.19 0.24 0.01 -0.31 -0.06 0.06 0.21 -0.01 -0.24 -0.21 -0.01
1 5 564 -0.15 -0.26 -0.06 -0.26 0.33 0.31 0.27 -0.06 -0.15 -0.02 0.26 0.15 -0.58 0.16 -0.09 0.16 0.02 0.12 -0.19 0.03
1 8 598 0.10 0.11 -0.23 -0.05 0.16 -0.20 0.22 -0.23 -0.35 -0.16 0.25 0.27 0.19 -0.43 0.09 0.23 -0.32 0.20 -0.06 0.20
1 12 13 0.23 -0.48 -0.18 0.02 0.45 -0.14 0.08 0.10 -0.29 -0.36 0.29 -0.06 0.10 0.25 -0.05 -0.01 -0.01 -0.19 0.14 0.10
1 15 59 0.17 -0.42 -0.04 0.17 -0.24 -0.04 0.02 0.18 -0.02 0.27 0.03 0.06 0.04 -0.18 -0.05 0.43 0.11 -0.28 -0.47 0.25
1 21 79 -0.08 -0.03 0.35 0.33 -0.11 -0.07 -0.09 -0.23 0.10 0.21 0.19 -0.20 0.04 -0.03 0.56 -0.10 -0.31 -0.27 -0.03 -0.23
1 22 80 0.18 -0.08 -0.02 -0.41 0.37 -0.10 -0.49 0.26 0.17 -0.03 -0.03 -0.14 0.22 0.14 0.15 -0.09 -0.18 0.30 -0.27 0.05
1 39 225 0.22 -0.43 -0.14 0.56 -0.12 -0.33 0.18 0.24 0.01 0.07 -0.08 0.06 -0.23 0.16 -0.22 -0.10 0.09 -0.16 0.04 0.18
1 42 566 0.06 -0.25 -0.38 0.02 -0.36 -0.33 0.05 -0.05 -0.27 0.25 0.15 0.38 0.25 0.03 -0.15 0.12 0.28 -0.13 0.20 0.14
1 52 346 0.09 -0.13 0.12 0.01 0.02 -0.26 0.23 0.08 -0.28 -0.30 0.13 -0.05 -0.18 -0.43 0.47 0.06 -0.22 0.19 0.30 0.14
1 65 135 -0.04 -0.23 0.38 0.32 -0.15 0.16 0.43 0.16 -0.37 -0.16 -0.05 -0.15 0.00 0.03 0.11 -0.07 -0.22 0.18 0.05 -0.39
1 85 110 -0.07 -0.01 -0.21 0.45 -0.47 -0.06 0.08 -0.37 0.33 -0.07 -0.07 -0.16 0.32 0.24 -0.19 0.13 -0.05 -0.06 0.14 0.09
1 93 421 -0.47 -0.27 0.31 0.00 0.13 0.02 -0.14 0.29 0.32 0.13 -0.30 -0.24 -0.17 -0.07 -0.14 0.00 0.26 -0.11 0.20 0.23
1 98 228 0.14 -0.48 0.26 -0.24 0.10 0.26 -0.09 0.15 -0.01 -0.06 -0.07 -0.03 -0.11 0.00 0.49 -0.06 0.34 -0.16 -0.31 -0.12
1 100 230 0.00 0.21 -0.18 -0.13 0.24 0.47 -0.47 0.00 -0.17 -0.28 0.22 -0.05 0.11 -0.23 0.03 0.05 0.32 -0.09 -0.19 0.16
1 105 234 0.02 -0.33 0.17 0.24 0.18 -0.13 0.21 0.11 -0.25 -0.11 -0.25 0.13 0.31 0.37 -0.44 0.03 -0.03 0.18 -0.21 -0.19
1 106 428 -0.14 -0.15 0.21 -0.13 0.49 -0.44 0.22 0.06 -0.11 0.31 -0.28 -0.23 -0.12 0.02 0.03 0.08 0.17 -0.09 -0.17 0.28
1 115 153 -0.08 -0.16 -0.09 0.19 -0.07 -0.09 0.19 -0.09 -0.08 -0.05 -0.05 -0.16 -0.06 -0.03 0.90 -0.10 -0.08 -0.01 -0.03 -0.05
1 118 588 -0.04 -0.12 0.13 0.26 -0.33 0.21 0.33 0.21 -0.21 -0.12 -0.11 -0.07 0.53 0.16 -0.29 0.11 -0.20 -0.15 -0.08 -0.21
1 124 175 -0.11 0.12 0.03 0.12 0.06 0.04 -0.13 0.40 -0.40 -0.30 -0.38 -0.20 -0.08 -0.10 0.01 0.37 0.28 0.09 0.29 -0.14
1 139 608 0.08 -0.26 -0.28 0.13 0.15 0.32 -0.48 0.41 0.08 -0.21 0.21 -0.07 -0.26 -0.19 0.22 -0.06 0.12 -0.07 0.17 -0.01
1 154 157 0.38 -0.12 0.12 0.19 -0.08 0.10 0.11 -0.18 0.27 -0.44 -0.01 -0.37 -0.41 0.22 -0.11 0.20 -0.06 0.19 0.10 -0.12
1 166 275 0.01 -0.31 0.07 0.17 -0.02 -0.11 -0.13 0.02 -0.10 -0.02 0.14 0.03 -0.24 -0.34 0.33 -0.12 -0.17 0.35 -0.15 0.59
1 176 555 0.95 -0.02 -0.08 -0.09 0.03 -0.06 -0.06 -0.15 -0.04 -0.05 -0.05 -0.04 -0.04 0.00 -0.09 -0.12 -0.09 0.06 0.01 -0.08
1 196 455 0.32 -0.22 0.04 0.06 -0.25 0.08 0.08 0.48 0.04 -0.14 -0.20 -0.31 0.18 0.25 -0.12 -0.44 0.00 0.24 0.04 -0.14
1 198 208 -0.26 -0.13 0.26 0.02 0.29 -0.03 0.03 -0.63 -0.05 0.48 -0.11 -0.02 -0.02 0.21 -0.01 0.03 -0.20 -0.06 0.13 0.09
1 205 465 -0.07 -0.19 0.00 -0.15 0.21 -0.09 -0.16 0.31 0.03 0.55 -0.25 0.05 0.10 -0.35 0.03 -0.37 -0.10 0.32 0.02 0.10
1 212 529 -0.13 -0.13 0.03 0.14 -0.08 0.25 -0.26 -0.36 -0.35 0.25 -0.06 0.09 -0.41 0.46 0.09 0.24 -0.04 0.01 0.08 0.19
1 233 252 -0.16 -0.06 0.18 -0.07 -0.58 0.33 0.30 0.04 -0.15 0.24 -0.04 -0.14 0.32 0.26 -0.23 -0.05 0.08 -0.20 0.10 -0.16
1 236 347 -0.26 0.11 0.28 0.13 -0.07 -0.15 -0.06 -0.04 0.14 0.31 -0.01 -0.46 -0.31 0.18 0.08 -0.06 0.42 0.05 -0.39 0.08
1 251 527 0.04 -0.15 -0.08 0.06 0.25 -0.32 0.18 0.13 -0.35 0.22 -0.15 0.27 -0.24 0.12 0.32 -0.08 -0.18 -0.42 0.26 0.16
1 269 270 -0.21 -0.18 -0.11 0.29 0.06 0.40 -0.17 0.24 0.12 -0.20 0.08 -0.01 0.26 -0.04 -0.55 0.06 0.07 0.14 -0.33 0.09
1 271 281 -0.16 0.18 0.06 -0.27 -0.20 0.24 0.00 0.32 -0.42 0.24 -0.13 0.51 0.03 -0.09 -0.21 0.12 -0.03 0.16 -0.19 -0.16
1 282 361 -0.02 -0.28 -0.18 0.34 -0.38 0.31 -0.09 0.04 -0.07 0.00 0.11 0.50 0.01 -0.13 -0.22 -0.01 -0.09 0.36 0.01 -0.25
1 292 293 0.04 -0.18 0.13 -0.25 0.09 0.14 0.01 0.22 -0.07 0.46 -0.24 -0.31 0.26 -0.23 -0.17 -0.28 -0.07 -0.16 0.30 0.31
1 315 556 0.17 -0.10 -0.19 -0.28 0.19 0.08 -0.11 0.22 -0.29 -0.12 0.17 0.55 0.11 -0.34 0.32 -0.07 -0.06 -0.24 -0.11 0.10
1 335 364 0.10 0.00 -0.47 -0.06 0.03 0.21 -0.01 -0.11 0.49 0.24 0.29 -0.06 0.00 -0.12 0.24 -0.17 -0.09 -0.36 0.12 -0.26
1 340 341 -0.05 -0.03 -0.16 -0.18 0.22 0.06 0.31 -0.22 -0.04 0.01 -0.19 -0.21 -0.19 -0.02 0.69 0.02 -0.06 -0.29 0.20 0.13
1 362 515 0.24 -0.17 -0.16 -0.11 0.16 -0.18 -0.14 0.22 -0.26 0.34 0.18 -0.06 0.06 -0.24 0.21 0.21 0.15 -0.26 -0.47 0.27
1 376 473 -0.19 -0.37 0.01 0.00 -0.26 0.41 -0.10 0.02 0.49 -0.10 -0.10 -0.07 0.42 -0.03 0.03 -0.26 0.20 -0.17 0.05 0.02
1 390 391 0.01 -0.15 -0.06 0.04 -0.03 0.53 -0.34 0.10 0.22 -0.40 0.16 0.19 -0.27 -0.05 0.06 0.33 0.01 -0.33 -0.03 0.04
1 392 393 -0.09 -0.04 -0.31 -0.17 0.49 -0.16 0.39 0.02 0.15 -0.16 -0.03 -0.03 -0.02 -0.22 -0.18 -0.10 0.13 0.47 0.08 -0.23
1 394 431 0.05 -0.26 0.07 0.11 -0.22 -0.10 -0.17 0.27 -0.46 0.08 0.31 -0.44 0.13 0.29 -0.02 0.24 0.12 -0.20 0.19 0.01
1 397 549 0.07 -0.01 0.07 0.00 0.07 0.07 0.00 0.07 -0.01 -0.96 0.07 0.00 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07
1 402 417 0.20 -0.17 0.18 0.34 -0.02 -0.17 0.08 0.26 0.02 -0.24 -0.26 -0.41 -0.15 -0.11 0.08 0.41 0.31 0.02 -0.27 -0.10
1 407 411 -0.06 -0.08 -0.11 -0.03 0.21 -0.09 0.19 0.35 -0.33 0.18 0.15 -0.39 -0.18 0.30 -0.02 -0.06 -0.02 0.20 -0.46 0.26
1 409 414 0.03 0.16 0.00 -0.02 0.16 -0.26 -0.06 -0.09 -0.48 0.20 -0.12 -0.35 0.36 0.28 0.02 -0.08 0.16 -0.35 0.17 0.27
218
Table B.2: (continued)
1 429 430 -0.38 -0.15 0.28 0.52 0.30 -0.17 -0.28 -0.24 0.08 0.26 0.13 -0.08 -0.22 0.11 0.08 -0.22 -0.01 -0.09 -0.01 0.11
1 439 440 -0.07 -0.42 0.11 -0.28 0.12 0.27 -0.22 0.12 0.30 -0.13 0.45 -0.02 -0.10 -0.13 0.10 -0.04 0.04 -0.10 -0.32 0.33
1 447 448 0.19 -0.20 0.00 -0.39 -0.21 -0.19 -0.44 0.18 0.18 0.21 0.23 0.27 0.10 0.17 0.16 0.05 -0.39 -0.08 0.17 -0.01
1 460 607 -0.07 -0.03 -0.36 -0.04 -0.13 -0.03 0.01 -0.41 0.05 0.07 0.37 0.41 -0.14 0.09 -0.16 0.20 -0.26 -0.16 0.35 0.23
1 462 463 0.48 -0.18 0.13 -0.07 0.05 0.16 -0.20 0.25 0.05 -0.02 0.01 -0.33 0.18 -0.10 -0.16 0.27 0.20 -0.01 -0.20 -0.50
1 482 484 -0.06 -0.45 0.14 0.38 0.21 -0.25 -0.34 0.13 0.23 0.09 -0.12 -0.26 0.11 -0.29 0.22 0.00 0.28 0.09 -0.11 0.00
1 483 499 0.32 -0.31 0.01 0.21 0.19 -0.15 -0.10 0.03 -0.12 -0.34 -0.26 -0.44 0.18 0.03 0.46 0.05 0.09 0.18 -0.06 0.03
1 501 502 -0.12 -0.03 0.24 0.51 -0.12 0.10 0.35 -0.03 -0.02 -0.25 -0.20 -0.44 -0.23 0.04 -0.15 0.12 0.06 0.31 0.05 -0.19
1 513 570 -0.13 -0.30 -0.08 0.15 0.21 -0.28 0.38 0.03 0.08 -0.12 -0.05 0.00 0.13 0.47 -0.03 -0.49 0.20 -0.10 0.11 -0.18
1 531 533 -0.10 -0.45 0.00 0.14 -0.09 -0.09 0.48 -0.27 -0.29 0.19 -0.05 -0.31 0.10 0.24 0.05 -0.21 0.08 0.17 0.19 0.22
1 582 585 0.23 -0.51 0.03 0.24 0.41 0.01 0.17 0.34 -0.11 -0.24 -0.17 -0.07 -0.02 0.02 0.10 0.13 0.09 -0.30 -0.28 -0.07
1 583 584 0.14 -0.43 -0.22 0.11 0.32 -0.21 0.12 -0.12 -0.28 0.12 0.11 -0.07 0.24 -0.21 0.06 0.30 0.21 -0.44 0.11 0.12
0.9999 78 396 553 -0.09 0.15 -0.07 0.05 -0.05 -0.26 -0.17 0.12 0.53 0.32 -0.47 -0.23 -0.05 -0.13 -0.02 0.14 0.33 -0.19 0.05 0.04
0.9989 169 474 548 -0.15 -0.40 -0.11 -0.03 -0.02 0.03 0.36 0.14 -0.17 -0.13 0.21 0.33 0.30 -0.11 0.30 -0.20 -0.23 -0.19 -0.22 0.30
0.9959 72 535 552 586 -0.19 0.14 -0.01 0.03 0.55 0.03 0.07 -0.24 -0.10 -0.05 -0.05 0.05 0.65 -0.22 -0.16 -0.07 -0.02 -0.20 -0.10 -0.10















Table B.3: PCA Generated Amino Acid Indices With Single Linkage 0.65
Variance Indices A R N D C Q E G H I L K M F P S T W Y V
1 1 17 -0.19 -0.11 0.08 0.09 0.13 -0.16 -0.20 -0.41 -0.01 0.51 0.44 -0.18 -0.10 0.02 -0.02 -0.10 -0.20 0.04 -0.01 0.37
1 2 132 0.17 -0.19 0.23 0.36 -0.03 -0.07 0.09 -0.03 0.17 -0.21 -0.23 0.37 -0.42 0.04 0.00 -0.13 -0.13 0.38 -0.03 -0.34
1 3 4 -0.33 -0.16 0.05 0.01 0.66 0.27 -0.03 -0.05 0.10 -0.19 0.24 0.01 -0.31 -0.06 0.06 0.21 -0.01 -0.24 -0.21 -0.01
1 5 564 -0.15 -0.26 -0.06 -0.26 0.33 0.31 0.27 -0.06 -0.15 -0.02 0.26 0.15 -0.58 0.16 -0.09 0.16 0.02 0.12 -0.19 0.03
1 8 598 0.10 0.11 -0.23 -0.05 0.16 -0.20 0.22 -0.23 -0.35 -0.16 0.25 0.27 0.19 -0.43 0.09 0.23 -0.32 0.20 -0.06 0.20
1 9 109 -0.46 0.04 0.03 0.51 0.09 0.01 -0.04 -0.25 -0.03 0.22 0.22 -0.23 0.00 0.11 -0.12 0.37 -0.13 -0.33 0.07 -0.09
1 10 319 -0.21 -0.30 0.24 -0.15 0.01 -0.11 0.20 -0.35 0.16 0.13 0.07 0.04 0.38 -0.35 0.28 0.16 0.12 -0.38 -0.09 0.15
1 12 13 0.23 -0.48 -0.18 0.02 0.45 -0.14 0.08 0.10 -0.29 -0.36 0.29 -0.06 0.10 0.25 -0.05 -0.01 -0.01 -0.19 0.14 0.10
1 15 59 0.17 -0.42 -0.04 0.17 -0.24 -0.04 0.02 0.18 -0.02 0.27 0.03 0.06 0.04 -0.18 -0.05 0.43 0.11 -0.28 -0.47 0.25
1 21 79 -0.08 -0.03 0.35 0.33 -0.11 -0.07 -0.09 -0.23 0.10 0.21 0.19 -0.20 0.04 -0.03 0.56 -0.10 -0.31 -0.27 -0.03 -0.23
1 22 80 0.18 -0.08 -0.02 -0.41 0.37 -0.10 -0.49 0.26 0.17 -0.03 -0.03 -0.14 0.22 0.14 0.15 -0.09 -0.18 0.30 -0.27 0.05
1 24 560 0.04 -0.97 0.07 0.06 0.06 0.05 0.05 0.07 0.05 0.04 0.04 0.05 0.04 0.04 0.07 0.06 0.05 0.04 0.05 0.04
1 35 505 -0.03 -0.04 -0.11 -0.04 -0.41 -0.04 0.11 0.04 0.08 0.20 -0.34 0.10 0.57 -0.22 0.36 0.11 0.10 -0.30 -0.13 0.00
1 37 227 0.12 0.11 0.30 -0.05 -0.72 0.17 0.05 0.06 0.02 -0.19 0.19 0.23 -0.24 -0.27 -6e-05 -0.11 0.05 0.23 0.08 -0.04
1 38 223 -0.37 0.25 0.22 -0.19 -0.08 0.63 -0.04 -0.02 0.25 -0.31 0.07 -0.11 0.17 -0.12 -0.11 -0.06 0.08 -0.26 0.05 -0.05
1 39 225 0.22 -0.43 -0.14 0.56 -0.12 -0.33 0.18 0.24 0.01 0.07 -0.08 0.06 -0.23 0.16 -0.22 -0.10 0.09 -0.16 0.04 0.18
1 40 53 -0.03 -0.14 0.07 0.14 0.00 0.18 0.24 0.21 0.31 -0.06 -0.12 0.22 -0.16 -0.23 -0.72 0.07 -0.07 -0.09 0.19 -0.01
1 41 565 0.19 -0.13 0.13 0.17 0.10 -0.05 -0.58 -0.24 -0.28 -0.03 -0.05 -0.14 -0.02 0.52 0.26 0.06 0.21 -0.11 0.01 -0.02
1 42 566 0.06 -0.25 -0.38 0.02 -0.36 -0.33 0.05 -0.05 -0.27 0.25 0.15 0.38 0.25 0.03 -0.15 0.12 0.28 -0.13 0.20 0.14
1 50 366 0.39 -0.49 -0.38 -0.20 0.02 0.24 0.25 0.05 0.01 0.16 0.26 -0.26 -0.15 -0.22 0.12 -0.07 -0.03 0.22 0.05 0.03
1 51 123 -0.02 -0.33 -0.06 0.10 -0.74 0.30 -0.19 0.20 0.13 0.00 0.18 0.02 0.08 0.15 0.06 -0.16 0.11 -0.08 0.13 0.12
1 52 346 0.09 -0.13 0.12 0.01 0.02 -0.26 0.23 0.08 -0.28 -0.30 0.13 -0.05 -0.18 -0.43 0.47 0.06 -0.22 0.19 0.30 0.14
1 56 58 0.33 -0.09 -0.12 -0.04 -0.07 0.06 0.31 -0.01 -0.09 0.34 0.04 -0.14 0.20 -0.33 0.03 0.37 -0.41 -0.39 -0.06 0.08
1 64 137 -0.13 -0.11 0.39 -0.36 0.07 -0.01 -0.47 0.17 -0.02 0.24 -0.17 0.30 -0.01 0.11 -0.43 0.18 -0.04 -0.01 0.15 0.13
1 65 135 -0.04 -0.23 0.38 0.32 -0.15 0.16 0.43 0.16 -0.37 -0.16 -0.05 -0.15 0.00 0.03 0.11 -0.07 -0.22 0.18 0.05 -0.39
1 67 603 -0.21 0.15 0.25 0.01 0.58 -0.13 -0.30 -0.10 0.43 -0.01 -0.21 0.16 0.18 -0.19 -0.20 -0.09 -0.22 0.01 -0.02 -0.10
1 68 534 0.22 -0.29 0.45 -0.04 0.24 -0.29 -0.30 0.11 0.17 -0.33 0.19 0.25 -0.15 -0.19 0.01 0.15 -0.22 0.08 0.12 -0.18
1 72 552 0.01 -0.02 0.25 0.46 -0.19 0.13 0.34 0.03 0.14 -0.26 -0.26 -0.27 -0.43 -0.03 -0.06 0.21 0.09 -0.05 0.16 -0.24
1 76 133 -0.08 -0.55 0.16 0.43 -0.13 0.05 0.22 -0.10 0.31 -0.09 -0.09 0.08 -0.03 -0.38 0.26 0.06 0.12 -0.21 0.03 -0.06
1 77 590 -0.04 0.00 0.00 0.00 0.96 -0.02 -0.01 -0.03 -0.04 -0.11 -0.11 0.01 -0.09 -0.11 -0.06 -0.04 -0.04 -0.13 -0.07 -0.08
1 85 110 -0.07 -0.01 -0.21 0.45 -0.47 -0.06 0.08 -0.37 0.33 -0.07 -0.07 -0.16 0.32 0.24 -0.19 0.13 -0.05 -0.06 0.14 0.09
1 89 324 0.14 -0.22 -0.04 -0.51 -0.10 0.43 0.14 -0.10 -0.04 -0.22 -0.10 0.02 0.14 -0.10 -0.22 -0.22 0.14 0.38 0.26 0.20
1 92 450 0.03 -0.29 0.33 -0.30 0.00 -0.09 0.37 -0.05 -0.09 -0.23 0.04 -0.28 0.02 0.04 -0.11 0.42 0.44 -0.03 -0.03 -0.22
1 93 421 -0.47 -0.27 0.31 0.00 0.13 0.02 -0.14 0.29 0.32 0.13 -0.30 -0.24 -0.17 -0.07 -0.14 0.00 0.26 -0.11 0.20 0.23
1 98 228 0.14 -0.48 0.26 -0.24 0.10 0.26 -0.09 0.15 -0.01 -0.06 -0.07 -0.03 -0.11 0.00 0.49 -0.06 0.34 -0.16 -0.31 -0.12
1 100 230 0.00 0.21 -0.18 -0.13 0.24 0.47 -0.47 0.00 -0.17 -0.28 0.22 -0.05 0.11 -0.23 0.03 0.05 0.32 -0.09 -0.19 0.16
1 104 107 -0.08 -0.08 0.58 0.36 0.00 0.29 -0.27 -0.02 -0.19 0.26 0.08 -0.26 0.02 0.07 -0.27 -0.17 -0.17 0.02 -0.20 0.02
1 105 234 0.02 -0.33 0.17 0.24 0.18 -0.13 0.21 0.11 -0.25 -0.11 -0.25 0.13 0.31 0.37 -0.44 0.03 -0.03 0.18 -0.21 -0.19
1 106 428 -0.14 -0.15 0.21 -0.13 0.49 -0.44 0.22 0.06 -0.11 0.31 -0.28 -0.23 -0.12 0.02 0.03 0.08 0.17 -0.09 -0.17 0.28
1 111 385 -0.09 -0.12 -0.16 0.41 0.20 -0.28 0.46 -0.06 -0.32 0.09 0.18 -0.03 0.07 0.13 -0.19 -0.26 -0.37 0.17 0.06 0.11
1 115 153 -0.08 -0.16 -0.09 0.19 -0.07 -0.09 0.19 -0.09 -0.08 -0.05 -0.05 -0.16 -0.06 -0.03 0.90 -0.10 -0.08 -0.01 -0.03 -0.05
1 118 588 -0.04 -0.12 0.13 0.26 -0.33 0.21 0.33 0.21 -0.21 -0.12 -0.11 -0.07 0.53 0.16 -0.29 0.11 -0.20 -0.15 -0.08 -0.21
1 119 170 0.15 -0.10 0.02 0.29 -0.14 0.08 -0.39 0.15 0.17 0.08 -0.27 -0.14 0.21 0.02 -0.57 -0.04 0.35 0.13 0.16 -0.15
1 120 171 -0.04 -0.10 -0.10 -0.03 -0.45 -0.02 -0.27 0.72 0.06 -0.03 -0.06 -0.02 0.13 0.12 0.30 -0.08 -0.03 -0.19 0.08 0.02
1 124 175 -0.11 0.12 0.03 0.12 0.06 0.04 -0.13 0.40 -0.40 -0.30 -0.38 -0.20 -0.08 -0.10 0.01 0.37 0.28 0.09 0.29 -0.14
1 127 508 0.26 -0.41 -0.01 0.15 -0.20 -0.09 -0.11 0.43 -0.22 -0.20 -0.22 0.15 -0.26 0.10 0.20 0.27 0.32 -0.09 0.10 -0.17
1 128 563 -0.20 0.24 -0.16 -0.06 -0.17 -0.10 -0.24 -0.25 0.28 0.22 0.14 0.15 0.03 0.32 -0.12 -0.34 -0.05 0.06 0.50 -0.23
1 134 454 0.17 0.11 -0.13 0.00 -0.29 -0.02 0.03 0.61 0.16 0.23 -0.24 0.13 0.28 -0.02 -0.33 -0.29 -0.20 -0.08 -0.04 -0.08
220
Table B.3: (continued)
1 139 608 0.08 -0.26 -0.28 0.13 0.15 0.32 -0.48 0.41 0.08 -0.21 0.21 -0.07 -0.26 -0.19 0.22 -0.06 0.12 -0.07 0.17 -0.01
1 140 408 0.04 -0.26 -0.08 0.38 0.04 -0.33 0.05 0.05 0.38 -0.23 0.49 0.11 -0.09 -0.18 -0.05 -0.13 0.08 0.16 -0.35 -0.07
1 151 481 0.57 0.41 -0.09 0.00 -0.02 0.07 -0.35 0.15 -0.08 0.00 -0.01 0.09 -0.03 -0.02 0.19 -0.32 -0.06 -0.44 -0.06 0.00
1 154 157 0.38 -0.12 0.12 0.19 -0.08 0.10 0.11 -0.18 0.27 -0.44 -0.01 -0.37 -0.41 0.22 -0.11 0.20 -0.06 0.19 0.10 -0.12
1 156 432 0.21 -0.15 -0.34 -0.10 0.00 -0.31 -0.13 0.08 0.15 0.44 -0.04 -0.17 -0.13 0.16 -0.29 0.14 0.34 -0.07 -0.15 0.39
1 161 253 -0.32 -0.04 0.01 0.03 0.23 0.25 -0.30 0.05 -0.33 -0.08 -0.35 -0.03 0.46 0.20 0.09 -0.26 0.26 0.22 -0.02 -0.08
1 162 222 -0.01 -0.28 -0.29 -0.02 0.01 -0.31 0.09 0.05 0.23 -0.35 0.05 -0.02 -0.29 0.46 0.22 0.09 0.03 0.39 -0.17 0.13
1 163 224 0.29 -0.24 -0.31 -0.02 -0.34 -0.10 0.41 -0.18 0.06 -0.02 0.08 0.07 -0.09 0.39 -0.25 0.04 0.38 0.10 -0.19 -0.06
1 166 275 0.01 -0.31 0.07 0.17 -0.02 -0.11 -0.13 0.02 -0.10 -0.02 0.14 0.03 -0.24 -0.34 0.33 -0.12 -0.17 0.35 -0.15 0.59
1 174 371 -0.16 -0.43 0.14 0.22 0.26 -0.01 -0.02 -0.15 -0.15 -0.04 -0.09 -0.16 0.59 -0.12 0.09 0.24 -0.01 -0.23 0.23 -0.21
1 176 555 0.95 -0.02 -0.08 -0.09 0.03 -0.06 -0.06 -0.15 -0.04 -0.05 -0.05 -0.04 -0.04 0.00 -0.09 -0.12 -0.09 0.06 0.01 -0.08
1 179 180 0.06 -0.38 0.25 0.30 -0.39 0.21 0.18 0.16 -0.36 -0.08 0.02 -0.29 -0.15 0.25 -0.15 0.04 0.30 0.05 0.10 -0.11
1 181 295 0.03 -0.24 0.00 -0.25 0.24 0.18 -0.44 -0.03 -0.05 -0.12 -0.19 -0.23 -0.29 0.06 0.41 0.27 0.12 0.27 0.00 0.26
1 182 296 0.03 -0.03 0.15 0.25 -0.29 -0.19 0.39 -0.32 0.11 0.06 0.15 0.28 0.41 -0.07 -0.37 -0.27 -0.10 0.01 -0.07 -0.14
1 184 593 0.21 -0.01 -0.02 -0.07 0.68 0.03 -0.15 0.00 -0.09 -0.02 0.10 0.17 -0.01 -0.21 -0.23 0.12 0.05 -0.42 -0.31 0.17
1 188 601 0.38 -0.25 0.10 0.21 -0.11 0.04 0.11 0.37 0.08 -0.41 -0.31 -0.47 -0.11 0.11 0.20 0.04 0.02 0.00 0.09 -0.11
1 190 192 0.04 -0.06 -0.44 -0.08 0.21 0.11 0.09 -0.21 0.13 -0.34 0.13 -0.23 0.33 -0.03 0.26 -0.04 0.32 0.29 -0.24 -0.23
1 191 193 -0.14 -0.07 0.49 -0.01 -0.11 -0.12 -0.18 0.06 -0.02 0.38 -0.11 0.07 -0.28 0.17 -0.20 -0.02 -0.29 -0.23 0.47 0.12
1 196 455 0.32 -0.22 0.04 0.06 -0.25 0.08 0.08 0.48 0.04 -0.14 -0.20 -0.31 0.18 0.25 -0.12 -0.44 0.00 0.24 0.04 -0.14
1 198 208 -0.26 -0.13 0.26 0.02 0.29 -0.03 0.03 -0.63 -0.05 0.48 -0.11 -0.02 -0.02 0.21 -0.01 0.03 -0.20 -0.06 0.13 0.09
1 201 457 0.10 -0.51 0.12 0.41 -0.17 0.01 0.36 0.14 0.15 -0.07 0.29 -0.43 -0.06 0.00 -0.16 -0.06 -0.18 0.01 0.02 0.04
1 205 465 -0.07 -0.19 0.00 -0.15 0.21 -0.09 -0.16 0.31 0.03 0.55 -0.25 0.05 0.10 -0.35 0.03 -0.37 -0.10 0.32 0.02 0.10
1 209 247 -0.30 -0.10 -0.02 0.11 -0.15 -0.01 -0.18 0.19 -0.44 0.17 0.21 -0.06 -0.44 0.03 0.45 0.21 0.14 -0.07 0.02 0.24
1 212 529 -0.13 -0.13 0.03 0.14 -0.08 0.25 -0.26 -0.36 -0.35 0.25 -0.06 0.09 -0.41 0.46 0.09 0.24 -0.04 0.01 0.08 0.19
1 215 216 -0.12 -0.17 0.22 0.24 -0.17 0.24 0.37 -0.36 0.33 -0.29 0.06 0.33 0.03 -0.06 0.05 -0.03 0.01 -0.35 -0.06 -0.25
1 233 252 -0.16 -0.06 0.18 -0.07 -0.58 0.33 0.30 0.04 -0.15 0.24 -0.04 -0.14 0.32 0.26 -0.23 -0.05 0.08 -0.20 0.10 -0.16
1 236 347 -0.26 0.11 0.28 0.13 -0.07 -0.15 -0.06 -0.04 0.14 0.31 -0.01 -0.46 -0.31 0.18 0.08 -0.06 0.42 0.05 -0.39 0.08
1 238 387 0.13 -0.38 -0.10 0.18 -0.14 0.06 0.04 0.00 -0.53 0.05 -0.18 -0.17 0.01 0.03 0.50 0.19 0.31 -0.13 0.01 0.14
1 240 241 -0.01 -0.04 0.08 0.04 -0.52 -0.13 0.07 0.01 0.37 0.28 0.18 0.33 -0.04 -0.16 -0.20 -0.42 -0.14 -0.09 0.16 0.21
1 251 527 0.04 -0.15 -0.08 0.06 0.25 -0.32 0.18 0.13 -0.35 0.22 -0.15 0.27 -0.24 0.12 0.32 -0.08 -0.18 -0.42 0.26 0.16
1 264 265 -0.27 -0.16 0.02 0.02 0.23 -0.44 0.30 -0.03 -0.25 0.22 -0.03 -0.11 0.16 0.09 -0.35 0.26 0.30 -0.20 -0.06 0.29
1 269 270 -0.21 -0.18 -0.11 0.29 0.06 0.40 -0.17 0.24 0.12 -0.20 0.08 -0.01 0.26 -0.04 -0.55 0.06 0.07 0.14 -0.33 0.09
1 271 281 -0.16 0.18 0.06 -0.27 -0.20 0.24 0.00 0.32 -0.42 0.24 -0.13 0.51 0.03 -0.09 -0.21 0.12 -0.03 0.16 -0.19 -0.16
1 279 280 -0.33 -0.14 0.10 0.07 -0.06 -0.32 -0.16 0.10 0.12 0.47 -0.14 0.07 -0.10 0.06 -0.27 -0.10 -0.12 -0.03 0.28 0.50
1 282 361 -0.02 -0.28 -0.18 0.34 -0.38 0.31 -0.09 0.04 -0.07 0.00 0.11 0.50 0.01 -0.13 -0.22 -0.01 -0.09 0.36 0.01 -0.25
1 289 290 -0.03 -0.34 -0.01 -0.26 -0.26 -0.13 0.01 0.42 0.26 0.08 0.35 0.43 0.09 -0.27 0.13 -0.10 -0.15 -0.21 0.01 -0.01
1 292 293 0.04 -0.18 0.13 -0.25 0.09 0.14 0.01 0.22 -0.07 0.46 -0.24 -0.31 0.26 -0.23 -0.17 -0.28 -0.07 -0.16 0.30 0.31
1 315 556 0.17 -0.10 -0.19 -0.28 0.19 0.08 -0.11 0.22 -0.29 -0.12 0.17 0.55 0.11 -0.34 0.32 -0.07 -0.06 -0.24 -0.11 0.10
1 335 364 0.10 0.00 -0.47 -0.06 0.03 0.21 -0.01 -0.11 0.49 0.24 0.29 -0.06 0.00 -0.12 0.24 -0.17 -0.09 -0.36 0.12 -0.26
1 340 341 -0.05 -0.03 -0.16 -0.18 0.22 0.06 0.31 -0.22 -0.04 0.01 -0.19 -0.21 -0.19 -0.02 0.69 0.02 -0.06 -0.29 0.20 0.13
1 343 348 -0.09 -0.25 -0.21 0.03 0.38 0.08 0.13 0.14 0.28 -0.18 -0.26 -0.01 0.13 0.25 -0.46 -0.30 0.13 0.31 -0.13 0.00
1 350 573 0.18 -0.32 -0.12 -0.11 0.32 0.04 -0.18 -0.02 -0.39 0.51 0.02 -0.03 0.31 -0.16 0.10 -0.02 -0.08 -0.33 0.14 0.15
1 352 479 0.21 -0.11 -0.17 -0.07 -0.41 -0.05 0.41 -0.16 -0.08 -0.13 0.09 -0.22 0.03 -0.09 0.18 -0.15 0.06 0.40 0.45 -0.18
1 362 515 0.24 -0.17 -0.16 -0.11 0.16 -0.18 -0.14 0.22 -0.26 0.34 0.18 -0.06 0.06 -0.24 0.21 0.21 0.15 -0.26 -0.47 0.27
1 376 473 -0.19 -0.37 0.01 0.00 -0.26 0.41 -0.10 0.02 0.49 -0.10 -0.10 -0.07 0.42 -0.03 0.03 -0.26 0.20 -0.17 0.05 0.02
1 386 504 -0.07 -0.09 -0.08 0.45 -0.06 -0.08 -0.09 -0.06 -0.08 -0.06 -0.06 -0.07 -0.06 -0.07 0.84 -0.07 -0.07 -0.07 -0.08 -0.07
1 390 391 0.01 -0.15 -0.06 0.04 -0.03 0.53 -0.34 0.10 0.22 -0.40 0.16 0.19 -0.27 -0.05 0.06 0.33 0.01 -0.33 -0.03 0.04
1 392 393 -0.09 -0.04 -0.31 -0.17 0.49 -0.16 0.39 0.02 0.15 -0.16 -0.03 -0.03 -0.02 -0.22 -0.18 -0.10 0.13 0.47 0.08 -0.23
















1 396 553 0.00 -0.03 0.24 0.00 -0.02 -0.65 -0.02 0.09 0.23 -0.10 -0.10 0.08 -0.05 -0.08 -0.06 0.02 -0.04 0.64 -0.06 -0.10
1 397 549 0.07 -0.01 0.07 0.00 0.07 0.07 0.00 0.07 -0.01 -0.96 0.07 0.00 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07
1 398 550 0.06 -0.11 0.08 0.17 0.09 0.07 -0.94 0.06 0.00 0.06 0.06 -0.08 0.06 0.07 0.05 0.07 0.07 0.06 0.07 0.06
1 399 554 -0.07 0.00 -0.01 0.02 0.02 -0.06 0.02 -0.01 -0.05 -0.17 -0.18 0.01 0.85 -0.19 -0.14 -0.03 -0.07 0.32 -0.14 -0.13
1 402 417 0.20 -0.17 0.18 0.34 -0.02 -0.17 0.08 0.26 0.02 -0.24 -0.26 -0.41 -0.15 -0.11 0.08 0.41 0.31 0.02 -0.27 -0.10
1 403 404 -0.07 -0.16 0.10 -0.17 -0.37 0.00 -0.19 -0.19 -0.14 0.02 -0.27 0.31 -0.01 0.16 -0.26 0.11 0.45 0.43 0.08 0.18
1 407 411 -0.06 -0.08 -0.11 -0.03 0.21 -0.09 0.19 0.35 -0.33 0.18 0.15 -0.39 -0.18 0.30 -0.02 -0.06 -0.02 0.20 -0.46 0.26
1 409 414 0.03 0.16 0.00 -0.02 0.16 -0.26 -0.06 -0.09 -0.48 0.20 -0.12 -0.35 0.36 0.28 0.02 -0.08 0.16 -0.35 0.17 0.27
1 420 434 0.28 0.44 0.10 -0.12 -0.18 0.10 0.06 0.14 -0.35 -0.43 0.08 0.31 0.03 -0.07 0.17 0.06 -0.26 0.12 -0.23 -0.24
1 426 427 -0.31 -0.07 0.07 -0.36 0.20 -0.23 0.48 0.35 0.14 0.19 -0.09 -0.23 0.02 0.15 -0.14 -0.37 0.01 0.00 0.12 0.06
1 429 430 -0.38 -0.15 0.28 0.52 0.30 -0.17 -0.28 -0.24 0.08 0.26 0.13 -0.08 -0.22 0.11 0.08 -0.22 -0.01 -0.09 -0.01 0.11
1 437 438 0.14 -0.38 0.27 -0.10 0.14 0.04 -0.33 0.02 -0.04 -0.37 0.13 0.16 0.03 0.04 0.00 0.58 0.01 -0.05 -0.30 0.02
1 439 440 -0.07 -0.42 0.11 -0.28 0.12 0.27 -0.22 0.12 0.30 -0.13 0.45 -0.02 -0.10 -0.13 0.10 -0.04 0.04 -0.10 -0.32 0.33
1 445 446 0.41 -0.13 0.21 -0.28 -0.29 0.01 -0.20 0.31 -0.07 0.06 0.09 -0.38 0.00 -0.01 0.27 0.29 -0.10 -0.33 -0.06 0.19
1 447 448 0.19 -0.20 0.00 -0.39 -0.21 -0.19 -0.44 0.18 0.18 0.21 0.23 0.27 0.10 0.17 0.16 0.05 -0.39 -0.08 0.17 -0.01
1 459 461 0.31 -0.10 -0.12 0.12 -0.13 -0.16 0.43 0.43 0.12 0.08 -0.02 -0.53 0.02 0.06 -0.19 -0.33 0.04 0.01 0.03 -0.10
1 460 607 -0.07 -0.03 -0.36 -0.04 -0.13 -0.03 0.01 -0.41 0.05 0.07 0.37 0.41 -0.14 0.09 -0.16 0.20 -0.26 -0.16 0.35 0.23
1 462 463 0.48 -0.18 0.13 -0.07 0.05 0.16 -0.20 0.25 0.05 -0.02 0.01 -0.33 0.18 -0.10 -0.16 0.27 0.20 -0.01 -0.20 -0.50
1 471 472 0.19 -0.42 -0.17 -0.35 0.18 -0.18 -0.43 0.04 -0.16 0.27 0.27 -0.07 0.19 0.26 0.09 0.06 -0.07 0.14 -0.07 0.25
1 474 548 0.83 -0.03 -0.37 -0.01 -0.06 0.33 -0.01 -0.02 -0.03 -0.08 -0.06 -0.18 -0.05 -0.05 0.00 -0.02 -0.02 -0.06 -0.05 -0.07
1 482 484 -0.06 -0.45 0.14 0.38 0.21 -0.25 -0.34 0.13 0.23 0.09 -0.12 -0.26 0.11 -0.29 0.22 0.00 0.28 0.09 -0.11 0.00
1 483 499 0.32 -0.31 0.01 0.21 0.19 -0.15 -0.10 0.03 -0.12 -0.34 -0.26 -0.44 0.18 0.03 0.46 0.05 0.09 0.18 -0.06 0.03
1 488 493 0.15 -0.21 -0.28 0.08 -0.39 -0.28 -0.05 -0.07 0.16 0.20 0.00 0.32 0.24 -0.12 -0.25 -0.12 -0.16 0.31 0.41 0.05
1 501 502 -0.12 -0.03 0.24 0.51 -0.12 0.10 0.35 -0.03 -0.02 -0.25 -0.20 -0.44 -0.23 0.04 -0.15 0.12 0.06 0.31 0.05 -0.19
1 510 539 0.01 -0.66 0.23 0.36 -0.01 0.16 0.34 0.05 -0.12 -0.12 -0.06 0.22 -0.13 -0.15 0.09 -0.13 -0.19 -0.03 0.22 -0.07
1 512 605 -0.02 0.30 0.05 -0.18 0.09 0.05 -0.09 0.04 0.44 0.13 0.11 -0.42 0.16 -0.10 0.06 -0.02 -0.01 -0.02 -0.64 0.09
1 513 570 -0.13 -0.30 -0.08 0.15 0.21 -0.28 0.38 0.03 0.08 -0.12 -0.05 0.00 0.13 0.47 -0.03 -0.49 0.20 -0.10 0.11 -0.18
1 514 543 0.49 -0.46 0.12 0.11 0.10 0.05 -0.37 -0.20 0.04 -0.35 -0.03 0.17 -0.15 0.08 0.09 0.16 0.06 -0.22 0.23 0.08
1 516 517 0.13 0.14 0.13 0.27 0.18 -0.41 -0.07 0.26 0.11 0.06 -0.22 -0.21 -0.20 -0.09 -0.48 0.30 -0.15 0.32 0.00 -0.08
1 518 519 -0.02 -0.42 0.02 0.20 0.57 0.09 0.29 -0.08 -0.06 -0.04 -0.20 0.13 0.00 -0.02 -0.40 -0.02 -0.22 0.08 0.24 -0.14
1 522 523 0.26 -0.20 -0.29 0.20 -0.35 -0.16 -0.10 -0.22 -0.04 -0.20 0.27 0.45 0.12 0.14 0.27 -0.01 -0.11 -0.15 0.28 -0.17
1 524 525 -0.03 -0.18 -0.02 0.14 0.06 0.07 -0.07 0.00 0.07 0.13 0.35 -0.03 0.21 -0.14 -0.15 0.18 0.23 -0.65 -0.38 0.21
1 531 533 -0.10 -0.45 0.00 0.14 -0.09 -0.09 0.48 -0.27 -0.29 0.19 -0.05 -0.31 0.10 0.24 0.05 -0.21 0.08 0.17 0.19 0.22
1 574 575 0.04 -0.41 -0.04 -0.17 0.21 0.00 -0.14 0.01 0.12 -0.10 -0.09 -0.47 0.04 0.09 -0.06 0.17 -0.04 0.49 0.43 -0.07
1 582 585 0.23 -0.51 0.03 0.24 0.41 0.01 0.17 0.34 -0.11 -0.24 -0.17 -0.07 -0.02 0.02 0.10 0.13 0.09 -0.30 -0.28 -0.07
1 583 584 0.14 -0.43 -0.22 0.11 0.32 -0.21 0.12 -0.12 -0.28 0.12 0.11 -0.07 0.24 -0.21 0.06 0.30 0.21 -0.44 0.11 0.12
222
Table B.4: PCA Generated Amino Acid Indices With Complete Linkage 1
Variance Indices A R N D C Q E G H I L K M F P S T W Y V
1 19 363 -0.04 -0.40 -0.05 -0.18 -0.06 0.41 -0.20 0.01 -0.02 -0.01 -0.10 -0.09 0.04 -0.33 0.14 -0.02 0.19 0.56 -0.12 0.28
1 20 283 0.10 -0.07 0.14 -0.24 0.15 -0.03 0.04 -0.33 -0.14 0.31 -0.15 0.05 -0.33 -0.09 0.00 0.33 0.20 -0.43 0.06 0.42
1 22 80 0.18 -0.08 -0.02 -0.41 0.37 -0.10 -0.49 0.26 0.17 -0.03 -0.03 -0.14 0.22 0.14 0.15 -0.09 -0.18 0.30 -0.27 0.05
1 31 284 0.21 0.19 0.25 0.08 0.04 0.10 0.19 -0.03 0.02 -0.57 -0.15 -0.11 0.26 -0.02 -0.56 -0.01 0.02 0.09 0.15 -0.15
1 34 509 0.10 0.48 -0.14 0.14 0.32 0.02 -0.01 0.21 0.21 -0.24 -0.02 -0.58 -0.13 -0.16 -0.01 -0.02 -0.10 0.21 -0.18 -0.08
1 35 505 -0.03 -0.04 -0.11 -0.04 -0.41 -0.04 0.11 0.04 0.08 0.20 -0.34 0.10 0.57 -0.22 0.36 0.11 0.10 -0.30 -0.13 0.00
1 39 225 0.22 -0.43 -0.14 0.56 -0.12 -0.33 0.18 0.24 0.01 0.07 -0.08 0.06 -0.23 0.16 -0.22 -0.10 0.09 -0.16 0.04 0.18
1 44 344 -0.05 -0.16 0.10 0.30 -0.02 0.11 0.04 -0.51 -0.25 0.00 -0.15 -0.42 -0.15 0.02 0.24 0.18 -0.01 0.38 0.28 0.04
1 49 321 -0.10 0.03 -0.29 0.10 0.66 0.07 -0.10 -0.19 0.40 -0.14 0.02 -0.21 -0.13 0.00 0.17 -0.22 -0.26 0.13 -0.01 0.07
1 60 185 -0.15 0.02 0.04 -0.08 0.00 0.47 -0.18 -0.09 0.13 0.10 -0.07 -0.53 0.12 -0.32 -0.20 0.21 0.18 0.41 -0.03 -0.02
1 63 117 0.02 -0.16 0.17 -0.27 -0.57 0.21 0.07 -0.17 -0.37 0.02 0.00 -0.10 -0.05 0.17 0.33 -0.03 0.32 0.00 0.26 0.14
1 70 86 -0.01 -0.21 0.54 0.05 -0.04 0.44 -0.15 -0.01 0.21 -0.22 -0.19 -0.23 -0.35 -0.21 -0.04 0.25 0.12 0.10 0.06 -0.10
1 74 90 0.01 -0.29 -0.23 0.25 -0.06 -0.13 0.08 -0.27 0.02 -0.13 0.21 -0.33 0.03 0.41 -0.15 -0.14 0.18 0.53 0.04 -0.02
1 87 425 -0.01 0.18 0.29 0.13 -0.04 0.03 0.07 -0.02 0.26 0.10 -0.01 -0.58 -0.35 0.12 -0.39 -0.06 0.17 -0.20 0.28 0.02
1 100 230 0.00 0.21 -0.18 -0.13 0.24 0.47 -0.47 0.00 -0.17 -0.28 0.22 -0.05 0.11 -0.23 0.03 0.05 0.32 -0.09 -0.19 0.16
1 106 428 -0.14 -0.15 0.21 -0.13 0.49 -0.44 0.22 0.06 -0.11 0.31 -0.28 -0.23 -0.12 0.02 0.03 0.08 0.17 -0.09 -0.17 0.28
1 111 385 -0.09 -0.12 -0.16 0.41 0.20 -0.28 0.46 -0.06 -0.32 0.09 0.18 -0.03 0.07 0.13 -0.19 -0.26 -0.37 0.17 0.06 0.11
1 114 397 549 0.00 -0.62 0.19 0.29 -0.21 0.17 0.22 0.02 -0.51 -0.04 -0.04 0.04 -0.09 0.08 -0.05 0.12 0.08 0.15 0.20 -0.02
1 115 153 -0.08 -0.16 -0.09 0.19 -0.07 -0.09 0.19 -0.09 -0.08 -0.05 -0.05 -0.16 -0.06 -0.03 0.90 -0.10 -0.08 -0.01 -0.03 -0.05
1 124 175 -0.11 0.12 0.03 0.12 0.06 0.04 -0.13 0.40 -0.40 -0.30 -0.38 -0.20 -0.08 -0.10 0.01 0.37 0.28 0.09 0.29 -0.14
1 130 545 0.15 -0.28 0.09 0.21 -0.20 -0.08 0.17 0.31 -0.35 0.26 0.20 -0.06 -0.01 0.00 0.17 0.01 -0.15 -0.01 -0.60 0.17
1 134&454 0.17 0.11 -0.13 0.00 -0.29 -0.02 0.03 0.61 0.16 0.23 -0.24 0.13 0.28 -0.02 -0.33 -0.29 -0.20 -0.08 -0.04 -0.08
1 139 608 0.08 -0.26 -0.28 0.13 0.15 0.32 -0.48 0.41 0.08 -0.21 0.21 -0.07 -0.26 -0.19 0.22 -0.06 0.12 -0.07 0.17 -0.01
1 143 148 -0.15 -0.21 -0.28 0.42 0.13 -0.10 -0.03 0.04 -0.51 0.06 0.09 -0.22 -0.21 0.13 0.03 0.31 0.40 0.11 -0.04 0.02
1 147 221 0.00 0.13 0.09 0.40 -0.23 0.30 0.09 -0.10 0.00 -0.01 -0.05 -0.25 -0.22 -0.20 0.32 -0.18 -0.49 0.24 0.24 -0.10
1 149 297 -0.23 -0.20 0.03 0.27 0.11 0.60 0.00 -0.01 -0.18 0.10 -0.08 -0.14 0.17 0.11 -0.50 0.01 -0.01 0.07 0.14 -0.27
1 151 481 0.57 0.41 -0.09 0.00 -0.02 0.07 -0.35 0.15 -0.08 0.00 -0.01 0.09 -0.03 -0.02 0.19 -0.32 -0.06 -0.44 -0.06 0.00
1 152 395 0.14 -0.04 0.07 0.19 0.28 -0.19 0.18 -0.29 0.24 0.30 0.04 0.22 -0.22 0.11 -0.32 -0.30 -0.01 -0.50 0.09 0.01
1 156 432 0.21 -0.15 -0.34 -0.10 0.00 -0.31 -0.13 0.08 0.15 0.44 -0.04 -0.17 -0.13 0.16 -0.29 0.14 0.34 -0.07 -0.15 0.39
1 167 246 0.06 0.12 0.12 -0.01 0.15 -0.17 -0.11 0.06 -0.30 0.18 -0.16 0.23 0.03 -0.40 0.00 0.16 0.05 -0.58 0.26 0.32
1 174 371 -0.16 -0.43 0.14 0.22 0.26 -0.01 -0.02 -0.15 -0.15 -0.04 -0.09 -0.16 0.59 -0.12 0.09 0.24 -0.01 -0.23 0.23 -0.21
1 187 530 0.19 0.51 0.24 0.00 -0.10 -0.11 0.29 -0.11 -0.09 0.01 -0.59 0.07 0.15 -0.25 -0.17 -0.03 -0.02 -0.11 0.20 -0.05
1 189 532 0.06 -0.22 0.09 0.11 -0.26 -0.07 -0.17 0.04 -0.03 0.23 0.11 -0.55 0.28 0.22 -0.13 0.18 0.40 -0.09 0.13 -0.32
1 196 455 0.32 -0.22 0.04 0.06 -0.25 0.08 0.08 0.48 0.04 -0.14 -0.20 -0.31 0.18 0.25 -0.12 -0.44 0.00 0.24 0.04 -0.14
1 198 208 -0.26 -0.13 0.26 0.02 0.29 -0.03 0.03 -0.63 -0.05 0.48 -0.11 -0.02 -0.02 0.21 -0.01 0.03 -0.20 -0.06 0.13 0.09
1 205 465 -0.07 -0.19 0.00 -0.15 0.21 -0.09 -0.16 0.31 0.03 0.55 -0.25 0.05 0.10 -0.35 0.03 -0.37 -0.10 0.32 0.02 0.10
1 209 247 -0.30 -0.10 -0.02 0.11 -0.15 -0.01 -0.18 0.19 -0.44 0.17 0.21 -0.06 -0.44 0.03 0.45 0.21 0.14 -0.07 0.02 0.24
1 212 529 -0.13 -0.13 0.03 0.14 -0.08 0.25 -0.26 -0.36 -0.35 0.25 -0.06 0.09 -0.41 0.46 0.09 0.24 -0.04 0.01 0.08 0.19
1 218 380 0.12 0.19 -0.14 -0.37 0.11 -0.05 -0.17 0.01 0.02 0.03 0.00 0.44 -0.02 -0.46 -0.19 0.35 0.23 0.17 -0.30 0.05
1 219 478 0.49 -0.35 0.11 0.12 -0.36 -0.11 0.10 0.39 0.19 0.04 0.11 -0.38 0.10 -0.03 0.03 -0.24 -0.20 0.01 -0.04 0.03
1 220 298 -0.22 0.29 -0.38 -0.25 -0.17 0.13 0.10 0.12 -0.03 -0.02 0.06 0.07 0.06 -0.07 -0.14 0.13 0.52 0.33 -0.36 -0.15
1 233 252 -0.16 -0.06 0.18 -0.07 -0.58 0.33 0.30 0.04 -0.15 0.24 -0.04 -0.14 0.32 0.26 -0.23 -0.05 0.08 -0.20 0.10 -0.16
1 239 480 -0.17 -0.10 -0.21 -0.32 0.14 -0.05 -0.05 -0.13 0.67 0.02 0.00 0.18 0.25 -0.02 0.24 -0.18 0.09 -0.29 -0.16 0.10
1 249 250 -0.20 0.37 -0.01 -0.04 -0.54 0.08 0.12 -0.50 -0.01 0.13 0.02 0.04 -0.16 0.13 -0.10 0.00 0.09 0.41 0.10 0.06
1 251 378 527 -0.07 0.19 -0.20 -0.03 0.54 -0.20 -0.14 0.01 0.07 -0.12 -0.14 -0.45 0.24 -0.18 0.36 0.19 0.16 -0.18 0.05 -0.10
1 257 299 -0.03 -0.20 0.32 0.39 -0.12 -0.28 -0.02 -0.08 0.30 0.01 -0.09 0.06 -0.25 0.32 -0.42 0.11 -0.23 -0.09 0.02 0.29
1 259 327 -0.29 -0.23 0.08 0.16 0.23 0.08 0.50 -0.26 -0.23 -0.12 0.38 -0.24 -0.07 0.06 0.25 0.19 -0.17 -0.09 -0.11 -0.13
















1 271 281 -0.16 0.18 0.06 -0.27 -0.20 0.24 0.00 0.32 -0.42 0.24 -0.13 0.51 0.03 -0.09 -0.21 0.12 -0.03 0.16 -0.19 -0.16
1 272 401 -0.08 -0.03 -0.29 -0.13 0.22 0.06 -0.39 0.13 -0.02 0.34 -0.24 -0.01 0.10 -0.06 -0.37 -0.11 0.30 0.07 0.04 0.48
1 279 280 -0.33 -0.14 0.10 0.07 -0.06 -0.32 -0.16 0.10 0.12 0.47 -0.14 0.07 -0.10 0.06 -0.27 -0.10 -0.12 -0.03 0.28 0.50
1 282 361 -0.02 -0.28 -0.18 0.34 -0.38 0.31 -0.09 0.04 -0.07 0.00 0.11 0.50 0.01 -0.13 -0.22 -0.01 -0.09 0.36 0.01 -0.25
1 294 537 0.15 -0.12 -0.07 0.07 0.29 -0.56 -0.20 0.12 0.23 0.09 -0.12 0.04 -0.22 -0.38 0.41 0.22 -0.08 0.06 0.07 0.00
1 310 451 0.12 -0.31 -0.49 0.28 0.07 0.21 -0.28 0.20 -0.23 -0.05 0.12 0.03 -0.10 0.18 -0.18 0.14 0.40 0.03 -0.26 0.10
1 335 364 0.10 0.00 -0.47 -0.06 0.03 0.21 -0.01 -0.11 0.49 0.24 0.29 -0.06 0.00 -0.12 0.24 -0.17 -0.09 -0.36 0.12 -0.26
1 349 558 -0.38 -0.15 0.11 0.04 0.04 0.24 0.14 -0.08 0.15 0.36 0.07 0.32 0.00 0.10 0.20 -0.31 -0.32 -0.22 0.11 -0.41
1 369 589 0.03 -0.09 0.38 0.36 -0.35 -0.41 0.07 -0.42 0.37 -0.12 0.04 0.00 0.09 -0.03 -0.05 0.19 -0.11 0.12 0.00 -0.08
1 402 417 0.20 -0.17 0.18 0.34 -0.02 -0.17 0.08 0.26 0.02 -0.24 -0.26 -0.41 -0.15 -0.11 0.08 0.41 0.31 0.02 -0.27 -0.10
1 407 411 -0.06 -0.08 -0.11 -0.03 0.21 -0.09 0.19 0.35 -0.33 0.18 0.15 -0.39 -0.18 0.30 -0.02 -0.06 -0.02 0.20 -0.46 0.26
1 423 435 -0.17 -0.04 -0.12 0.13 0.59 0.07 -0.12 -0.31 -0.20 0.01 -0.01 0.17 -0.24 -0.07 0.40 -0.06 -0.08 0.21 -0.32 0.16
1 424 507 0.16 -0.20 0.03 0.15 -0.01 -0.05 -0.28 0.10 0.05 -0.37 -0.36 0.22 0.14 0.45 -0.17 -0.18 0.44 -0.14 0.03 -0.01
1 441 579 0.19 -0.13 0.11 0.28 -0.18 0.02 0.22 -0.24 0.11 -0.40 -0.25 0.10 -0.40 0.23 0.22 -0.07 -0.14 0.39 0.10 -0.15
1 462 463 0.48 -0.18 0.13 -0.07 0.05 0.16 -0.20 0.25 0.05 -0.02 0.01 -0.33 0.18 -0.10 -0.16 0.27 0.20 -0.01 -0.20 -0.50
1 464 597 0.13 0.22 0.25 0.18 -0.60 0.00 -0.04 -0.16 -0.18 0.05 0.01 0.02 -0.08 0.07 -0.04 -0.20 0.13 -0.09 0.55 -0.19
1 475 511 0.27 -0.17 -0.27 0.02 0.31 -0.26 0.04 0.09 -0.07 -0.11 -0.11 -0.14 0.49 -0.46 0.26 0.08 -0.10 0.07 -0.15 0.20
1 482 484 -0.06 -0.45 0.14 0.38 0.21 -0.25 -0.34 0.13 0.23 0.09 -0.12 -0.26 0.11 -0.29 0.22 0.00 0.28 0.09 -0.11 0.00
1 486 487 -0.04 0.12 -0.09 -0.08 0.20 0.51 -0.33 -0.15 -0.18 0.02 0.18 0.18 -0.16 -0.42 -0.04 -0.24 0.22 0.29 -0.13 0.15
1 489 494 0.22 0.00 -0.42 -0.13 -0.18 -0.25 -0.13 -0.26 -0.13 0.27 0.37 -0.01 0.35 0.23 0.31 -0.17 -0.22 0.06 0.06 0.03
1 501 502 -0.12 -0.03 0.24 0.51 -0.12 0.10 0.35 -0.03 -0.02 -0.25 -0.20 -0.44 -0.23 0.04 -0.15 0.12 0.06 0.31 0.05 -0.19
1 503 602 -0.07 -0.07 0.20 0.44 0.04 -0.13 0.27 0.21 0.13 -0.08 -0.38 0.25 0.27 0.01 -0.33 -0.09 -0.28 -0.05 -0.34 -0.01
1 514 543 0.49 -0.46 0.12 0.11 0.10 0.05 -0.37 -0.20 0.04 -0.35 -0.03 0.17 -0.15 0.08 0.09 0.16 0.06 -0.22 0.23 0.08
1 518 519 -0.02 -0.42 0.02 0.20 0.57 0.09 0.29 -0.08 -0.06 -0.04 -0.20 0.13 0.00 -0.02 -0.40 -0.02 -0.22 0.08 0.24 -0.14
1 557 577 0.17 -0.06 0.02 -0.22 0.26 -0.08 -0.05 -0.07 0.31 -0.23 0.12 -0.42 0.15 -0.19 -0.36 0.42 0.03 0.06 0.31 -0.15
1 561 571 -0.19 -0.13 -0.02 0.05 0.13 0.13 0.26 -0.42 0.08 0.07 0.11 0.14 0.22 -0.16 0.40 -0.02 -0.12 -0.57 0.17 -0.15
1 582 585 0.23 -0.51 0.03 0.24 0.41 0.01 0.17 0.34 -0.11 -0.24 -0.17 -0.07 -0.02 0.02 0.10 0.13 0.09 -0.30 -0.28 -0.07
0.9996 399 554 596 -0.09 -0.14 0.20 -0.11 0.01 0.46 -0.26 -0.39 0.33 -0.03 -0.09 -0.14 -0.18 0.11 0.49 -0.07 0.14 -0.01 -0.03 -0.20
0.999 521 522 523 0.05 0.30 -0.11 -0.33 0.12 0.10 0.19 0.05 0.37 -0.04 -0.18 -0.03 0.18 -0.21 -0.19 0.08 -0.09 -0.60 0.20 0.17
0.9989 169 474 548 -0.15 -0.40 -0.11 -0.03 -0.02 0.03 0.36 0.14 -0.17 -0.13 0.21 0.33 0.30 -0.11 0.30 -0.20 -0.23 -0.19 -0.22 0.30
0.9972 8 142 598 -0.33 0.42 -0.23 0.36 0.00 -0.32 0.03 0.00 -0.22 0.29 0.05 -0.09 -0.16 -0.02 0.26 -0.27 -0.12 -0.02 0.30 0.07
0.9959 72 535 552 586 -0.19 0.14 -0.01 0.03 0.55 0.03 0.07 -0.24 -0.10 -0.05 -0.05 0.05 0.65 -0.22 -0.16 -0.07 -0.02 -0.20 -0.10 -0.10
0.9953 191 193 195 0.10 -0.03 -0.47 -0.09 0.06 0.06 0.09 -0.09 0.01 -0.29 0.23 -0.14 0.39 -0.08 0.18 0.03 0.32 0.28 -0.42 -0.15
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Table B.5: PCA Generated Amino Acid Indices With Complete Linkage 0.65
Variance Indices A R N D C Q E G H I L K M F P S T W Y V
1 1 17 -0.19 -0.11 0.08 0.09 0.13 -0.16 -0.20 -0.41 -0.01 0.51 0.44 -0.18 -0.10 0.02 -0.02 -0.10 -0.20 0.04 -0.01 0.37
1 2 132 0.17 -0.19 0.23 0.36 -0.03 -0.07 0.09 -0.03 0.17 -0.21 -0.23 0.37 -0.42 0.04 0.00 -0.13 -0.13 0.38 -0.03 -0.34
1 3 4 -0.33 -0.16 0.05 0.01 0.66 0.27 -0.03 -0.05 0.10 -0.19 0.24 0.01 -0.31 -0.06 0.06 0.21 -0.01 -0.24 -0.21 -0.01
1 5 564 -0.15 -0.26 -0.06 -0.26 0.33 0.31 0.27 -0.06 -0.15 -0.02 0.26 0.15 -0.58 0.16 -0.09 0.16 0.02 0.12 -0.19 0.03
1 8 598 0.10 0.11 -0.23 -0.05 0.16 -0.20 0.22 -0.23 -0.35 -0.16 0.25 0.27 0.19 -0.43 0.09 0.23 -0.32 0.20 -0.06 0.20
1 9 109 -0.46 0.04 0.03 0.51 0.09 0.01 -0.04 -0.25 -0.03 0.22 0.22 -0.23 0.00 0.11 -0.12 0.37 -0.13 -0.33 0.07 -0.09
1 10 319 -0.21 -0.30 0.24 -0.15 0.01 -0.11 0.20 -0.35 0.16 0.13 0.07 0.04 0.38 -0.35 0.28 0.16 0.12 -0.38 -0.09 0.15
1 12 13 0.23 -0.48 -0.18 0.02 0.45 -0.14 0.08 0.10 -0.29 -0.36 0.29 -0.06 0.10 0.25 -0.05 -0.01 -0.01 -0.19 0.14 0.10
1 15 59 0.17 -0.42 -0.04 0.17 -0.24 -0.04 0.02 0.18 -0.02 0.27 0.03 0.06 0.04 -0.18 -0.05 0.43 0.11 -0.28 -0.47 0.25
1 18 604 -0.15 -0.05 0.18 -0.05 0.25 -0.03 0.13 0.17 -0.29 0.42 -0.10 -0.27 -7e-05 0.41 -0.43 0.03 0.09 -0.35 0.00 0.05
1 19 363 -0.04 -0.40 -0.05 -0.18 -0.06 0.41 -0.20 0.01 -0.02 -0.01 -0.10 -0.09 0.04 -0.33 0.14 -0.02 0.19 0.56 -0.12 0.28
1 20 283 0.10 -0.07 0.14 -0.24 0.15 -0.03 0.04 -0.33 -0.14 0.31 -0.15 0.05 -0.33 -0.09 0.00 0.33 0.20 -0.43 0.06 0.42
1 21 79 -0.08 -0.03 0.35 0.33 -0.11 -0.07 -0.09 -0.23 0.10 0.21 0.19 -0.20 0.04 -0.03 0.56 -0.10 -0.31 -0.27 -0.03 -0.23
1 22 80 0.18 -0.08 -0.02 -0.41 0.37 -0.10 -0.49 0.26 0.17 -0.03 -0.03 -0.14 0.22 0.14 0.15 -0.09 -0.18 0.30 -0.27 0.05
1 23 449 -0.06 -0.08 0.20 -0.22 -0.01 0.18 0.02 0.05 0.14 0.06 0.08 -0.25 -0.04 -0.10 -0.07 0.02 -0.37 -0.14 0.75 -0.18
1 24 560 0.04 -0.97 0.07 0.06 0.06 0.05 0.05 0.07 0.05 0.04 0.04 0.05 0.04 0.04 0.07 0.06 0.05 0.04 0.05 0.04
1 25 278 -0.06 -0.10 -0.15 -0.06 0.22 -0.22 0.27 0.14 0.10 -0.16 0.16 -0.16 0.36 0.06 -0.27 0.16 0.44 -0.23 -0.03 -0.46
1 27 330 0.21 -0.22 -0.22 -0.31 -0.02 0.00 0.13 -0.06 -0.09 0.04 -0.20 0.40 -0.13 0.22 -0.10 0.16 0.21 -0.40 -0.09 0.47
1 28 470 0.10 -0.09 0.10 0.10 0.10 -0.28 -0.27 0.10 -0.24 0.10 0.10 0.11 -0.47 -0.47 0.10 0.10 0.10 0.34 0.33 0.10
1 31 284 0.21 0.19 0.25 0.08 0.04 0.10 0.19 -0.03 0.02 -0.57 -0.15 -0.11 0.26 -0.02 -0.56 -0.01 0.02 0.09 0.15 -0.15
1 34 509 0.10 0.48 -0.14 0.14 0.32 0.02 -0.01 0.21 0.21 -0.24 -0.02 -0.58 -0.13 -0.16 -0.01 -0.02 -0.10 0.21 -0.18 -0.08
1 35 505 -0.03 -0.04 -0.11 -0.04 -0.41 -0.04 0.11 0.04 0.08 0.20 -0.34 0.10 0.57 -0.22 0.36 0.11 0.10 -0.30 -0.13 0.00
1 36 243 0.31 -0.02 -0.16 0.29 0.16 0.03 -0.26 -0.33 -0.01 -0.05 -0.02 -0.23 -0.09 -0.15 0.12 0.42 -0.13 -0.05 -0.29 0.45
1 37 227 0.12 0.11 0.30 -0.05 -0.72 0.17 0.05 0.06 0.02 -0.19 0.19 0.23 -0.24 -0.27 -6e-05 -0.11 0.05 0.23 0.08 -0.04
1 38 223 -0.37 0.25 0.22 -0.19 -0.08 0.63 -0.04 -0.02 0.25 -0.31 0.07 -0.11 0.17 -0.12 -0.11 -0.06 0.08 -0.26 0.05 -0.05
1 39 225 0.22 -0.43 -0.14 0.56 -0.12 -0.33 0.18 0.24 0.01 0.07 -0.08 0.06 -0.23 0.16 -0.22 -0.10 0.09 -0.16 0.04 0.18
1 40 53 -0.03 -0.14 0.07 0.14 0.00 0.18 0.24 0.21 0.31 -0.06 -0.12 0.22 -0.16 -0.23 -0.72 0.07 -0.07 -0.09 0.19 -0.01
1 41 565 0.19 -0.13 0.13 0.17 0.10 -0.05 -0.58 -0.24 -0.28 -0.03 -0.05 -0.14 -0.02 0.52 0.26 0.06 0.21 -0.11 0.01 -0.02
1 42 566 0.06 -0.25 -0.38 0.02 -0.36 -0.33 0.05 -0.05 -0.27 0.25 0.15 0.38 0.25 0.03 -0.15 0.12 0.28 -0.13 0.20 0.14
1 44 344 -0.05 -0.16 0.10 0.30 -0.02 0.11 0.04 -0.51 -0.25 0.00 -0.15 -0.42 -0.15 0.02 0.24 0.18 -0.01 0.38 0.28 0.04
1 45 186 0.08 -0.37 -0.08 0.44 0.32 -0.33 -0.36 0.21 0.25 -0.08 0.11 -0.26 0.03 0.08 -0.03 0.02 0.19 -0.25 0.05 -0.03
1 46 377 0.01 -0.13 -0.42 -0.09 -0.33 0.10 0.20 0.02 -0.13 0.25 0.33 0.02 -0.18 0.11 0.34 -0.03 0.01 0.40 -0.32 -0.16
1 49 321 -0.10 0.03 -0.29 0.10 0.66 0.07 -0.10 -0.19 0.40 -0.14 0.02 -0.21 -0.13 0.00 0.17 -0.22 -0.26 0.13 -0.01 0.07
1 50 366 0.39 -0.49 -0.38 -0.20 0.02 0.24 0.25 0.05 0.01 0.16 0.26 -0.26 -0.15 -0.22 0.12 -0.07 -0.03 0.22 0.05 0.03
1 51 123 -0.02 -0.33 -0.06 0.10 -0.74 0.30 -0.19 0.20 0.13 0.00 0.18 0.02 0.08 0.15 0.06 -0.16 0.11 -0.08 0.13 0.12
1 52 346 0.09 -0.13 0.12 0.01 0.02 -0.26 0.23 0.08 -0.28 -0.30 0.13 -0.05 -0.18 -0.43 0.47 0.06 -0.22 0.19 0.30 0.14
1 55 497 -0.16 0.07 0.09 0.06 0.03 0.03 0.50 -0.11 -0.35 -0.11 0.08 -0.18 -0.40 0.40 -0.25 0.16 0.16 0.18 0.02 -0.23
1 56 58 0.33 -0.09 -0.12 -0.04 -0.07 0.06 0.31 -0.01 -0.09 0.34 0.04 -0.14 0.20 -0.33 0.03 0.37 -0.41 -0.39 -0.06 0.08
1 60 185 -0.15 0.02 0.04 -0.08 0.00 0.47 -0.18 -0.09 0.13 0.10 -0.07 -0.53 0.12 -0.32 -0.20 0.21 0.18 0.41 -0.03 -0.02
1 63 117 0.02 -0.16 0.17 -0.27 -0.57 0.21 0.07 -0.17 -0.37 0.02 0.00 -0.10 -0.05 0.17 0.33 -0.03 0.32 0.00 0.26 0.14
1 64 137 -0.13 -0.11 0.39 -0.36 0.07 -0.01 -0.47 0.17 -0.02 0.24 -0.17 0.30 -0.01 0.11 -0.43 0.18 -0.04 -0.01 0.15 0.13
1 65 135 -0.04 -0.23 0.38 0.32 -0.15 0.16 0.43 0.16 -0.37 -0.16 -0.05 -0.15 0.00 0.03 0.11 -0.07 -0.22 0.18 0.05 -0.39
1 67 603 -0.21 0.15 0.25 0.01 0.58 -0.13 -0.30 -0.10 0.43 -0.01 -0.21 0.16 0.18 -0.19 -0.20 -0.09 -0.22 0.01 -0.02 -0.10
1 68 534 0.22 -0.29 0.45 -0.04 0.24 -0.29 -0.30 0.11 0.17 -0.33 0.19 0.25 -0.15 -0.19 0.01 0.15 -0.22 0.08 0.12 -0.18
1 70 86 -0.01 -0.21 0.54 0.05 -0.04 0.44 -0.15 -0.01 0.21 -0.22 -0.19 -0.23 -0.35 -0.21 -0.04 0.25 0.12 0.10 0.06 -0.10
1 72 552 0.01 -0.02 0.25 0.46 -0.19 0.13 0.34 0.03 0.14 -0.26 -0.26 -0.27 -0.43 -0.03 -0.06 0.21 0.09 -0.05 0.16 -0.24
1 74 90 0.01 -0.29 -0.23 0.25 -0.06 -0.13 0.08 -0.27 0.02 -0.13 0.21 -0.33 0.03 0.41 -0.15 -0.14 0.18 0.53 0.04 -0.02
















1 76 133 -0.08 -0.55 0.16 0.43 -0.13 0.05 0.22 -0.10 0.31 -0.09 -0.09 0.08 -0.03 -0.38 0.26 0.06 0.12 -0.21 0.03 -0.06
1 77 590 -0.04 0.00 0.00 0.00 0.96 -0.02 -0.01 -0.03 -0.04 -0.11 -0.11 0.01 -0.09 -0.11 -0.06 -0.04 -0.04 -0.13 -0.07 -0.08
1 82 84 -0.34 -0.01 -0.28 -0.18 0.27 -0.06 0.01 0.07 -0.09 -0.34 -0.10 -0.03 -0.07 0.23 0.57 0.16 0.05 0.17 0.23 -0.25
1 83 388 0.27 -0.10 0.23 0.34 0.02 0.29 0.33 -0.17 -0.09 -0.15 -0.30 0.08 -0.25 -0.29 0.13 0.09 -0.14 0.23 -0.29 -0.23
1 85 110 -0.07 -0.01 -0.21 0.45 -0.47 -0.06 0.08 -0.37 0.33 -0.07 -0.07 -0.16 0.32 0.24 -0.19 0.13 -0.05 -0.06 0.14 0.09
1 87 425 -0.01 0.18 0.29 0.13 -0.04 0.03 0.07 -0.02 0.26 0.10 -0.01 -0.58 -0.35 0.12 -0.39 -0.06 0.17 -0.20 0.28 0.02
1 89 324 0.14 -0.22 -0.04 -0.51 -0.10 0.43 0.14 -0.10 -0.04 -0.22 -0.10 0.02 0.14 -0.10 -0.22 -0.22 0.14 0.38 0.26 0.20
1 92 450 0.03 -0.29 0.33 -0.30 0.00 -0.09 0.37 -0.05 -0.09 -0.23 0.04 -0.28 0.02 0.04 -0.11 0.42 0.44 -0.03 -0.03 -0.22
1 93 421 -0.47 -0.27 0.31 0.00 0.13 0.02 -0.14 0.29 0.32 0.13 -0.30 -0.24 -0.17 -0.07 -0.14 0.00 0.26 -0.11 0.20 0.23
1 96 159 0.30 -0.32 0.05 0.03 0.06 0.08 0.08 0.26 0.03 -0.04 0.02 -0.33 -0.07 -0.22 -0.13 0.24 0.03 0.44 -0.53 0.01
1 98 228 0.14 -0.48 0.26 -0.24 0.10 0.26 -0.09 0.15 -0.01 -0.06 -0.07 -0.03 -0.11 0.00 0.49 -0.06 0.34 -0.16 -0.31 -0.12
1 100 230 0.00 0.21 -0.18 -0.13 0.24 0.47 -0.47 0.00 -0.17 -0.28 0.22 -0.05 0.11 -0.23 0.03 0.05 0.32 -0.09 -0.19 0.16
1 102 231 -0.02 -0.19 0.02 -0.01 0.14 -0.13 0.45 -0.05 -0.10 -0.09 -0.45 -0.07 0.38 -0.06 0.04 -0.15 -0.03 -0.16 -0.06 0.54
1 104 107 -0.08 -0.08 0.58 0.36 0.00 0.29 -0.27 -0.02 -0.19 0.26 0.08 -0.26 0.02 0.07 -0.27 -0.17 -0.17 0.02 -0.20 0.02
1 105 234 0.02 -0.33 0.17 0.24 0.18 -0.13 0.21 0.11 -0.25 -0.11 -0.25 0.13 0.31 0.37 -0.44 0.03 -0.03 0.18 -0.21 -0.19
1 106 428 -0.14 -0.15 0.21 -0.13 0.49 -0.44 0.22 0.06 -0.11 0.31 -0.28 -0.23 -0.12 0.02 0.03 0.08 0.17 -0.09 -0.17 0.28
1 111 385 -0.09 -0.12 -0.16 0.41 0.20 -0.28 0.46 -0.06 -0.32 0.09 0.18 -0.03 0.07 0.13 -0.19 -0.26 -0.37 0.17 0.06 0.11
1 115 153 -0.08 -0.16 -0.09 0.19 -0.07 -0.09 0.19 -0.09 -0.08 -0.05 -0.05 -0.16 -0.06 -0.03 0.90 -0.10 -0.08 -0.01 -0.03 -0.05
1 118 588 -0.04 -0.12 0.13 0.26 -0.33 0.21 0.33 0.21 -0.21 -0.12 -0.11 -0.07 0.53 0.16 -0.29 0.11 -0.20 -0.15 -0.08 -0.21
1 119 170 0.15 -0.10 0.02 0.29 -0.14 0.08 -0.39 0.15 0.17 0.08 -0.27 -0.14 0.21 0.02 -0.57 -0.04 0.35 0.13 0.16 -0.15
1 120 171 -0.04 -0.10 -0.10 -0.03 -0.45 -0.02 -0.27 0.72 0.06 -0.03 -0.06 -0.02 0.13 0.12 0.30 -0.08 -0.03 -0.19 0.08 0.02
1 124 175 -0.11 0.12 0.03 0.12 0.06 0.04 -0.13 0.40 -0.40 -0.30 -0.38 -0.20 -0.08 -0.10 0.01 0.37 0.28 0.09 0.29 -0.14
1 126 173 -0.08 -0.37 0.30 0.12 -0.60 0.01 0.04 -0.18 0.14 0.03 -0.03 -0.12 0.25 0.01 0.13 0.30 -0.20 0.20 -0.16 0.20
1 127 508 0.26 -0.41 -0.01 0.15 -0.20 -0.09 -0.11 0.43 -0.22 -0.20 -0.22 0.15 -0.26 0.10 0.20 0.27 0.32 -0.09 0.10 -0.17
1 128 563 -0.20 0.24 -0.16 -0.06 -0.17 -0.10 -0.24 -0.25 0.28 0.22 0.14 0.15 0.03 0.32 -0.12 -0.34 -0.05 0.06 0.50 -0.23
1 130 545 0.15 -0.28 0.09 0.21 -0.20 -0.08 0.17 0.31 -0.35 0.26 0.20 -0.06 -0.01 0.00 0.17 0.01 -0.15 -0.01 -0.60 0.17
1 131 559 -0.12 -0.37 0.36 0.41 0.00 0.29 0.21 -0.12 -0.01 0.15 -0.18 -0.39 -0.26 0.29 0.01 0.04 -0.17 0.01 -0.07 -0.10
1 134 454 0.17 0.11 -0.13 0.00 -0.29 -0.02 0.03 0.61 0.16 0.23 -0.24 0.13 0.28 -0.02 -0.33 -0.29 -0.20 -0.08 -0.04 -0.08
1 139 608 0.08 -0.26 -0.28 0.13 0.15 0.32 -0.48 0.41 0.08 -0.21 0.21 -0.07 -0.26 -0.19 0.22 -0.06 0.12 -0.07 0.17 -0.01
1 140 408 0.04 -0.26 -0.08 0.38 0.04 -0.33 0.05 0.05 0.38 -0.23 0.49 0.11 -0.09 -0.18 -0.05 -0.13 0.08 0.16 -0.35 -0.07
1 143 148 -0.15 -0.21 -0.28 0.42 0.13 -0.10 -0.03 0.04 -0.51 0.06 0.09 -0.22 -0.21 0.13 0.03 0.31 0.40 0.11 -0.04 0.02
1 147 221 0.00 0.13 0.09 0.40 -0.23 0.30 0.09 -0.10 0.00 -0.01 -0.05 -0.25 -0.22 -0.20 0.32 -0.18 -0.49 0.24 0.24 -0.10
1 149 297 -0.23 -0.20 0.03 0.27 0.11 0.60 0.00 -0.01 -0.18 0.10 -0.08 -0.14 0.17 0.11 -0.50 0.01 -0.01 0.07 0.14 -0.27
1 151 481 0.57 0.41 -0.09 0.00 -0.02 0.07 -0.35 0.15 -0.08 0.00 -0.01 0.09 -0.03 -0.02 0.19 -0.32 -0.06 -0.44 -0.06 0.00
1 152 395 0.14 -0.04 0.07 0.19 0.28 -0.19 0.18 -0.29 0.24 0.30 0.04 0.22 -0.22 0.11 -0.32 -0.30 -0.01 -0.50 0.09 0.01
1 154 157 0.38 -0.12 0.12 0.19 -0.08 0.10 0.11 -0.18 0.27 -0.44 -0.01 -0.37 -0.41 0.22 -0.11 0.20 -0.06 0.19 0.10 -0.12
1 156 432 0.21 -0.15 -0.34 -0.10 0.00 -0.31 -0.13 0.08 0.15 0.44 -0.04 -0.17 -0.13 0.16 -0.29 0.14 0.34 -0.07 -0.15 0.39
1 160 568 -0.05 -0.40 -0.28 0.16 0.12 0.11 0.36 -0.29 0.12 0.07 -0.24 0.19 -0.04 -0.24 0.16 0.23 0.23 -0.22 -0.27 0.29
1 161 253 -0.32 -0.04 0.01 0.03 0.23 0.25 -0.30 0.05 -0.33 -0.08 -0.35 -0.03 0.46 0.20 0.09 -0.26 0.26 0.22 -0.02 -0.08
1 162 222 -0.01 -0.28 -0.29 -0.02 0.01 -0.31 0.09 0.05 0.23 -0.35 0.05 -0.02 -0.29 0.46 0.22 0.09 0.03 0.39 -0.17 0.13
1 163 224 0.29 -0.24 -0.31 -0.02 -0.34 -0.10 0.41 -0.18 0.06 -0.02 0.08 0.07 -0.09 0.39 -0.25 0.04 0.38 0.10 -0.19 -0.06
1 166 275 0.01 -0.31 0.07 0.17 -0.02 -0.11 -0.13 0.02 -0.10 -0.02 0.14 0.03 -0.24 -0.34 0.33 -0.12 -0.17 0.35 -0.15 0.59
1 167 246 0.06 0.12 0.12 -0.01 0.15 -0.17 -0.11 0.06 -0.30 0.18 -0.16 0.23 0.03 -0.40 0.00 0.16 0.05 -0.58 0.26 0.32
1 172 382 -0.41 -0.17 -0.04 0.36 -0.34 0.14 0.15 -0.20 0.37 -0.06 -0.10 -0.12 0.40 -0.05 0.05 -0.15 -0.23 0.06 0.24 0.10
1 174 371 -0.16 -0.43 0.14 0.22 0.26 -0.01 -0.02 -0.15 -0.15 -0.04 -0.09 -0.16 0.59 -0.12 0.09 0.24 -0.01 -0.23 0.23 -0.21
1 176 555 0.95 -0.02 -0.08 -0.09 0.03 -0.06 -0.06 -0.15 -0.04 -0.05 -0.05 -0.04 -0.04 0.00 -0.09 -0.12 -0.09 0.06 0.01 -0.08
1 179 180 0.06 -0.38 0.25 0.30 -0.39 0.21 0.18 0.16 -0.36 -0.08 0.02 -0.29 -0.15 0.25 -0.15 0.04 0.30 0.05 0.10 -0.11
1 181 295 0.03 -0.24 0.00 -0.25 0.24 0.18 -0.44 -0.03 -0.05 -0.12 -0.19 -0.23 -0.29 0.06 0.41 0.27 0.12 0.27 0.00 0.26
1 182 296 0.03 -0.03 0.15 0.25 -0.29 -0.19 0.39 -0.32 0.11 0.06 0.15 0.28 0.41 -0.07 -0.37 -0.27 -0.10 0.01 -0.07 -0.14
226
Table B.5: (continued)
1 184 593 0.21 -0.01 -0.02 -0.07 0.68 0.03 -0.15 0.00 -0.09 -0.02 0.10 0.17 -0.01 -0.21 -0.23 0.12 0.05 -0.42 -0.31 0.17
1 187 530 0.19 0.51 0.24 0.00 -0.10 -0.11 0.29 -0.11 -0.09 0.01 -0.59 0.07 0.15 -0.25 -0.17 -0.03 -0.02 -0.11 0.20 -0.05
1 188 601 0.38 -0.25 0.10 0.21 -0.11 0.04 0.11 0.37 0.08 -0.41 -0.31 -0.47 -0.11 0.11 0.20 0.04 0.02 0.00 0.09 -0.11
1 189 532 0.06 -0.22 0.09 0.11 -0.26 -0.07 -0.17 0.04 -0.03 0.23 0.11 -0.55 0.28 0.22 -0.13 0.18 0.40 -0.09 0.13 -0.32
1 190 192 0.04 -0.06 -0.44 -0.08 0.21 0.11 0.09 -0.21 0.13 -0.34 0.13 -0.23 0.33 -0.03 0.26 -0.04 0.32 0.29 -0.24 -0.23
1 191 193 -0.14 -0.07 0.49 -0.01 -0.11 -0.12 -0.18 0.06 -0.02 0.38 -0.11 0.07 -0.28 0.17 -0.20 -0.02 -0.29 -0.23 0.47 0.12
1 196 455 0.32 -0.22 0.04 0.06 -0.25 0.08 0.08 0.48 0.04 -0.14 -0.20 -0.31 0.18 0.25 -0.12 -0.44 0.00 0.24 0.04 -0.14
1 198 208 -0.26 -0.13 0.26 0.02 0.29 -0.03 0.03 -0.63 -0.05 0.48 -0.11 -0.02 -0.02 0.21 -0.01 0.03 -0.20 -0.06 0.13 0.09
1 201 457 0.10 -0.51 0.12 0.41 -0.17 0.01 0.36 0.14 0.15 -0.07 0.29 -0.43 -0.06 0.00 -0.16 -0.06 -0.18 0.01 0.02 0.04
1 203 204 0.03 0.16 -0.29 0.13 0.24 -0.02 0.28 -0.16 -0.11 0.01 -0.40 -0.26 -0.11 -0.07 -0.13 0.04 0.59 -0.15 0.00 0.23
1 205 465 -0.07 -0.19 0.00 -0.15 0.21 -0.09 -0.16 0.31 0.03 0.55 -0.25 0.05 0.10 -0.35 0.03 -0.37 -0.10 0.32 0.02 0.10
1 209 247 -0.30 -0.10 -0.02 0.11 -0.15 -0.01 -0.18 0.19 -0.44 0.17 0.21 -0.06 -0.44 0.03 0.45 0.21 0.14 -0.07 0.02 0.24
1 210 381 -0.05 -0.01 0.10 0.23 0.14 -0.19 0.16 -0.20 0.38 -0.26 -0.21 -0.02 0.11 0.17 -0.12 0.45 -0.43 0.14 -0.09 -0.29
1 211 313 0.11 -0.64 0.08 0.09 0.09 0.05 -0.35 0.09 0.35 0.26 0.10 0.13 0.13 -0.09 0.09 0.11 0.03 -0.33 -0.24 -0.06
1 212 529 -0.13 -0.13 0.03 0.14 -0.08 0.25 -0.26 -0.36 -0.35 0.25 -0.06 0.09 -0.41 0.46 0.09 0.24 -0.04 0.01 0.08 0.19
1 215 216 -0.12 -0.17 0.22 0.24 -0.17 0.24 0.37 -0.36 0.33 -0.29 0.06 0.33 0.03 -0.06 0.05 -0.03 0.01 -0.35 -0.06 -0.25
1 218 380 0.12 0.19 -0.14 -0.37 0.11 -0.05 -0.17 0.01 0.02 0.03 0.00 0.44 -0.02 -0.46 -0.19 0.35 0.23 0.17 -0.30 0.05
1 219 478 0.49 -0.35 0.11 0.12 -0.36 -0.11 0.10 0.39 0.19 0.04 0.11 -0.38 0.10 -0.03 0.03 -0.24 -0.20 0.01 -0.04 0.03
1 220 298 -0.22 0.29 -0.38 -0.25 -0.17 0.13 0.10 0.12 -0.03 -0.02 0.06 0.07 0.06 -0.07 -0.14 0.13 0.52 0.33 -0.36 -0.15
1 226 237 0.12 0.00 0.04 -0.11 -0.04 -0.41 0.19 -0.29 -0.11 0.35 0.08 -0.10 0.04 0.11 -0.27 0.09 0.06 -0.36 0.56 0.05
1 229 258 0.31 -0.03 0.24 0.26 -0.23 -0.36 -0.14 0.39 -0.34 -0.08 0.04 -0.25 0.21 -0.06 0.04 -0.15 0.16 0.30 -0.14 -0.18
1 232 375 0.02 -0.09 -0.07 0.05 0.16 -0.05 0.34 -0.25 -0.28 -0.16 -0.20 0.10 -0.36 0.09 0.43 0.16 -0.25 0.06 0.44 -0.14
1 233 252 -0.16 -0.06 0.18 -0.07 -0.58 0.33 0.30 0.04 -0.15 0.24 -0.04 -0.14 0.32 0.26 -0.23 -0.05 0.08 -0.20 0.10 -0.16
1 236 347 -0.26 0.11 0.28 0.13 -0.07 -0.15 -0.06 -0.04 0.14 0.31 -0.01 -0.46 -0.31 0.18 0.08 -0.06 0.42 0.05 -0.39 0.08
1 238 387 0.13 -0.38 -0.10 0.18 -0.14 0.06 0.04 0.00 -0.53 0.05 -0.18 -0.17 0.01 0.03 0.50 0.19 0.31 -0.13 0.01 0.14
1 239 480 -0.17 -0.10 -0.21 -0.32 0.14 -0.05 -0.05 -0.13 0.67 0.02 0.00 0.18 0.25 -0.02 0.24 -0.18 0.09 -0.29 -0.16 0.10
1 240 241 -0.01 -0.04 0.08 0.04 -0.52 -0.13 0.07 0.01 0.37 0.28 0.18 0.33 -0.04 -0.16 -0.20 -0.42 -0.14 -0.09 0.16 0.21
1 242 546 -0.02 -0.06 -0.20 0.09 -0.07 0.19 0.19 0.31 -0.35 -0.25 -0.13 -0.25 0.49 -0.07 -0.06 0.34 -0.04 -0.16 -0.19 0.27
1 249 250 -0.20 0.37 -0.01 -0.04 -0.54 0.08 0.12 -0.50 -0.01 0.13 0.02 0.04 -0.16 0.13 -0.10 0.00 0.09 0.41 0.10 0.06
1 251 527 0.04 -0.15 -0.08 0.06 0.25 -0.32 0.18 0.13 -0.35 0.22 -0.15 0.27 -0.24 0.12 0.32 -0.08 -0.18 -0.42 0.26 0.16
1 257 299 -0.03 -0.20 0.32 0.39 -0.12 -0.28 -0.02 -0.08 0.30 0.01 -0.09 0.06 -0.25 0.32 -0.42 0.11 -0.23 -0.09 0.02 0.29
1 259 327 -0.29 -0.23 0.08 0.16 0.23 0.08 0.50 -0.26 -0.23 -0.12 0.38 -0.24 -0.07 0.06 0.25 0.19 -0.17 -0.09 -0.11 -0.13
1 261 262 -0.14 0.07 -0.04 0.64 -0.07 -0.14 0.01 -0.44 -0.05 -0.02 -0.24 -0.32 0.17 0.20 0.14 0.06 0.11 0.24 -0.02 -0.15
1 263 338 -0.29 0.01 0.26 -0.24 0.32 0.08 -0.03 0.04 0.29 -0.66 0.05 0.13 0.13 0.19 -0.02 -0.04 -0.06 -0.25 0.13 -0.03
1 264 265 -0.27 -0.16 0.02 0.02 0.23 -0.44 0.30 -0.03 -0.25 0.22 -0.03 -0.11 0.16 0.09 -0.35 0.26 0.30 -0.20 -0.06 0.29
1 267 268 0.35 0.15 0.07 -0.01 0.05 0.13 -0.01 -0.37 -0.20 -0.05 0.26 -0.32 0.04 0.03 -0.36 -0.23 0.36 -0.27 0.11 0.28
1 269 270 -0.21 -0.18 -0.11 0.29 0.06 0.40 -0.17 0.24 0.12 -0.20 0.08 -0.01 0.26 -0.04 -0.55 0.06 0.07 0.14 -0.33 0.09
1 271 281 -0.16 0.18 0.06 -0.27 -0.20 0.24 0.00 0.32 -0.42 0.24 -0.13 0.51 0.03 -0.09 -0.21 0.12 -0.03 0.16 -0.19 -0.16
1 272 401 -0.08 -0.03 -0.29 -0.13 0.22 0.06 -0.39 0.13 -0.02 0.34 -0.24 -0.01 0.10 -0.06 -0.37 -0.11 0.30 0.07 0.04 0.48
1 279 280 -0.33 -0.14 0.10 0.07 -0.06 -0.32 -0.16 0.10 0.12 0.47 -0.14 0.07 -0.10 0.06 -0.27 -0.10 -0.12 -0.03 0.28 0.50
1 282 361 -0.02 -0.28 -0.18 0.34 -0.38 0.31 -0.09 0.04 -0.07 0.00 0.11 0.50 0.01 -0.13 -0.22 -0.01 -0.09 0.36 0.01 -0.25
1 285 301 0.11 -0.25 0.24 -0.23 -0.40 -0.09 -0.01 0.34 0.39 -0.31 0.00 0.29 -0.10 -0.18 0.00 0.31 0.03 0.05 0.03 -0.22
1 287 288 -0.06 0.29 -0.08 0.28 -0.16 0.10 0.08 -0.19 -0.16 -0.21 0.01 -0.46 0.12 0.22 0.01 0.13 0.43 0.22 -0.33 -0.21
1 289 290 -0.03 -0.34 -0.01 -0.26 -0.26 -0.13 0.01 0.42 0.26 0.08 0.35 0.43 0.09 -0.27 0.13 -0.10 -0.15 -0.21 0.01 -0.01
1 292 293 0.04 -0.18 0.13 -0.25 0.09 0.14 0.01 0.22 -0.07 0.46 -0.24 -0.31 0.26 -0.23 -0.17 -0.28 -0.07 -0.16 0.30 0.31
1 294 537 0.15 -0.12 -0.07 0.07 0.29 -0.56 -0.20 0.12 0.23 0.09 -0.12 0.04 -0.22 -0.38 0.41 0.22 -0.08 0.06 0.07 0.00
1 302 442 0.01 0.11 0.47 -0.08 0.15 -0.01 0.10 0.11 -0.25 -0.12 0.39 0.20 -0.48 -0.02 -0.41 -0.09 -0.02 -0.02 0.11 -0.15
1 310 451 0.12 -0.31 -0.49 0.28 0.07 0.21 -0.28 0.20 -0.23 -0.05 0.12 0.03 -0.10 0.18 -0.18 0.14 0.40 0.03 -0.26 0.10
















1 322 354 -0.23 -0.11 0.35 0.23 0.00 0.19 0.07 -0.19 0.43 -0.11 0.04 0.00 0.04 0.27 -0.40 -0.04 -0.08 -0.43 0.15 -0.19
1 328 329 -0.26 -0.09 0.02 -0.07 0.34 -0.33 -0.18 0.02 -0.29 0.10 0.06 -0.19 -0.07 0.35 -0.09 0.02 0.06 0.39 -0.23 0.43
1 333 416 0.16 -0.15 0.03 0.06 0.24 0.02 -0.37 0.16 -0.47 0.23 0.21 0.04 0.19 -0.36 0.21 0.30 -0.26 -0.20 -0.02 0.00
1 335 364 0.10 0.00 -0.47 -0.06 0.03 0.21 -0.01 -0.11 0.49 0.24 0.29 -0.06 0.00 -0.12 0.24 -0.17 -0.09 -0.36 0.12 -0.26
1 340 341 -0.05 -0.03 -0.16 -0.18 0.22 0.06 0.31 -0.22 -0.04 0.01 -0.19 -0.21 -0.19 -0.02 0.69 0.02 -0.06 -0.29 0.20 0.13
1 343 348 -0.09 -0.25 -0.21 0.03 0.38 0.08 0.13 0.14 0.28 -0.18 -0.26 -0.01 0.13 0.25 -0.46 -0.30 0.13 0.31 -0.13 0.00
1 349 558 -0.38 -0.15 0.11 0.04 0.04 0.24 0.14 -0.08 0.15 0.36 0.07 0.32 0.00 0.10 0.20 -0.31 -0.32 -0.22 0.11 -0.41
1 350 573 0.18 -0.32 -0.12 -0.11 0.32 0.04 -0.18 -0.02 -0.39 0.51 0.02 -0.03 0.31 -0.16 0.10 -0.02 -0.08 -0.33 0.14 0.15
1 352 479 0.21 -0.11 -0.17 -0.07 -0.41 -0.05 0.41 -0.16 -0.08 -0.13 0.09 -0.22 0.03 -0.09 0.18 -0.15 0.06 0.40 0.45 -0.18
1 357 547 -0.07 -0.58 -0.28 -0.26 0.25 -0.16 -0.04 0.11 -0.02 0.25 0.23 0.04 -0.09 0.30 -0.21 -0.06 0.19 -0.07 0.19 0.27
1 360 412 0.26 -0.08 0.12 0.39 -0.33 -0.25 0.02 0.31 -0.01 -0.46 0.13 0.16 0.34 -0.13 -0.11 0.14 -0.19 0.01 -0.17 -0.12
1 362 515 0.24 -0.17 -0.16 -0.11 0.16 -0.18 -0.14 0.22 -0.26 0.34 0.18 -0.06 0.06 -0.24 0.21 0.21 0.15 -0.26 -0.47 0.27
1 369 589 0.03 -0.09 0.38 0.36 -0.35 -0.41 0.07 -0.42 0.37 -0.12 0.04 0.00 0.09 -0.03 -0.05 0.19 -0.11 0.12 0.00 -0.08
1 376 473 -0.19 -0.37 0.01 0.00 -0.26 0.41 -0.10 0.02 0.49 -0.10 -0.10 -0.07 0.42 -0.03 0.03 -0.26 0.20 -0.17 0.05 0.02
1 383 536 -0.15 -0.31 0.41 0.13 0.35 -0.09 0.03 0.00 0.23 -0.21 -0.23 -0.19 -0.10 0.29 0.23 0.00 0.17 -0.37 0.05 -0.24
1 386 504 -0.07 -0.09 -0.08 0.45 -0.06 -0.08 -0.09 -0.06 -0.08 -0.06 -0.06 -0.07 -0.06 -0.07 0.84 -0.07 -0.07 -0.07 -0.08 -0.07
1 389 477 0.29 -0.11 0.18 0.43 -0.06 -0.04 0.01 0.34 -0.33 -0.29 -0.09 -0.14 -0.31 0.32 0.19 0.08 -0.29 0.03 -0.08 -0.11
1 390 391 0.01 -0.15 -0.06 0.04 -0.03 0.53 -0.34 0.10 0.22 -0.40 0.16 0.19 -0.27 -0.05 0.06 0.33 0.01 -0.33 -0.03 0.04
1 392 393 -0.09 -0.04 -0.31 -0.17 0.49 -0.16 0.39 0.02 0.15 -0.16 -0.03 -0.03 -0.02 -0.22 -0.18 -0.10 0.13 0.47 0.08 -0.23
1 394 431 0.05 -0.26 0.07 0.11 -0.22 -0.10 -0.17 0.27 -0.46 0.08 0.31 -0.44 0.13 0.29 -0.02 0.24 0.12 -0.20 0.19 0.01
1 396 553 0.00 -0.03 0.24 0.00 -0.02 -0.65 -0.02 0.09 0.23 -0.10 -0.10 0.08 -0.05 -0.08 -0.06 0.02 -0.04 0.64 -0.06 -0.10
1 397 549 0.07 -0.01 0.07 0.00 0.07 0.07 0.00 0.07 -0.01 -0.96 0.07 0.00 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07
1 398 550 0.06 -0.11 0.08 0.17 0.09 0.07 -0.94 0.06 0.00 0.06 0.06 -0.08 0.06 0.07 0.05 0.07 0.07 0.06 0.07 0.06
1 399 554 -0.07 0.00 -0.01 0.02 0.02 -0.06 0.02 -0.01 -0.05 -0.17 -0.18 0.01 0.85 -0.19 -0.14 -0.03 -0.07 0.32 -0.14 -0.13
1 400 419 -0.13 -0.12 0.26 0.09 0.29 0.00 -0.40 -0.18 -0.09 -0.04 -0.04 0.05 0.02 -0.11 0.32 0.17 -0.52 0.33 -0.16 0.25
1 402 417 0.20 -0.17 0.18 0.34 -0.02 -0.17 0.08 0.26 0.02 -0.24 -0.26 -0.41 -0.15 -0.11 0.08 0.41 0.31 0.02 -0.27 -0.10
1 403 404 -0.07 -0.16 0.10 -0.17 -0.37 0.00 -0.19 -0.19 -0.14 0.02 -0.27 0.31 -0.01 0.16 -0.26 0.11 0.45 0.43 0.08 0.18
1 405 406 0.22 -0.08 -0.05 0.38 0.17 0.23 -0.14 0.06 0.39 -0.32 0.04 -0.21 0.15 0.07 -0.54 -0.10 0.10 -0.12 -0.20 -0.06
1 407 411 -0.06 -0.08 -0.11 -0.03 0.21 -0.09 0.19 0.35 -0.33 0.18 0.15 -0.39 -0.18 0.30 -0.02 -0.06 -0.02 0.20 -0.46 0.26
1 409 414 0.03 0.16 0.00 -0.02 0.16 -0.26 -0.06 -0.09 -0.48 0.20 -0.12 -0.35 0.36 0.28 0.02 -0.08 0.16 -0.35 0.17 0.27
1 410 495 0.29 -0.10 -0.25 0.23 0.08 0.10 0.27 0.03 -0.20 0.46 -0.42 0.07 -0.28 -0.08 -0.08 -0.07 0.13 -0.28 -0.15 0.25
1 420 434 0.28 0.44 0.10 -0.12 -0.18 0.10 0.06 0.14 -0.35 -0.43 0.08 0.31 0.03 -0.07 0.17 0.06 -0.26 0.12 -0.23 -0.24
1 423 435 -0.17 -0.04 -0.12 0.13 0.59 0.07 -0.12 -0.31 -0.20 0.01 -0.01 0.17 -0.24 -0.07 0.40 -0.06 -0.08 0.21 -0.32 0.16
1 424 507 0.16 -0.20 0.03 0.15 -0.01 -0.05 -0.28 0.10 0.05 -0.37 -0.36 0.22 0.14 0.45 -0.17 -0.18 0.44 -0.14 0.03 -0.01
1 426 427 -0.31 -0.07 0.07 -0.36 0.20 -0.23 0.48 0.35 0.14 0.19 -0.09 -0.23 0.02 0.15 -0.14 -0.37 0.01 0.00 0.12 0.06
1 429 430 -0.38 -0.15 0.28 0.52 0.30 -0.17 -0.28 -0.24 0.08 0.26 0.13 -0.08 -0.22 0.11 0.08 -0.22 -0.01 -0.09 -0.01 0.11
1 437 438 0.14 -0.38 0.27 -0.10 0.14 0.04 -0.33 0.02 -0.04 -0.37 0.13 0.16 0.03 0.04 0.00 0.58 0.01 -0.05 -0.30 0.02
1 439 440 -0.07 -0.42 0.11 -0.28 0.12 0.27 -0.22 0.12 0.30 -0.13 0.45 -0.02 -0.10 -0.13 0.10 -0.04 0.04 -0.10 -0.32 0.33
1 441 579 0.19 -0.13 0.11 0.28 -0.18 0.02 0.22 -0.24 0.11 -0.40 -0.25 0.10 -0.40 0.23 0.22 -0.07 -0.14 0.39 0.10 -0.15
1 445 446 0.41 -0.13 0.21 -0.28 -0.29 0.01 -0.20 0.31 -0.07 0.06 0.09 -0.38 0.00 -0.01 0.27 0.29 -0.10 -0.33 -0.06 0.19
1 447 448 0.19 -0.20 0.00 -0.39 -0.21 -0.19 -0.44 0.18 0.18 0.21 0.23 0.27 0.10 0.17 0.16 0.05 -0.39 -0.08 0.17 -0.01
1 459 461 0.31 -0.10 -0.12 0.12 -0.13 -0.16 0.43 0.43 0.12 0.08 -0.02 -0.53 0.02 0.06 -0.19 -0.33 0.04 0.01 0.03 -0.10
1 460 607 -0.07 -0.03 -0.36 -0.04 -0.13 -0.03 0.01 -0.41 0.05 0.07 0.37 0.41 -0.14 0.09 -0.16 0.20 -0.26 -0.16 0.35 0.23
1 462 463 0.48 -0.18 0.13 -0.07 0.05 0.16 -0.20 0.25 0.05 -0.02 0.01 -0.33 0.18 -0.10 -0.16 0.27 0.20 -0.01 -0.20 -0.50
1 464 597 0.13 0.22 0.25 0.18 -0.60 0.00 -0.04 -0.16 -0.18 0.05 0.01 0.02 -0.08 0.07 -0.04 -0.20 0.13 -0.09 0.55 -0.19
1 471 472 0.19 -0.42 -0.17 -0.35 0.18 -0.18 -0.43 0.04 -0.16 0.27 0.27 -0.07 0.19 0.26 0.09 0.06 -0.07 0.14 -0.07 0.25
1 474 548 0.83 -0.03 -0.37 -0.01 -0.06 0.33 -0.01 -0.02 -0.03 -0.08 -0.06 -0.18 -0.05 -0.05 0.00 -0.02 -0.02 -0.06 -0.05 -0.07
1 475 511 0.27 -0.17 -0.27 0.02 0.31 -0.26 0.04 0.09 -0.07 -0.11 -0.11 -0.14 0.49 -0.46 0.26 0.08 -0.10 0.07 -0.15 0.20
1 482 484 -0.06 -0.45 0.14 0.38 0.21 -0.25 -0.34 0.13 0.23 0.09 -0.12 -0.26 0.11 -0.29 0.22 0.00 0.28 0.09 -0.11 0.00
228
Table B.5: (continued)
1 483 499 0.32 -0.31 0.01 0.21 0.19 -0.15 -0.10 0.03 -0.12 -0.34 -0.26 -0.44 0.18 0.03 0.46 0.05 0.09 0.18 -0.06 0.03
1 486 487 -0.04 0.12 -0.09 -0.08 0.20 0.51 -0.33 -0.15 -0.18 0.02 0.18 0.18 -0.16 -0.42 -0.04 -0.24 0.22 0.29 -0.13 0.15
1 488 493 0.15 -0.21 -0.28 0.08 -0.39 -0.28 -0.05 -0.07 0.16 0.20 0.00 0.32 0.24 -0.12 -0.25 -0.12 -0.16 0.31 0.41 0.05
1 489 494 0.22 0.00 -0.42 -0.13 -0.18 -0.25 -0.13 -0.26 -0.13 0.27 0.37 -0.01 0.35 0.23 0.31 -0.17 -0.22 0.06 0.06 0.03
1 501 502 -0.12 -0.03 0.24 0.51 -0.12 0.10 0.35 -0.03 -0.02 -0.25 -0.20 -0.44 -0.23 0.04 -0.15 0.12 0.06 0.31 0.05 -0.19
1 503 602 -0.07 -0.07 0.20 0.44 0.04 -0.13 0.27 0.21 0.13 -0.08 -0.38 0.25 0.27 0.01 -0.33 -0.09 -0.28 -0.05 -0.34 -0.01
1 510 539 0.01 -0.66 0.23 0.36 -0.01 0.16 0.34 0.05 -0.12 -0.12 -0.06 0.22 -0.13 -0.15 0.09 -0.13 -0.19 -0.03 0.22 -0.07
1 512 605 -0.02 0.30 0.05 -0.18 0.09 0.05 -0.09 0.04 0.44 0.13 0.11 -0.42 0.16 -0.10 0.06 -0.02 -0.01 -0.02 -0.64 0.09
1 513 570 -0.13 -0.30 -0.08 0.15 0.21 -0.28 0.38 0.03 0.08 -0.12 -0.05 0.00 0.13 0.47 -0.03 -0.49 0.20 -0.10 0.11 -0.18
1 514 543 0.49 -0.46 0.12 0.11 0.10 0.05 -0.37 -0.20 0.04 -0.35 -0.03 0.17 -0.15 0.08 0.09 0.16 0.06 -0.22 0.23 0.08
1 516 517 0.13 0.14 0.13 0.27 0.18 -0.41 -0.07 0.26 0.11 0.06 -0.22 -0.21 -0.20 -0.09 -0.48 0.30 -0.15 0.32 0.00 -0.08
1 518 519 -0.02 -0.42 0.02 0.20 0.57 0.09 0.29 -0.08 -0.06 -0.04 -0.20 0.13 0.00 -0.02 -0.40 -0.02 -0.22 0.08 0.24 -0.14
1 522 523 0.26 -0.20 -0.29 0.20 -0.35 -0.16 -0.10 -0.22 -0.04 -0.20 0.27 0.45 0.12 0.14 0.27 -0.01 -0.11 -0.15 0.28 -0.17
1 524 525 -0.03 -0.18 -0.02 0.14 0.06 0.07 -0.07 0.00 0.07 0.13 0.35 -0.03 0.21 -0.14 -0.15 0.18 0.23 -0.65 -0.38 0.21
1 531 533 -0.10 -0.45 0.00 0.14 -0.09 -0.09 0.48 -0.27 -0.29 0.19 -0.05 -0.31 0.10 0.24 0.05 -0.21 0.08 0.17 0.19 0.22
1 541 542 0.08 -0.21 0.59 -0.32 -0.17 0.01 0.37 -0.02 -0.07 0.01 0.08 0.11 -0.05 -0.05 -0.26 -0.06 0.23 0.20 -0.35 -0.10
1 557 577 0.17 -0.06 0.02 -0.22 0.26 -0.08 -0.05 -0.07 0.31 -0.23 0.12 -0.42 0.15 -0.19 -0.36 0.42 0.03 0.06 0.31 -0.15
1 561 571 -0.19 -0.13 -0.02 0.05 0.13 0.13 0.26 -0.42 0.08 0.07 0.11 0.14 0.22 -0.16 0.40 -0.02 -0.12 -0.57 0.17 -0.15
1 574 575 0.04 -0.41 -0.04 -0.17 0.21 0.00 -0.14 0.01 0.12 -0.10 -0.09 -0.47 0.04 0.09 -0.06 0.17 -0.04 0.49 0.43 -0.07
1 582 585 0.23 -0.51 0.03 0.24 0.41 0.01 0.17 0.34 -0.11 -0.24 -0.17 -0.07 -0.02 0.02 0.10 0.13 0.09 -0.30 -0.28 -0.07















Table B.6: PCA Generated Amino Acid Indices With Average Linkage 1 and 0.45
Variance Indices A R N D C Q E G H I L K M F P S T W Y V
1 12 13 -0.23 0.48 0.18 -0.02 -0.45 0.14 -0.08 -0.10 0.29 0.36 -0.29 0.06 -0.10 -0.25 0.05 0.01 0.01 0.19 -0.14 -0.10
1 18 604 0.15 0.05 -0.18 0.05 -0.25 0.03 -0.13 -0.17 0.29 -0.42 0.10 0.27 7e-05 -0.41 0.43 -0.03 -0.09 0.35 0.00 -0.05
1 25 591 -0.05 0.15 -0.11 -0.19 0.02 0.21 0.12 -0.17 -0.21 -0.21 0.08 0.02 0.20 -0.14 0.19 0.39 0.03 0.39 -0.15 -0.57
1 27 330 0.21 -0.22 -0.22 -0.31 -0.02 0.00 0.13 -0.06 -0.09 0.04 -0.20 0.40 -0.13 0.22 -0.10 0.16 0.21 -0.40 -0.09 0.47
1 31 284 -0.21 -0.19 -0.25 -0.08 -0.04 -0.10 -0.19 0.03 -0.02 0.57 0.15 0.11 -0.26 0.02 0.56 0.01 -0.02 -0.09 -0.15 0.15
1 35 505 0.03 0.04 0.11 0.04 0.41 0.04 -0.11 -0.04 -0.08 -0.20 0.34 -0.10 -0.57 0.22 -0.36 -0.11 -0.10 0.30 0.13 0.00
1 39 225 0.22 -0.43 -0.14 0.56 -0.12 -0.33 0.18 0.24 0.01 0.07 -0.08 0.06 -0.23 0.16 -0.22 -0.10 0.09 -0.16 0.04 0.18
1 40 53 0.03 0.14 -0.07 -0.14 0.00 -0.18 -0.24 -0.21 -0.31 0.06 0.12 -0.22 0.16 0.23 0.72 -0.07 0.07 0.09 -0.19 0.01
1 44 334 0.25 0.12 -0.37 0.21 -0.08 0.39 0.10 -0.19 -0.30 0.13 0.03 -0.12 0.13 -0.54 0.25 -0.13 -0.04 0.08 -0.03 0.11
1 52 346 0.09 -0.13 0.12 0.01 0.02 -0.26 0.23 0.08 -0.28 -0.30 0.13 -0.05 -0.18 -0.43 0.47 0.06 -0.22 0.19 0.30 0.14
1 65 135 0.04 0.23 -0.38 -0.32 0.15 -0.16 -0.43 -0.16 0.37 0.16 0.05 0.15 0.00 -0.03 -0.11 0.07 0.22 -0.18 -0.05 0.39
1 74 90 0.01 -0.29 -0.23 0.25 -0.06 -0.13 0.08 -0.27 0.02 -0.13 0.21 -0.33 0.03 0.41 -0.15 -0.14 0.18 0.53 0.04 -0.02
1 75 418 0.13 -0.52 -0.41 -0.01 0.00 -0.24 -0.09 0.30 -0.03 0.23 0.27 -0.25 -0.07 0.02 -0.09 0.11 0.01 0.12 0.15 0.37
1 86 509 0.09 -0.22 -0.29 0.19 0.12 0.05 0.04 0.13 0.07 -0.38 -0.06 0.20 0.05 -0.16 0.64 -0.10 -0.09 -0.21 0.17 -0.25
1 92 450 0.03 -0.29 0.33 -0.30 0.00 -0.09 0.37 -0.05 -0.09 -0.23 0.04 -0.28 0.02 0.04 -0.11 0.42 0.44 -0.03 -0.03 -0.22
1 100 230 0.00 -0.21 0.18 0.13 -0.24 -0.47 0.47 0.00 0.17 0.28 -0.22 0.05 -0.11 0.23 -0.03 -0.05 -0.32 0.09 0.19 -0.16
1 104 107 0.08 0.08 -0.58 -0.36 0.00 -0.29 0.27 0.02 0.19 -0.26 -0.08 0.26 -0.02 -0.07 0.27 0.17 0.17 -0.02 0.20 -0.02
1 106 428 -0.14 -0.15 0.21 -0.13 0.49 -0.44 0.22 0.06 -0.11 0.31 -0.28 -0.23 -0.12 0.02 0.03 0.08 0.17 -0.09 -0.17 0.28
1 114 397 549 0.00 -0.62 0.19 0.29 -0.21 0.17 0.22 0.02 -0.51 -0.04 -0.04 0.04 -0.09 0.08 -0.05 0.12 0.08 0.15 0.20 -0.02
1 121 226 0.05 -0.25 -0.05 -0.29 0.07 0.31 -0.33 0.16 -0.53 0.14 -0.21 -0.11 0.23 0.28 -0.05 0.19 -0.06 0.18 0.24 0.01
1 124 175 0.11 -0.12 -0.03 -0.12 -0.06 -0.04 0.13 -0.40 0.40 0.30 0.38 0.20 0.08 0.10 -0.01 -0.37 -0.28 -0.09 -0.29 0.14
1 139 608 0.08 -0.26 -0.28 0.13 0.15 0.32 -0.48 0.41 0.08 -0.21 0.21 -0.07 -0.26 -0.19 0.22 -0.06 0.12 -0.07 0.17 -0.01
1 145 547 -0.30 0.37 -0.25 -0.06 -0.08 0.04 0.17 -0.08 0.37 -0.03 -0.05 -0.12 -0.16 0.43 -0.50 0.00 0.01 0.21 0.08 -0.05
1 149 297 -0.23 -0.20 0.03 0.27 0.11 0.60 0.00 -0.01 -0.18 0.10 -0.08 -0.14 0.17 0.11 -0.50 0.01 -0.01 0.07 0.14 -0.27
1 151 481 -0.57 -0.41 0.09 0.00 0.02 -0.07 0.35 -0.15 0.08 0.00 0.01 -0.09 0.03 0.02 -0.19 0.32 0.06 0.44 0.06 0.00
1 152 395 0.14 -0.04 0.07 0.19 0.28 -0.19 0.18 -0.29 0.24 0.30 0.04 0.22 -0.22 0.11 -0.32 -0.30 -0.01 -0.50 0.09 0.01
1 156 432 0.21 -0.15 -0.34 -0.10 0.00 -0.31 -0.13 0.08 0.15 0.44 -0.04 -0.17 -0.13 0.16 -0.29 0.14 0.34 -0.07 -0.15 0.39
1 167 246 0.06 0.12 0.12 -0.01 0.15 -0.17 -0.11 0.06 -0.30 0.18 -0.16 0.23 0.03 -0.40 0.00 0.16 0.05 -0.58 0.26 0.32
1 187 237 -0.27 0.47 -0.03 -0.14 0.32 0.05 -0.24 -0.10 0.22 -0.07 -0.03 -0.08 -0.04 -0.48 0.26 0.06 -0.06 0.20 -0.24 0.21
1 196 455 0.32 -0.22 0.04 0.06 -0.25 0.08 0.08 0.48 0.04 -0.14 -0.20 -0.31 0.18 0.25 -0.12 -0.44 0.00 0.24 0.04 -0.14
1 198 208 -0.26 -0.13 0.26 0.02 0.29 -0.03 0.03 -0.63 -0.05 0.48 -0.11 -0.02 -0.02 0.21 -0.01 0.03 -0.20 -0.06 0.13 0.09
1 205 465 0.07 0.19 0.00 0.15 -0.21 0.09 0.16 -0.31 -0.03 -0.55 0.25 -0.05 -0.10 0.35 -0.03 0.37 0.10 -0.32 -0.02 -0.10
1 209 247 0.30 0.10 0.02 -0.11 0.15 0.01 0.18 -0.19 0.44 -0.17 -0.21 0.06 0.44 -0.03 -0.45 -0.21 -0.14 0.07 -0.02 -0.24
1 213 388 -0.28 0.36 -0.17 -0.08 -0.29 0.14 0.04 0.42 -0.32 0.30 -0.15 0.12 -0.24 -0.03 -0.24 0.00 0.20 -0.12 0.09 0.26
1 219 478 -0.49 0.35 -0.11 -0.12 0.36 0.11 -0.10 -0.39 -0.19 -0.04 -0.11 0.38 -0.10 0.03 -0.03 0.24 0.20 -0.01 0.04 -0.03
1 220 298 0.22 -0.29 0.38 0.25 0.17 -0.13 -0.10 -0.12 0.03 0.02 -0.06 -0.07 -0.06 0.07 0.14 -0.13 -0.52 -0.33 0.36 0.15
1 233 252 0.16 0.06 -0.18 0.07 0.58 -0.33 -0.30 -0.04 0.15 -0.24 0.04 0.14 -0.32 -0.26 0.23 0.05 -0.08 0.20 -0.10 0.16
1 249 250 0.20 -0.37 0.01 0.04 0.54 -0.08 -0.12 0.50 0.01 -0.13 -0.02 -0.04 0.16 -0.13 0.10 0.00 -0.09 -0.41 -0.10 -0.06
1 254 338 0.23 0.03 -0.17 0.37 -0.38 -0.05 0.08 0.18 0.13 -0.04 -0.17 -0.06 0.17 -0.08 -0.07 0.17 0.09 0.02 -0.66 0.20
1 267 268 -0.35 -0.15 -0.07 0.01 -0.05 -0.13 0.01 0.37 0.20 0.05 -0.26 0.32 -0.04 -0.03 0.36 0.23 -0.36 0.27 -0.11 -0.28
1 269 270 0.21 0.18 0.11 -0.29 -0.06 -0.40 0.17 -0.24 -0.12 0.20 -0.08 0.01 -0.26 0.04 0.55 -0.06 -0.07 -0.14 0.33 -0.09
1 271 281 0.16 -0.18 -0.06 0.27 0.20 -0.24 0.00 -0.32 0.42 -0.24 0.13 -0.51 -0.03 0.09 0.21 -0.12 0.03 -0.16 0.19 0.16
1 289 290 0.03 0.34 0.01 0.26 0.26 0.13 -0.01 -0.42 -0.26 -0.08 -0.35 -0.43 -0.09 0.27 -0.13 0.10 0.15 0.21 -0.01 0.01
1 305 568 0.07 -0.28 -0.12 0.27 -0.40 0.14 0.03 -0.29 0.02 0.22 -0.32 0.20 -0.37 0.06 -0.18 0.28 0.16 0.18 0.11 0.22
1 310 451 0.12 -0.31 -0.49 0.28 0.07 0.21 -0.28 0.20 -0.23 -0.05 0.12 0.03 -0.10 0.18 -0.18 0.14 0.40 0.03 -0.26 0.10
1 322 354 0.23 0.11 -0.35 -0.23 0.00 -0.19 -0.07 0.19 -0.43 0.11 -0.04 0.00 -0.04 -0.27 0.40 0.04 0.08 0.43 -0.15 0.19
1 335 364 0.10 0.00 -0.47 -0.06 0.03 0.21 -0.01 -0.11 0.49 0.24 0.29 -0.06 0.00 -0.12 0.24 -0.17 -0.09 -0.36 0.12 -0.26
1 403 404 0.07 0.16 -0.10 0.17 0.37 0.00 0.19 0.19 0.14 -0.02 0.27 -0.31 0.01 -0.16 0.26 -0.11 -0.45 -0.43 -0.08 -0.18
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Table B.6: (continued)
1 407 411 0.06 0.08 0.11 0.03 -0.21 0.09 -0.19 -0.35 0.33 -0.18 -0.15 0.39 0.18 -0.30 0.02 0.06 0.02 -0.20 0.46 -0.26
1 429 430 -0.38 -0.15 0.28 0.52 0.30 -0.17 -0.28 -0.24 0.08 0.26 0.13 -0.08 -0.22 0.11 0.08 -0.22 -0.01 -0.09 -0.01 0.11
1 441 579 0.19 -0.13 0.11 0.28 -0.18 0.02 0.22 -0.24 0.11 -0.40 -0.25 0.10 -0.40 0.23 0.22 -0.07 -0.14 0.39 0.10 -0.15
1 462 463 0.48 -0.18 0.13 -0.07 0.05 0.16 -0.20 0.25 0.05 -0.02 0.01 -0.33 0.18 -0.10 -0.16 0.27 0.20 -0.01 -0.20 -0.50
1 464 597 0.13 0.22 0.25 0.18 -0.60 0.00 -0.04 -0.16 -0.18 0.05 0.01 0.02 -0.08 0.07 -0.04 -0.20 0.13 -0.09 0.55 -0.19
1 470 580 0.10 -0.19 -0.27 -0.22 -0.20 -0.15 -0.13 0.08 -0.16 0.23 0.22 0.45 0.02 -0.27 0.23 -0.29 -0.06 0.41 0.01 0.20
1 489 494 0.22 0.00 -0.42 -0.13 -0.18 -0.25 -0.13 -0.26 -0.13 0.27 0.37 -0.01 0.35 0.23 0.31 -0.17 -0.22 0.06 0.06 0.03
1 501 502 -0.12 -0.03 0.24 0.51 -0.12 0.10 0.35 -0.03 -0.02 -0.25 -0.20 -0.44 -0.23 0.04 -0.15 0.12 0.06 0.31 0.05 -0.19
1 513 570 0.13 0.30 0.08 -0.15 -0.21 0.28 -0.38 -0.03 -0.08 0.12 0.05 0.00 -0.13 -0.47 0.03 0.49 -0.20 0.10 -0.11 0.18
1 514 543 -0.49 0.46 -0.12 -0.11 -0.10 -0.05 0.37 0.20 -0.04 0.35 0.03 -0.17 0.15 -0.08 -0.09 -0.16 -0.06 0.22 -0.23 -0.08
1 518 519 0.02 0.42 -0.02 -0.20 -0.57 -0.09 -0.29 0.08 0.06 0.04 0.20 -0.13 0.00 0.02 0.40 0.02 0.22 -0.08 -0.24 0.14
1 582 585 0.23 -0.51 0.03 0.24 0.41 0.01 0.17 0.34 -0.11 -0.24 -0.17 -0.07 -0.02 0.02 0.10 0.13 0.09 -0.30 -0.28 -0.07
0.9989 169 474 548 0.15 0.40 0.11 0.03 0.02 -0.03 -0.36 -0.14 0.17 0.13 -0.21 -0.33 -0.30 0.11 -0.30 0.20 0.23 0.19 0.22 -0.30
0.9957 8 424 598 0.35 -0.20 0.12 -0.15 -0.26 0.19 0.28 -0.37 0.23 -0.42 0.16 0.17 0.31 -0.12 0.20 -0.10 -0.06 -0.05 -0.15 -0.13
0.9953 191 193 195 0.10 -0.03 -0.47 -0.09 0.06 0.06 0.09 -0.09 0.01 -0.29 0.23 -0.14 0.39 -0.08 0.18 0.03 0.32 0.28 -0.42 -0.15
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.1: Dendrogram using DFT and Bulkiness
234
Figure C.2: Dendrogram using DFT and Isoelectric Point
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.3: Dendrogram using DFT and Absolute Entropy
236
Figure C.4: Dendrogram using DFT and Size
237
C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.5: Dendrogram using DFT and Polarity
238
Figure C.6: Dendrogram using DFT and Volume
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.7: Dendrogram using DFT and Molecular Weight
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Figure C.8: Dendrogram using DFT and Melting Point
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.9: Dendrogram using DFT and Hydrophobicity Index
242
Figure C.10: Dendrogram using DFT and the stability Scale from the Knowledge-Based
atom-atom Potential
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.11: Dendrogram using DFT and Long Range non-Bonded Energy per Atom
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Figure C.12: Dendrogram using DFT and Average Surrounding Hydrophobicity
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.13: Dendrogram using DFT and Hydrophobicity Index
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Figure C.14: Dendrogram using DFT and Hydration Potential
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.15: Dendrogram using DFT and Smoothed Upsilon Steric Parameter
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Figure C.16: Dendrogram using DFT and Hydrophobicity Index
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.17: Dendrogram using DFT and Electron-Ion Interaction Potential
250
Figure C.18: Dendrogram using DFT and Positive Charge
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.19: Dendrogram using DFT and Negative Charge
252
Figure C.20: Dendrogram using DFT and Number of Hydrogen Bond Donors
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.21: Dendrogram using DFT and Hydropathy Index
254
Figure C.22: Dendrogram using DFT and Average Flexibility Indices
255
C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.23: Dendrogram using DFT and Recognition Factors
256
Figure C.24: Dendrogram using DFT and Long-Range Contacts
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C. SIGNAL-PROCESSING BASED BIOINFORMATICS APPROACH FOR
MULTIPLE PROTEIN SEQUENCE ALIGNMENT
Figure C.25: Dendrogram using DFT and Relative Connectivity
258
Appendix D
List of Influenza Neuraminidase A
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D. LIST OF INFLUENZA NEURAMINIDASE A PROTEIN SEQUENCES
Table D.1: H1N1 1933-1946 Protein Sequences
Uniprot ID Description Uniprot ID Description
ABP49330 A/AA/Huston/1945 ABD77678 A/Puerto Rico/8/1934
ABO38057 A/AA/Marton/1943 AAM75160 A/Puerto Rico/8/34/Mount Sinai
ABD62845 A/Bellamy/1942 ACV49537 A/United Kingdom/1/1933
ABD79115 A/Cameron/1946 AAA91327 A/WS/1933
ABO38354 A/Henry/1936 ABF47958 A/WSN/1933
ABI20829 A/Hickox/1940 AAA43397 A/WSN/1933
AAM75501 A/Marton/43 AAA91328 A/WSN/1933
ACV49559 A/Melbourne/1/1946 ACF54601 A/WSN/1933
ABD62784 A/Melbourne/1935 AAF77045 A/Weiss/1943
AAA91326 A/NWS/1933 AAM76692 A/Weiss/1943
ABO38387 A/Phila/1935 ABD79104 A/Weiss/1943
ACV49548 A/Puerto Rico/8-1/1934 ABD77799 A/Wilson-Smith/1933
ACR15351 A/Puerto Rico/8-SV14/1934 ABF21334 A/Wilson-Smith/1933
AAA43412 A/Puerto Rico/8/1934(Cambridge)
Table D.2: H1N1 1947-1957 Protein Sequences
Uniprot ID Description Uniprot ID Description
ABP49484 A/Albany/12/1951 AAF77037 A/Fort Monmouth/1/1947
ABQ44474 A/Albany/14/1951 ABD61738 A/Fort Worth/1950
ABN59404 A/Albany/4835/1948 AAA43797 A/Leningrad/1954
ABD15262 A/Denver/1957 ABD60969 A/Malaysia/1954
AAM76693 A/Fort Monmouth/1/1947 AAM75502 A/Rhodes/1947
ABD77810 A/Fort Monmouth/1/1947 ABN59437 A/Roma/1949
Table D.3: H1N1 1979-1989 Protein Sequences
Uniprot ID Description Uniprot ID Description
ABW36314 A/Albany/8/1979 ABF47828 A/Memphis/16/1983
ABD95342 A/Baylor/11515/1982 ABG88347 A/Memphis/2/1983
ABD77821 A/Baylor/11735/1982 ABK40549 A/Memphis/24/1983
ABO52261 A/Baylor/4052/1981 ABK40593 A/Memphis/30/1983
ABP49341 A/California/10/1978 ABM66889 A/Memphis/31/1983
ABY81352 A/California/45/1978 ABN50903 A/Memphis/49/1983
CAA33354 A/Chile/1/1983 ABI92305 A/Memphis/6/1983
AAA96671 A/Chile/1/1983 ABQ44397 A/New Jersey/1976
ABO38343 A/Chile/1/1983 AAA43210 A/New Jersey/8/1976
ABO52800 A/Christ’s Hospital/157/1982 ACQ99824 A/New Jersey/8/1976
BAA06714 A/Hokkaido/11/1988 ABU80403 A/Ohio/3559/1988
ABD60947 A/Hong Kong/117/1977 ACK99446 A/Siena/10/1989
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Table D.3: (continued)
ABO38365 A/India/6263/1980 ACV49669 A/Siena/4/1987
AAM76694 A/India/80 ACL12264 A/Siena/9/1989
AAA43435 A/Kiev/59/1979 ABO38398 A/Singapore/6/1986
ABO33009 A/Maryland/2/1980 ABF21330 A/Taiwan/01/1986
ABN50759 A/Memphis/1/1979 ABO44126 A/Texas/2922-3/1986
ABG88336 A/Memphis/1/1983 ABO44137 A/Tientsin/78/1977
ABP49352 A/Memphis/1/1984 ABO38409 A/Tonga/14/1984
ABQ44419 A/Memphis/1/1987 AAA43449 A/USSR/90/1977
ABI30381 A/Memphis/10/1983 ABD60936 A/USSR/92/1977
ABF47707 A/Memphis/11/1978 ABV45841 A/Wisconsin/301/1976
ABM22249 A/Memphis/12/1986 BAA06718 A/Yamagata/120/1986
ABI20862 A/Memphis/14/1983 BAA06720 A/Yamagata/32/1989
Table D.4: H1N1 2009 Protein Sequences
Uniprot ID Description Uniprot ID Description
ADK33724 A/Aarhus/INS242/2009 ADJ80697 A/California/VRDL107/2009
ADK33814 A/Aarhus/INS253/2009 ADJ80707 A/California/VRDL108/2009
ADK33824 A/Aarhus/INS254/2009 ADD21777 A/California/VRDL11/2009
ADA83034 A/Abakan/02/2009 ADJ80727 A/California/VRDL110/2009
ADM14968 A/Addis Ababa/WR2848N/2009 ADJ80747 A/California/VRDL112/2009
ACU44306 A/Alaska/01/2009 ADJ80861 A/California/VRDL123/2009
ADM14469 A/Amman/WR0060N/2009 ADJ80896 A/California/VRDL126/2009
ADM14702 A/Amman/WR1335T/2009 ADJ80913 A/California/VRDL127/2009
ADC32390 A/Ancona/15/2009 ADJ80940 A/California/VRDL129/2009
ADC32407 A/Ancona/254/2009 ADM07463 A/California/VRDL149/2009
ADC32403 A/Ancona/310/2009 ADN06281 A/California/VRDL152/2009
ADC32405 A/Ancona/508/2009 ADN06314 A/California/VRDL155/2009
ADM14711 A/Ankara/WR1429T/2009 ADN06336 A/California/VRDL167/2009
ADA83582 A/Argentina/HNRG13/2009 ADN06347 A/California/VRDL175/2009
ADA83588 A/Argentina/HNRG14/2009 ADD21807 A/California/VRDL18/2009
ADA83592 A/Argentina/HNRG15/2009 ADN89053 A/California/VRDL180/2009
ADA83596 A/Argentina/HNRG16/2009 ADN89064 A/California/VRDL186/2009
ADA83600 A/Argentina/HNRG17/2009 ADN89108 A/California/VRDL194/2009
ADA83604 A/Argentina/HNRG18/2009 ADJ81006 A/California/VRDL2/2010
ADA83608 A/Argentina/HNRG20/2009 ADN89119 A/California/VRDL200/2009
ADA83612 A/Argentina/HNRG21/2009 ADN89130 A/California/VRDL202/2009
ADA83616 A/Argentina/HNRG23/2009 ADN89218 A/California/VRDL220/2009
ADA83634 A/Argentina/HNRG31/2009 ADN06358 A/California/VRDL229/2009
ADA83642 A/Argentina/HNRG33/2009 ADB89354 A/California/VRDL23/2009
ADB24796 A/Argentina/HNRG36/2009 ADN89317 A/California/VRDL232/2009
ADA83649 A/Argentina/HNRG37/2009 ADN89328 A/California/VRDL235/2009
ADA83657 A/Argentina/HNRG40/2009 ADN89361 A/California/VRDL238/2009
ADA83665 A/Argentina/HNRG42/2009 ADN89405 A/California/VRDL249/2009
ADA83681 A/Argentina/HNRG5/2009 ADN89427 A/California/VRDL252/2009
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Table D.4: (continued)
ACU44276 A/Arkansas/01/2009 ADN89449 A/California/VRDL256/2009
ACU44287 A/Arkansas/02/2009 ADN89471 A/California/VRDL264/2009
ADL39469 A/Arkansas/WRAIR1249P/2009 ADN89493 A/California/VRDL270/2009
ADG59596 A/Astrakhan/CRIE-CHRM/2009 ADN89515 A/California/VRDL275/2009
ADG42176 A/Athens/INS123/2009 ADN89559 A/California/VRDL283/2009
ADH02001 A/Athens/INS153/2009 ADN89581 A/California/VRDL289/2009
ADG42336 A/Athens/INS155/2009 ADB89404 A/California/VRDL29/2009
ADG42366 A/Athens/INS159/2009 ADB89474 A/California/VRDL36/2009
ADG42386 A/Athens/INS161/2009 ADN89801 A/California/VRDL371/2009
ADG42406 A/Athens/INS163/2009 ADB89254 A/California/VRDL4/2009
ADK33844 A/Athens/INS259/2009 ADB89534 A/California/VRDL45/2009
ADK33874 A/Athens/INS262/2009 ADB89544 A/California/VRDL48/2009
ADK21826 A/Athens/INS274/2009 ADB89554 A/California/VRDL50/2009
ADM31671 A/Athens/INS329/2009 ADB89584 A/California/VRDL53/2009
ADM32884 A/Athens/INS330/2009 ADB89274 A/California/VRDL6/2009
ADM31691 A/Athens/INS332/2009 ADB89614 A/California/VRDL61/2009
ADM31731 A/Athens/INS336/2009 ADB89654 A/California/VRDL68/2009
ADM31761 A/Athens/INS339/2009 ADJ81046 A/California/VRDL7/2010
ADM31771 A/Athens/INS340/2009 ADJ81056 A/California/VRDL8/2010
ADM31781 A/Athens/INS341/2009 ADF87354 A/California/VRDL83/2009
ADM31791 A/Athens/INS342/2009 ADF87384 A/California/VRDL86/2009
ADM31801 A/Athens/INS344/2009 ADG42636 A/California/VRDL88/2009
ADM31811 A/Athens/INS345/2009 ADG42646 A/California/VRDL89/2009
ADM13074 A/Athens/INS390/2010 ADG42676 A/California/VRDL92/2009
ADO00743 A/Athens/INS393/2010 ADM14601 A/California/WR1316P/2009
ADM13094 A/Athens/INS396/2010 ADM14611 A/California/WR1317P/2009
ADM13224 A/Athens/INS412/2010 ADM14639 A/California/WR1320P/2009
ACQ42240 A/Auckland/1/2009 ADM14648 A/California/WR1321P/2009
ACR08499 A/Auckland/1/2009 ADL39447 A/California/WRAIR1243P/2009
ACR40631 A/Auckland/1/2009 ACT68161 A/Canada-MB/RV2023/2009
ACR01020 A/Auckland/4/2009 ACT68169 A/Canada-QC/RV1759/2009
ADD22607 A/Australia/27/2009 ACT68170 A/Canada-SK/RV1767/2009
ADB89694 A/Australia/3/2009 ACU31177 A/Canada-SK/RV2486/2009
ADD22678 A/Australia/39/2009 ADH29478 A/Che/NIV658/2009
ADD22688 A/Australia/40/2009 ADO12236 A/Chile/158/2009
ADD22755 A/Australia/47/2009 ADO12276 A/Chile/1599/2009
ADD22765 A/Australia/48/2009 ADG59615 A/Chita/CRIE-8/2009
ADD22964 A/Australia/69/2009 ACQ83302 A/Christchurch/2/2009
ADD23085 A/Australia/73/2009 ACR01016 A/Christchurch/2/2009
ADD21887 A/Australia/9/2009 ACU44294 A/Colorado/07/2009
ADM13294 A/Bangkok/INS424/2010 ADD75091 A/Copenhagen/INS96/2009
ADM13334 A/Bangkok/INS428/2010 ACU44310 A/Delaware/01/2009
ADI49395 A/Barcelona/INS190/2009 ACV67183 A/District of Columbia/03/2009
ADM86443 A/Barcelona/INS378/2009 ADD23253 A/District of Columbia/INS17/2009
ACZ98548 A/Beijing/718/2009 ADD23263 A/District of Columbia/INS18/2009
ACZ98554 A/Beijing/719/2009 ADD23273 A/District of Columbia/INS19/2009
ACZ98562 A/Beijing/720/2009 ADK32680 A/District of Columbia/INS226/2009
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ADC39000 A/Bishkek/03/2009 ADD23323 A/District of Columbia/INS27/2009
ACZ97474 A/Blore/NIV236/2009 ADD74961 A/District of Columbia/INS44/2009
ADG42596 A/Bochum/INS187/2009 ACU56927 A/Ekaterinburg/01/2009
ADK33774 A/Bochum/INS249/2009 ACU44283 A/Florida/03/2009
ACY77870 A/Bogota/WR0090N/2009 ACR08565 A/Florida/04/2009
ADL39150 A/Bogota/WRAIR0088N/2009 ACU44302 A/Florida/07/2009
ADK21846 A/Bonn/INS277/2009 ACS72707 A/Florida/09/2009
ADI48645 A/Boston/106/2009 ACS72708 A/Florida/10/2009
ADI48675 A/Boston/115/2009 ACV67175 A/Florida/16/2009
ADI48685 A/Boston/116/2009 ADL32457 A/Frankfurt/INS301/2009
ADI48755 A/Boston/124/2009 ADM31481 A/Frankfurt/INS302/2009
ADI49253 A/Boston/132/2009 ADM31501 A/Frankfurt/INS305/2009
ADI49345 A/Boston/141/2009 ADM13134 A/Frankfurt/INS401/2009
ADO25095 A/Boston/584/2009 ADM13144 A/Frankfurt/INS402/2010
ADO25105 A/Boston/591/2009 ADM14720 A/Ft Carson/WR1446P/2009
ACT33116 A/Brandenburg/20/2009 ADM14730 A/Ft Carson/WR1448P/2009
ACT79155 A/Brawley/40082/2009 ADF80463 A/Gangwon/1805/2009
ACZ97356 A/Brownsville/39H/2009 ACS72680 A/Georgia/03/2009
ADK33734 A/Brussels/INS243/2009 ACX56269 A/Ghom/1550/2009
ACP41107 A/California/04/2009 ADJ40647 A/Guam/NHRC0002/2009
ACP41931 A/California/05/2009 ADL29753 A/Guam/NHRC0010/2009
ACT36688 A/California/07/2009 ADL32020 A/Guam/NHRC0015/2009
ACT36692 A/California/12/2009 ADL32357 A/Guam/NHRC0023/2009
ADG42736 A/California/VRDL100/2009 ADM12894 A/Guam/NHRC0030/2009
Table D.5: H2N2 Protein Sequences
Uniprot ID Description Uniprot ID Description
AAA43413 A/RI/5-/1957 AAO46221 A/Panama/1/61
AAA96710 A/Leningrad/134/17/1957 AAO46222 A/Taiwan/1/1962
AAA96711 A/Leningrad/134/47/1957 AAO46225 A/Netherlands/60/62
BAC77660 A/Japan/305/1957 AAO46226 A/Albany/1/63
AAO46211 A/Singapore/1/1957 AAO46227 A/Netherlands/65/63
AAO46212 A/Chile/13/57 BAC77661 A/Murakami/4/64
AAO46213 A/Davis/1/57 AAO46228 A/Taiwan/1964
AAO46214 A/El Salvador/2/1957 ABF21331 A/Taiwan/1964
BAD16637 A/Adachi/2/1957 ACD85190 A/Berlin/3/1964
BAD16638 A/Singapore/1/1957 ACD85223 A/Cottbus/1/1964
AAT66420 A/Japan/305/1957 BAA04722 A/Kumamoto/5/1965
ABF21326 A/Japan/305/1957 AAO46230 A/NewJersey/3/65
ABF82433 A/RI/5+/1957 AAO46231 A/Albany/1/65
ABF82434 A/RI/5+/1957 AAO46232 A/Pittsburgh/2/65
ABF82435 A/RI/5+/1957 AAO46233 A/Kumamoto/1/1965
BAF48642 A/Singapore/1/1957 ACD56327 A/Moscow/1019/1965
ABP49462 A/Albany/22/1957 ACD85201 A/Potsdam/2/1965
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Table D.5: (continued)
ACD56294 A/Ann Arbor/23/1957 AAO46234 A/Berkeley/1/1966
ACD85234 A/Guiyang/1/1957 AAO46236 A/Canada/1/1966
ACF54491 A/Singapore/1-MA12/1957 AAO46237 A/Panama/1/66
ACF54524 A/Singapore/1-MA12D/1957 ACI25727 A/Czech Republic/1/1966
ACU79962 A/Japan/305/1957 AAB05621 A/Tokyo/3/1967
ABI84962 A/Japan/305/1957 AAO46238 A/Panama/1/67
ADG59707 A/El Salvador/2/1957 AAO46239 A/AnnArbor/7/1967
ADG59718 A/El Salvador/2-Q226L/1957 AAO46240 A/England/10/67
ABO38310 A/Albany/26/1957 AAO46242 A/Poland/5/67
AAO46215 A/Albany/6/58 AAO46243 A/Montevideo/2208/67
AAO46216 A/Malaya/16/58 AAO46244 A/Georgia/1/1967
ABO38299 A/Albany/4/1958 AAO46245 A/Tokyo/3/1967
ABO52305 A/Albany/3/1958 AAO46246 A/Johannesburg/567/1967
ABP49440 A/Albany/24/1958 ABO38704 A/Albany/6/1967
ABO52239 A/Albany/5/1958 ABO44060 A/Albany/9/1967
AAO46217 A/Sao Paolo/3/1959 ABO44104 A/Albany/8/1967
AAO46218 A/Victoria/15681/59 ACD85245 A/Tashkent/1046/1967
ABO44093 A/Albany/1/1959 ACD85256 A/Johannesburg/617/1967
AAO46219 A/Ann Arbor/6/1960 AAO46248 A/Korea/426/1968
ABQ01358 A/Albany/1/1960 AAO46249 A/Berkeley/1/1968
AAO46220 A/England/1/61 ACF41694 A/Berkeley/1/1968
Table D.6: H3N2 Protein Sequences
Uniprot ID Description Uniprot ID Description
BAD16642 A/Aichi/2/1968 ACF36462 A/Hong Kong/CUHK10132/1999
ABQ53724 A/Alabama/01/1998 ACF36463 A/Hong Kong/CUHK10133/1999
ABQ01369 A/Albany/1/1976 ACF36464 A/Hong Kong/CUHK10151/1999
ABO33072 A/Albany/14/1978 ACF36469 A/Hong Kong/CUHK10537/1998
ABP49495 A/Albany/15/1976 ACF36470 A/Hong Kong/CUHK10554/1998
ABO52360 A/Albany/17/1968 ACF36472 A/Hong Kong/CUHK10632/1998
ABO44071 A/Albany/18/1968 ACF36473 A/Hong Kong/CUHK10660/1998
ABN51124 A/Albany/19/1968 ACF36474 A/Hong Kong/CUHK10756/1998
ABO52338 A/Albany/20/1974 ACF36475 A/Hong Kong/CUHK10954/1998
ABS49913 A/Albany/3/1970 ACF36477 A/Hong Kong/CUHK10960/1998
ABO52349 A/Albany/4/1977 ACF36478 A/Hong Kong/CUHK11163/1999
ABO52316 A/Albany/42/1975 ACF36485 A/Hong Kong/CUHK12160/1997
ABO52371 A/Albany/6/1970 ACF36491 A/Hong Kong/CUHK12563/1997
AAG49328 A/Athens/135/1999 ACF36493 A/Hong Kong/CUHK12572/1999
AAG49333 A/Athens/16/1998 ACF36494 A/Hong Kong/CUHK12580/1999
AAG49330 A/Athens/2/1997 ACF36496 A/Hong Kong/CUHK12794/1997
ABQ53717 A/Athens/23/1997 ACF36497 A/Hong Kong/CUHK12897/1999
AAG49323 A/Athens/76/1998 ACF36512 A/Hong Kong/CUHK13763/1999
ABU80180 A/Auckland/583/2000 ACF36513 A/Hong Kong/CUHK14627/1999
ABS50023 A/Auckland/600/2000 ACF36514 A/Hong Kong/CUHK14672/1999
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AAA43386 A/Bangkok/1/1979 ACF36517 A/Hong Kong/CUHK16614/1998
ABF21324 A/Bangkok/1/1979 ACF36518 A/Hong Kong/CUHK17464/1998
ACF41859 A/Beijing/32/1992 ACF36519 A/Hong Kong/CUHK17603/1998
ABF21325 A/Beijing/353/1989 ACF36520 A/Hong Kong/CUHK17643/1998
ABB46395 A/Beijing/39/1975 ACF36521 A/Hong Kong/CUHK17697/1998
ABQ53708 A/Brazil/207/1996 ACF36523 A/Hong Kong/CUHK17707/1998
ABQ53726 A/Brazil/97/1997 ACF36525 A/Hong Kong/CUHK18036/1998
AAQ10332 A/Buenos Aires/4057/95 ACF36526 A/Hong Kong/CUHK18194/1998
AAQ10333 A/Buenos Aires/4064/95 ACF36527 A/Hong Kong/CUHK18218/1998
AAQ10339 A/Buenos Aires/4559/96 ACF36529 A/Hong Kong/CUHK18351/1998
ABQ53694 A/Bur/23/1996 ACF36530 A/Hong Kong/CUHK18358/1998
AAO46480 A/Canada/2/70 ACF36531 A/Hong Kong/CUHK18610/1998
ABQ53695 A/Canada/2974/1997 ACF36533 A/Hong Kong/CUHK19579/1998
ABQ53701 A/Canada/318/1996 ACF36536 A/Hong Kong/CUHK20173/2000
AAY88205 A/Canada/33312/99 ACF36538 A/Hong Kong/CUHK20200/2000
ABC85790 A/Canterbury/17/2000 ACF36539 A/Hong Kong/CUHK20213/1997
ABD60837 A/Canterbury/3/2000 ACF36540 A/Hong Kong/CUHK20217/1997
ABD16295 A/Canterbury/56/2000 ACF36541 A/Hong Kong/CUHK20236/1997
ABF82654 A/Canterbury/62/2000 ACF36542 A/Hong Kong/CUHK20292/2000
ABJ09110 A/Canterbury/75/2000 ACF36545 A/Hong Kong/CUHK20320/1997
AAY88201 A/Charlottesville/10/99 ACF36546 A/Hong Kong/CUHK20523/1997
AAY88204 A/Charlottesville/49/99 ACF36548 A/Hong Kong/CUHK20992/1997
ABQ53702 A/Dakar/5/1997 ACF36554 A/Hong Kong/CUHK21250/2000
ABQ53703 A/Delaware/1/1997 ACF36566 A/Hong Kong/CUHK22013/1997
ABU92840 A/Denmark/201/2000 ACF36567 A/Hong Kong/CUHK22048/1997
ABU92841 A/Denmark/202/2000 ACF36568 A/Hong Kong/CUHK22072/2000
ABU92842 A/Denmark/203/2000 ACF36569 A/Hong Kong/CUHK22078/2000
ABQ53698 A/Denmark/22511/1998 ACF36570 A/Hong Kong/CUHK22087/2000
ABU92771 A/Denmark/38/2000 ACF36572 A/Hong Kong/CUHK22163/2000
CAD29985 A/Denmark/41/2000 ACF36598 A/Hong Kong/CUHK26846/2000
CAD29960 A/Denmark/511/1998 ACF36600 A/Hong Kong/CUHK26969/2000
ABQ53727 A/Eng/23/1996 ACF36601 A/Hong Kong/CUHK26980/2000
AAO46488 A/England/42/1972 ACF36602 A/Hong Kong/CUHK27157/2000
AAO46476 A/England/878/1969 ACF36603 A/Hong Kong/CUHK27183/2000
CAD29993 A/Finland/620/99 ACF36604 A/Hong Kong/CUHK27348/2000
AAO46470 A/Georgia/122/68 ACF36605 A/Hong Kong/CUHK27374/2000
AAG49325 A/Greece/106/98 ACF36606 A/Hong Kong/CUHK28038/2000
AAG49326 A/Greece/109/99 ACF36608 A/Hong Kong/CUHK28044/2000
AAG49327 A/Greece/132/99 ACF36616 A/Hong Kong/CUHK31448/1999
AAG49334 A/Greece/18/98 ACF36617 A/Hong Kong/CUHK31490/1999
ABC67568 A/Guandong/243/1972 ACF36618 A/Hong Kong/CUHK31510/1999
ABQ53709 A/Guangdong/57/1998 ACF36619 A/Hong Kong/CUHK32796/1999
ACF41738 A/Hong Kong/1-1-MA-12/1968 ACF36629 A/Hong Kong/CUHK33829/1999
ACF22213 A/Hong Kong/1-1/1968 ACF36633 A/Hong Kong/CUHK33915/1999
ACF41782 A/Hong Kong/1-11-MA21-1/1968 ACF36647 A/Hong Kong/CUHK41114/1997
ACF41815 A/Hong Kong/1-12-MA21-1/1968 ACF36648 A/Hong Kong/CUHK41222/1997
ACU79907 A/Hong Kong/1-6-MA21-1/1968 ACF36649 A/Hong Kong/CUHK41459/1997
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ACF54447 A/Hong Kong/1-8-MA21-1/1968 ACF36651 A/Hong Kong/CUHK41507/1997
ACF54458 A/Hong Kong/1-8-MA21-3/1968 ACF36652 A/Hong Kong/CUHK41757/1997
ACF41749 A/Hong Kong/1-9-MA21-1/1968 ACF36654 A/Hong Kong/CUHK4245/1997
ACF41760 A/Hong Kong/1-9-MA21-2/1968 ACF36658 A/Hong Kong/CUHK4391/1997
ACF41771 A/Hong Kong/1-9-MA21-3/1968 ACF36661 A/Hong Kong/CUHK4542/1997
AAK51726 A/Hong Kong/1/1968 ACF36663 A/Hong Kong/CUHK4803/1997
ACU79874 A/Hong Kong/1/1968 ACF36668 A/Hong Kong/CUHK50552/1998
ABB46406 A/Hong Kong/1/1982 ACF36671 A/Hong Kong/CUHK50722/1998
ABB04341 A/Hong Kong/11/1973 AAO46486 A/Hungary/2/1971
AAK63827 A/Hong Kong/1143/99 ABQ53718 A/Inverness/580868097/1997
AAK63828 A/Hong Kong/1143/99 CAD29992 A/Ireland/10586/99
AAK63829 A/Hong Kong/1144/99 ABQ53710 A/Japan/1268/1998
AAK70429 A/Hong Kong/1179/99 CAD29974 A/Johannesburg/33/1994
AAK70431 A/Hong Kong/1180/99 BAD16645 A/Kumamoto/55/76
AAK70432 A/Hong Kong/1180/99 ABF21327 A/Leningrad/360/1986
ABB04297 A/Hong Kong/14/1974 CAD29984 A/Lyon/1242/2000
ABB04909 A/Hong Kong/14/1992 CAC87416 A/Lyon/2573/1998
CAC40040 A/Hong Kong/1774/99 AAO46468 A/Malaysia/221/68
CAD29961 A/Hong Kong/1789/2000 ABR20817 A/Mecklenburg-Vorpommern/9/99
ABB04319 A/Hong Kong/2/1988 BAC77664 A/Memphis/1/1971
ABB04330 A/Hong Kong/24/1985 ABB96377 A/Memphis/1/1977
ABB04920 A/Hong Kong/26/1983 ABA43339 A/Memphis/1/1990
ABB80037 A/Hong Kong/3/1969 ABB96355 A/Memphis/101/1974
ABD60793 A/Hong Kong/33/1973 BAD16643 A/Memphis/102/1972
ABB79802 A/Hong Kong/4/1984 ABC84545 A/Memphis/103/1972
ABB04931 A/Hong Kong/43/1975 ABC97377 A/Memphis/105/1972
ABB46550 A/Hong Kong/45/1980 ABD61760 A/Memphis/105/1976
ABB04286 A/Hong Kong/46/1980 ABD16743 A/Memphis/108/1976
ABC40622 A/Hong Kong/49/1974 ABB96333 A/Memphis/12/1978
ABB80026 A/Hong Kong/50/1972 ABG37211 A/Memphis/12/1985
ABQ97206 A/Hong Kong/68 ABB96512 A/Memphis/13/1988
ABB04953 A/Hong Kong/7/1984 ABB96344 A/Memphis/18/1978
ACF36461 A/Hong Kong/CUHK10100/1999 ABB96322 A/Memphis/2/1978
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CAD29972 A/Egypt/84/2001 ABU92910 A/Denmark/86/2003
AAN64882 A/Wisconsin/12/2001 ABU92911 A/Denmark/56/2003
AAN64883 A/Texas/7/2001 ABU92912 A/Denmark/12/2003
AAN64888 A/Egypt/21181/2001 ABB83018 A/New York/481/2003
AAN64890 A/India/77251/2001 AAZ79552 A/New York/300/2003
CAD35672 A/England/627/01 ABB53732 A/New York/491/2003
CAD35673 A/England/691/01 ABA42283 A/New York/226/2003
ABU50446 A/Pennsylvania/1/2001 AAZ74377 A/New York/296/2003
BAD02347 A/Yokohama/22/2002 ABB83141 A/New York/492/2003
ABU50429 A/Pennsylvania/1/2002 ABD94946 A/New York/229/2003
ABC40634 A/New York/417/2002 ABB53606 A/New York/219/2003
AAY78942 A/New York/78/2002 ABU50434 A/Virginia/20/2003
ABU50432 A/New York/26/2002 ABK57099 A/Philippines/344/2004
ABB02784 A/New York/217/2002
Table D.8: H5N1 ASIA Protein Sequences
Uniprot ID Description Uniprot ID Description
ABU94738 A/Anhui/1/2005 ABI49417 A/Indonesia/CDC759/2006
ADG59213 A/Anhui/1/2005 ABL31746 A/Indonesia/CDC835/2006
ABV23945 A/Azerbaijan/002-115/2006 ABL31782 A/Indonesia/CDC887/2006
ABV23981 A/Azerbaijan/006-207/2006 ABL07010 A/Indonesia/CDC938/2006
ABV23961 A/Azerbaijan/011-162/2006 ABL07032 A/Indonesia/CDC940/2006
ABO10176 A/Cambodia/JP52a/2005 ACB87566 A/Jiangsu/2/2007
ADM95394 A/Cambodia/Q0405047/2006 BAH24021 A/Shanghai/1/2006
ACI06179 A/Cambodia/R0405050/2007 ABC72646 A/Thailand/676/2005
ADM95372 A/Cambodia/S1211394/2008 ABJ98533 A/Thailand/NA60/2005
ABI16506 A/China/GD01/2006 ACU46645 A/Thailand/NBL1/2006
ABX57872 A/China/GD02/2006 ABD16286 A/Thailand/NK165/2005
ADG59235 A/Guangxi/1/2005 ABJ98528 A/Thailand/RPFE/2005
ABW06346 A/Indonesia/160H/2005 ABQ58916 A/Turkey/12/2006
ABW06357 A/Indonesia/175H/2005 ABQ58918 A/Turkey/651242/2006
ABW06314 A/Indonesia/245H/2005 AAZ72720 A/Vietnam/BL-014/2005
ABW06303 A/Indonesia/283H/2006 AAZ72721 A/Vietnam/DT-036/2005
ABW06294 A/Indonesia/286H/2006 AAZ72722 A/Vietnam/HG-207/2005
ABW06254 A/Indonesia/321H/2006 ABO10180 A/Vietnam/HN30408/2005
ABW06243 A/Indonesia/341H/2006 ABY19420 A/Vietnam/HN31242/2007
ABW06107 A/Indonesia/5/2005 ABY19421 A/Vietnam/HN31242/2007
ABW06199 A/Indonesia/535H/2006 ABO10179 A/Vietnam/JP14/2005
ABW06210 A/Indonesia/538H/2006 ABO10178 A/Vietnam/JP4207/2005
ABW06159 A/Indonesia/560H/2006 ABE97719 A/Vietnam/CL105/2005
ABW06376 A/Indonesia/6/2005 ABB76120 A/Vietnam/CL115/2005
ABM90480 A/Indonesia/CDC1032/2007 ADF83610 A/Vietnam/HN31388M1/2007
ABM90513 A/Indonesia/CDC1046/2007 ADF83606 A/Vietnam/HN31432M/2008
267
D. LIST OF INFLUENZA NEURAMINIDASE A PROTEIN SEQUENCES
Table D.8: (continued)
ABI36200 A/Indonesia/CDC523/2006 ABF56651 A/Vietnam/PEV16T/2005
ABI36146 A/Indonesia/CDC594/2006 ADF83617 A/Vietnam/UT30408III/2005
ABI36314 A/Indonesia/CDC610/2006 ADF83616 A/Vietnam/UT30850/2005
ABI36325 A/Indonesia/CDC623/2006 ADF83615 A/Vietnam/UT31203A/2007
ABI36347 A/Indonesia/CDC624/2006 ADF83611 A/Vietnam/UT31312II/2007
ABI36380 A/Indonesia/CDC634/2006 ADF83609 A/Vietnam/UT31394II/2008
ABI36465 A/Indonesia/CDC644T/2006 ADF83608 A/Vietnam/UT31412II/2008
ABI36435 A/Indonesia/CDC669/2006 ADF83607 A/Vietnam/UT31413II/2008
ABI49409 A/Indonesia/CDC742/2006 ABG23658 A/Zhejiang/16/2006
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Table E.1: Uniprot IDs for Allergens Training Set - Allerhunter vs Allergenonline Database
ID ID ID ID ID ID
P83885.1 ABH06347.1 ACK76297.1 Q9M7M9.1 AAK58515.1 P02761.1
CAB58171.1 P82971.1 ACK76299.1 Q9M7M8.1 AAD05375.1 Q63213
BAC77154.1 ACI01048.1 BAD74060.2 Q9LEI8.1 AAO33897.1 XP 001067036.1
CAK50389.1 AAA30478.1 P16311.2 CAA11041.1 AAL92578.1 Q870B9.1
BAF43534.1 AAA30479.1 BAC53948.1 CAA11042.1 ACZ57582.1 AAT37679.1
Q7M1Y0 AAA30480.1 BAA04558.1 AAR98518.1 AAY88919.1 P01089.2
Q7M1X6 AAB29137.1 AAM64112.1 CAE85467.1 I53806 Q91483.3
G37396 CAA76847.1 BAA01241.1 1WKX E53806 Q91482.1
A59055 NP 851341.1 AAB30829.1 Q39967.3 F53806 ACI68103.1
Q9BMK4.1 P02754.3 AAL47677.1 ABN03965.1 G53806 P83181 1
Q7M4I5.1 P00711.2 AAA99805.1 CAD24068.1 D53806 P83181 2
P01502.1 Q28133.1 P49275.2 CAA93121.1 H53806 P83181 3
MEHB2 ABW98943.1 Q26456.1 AAG42255.1 BAE54432.1 P83181 4
P01501.1 ABW98945.1 AAM19082.1 CAB10765.1 P86432.1 ACS34771.1
NP 001035360.1 ABW98953.1 P39673.1 CAB10766.1 P86431.1 AAX11262.1
ABF21077.1 ACG59280.1 P49276.2 CAA10140.1 BAF95206.1 AAT99258.1
ABF21078.1 P02769.4 AAB27594.1 P43216.1 AAA86533.1 ACO34813.1
ABD51779.1 NP 776945.1 CAI05850.1 O44119.1 Q948T6.2 AAX11261.1
P00630.3 Q28050.1 CAI05849.1 AAC48288.1 AAF72991.1 CAX32966.1
Q08169.1 CAA29664.1 P16312.1 CAA42832.1 BAA07774.1 CAX32967.1
P81943 1 CAA32835.1 AAY84563.1 CAA35188.1 BAA07710.1 AAO15607.1
P81943 2 AAA62707.1 ABA39437.1 P16968.2 BAA07711.1 AAX37321.1
P81943 3 AAA30430.1 ABB52642.1 AAA32970.1 BAA07712.1 CAQ68366.1
P81943 4 AAA30429.1 2AS8 P32936.2 BAA07713.1 BAH10151.1
P92918.1 AAA30428.1 ABC73706.1 CAA41956.1 AAB99797.1 D37396
AAD29409.1 AAA30413.1 CAK22338.1 CAA49555.1 BAB71741.1 Q7M1Y1
P49372.1 AAA30431.1 CAA46317.1 CAA08836.1 Q01882.2 C37396
AAT00595.1 AAA30433.1 P46419.1 CAA46705.1 Q01883.2 AAP06493.1
AAT00594.1 P80207.1 P49273.1 AAP94213.1 BAC19997.1 AAC67308.1
AAT00596.1 P80208.1 ABG76196.1 AAP15199.1 BAC20650.1 BAC66618.1
AAM93157.1 S65144 ABV66255.1 AAP15200.1 Q40638.2 CAX32965.1
ABI17154.1 S65145 1A9V AAM54366.1 BAC20657.1 Q9S8H2
ABP97433.1 AAN86249.1 ABY53034.1 AAM54365.1 BAA01998.1 CAH92627.1
1W2Q P69198.1 3F5V AAF18269.1 BAA01996.1 CAH92630.1
ACA79908.1 P69196.1 ACG58378.1 AAB41308.1 BAA07772.1 Q7M263
AAK96887.1 S65143 ACI32128.1 ACI47547.1 BAA07773.1 BAE54429.1
ACN62248.1 P81729.1 CAQ68249.1 AAW29810.1 ACA96507.1 BAE54430.1
ABW17159.1 P69197.1 CAQ68250.1 P81294.1 BAF47264.1 AAK15089.1
ACH91862.1 P69199.1 AAA28296.1 Q9FY19.1 O61379.1 ACI41244.1
3C3V AAN11300.1 P08176.2 P81295.1 BAF47266.1 ACH85188.1
ABX56711.1 P30575.1 CAD38361.1 CAC48400.1 BAF47265.1 Q9XHP2
ABX75045.1 O18873.1 CAD38362.1 O64943.2 P55958.1 AAK15088.1
Q647G9.1 O18874.1 CAD38363.1 AAR21072.1 CAA65122.1 AAD42943.1
ADB96066.1 CAD82911.1 CAD38364.1 AAR21071.1 Q9T0M8.1 CAA62910.1
P43237.1 CAD82912.1 CAD38365.1 AAF80166.1 Q9XG85.1 P15322.2
P43238.1 AAB30434.1 CAD38366.1 Q9LD79.2 Q40905.1 AAX77383.1
AAM78596.1 CAA76841.1 CAD38367.1 AAF80164.1 P43217.3 AAX77384.1
AAN77576.1 CAB64867.1 CAD38368.1 CAD87731.1 2008179A CAA62909.1
AAC63045.1 CAD10376.1 CAD38369.1 CAD87730.1 CAA65123.1 CAA62908.1
AAD47382.1 P00784.1 CAD38370.1 AAQ73492.1 AAB46819.1 CAA62911.1
AAD55587.1 ABZ81043.1 CAD38371.1 AAQ73493.1 Q7M1E8 CAA62912.1
AAD56337.1 ABZ81042.1 AAB69424.1 AAQ73494.1 AAB36008.1 P16348.1
AAD56719.1 ABZ81041.1 CAA75141.1 P80384.2 AAB36009.1 P20347.3
AAQ91847.1 CAA47357.1 AAM21322.1 Q9NFZ4.1 AAB36010.1 P30941.2
AAB22817.1 P38949.2 P49278.1 Q9U5P1.1 AAB36011.1 P15476.2
AAL37561.1 P38950.2 1KTJ S66499 AAB36012.1 ABB16985.1
AAM46958.1 CAB02214.1 CAD38372.1 CAD32313.1 AAB46820.1 ABA81885.1
CAG26895.1 CAB02206.1 CAD38373.1 CAD32314.1 ACA23876.1 AAA33819.1
CAK50834.1 CAB02207.1 CAD38374.1 2118249B AAO15713.1 CAA27588.1
ACE07186.1 CAB02208.1 CAD38375.1 2118249A BAF47262.1 CAA27571.1
ACE07187.1 CAB02212.1 CAD38376.1 Q9U5P2.1 AAX11194.1 CAA31575.1
ACE07188.1 CAB02215.1 CAD38377.1 Q9U1G2.1 AAB34785.1 CAA45723.1
ACE07189.1 CAB02216.1 CAD38378.1 AAQ73484.1 AAF71379.1 BAH10156.1
AAO24900.1 CAB02217.1 CAD38379.1 AAQ73486.1 AAM33821.1 AAF65312.1
AAX85388.1 AAB20453.1 CAD38381.1 AAQ73487.1 AAF23726.1 AAF65313.1
P0C088.1 ABZ81044.1 CAD38382.1 AAQ73488.1 AAG44693.2 AAC97370.1
Q8H2C9.3 ABZ81040.1 CAD38383.1 AAQ73489.1 AAD25926.1 P35777.2
Q8H2C8.3 CAA64868.1 AAA19973.1 AAQ73490.1 AAD25995.1 AAB36117.1
CAD23613.1 CAD10374.1 AAD38942.1 AAQ73491.1 AAG44480.1 AAB36119.1
CAD23614.1 ACJ23863.1 P14004.2 CAP17694.1 Q96X46.3 AAB36120.1
CAD23611.1 ACJ23861.1 AAB32842.1 CAC84590.2 Q92260.1 AAB36121.1
BAH09387.1 ACJ23862.1 CAD69036.1 CAC84593.2 AAD42074.1 AAT95008.1
270
Table E.1: (continued)
AAD13651.1 P83507.1 P49277.1 O82015.2 AAR17475.1 P35775.1
AAD13652.1 P83508.1 CAC09234.1 CAA54819.1 AAG44478.1 P35778.2
AAB93837.1 Q7M1E7.1 AAO73464.1 AAZ91659.1 ADB92492.1 P35779.2
AAB93839.1 BAF32143.1 AAN02510.1 AAL07320.1 ADB92493.1 P35776.2
AAD13646.1 Q96385.1 P49274.1 ABC02750.1 ADD17628.1 P34071.1
ACN32322.1 Q9N2R3.1 AAX47076.1 ACM89179.1 AAC34736.1 P20723.1
AAD13648.1 Q8LGR0.1 AAX37326.1 ACC76803.1 AAB82404.1 1ESF
AAD13650.1 ACR77509.1 ABC96702.1 ABI98020.1 AAD13533.1 CAJ43561.1
AAD13644.1 AAL92870.1 Q05108.1 CAA10350.1 AAC34312.1 P06886.1
AAD13645.1 AAL92871.1 P10737.3 Q9SC98 AAC34737.1 AAS75831.1
AAD13647.1 BAF47267.1 P10736.1 Q7M1X5.1 AAB09632.1 P00791.3
AAD13649.1 O96764.2 P53357.1 P14947.1 AAB62731.1 S43242
AAB26195.1 P02221.2 Q06478.1 CAA51775.1 AAB63595.1 S43243
Q06811.2 P02222.2 P49371.1 P14948.1 AAD19606.1 S43244
Q9UVU3 P02231.1 P83340.1 Q40240.1 Q25641.1 ACT33296.1
Q8J0P4.2 P02224.2 P81217.1 Q40237.1 AAP13554.1 Q7M4K8
Q8NKF4.2 P84296.1 P82615 AAD20386.1 AAX33728.1 AAK63089.1
Q96X30.3 P12548.1 P35747.1 CAB64344.1 Q9UB83.1 AAK63088.1
Q9UUZ6.2 P84298.1 P82615.3 CAH92637.1 3EBW BAE54431.1
CAA06305.1 P12549.1 Q95182.1 AAA63279.1 ACJ37391.1 BAE46763.1
AAF86369.1 P12550.1 P81216.1 P14946.2 ACS14052.1 BAH10155.1
CAA59419.1 P02227.1 BAF47269.1 AAA63278.1 AAL86701.1 AAF07903.2
CAB44442.1 P02228.1 BAF47268.1 ACB05815.1 AAG08988.1 AAD52013.1
P40292.3 P02229.2 BAF76431.1 ABR21772.1 CAB01591.1 AAD52012.1
AAC61261.1 P02230.1 BAF76430.1 ABR21771.1 P56167.1 CAD23374.1
AAB07620.1 P84160.1 AAC82350.1 CAD10377.1 Q41260.1 CAA31396.1
P79017.2 P84177.2 Q9TZZ2.2 AAL29690.1 P56166.1 CAA25593.1
AAK49451.1 P84161.1 BAB79444.1 AAL75449.1 P56165.1 CAA26383.1
AAB95638.1 P84159.1 AAX57578.1 AAL75450.1 P56164.1 CAA26384.1
CAA04959.1 CAH03799.1 ABC18306.1 CAJ19706.1 AAB27445.1 CAA26385.1
AAB60779.1 ABQ59329.1 O23878.1 CAJ19705.1 ADC80502.1 CAA31685.1
O42799.2 AAK67491.1 O23880.1 ADC55380.1 ADC80503.1 CAA26847.1
CAB64688.1 CAB39376.1 Q9XFM4.1 Q01940.1 AAC25998.1 CAA30570.1
CAA11266.1 CAA50326.1 ABQ10638.1 P56577.1 O82040.1 CAA24934.1
CAA73782.1 CAA96548.1 AAF34634.1 P56578.1 ABB78007.1 CAA43361.1
AAM43909.1 CAA96549.1 ABO93594.1 AAD25927.1 CAD38384.1 AAA34272.1
P67875.1 AAD48405.1 ABI32184.1 CAI43283.4 CAD38385.1 AAA34274.1
Q92450.3 AAG40329.1 AAZ76743.1 2J23 CAD38386.1 AAA34275.1
O60024.2 AAG40330.1 Q8WNR9.1 CAD68071.1 CAD38387.1 AAA34276.1
EAL90121.1 AAG40331.1 P30440.1 CAA09883.1 CAD38388.1 AAA34279.1
EAL87477.1 CAC14168.1 CAA44343.1 CAA09884.1 CAD38389.1 AAA34280.1
EAL85811.1 AAK01235.1 CAA44344.1 CAA09885.1 CAD38390.1 AAA34281.1
EAL89830.1 AAK01236.1 P30438.2 CAA09886.2 CAD38391.1 AAA34282.1
AAD13106.1 AAK28533.1 AAC37318.1 CAA09887.4 CAD38392.1 AAA34283.1
CAB06417.1 AAL73404.1 CAA44345.1 AAT80662.1 CAD38393.1 AAA34284.1
AAA32702.1 Q08407.3 Q5VFH6.1 AAT80659.1 CAD38394.1 AAA34285.1
P12547.2 AAO65960.1 NP 001041618.1 AAT80649.1 CAD38395.1 AAA34286.1
P0C1B3.1 ACO56333.1 P49064.1 AAR22488.1 CAD38396.1 AAA34287.1
P29600.1 AAL86739.1 ACD65080.1 AAX18307.1 CAD38397.1 AAA34288.1
P00780.1 CAA50328.1 ACD65081.1 AAX18318.1 CAD87529.1 AAA34289.1
AAG31026.1 CAA50325.1 CAJ85641.1 AAX19848.1 1NLX AAB02788.1
BAA05540.1 BAH10152.1 ABD39049.1 AAX19851.1 CAD54670.2 AAA17741.1
BAF46896.1 AAK96889.1 CAJ85642.1 AAX19854.1 CAG24374.1 O22116
Q7M3Y8 1 AAC61869.1 CAJ85646.1 AAX19856.1 CAF32567.2 CAA27052.1
Q7M3Y8 2 AAW81034.1 Q5ULZ4 3 AAX19858.1 CAF32566.2 CAA59338.1
BAH10149.1 BAF32110.1 Q5ULZ4 2 AAX19860.1 P43214.1 CAA59339.1
CAA38363.1 BAF32116.1 CAJ85644.1 Q9FSG7.1 P43213.1 CAA59340.1
P04403.2 BAF32119.1 AAQ83588.1 Q40280.3 Q8H6L7.1 CAA24933.1
AAO38859.1 BAF32122.1 AAV74343.1 Q9M5X7.1 2118271A CAA61944.1
CAA07328.1 BAF32128.1 AAQ08947.1 CAK93713.1 CAQ55938.1 CAA61945.1
CAA07320.1 BAF32130.1 BAH10153.1 CAK93753.1 CAQ55939.1 CAA61943.1
1CQA BAF32133.1 AAN73248.1 CAK93757.1 CAQ55940.1 BAA11251.1
A45786 BAF32134.1 Q8TFM8.1 CAT99618.1 CAQ55941.1 AAB35353.1
CAA54696.1 BAF32137.1 Q8TFM9.1 CAT99619.1 1N10 BAA12318.1
CAA54695.1 BAF51970.1 P02622.1 CAT99617.1 CAA81613.1 CAA72273.1
CAA54694.1 BAF45320.1 AAK63086.1 CAT99612.1 P35079.1 O22108
P43177.2 P18632.2 AAK63087.1 CAT99611.1 CAA70609.1 CAC14917.1
CAA05186.1 BAB86286.1 CAM56785.1 Q941P6 CAA70610.1 CAI79052.1
CAA05187.1 P43212.1 CAM56786.1 Q941P5 CAB42886.1 CAI78902.1
CAA05188.1 BAC23082.1 CAA23681.1 CAA88833.1 S32101 P81496.1
CAA05190.1 BAC23083.1 P01012.2 CAA96534.1 S38584 CAI64396.1
CAA07318.1 BAC23084.1 CAA23682.1 AAD26546.1 Q7M1L8 CAI64397.1
CAA07319.1 AAK27264.1 1JTI AAD26547.1 CAA50281.1 CAI64398.1
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CAA07323.1 BAD77932.1 CAA26040.1 AAD26548.1 Q40963.2 BAE20328.1
CAA07324.1 BAA05543.1 P02789.2 AAD26552.1 AAK25823.1 CAR82265.1
CAA07325.1 BAF32105.1 P00698.1 AAD26553.1 1L3P CAR82266.1
CAA07326.1 CAD92666.1 AAA48944.1 AAD26554.1 CAA52753.1 CAR82267.1
CAA07327.1 AAW69549.1 1UHG AAD26555.1 AAC25994.1 ACG59281.1
CAA07329.1 P83834 1 P19121.2 AAD26558.1 CAB05372.1 P08819.2
CAA07330.1 P83834 2 NP 001106132.1 CAD10375.1 AAC16525.1 ABS58503.1
CAA04823.1 Q39547.1 ACJ04729.1 AAO25113.1 AAC16526.1 ACE82288.1
CAA04826.1 P83834 3 CAX32963.1 P43211.2 AAC16527.1 ACE82289.1
CAA04827.1 ACB45874.1 P01005.1 Q9XF40.1 AAC16528.1 ACE82290.1
CAA04828.1 AAP13533.2 XP 385781.1 Q9XF41.1 CAB05371.1 ACE82291.1
CAA04829.1 CAC05258.1 AAF82096.1 Q9XF42.1 CAA76556.1 ACE82292.1
1QMR ABK78766.1 ADD19989.1 CAD46559.1 CAA76557.1 CAZ76052.1
1LLT Q9SCG9.1 ADD19985.1 CAD46561.1 2023228A CBA13559.1
P15494.2 ACY01951.1 ADD18879.1 CAD46560.1 CAA76558.1 P24296.2
1B6F CAC37790.2 CAA33217.1 AAB35897.1 AAC25995.1 P82977.2
AAD26560.1 AAR21075.1 CAA37044.1 AAT80665.1 AAC25997.1 CAA35238.1
AAD26561.1 AAR21074.1 CAA45777.1 AAT80664.1 CAD10390.1 CAA35598.1
AAD26562.1 AAF72625.1 CAA45778.1 BAF47263.1 ABO36677.1 CAA42453.1
P45431.2 AAF72626.1 P22895.1 CAA73720.1 ABG73110.1 CAA35597.1
P43176.2 AAF72627.1 AAA33947.1 Q25456.1 ABG73109.1 CAA43331.1
P43178.2 AAF72628.1 AAB01374.1 AAG08989.1 ABG73108.1 AAB21323.1
P43180.2 AAF72629.1 AAA33964.1 P85894.1 ABU42022.1 S16031
P43183.2 AAL14078.1 AAA33965.1 P02762.2 CAF25233.1 CAA34709.1
P43184.2 AAK96255.1 AAB23463.1 AAK54834.1 CAF25232.1 CAA39099.1
P43185.2 AAL14077.1 AAB23464.1 AAB50883.1 CAD80019.1 CAA36063.1
CAA96541.1 AAL14079.1 AAB23482.1 Q07932.1 CAC41633.1 CAA44473.1
CAA96546.1 AAF80379.2 AAB23483.1 2206305A CAC41634.1 AAA34290.1
CAA96539.1 CAA69670.1 CAA56343.1 Q26464.1 CAC41635.1 ACL36923.1
CAA96540.1 CAA62634.1 CAA26478.1 BAH10150.1 ABY21305.1 AAU11502.1
CAA96542.1 CAA01909.1 AAB09252.1 CAE17317.1 Q8GT41.1 ABZ81991.1
CAA96543.1 CAA01910.1 BAA25899.1 CAE17316.1 CAE52833.1 ABU97480.1
CAA96544.1 AAB28566.1 BAB21619.1 BAE54433.1 CAC85911.1 ABU97479.1
CAA96547.1 AAB28567.1 ABA54897.1 AAO22133.1 A60373 ABQ96644.1
CAA96545.1 AAB32317.1 P82947.1 AAO22132.1 P22285.1 ABM53751.1
CAB02155.1 O04701.1 ABA54898.1 AAN18044.1 CAA10348.1 O02380.1
CAB02156.1 CAC83659.1 P26987.1 AAQ10281.1 A60372 AAT40866.1
CAB02157.1 CAC83658.1 ABU97472.1 AAQ10280.1 F37396 P35781.1
CAB02158.1 CAD20406.1 ACD36976.1 AAQ10279.1 CAA10520.1 P35782.1
CAB02159.1 2103117A ACD36975.1 AAQ10278.1 AAG42254.1 P81657.1
CAB02160.1 CAA10345.1 ACD36974.1 AAQ10277.1 P22284.1 P35783.1
CAB02161.1 AAK62278.1 ACD36978.1 AAQ10276.1 P22286.1 CAL59818.1
P43179.2 CAD20405.1 AAB34755.1 AAQ10274.1 AAA29793.1 CAL59819.1
P43186.2 P93124.1 A57106 AAQ10271.1 Q9U6V9.1 P35784.1
AAP37482.1 P82946 4 CAA11755.1 AAQ10268.1 Q9U6W0.1 CAJ28930.1
P25816.1 P82946 3 O65809.1 AAQ08190.1 AAT95010.1 CAJ28931.1
P43187.1 P82946 2 CAA35691.1 ABP58627.1 AAS67044.1 P35760.1
Q39419.1 P82946 1 CAA26575.1 ABP58632.1 AAP37412.1 P51528.1
AAG22740.1 AAP96759.1 CAA26723.1 ABP58633.1 AAS67043.1 ABC73068.1
CAC84116.1 BAB88129.1 CAA33215.1 ABP58635.1 AAS67042.1 P35785.1
B45786 O04298.1 CAA33216.1 ABP58636.1 AAS67041.1 P35786.1
AAB20452.1 Q8SAE6.1 CAA60533.1 ABP58637.1 AAT95009.1 P35787.1
BAB21489.1 BAA13604.1 CAA55977.1 ABX26131.1 P35759.1 1QNX
BAB21490.1 CAB03715.1 Q9U5P7.1 ABX26132.1 P35780.1 CAI77218.1
BAB21491.1 CAB03716.1 Q9NFQ4.1 ABX26134.1 P83542.1 2ATM
AAB25850.1 AAL76932.1 AAQ54603.1 ABX26138.1 P83377.1 AAB48072.1
AAB25851.1 AAB01092.1 BAH10148.1 ABX26139.1 BAH59276.1 P49370.1
ABP04043.1 P42039.3 AAG08987.1 ABX26140.1 P81651.2 AAA30333.1
ABP04044.1 CAA55070.1 P23110.1 ABX26141.1 AAD29411.1 CAB42887.1
ABP35603.1 P42040.2 CAA75506.1 ABX26143.1 AAF26449.1 AAX19889.1
ACJ37389.1 P42059.1 O97192.1 ABX26145.1 AAB38064.1 P80274.1
ABX57814.1 P40918.1 ABN03966.1 ABX26147.1 AAS47035.1 P80273.2
ACF53836.1 CAD38166.1 ABN09653.1 ABX54842.1 AAS47036.1 P33556.1
ACF53837.1 CAD42710.1 ABN09654.1 ABX54844.1 AAS47037.1 CAR48256.1
AAD13530.2 P0C0Y5.1 ABN09655.1 ABX54849.1 AAC02632.1 CAI64400.1
AAD13531.1 P40108.2 Q9LEI9.1 ABX54859.1 1H2O ABD79094.1
P54958.1 AAX14379.1 Q9LEJ0.1 ABX54862.1 P82534.1 ABD79095.1
AAA87851.1 P42038.1 Q7Y1X1.1 ABX54864.1 P82952.1 ABD79096.1
O18598.3 CAI05848.1 ABW34946.1 ABX54866.1 3EHK ABD79097.1
1YG9 ABA39436.1 3F55 ABX54869.1 AAL91662.1 ABD79098.1
AAB29344.1 ABA39438.1 ACY91851.1 ABX54876.1 ACE80972.1 ABF81661.1
AAB29345.1 2A0A ACZ74626.1 2JON ACE80970.1 ABF81662.1
AAF72534.1 AAP35077.1 P15252.2 P19963.2 AAV40850.1 ABG81312.1
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ABH06346.1 Q967Z0.1 AAA16792.1 A38968 ABB78006.1 ABG81313.1
ABH06348.1 Q23939.2 CAB53458.1 AAB32652.2 P81402.1 ABG81314.1
ABH06344.1 AAX34048.1 CAC13961.1 A53806 2B5S ABG81315.1
Q17284.1 ABO84963.1 CAC42881.1 B53806 CAD37201.1 ABG81316.1
ABH06352.1 ABO84964.1 AAL25839.1 C53806 CAD37202.1 ABG81317.1
ABH06359.1 ABO84966.1 AAA87456.1 CAA73038.1 BAH10154.1 ABG81318.1
ABU97466.1 ABO84967.1 AAP87281.1 CAA73037.1 AAC24001.1 2HCZ
2JMH ABO84968.1 O82803.1 CAA73036.1 AAD29410.1 Q1ZYQ8.2
AAK58415.1 ABO84969.1 P02877.2 O24169.1 AAC13315.1 P0C1Y5.1
AAM83103.1 ABU49605.1 CAA05978.1 O24170.1 D53288 P19656.1
AAD10850.1 ABU68318.1 AAF25553.1 O24171.1 ABZ81046.1 2209273A
AAM10779.1 ABY28115.1 AAC27724.1 P80740.2 ABZ81045.1 AAB86960.1
AAQ24541.1 ACK76300.1 CAA75312.1 O24172.1 CAC83046.1 AAO45607.1
AAQ24542.1 ACK76291.1 1G5U P81430.2 CAC95152.1 AAO45608.1
AAP35071.1 ACK76292.1 Q9STB6.1 AAF31152.1 CAC83047.1 AAK56124.1
ABH06350.1 ACK76296.1 Q9M7N0.1 Q9M7R0.1 CAC95153.1 AAX40948.1
Table E.2: Uniprot IDs for Allergens Training Set - Allerhunter vs Uniprot Database
ID ID ID ID ID ID ID ID
P81217 Q10G40 Q9LEH8 O04403 Q0CBV0 P86755 Q8J1L4 P60623
P18153 Q946J4 P24337 P81651 O59939 P86758 Q24702 Q94424
P92918 Q6H677 P80514 P82534 Q00645 P86763 Q9M0C2 Q39547
Q7M1G9 Q7XT40 P78983 P81402 P04959 P86766 Q9ZV52 P81531
P82258 Q0DZ85 P40918 O04004 P11073 P86770 Q9ZP41 P86472
P79017 Q7X6J9 Q92260 P0C088 P18209 P86772 Q9LEJ0 Q6TPK4
Q28133 Q5W6Z9 P40292 P86838 P04960 P86776 Q9LEI9 Q8WNR9
O18874 Q9LZT4 P49370 P84160 P0C1A4 P86777 Q9HDT3 O04298
Q00855 Q10S70 Q5D7H4 P84161 P0C1A5 P86746 Q96X30 P49275
P49278 Q9SVE5 Q08169 P19656 P16530 P86754 P42040 P49276
Q9TZZ2 Q7XCL0 P49371 Q9M5X7 P39116 P86760 Q96X46 P39675
P80384 Q9LZT5 Q9U6V9 Q9M5X8 P40973 P86767 Q870B9 P49277
P82952 Q8H274 P86687 Q9M5X6 Q59671 P02622 O14638 Q8J1M3
Q965E2 Q5Z980 P0CH89 Q8NJ52 Q51915 Q90YK9 P83340 Q9UW98
O02380 O23547 P86875 O49813 P72242 P02620 B2D0J5 P12319
O01949 Q850K7 Q8NIN9 P01012 Q60140 P59747 Q7Y1X1 P20489
P82259 Q9LDR9 P16968 Q06478 P40972 P33050 O97370 P12371
O60024 Q7XUD0 P01085 Q6Q252 Q56806 Q65DC2 Q1ZYQ8 Q01362
Q5VFH6 Q9LNU3 P13691 P53357 O24554 Q8GCB2 Q8H7T4 P20490
P80741 Q4PNY1 P01083 Q6Q251 O43099 B1B6T1 P0C1Y5 P13386
P82947 Q9LDJ3 P10846 Q6Q250 P14292 Q9WYR4 P04721 P30438
P81943 Q7G6Z2 P81367 Q6Q249 P14293 B1L969 P04722 P30440
O96870 Q9M9P0 P81368 Q9U6W0 P83181 Q10464 P04723 Q92949
P14004 Q4PR52 P01084 P83542 P69196 O65200 P04724 Q5ULZ4
Q39967 Q9FMA0 P28041 A2VBC4 P69197 P85126 P04725 Q8J1X7
Q9U5P2 Q4PR51 P32936 Q68KK0 Q8VWY6 Q01881 P04726 P81010
P83563 O80622 P16850 P0CH87 P69198 Q01883 P04727 Q17040
O24172 Q4PR50 P16851 Q3ZU95 P69199 Q01882 P04728 P02863
O42799 Q9M2S9 P17314 P51528 O64943 O49065 P18573 P38950
Q26456 Q69XV9 P34951 P0CH47 Q8VWY7 P15252 P48060 P38948
P49273 Q9ZSI1 P11643 P0CH86 Q84V36 Q8NKF4 Q9CWG1 Q41183
Q9U1G2 Q4PR49 P01086 P49369 O81092 P49148 P84159 P93124
P81430 Q9LQ07 P01087 Q9BMK4 P58171 P50344 Q32LB5 P82946
Q9M7R0 Q4PR48 P16969 Q7M4I5 O81701 P42037 Q6UWM5 P43216
P43187 Q7G6Z5 P16159 P00630 Q39419 Q9UUZ6 Q9CQ35 P81294
P85063 Q9SZM1 P16852 P82971 P94092 P42039 O18598 Q9LLT1
P79085 Q10RK1 Q5EF78 Q7M4I6 O82040 Q8TFM9 P46419 P81826
Q5EZC5 Q9FL81 Q5BLY4 P00784 P85444 P67875 Q6R4B4 P14946
Q5EZ82 Q10KN4 P83207 Q00002 P35792 Q28050 P43317 P14947
O94095 Q9FL80 P35225 O34819 P35793 P26987 P02877 P14948
P42058 Q4PR44 P01005 P94449 Q08697 P18632 P43213 P83466
P49274 Q9FL79 P93105 A1CFS2 P08299 O43290 P43214 Q41260
Q7Z1K3 Q4PR43 P01088 B0XT36 P09042 P80740 P43215 P24396
P83885 Q9FL76 P02538 B8N6W5 P83834 P86254 P10414 Q9LFP5
P16348 Q4PR42 P43393 Q4WV10 Q05968 Q92450 P0C0Y4 Q940Q1
P59704 Q9FL77 Q9D2H2 A2R3I1 Q40374 Q8MQS8 P0C0Y5 P0C1C0
P50635 Q4PR41 C7E3T4 Q01172 P11670 P0CH88 P02762 Q6CZT4
Q5GQ85 Q9FL78 Q95PM9 Q2TXM4 Q9U6R6 Q7M4I3 P83507 Q93WF1
P54958 Q2QP13 P85261 Q0CYL8 Q00008 Q7Z269 P02761 Q9FM66
Q16937 Q7XE35 P84527 Q00374 Q64LH1 P30941 P86703 Q93Z25
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P85446 Q4PR40 P02754 Q5BAU9 Q42449 O82803 Q07932 O65388
P85445 Q4PR39 P00711 Q12639 Q8H2C9 P0C8D4 Q26464 P0C1C1
Q09095 Q8W2X8 P13447 A1CYC2 P84177 P0C8D6 Q9NJA9 Q6CZT3
Q09114 Q75I75 P82615 B0YCL3 O65812 P0C8D5 Q8MUF6 Q9M9S2
Q09097 Q6YYW5 Q948T6 Q4WIS6 Q9XF40 P0C8D7 Q967Z0 P0C1C2
P83508 P0C1Y4 O82015 A2QFN7 O24169 P0C8D8 Q13765 Q6CZT2
Q9BQE9 Q9C554 Q7M1X5 Q00205 Q9XG85 Q9UW97 Q67A25 P86739
P85983 Q7XWU8 P85894 Q2TWM1 P35079 Q8J077 P43217 P86744
P15494 Q38866 P00698 Q5BA61 O65809 Q8WQ47 O04404 P86745
P45431 Q40636 P39674 A2QW65 P49232 Q9UW02 Q40905 P86749
P43176 O80932 P39673 Q5MBK3 Q64LH2 Q8TFM8 P0C1C3 P86756
P43177 Q40637 P43211 Q2UCT7 Q8H2C8 P83958 Q9C8G4 P86761
P43178 O48818 Q40280 Q5BEB9 Q9STB6 P81370 P15721 P86764
P43179 A2Y5R6 Q01940 B8NVB7 Q9XF41 P50694 P15722 P86768
P43180 Q0DHB7 P56577 A2RBL2 O24170 Q9FSG7 Q9FXD8 P86773
P43183 Q38864 P56578 P22864 Q9T0M8 P85814 O64510 P86774
P43184 Q6ZGU9 P68407 Q2TXS4 O24650 Q9NAS5 Q9SRH4 P86778
P43185 Q38865 Q8LW54 Q5AQJ1 Q93YG7 Q9N2R3 Q9M8Z8 P86431
P43186 Q9M4X7 P01502 P24112 O65810 O96764 Q9LRM5 Q91482
P85412 Q9LN94 P01504 P27027 P49233 A2V735 B0XT32 Q90YK8
P54962 Q852A1 P01501 B3GQR3 Q64LH0 Q23939 B8NE46 Q05109
O23791 O22874 P59261 Q0CFF7 Q9M7N0 O18416 Q4WIT0 P81656
P02662 Q9XHX0 P59262 Q0CZD4 Q9XF42 Q9GZ71 A2QV36 P35759
P92919 Q9LZ99 P68408 B0Y0L8 O24171 O97192 Q9C2Z0 P35780
P08819 Q4PR53 P68409 B8N316 O24282 O44119 Q2U8R6 P83377
P80325 Q9SKU2 Q9BPX6 A2R6A1 P49234 Q9NFZ4 P0C1A3 P86686
Q9JKC0 P58738 P86158 Q8NJK6 Q9M7M9 Q25456 Q5AVN4 Q7Z156
P81729 Q40638 P56924 Q2UJA7 Q9M7M8 Q9GZ69 P0C1A2 B2MVK7
Q8LGR0 Q9SHY6 P27759 Q5B3J8 Q9LEI8 O61379 A1CYB8 P85840
P86473 O24230 P27760 A1DEH0 Q94JN2 A1KYZ2 B8NBC2 P35783
P42059 Q9M0I2 P27761 P16311 Q9XF37 Q9UB83 P86741 P35784
Q6PSU2 Q336T5 P28744 P16312 Q9SQI9 Q9GZ70 P86743 P81657
Q647G9 Q9SHD1 P56164 P08176 P25816 Q7M3Y8 P86747 P35760
Q9UW00 Q94LR4 P56165 P25780 P85984 P02789 P86750 P86870
Q8J0P4 Q9M203 P56166 Q1EIQ3 Q93YI9 O64432 P86752 Q05110
P54107 Q7XT39 P56167 Q03211 Q84V37 P45669 P86757 Q2L6Z1
Q9XSD3 Q7XCA7 P43174 Q7M1E7 Q5EF31 P85413 P86759 P85860
Q25641 Q9LD07 Q40240 P43212 Q5FX67 P35775 P86762 C9WMM5
P83908 Q10T32 Q40962 Q9FY19 O04725 P35776 P86765 B1A4F7
Q2XXR2 Q07154 P43175 Q6H9K0 Q8SAE6 A5X2H7 P86769 B2D0J4
Q2XXR1 Q7XCG7 Q40237 Q8H6L7 P0C0Y3 P35778 P86771 Q9LDH0
Q2XXQ8 P85293 Q40963 Q56S59 O81982 P35779 P86775 Q6H676
Q2XXP2 Q55G31 P22284 Q8GT41 Q941H7 Q9NH75 P86779 Q9FSI9
Q2XXP1 Q54PA4 P22285 P82242 O49894 P35777 P86432 P55958
Q8JI40 Q7KWS2 P22286 Q9LJ42 Q94JN3 P35781 Q91483 Q2TZY0
Q7ZTA0 Q86AV4 P27762 Q9LTZ0 Q9XF39 P10736 Q90YK7 P86753
Q7ZT99 Q55G32 P00304 Q9SCP2 Q8GSL5 D4P2Y4 P86740
Q2XXQ0 Q54J35 P02878 Q93Z04 Q8GT39 P35782 P86742
Q09GJ9 Q54C80 P38949 Q9SVQ6 Q9XF38 P10737 P86748
B0VXV6 Q54C78 Q96385 Q944R1 P81295 Q05108 P86751
Q8JI39 O76821 Q08407 O65456 Q9LD79 A9QQ26 P35785
Q7ZZN9 Q17284 Q9SCG9 O65457 O50001 A9YME1 P35786
P79845 Q9U5P1 O04701 Q9C5M8 O24248 C0ITL3 P35787
Table E.3: Uniprot IDs for Non-Allergens Training Set - Allerhunter vs Allergenonline
Database
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P04229 P14540 O75531 P83917 P25859 P25859 P52594 P01233
P01912 Q9UM73 Q99933 Q13185 Q7Z460 Q7Z460 O04379 P0A6F5
P13760 Q96Q42 O95817 O00257 O75122 O75122 Q9UKV8 P10809
Q30134 P02760 P46379 P45973 Q9NBD7 Q9NBD7 O00253 O14646
Q95IE3 Q99217 Q9UQB8 P92973 Q9UJ71 Q9UJ71 Q8N157 P32657
Q5Y7A7 P46883 Q94F62 Q9H6F5 Q9H2X3 Q9H2X3 Q9C5U2 Q12873
Q9GIY3 Q01433 Q92560 Q16204 Q9BXN2 Q9BXN2 Q9C5U1 Q14839
P01911 P50579 Q99728 P13500 Q9UQC9 Q9UQC9 Q9C5U0 Q9P2D1
Q29974 P15144 P35613 P10147 P37019 P37019 Q09666 Q9HCK8
P26439 P30533 P18572 P13236 P35523 P35523 P38013 Q3L8U1
HSD3B2 P54144 Q07812 P13501 P51795 P51795 P35869 P07363
P78314 P69681 Q9NRL2 P14635 P51798 P51798 P30561 P0AE67
P29372 P04745 Q9UIG0 P24385 Q00610 Q00610 P55008 Q96EP1
P11171 P0C1B3 Q9UIF9 P30281 O00299 O00299 O95831 Q9UNE7
Q13541 P10538 Q96RK4 P24864 Q9Y696 Q9Y696 Q12904 O14757
Q9NRA8 P04746 P50895 P51946 P30622 P30622 O43918 Q6DE87
P08195 P00690 P56945 O75909 P49759 P49759 P14550 O96017
P28335 P06278 Q9P287 Q9UK58 P49761 P49761 Q04828 P70232
P46098 P39687 O95999 O60563 Q13286 Q13286 P52895 P06276
Q9H0P0 P54802 P10415 Q8ND76 P63284 P63284 P42330 P00183
P02763 P10275 Q86UU0 P00431 Q9HAW4 Q9HAW4 P17516 P17927
P01009 P01160 Q9NYF8 P31384 P10909 P10909 Q02952 P20023
P08697 P03950 Q6W2J9 P51681 O80809 O80809 P15848 P43320
P01023 P01019 P11274 Q6YHK3 P05059 P05059 P18440 P16220
P05067 P16157 Q9Y276 Q9UQ88 P10645 P10645 P11245 Q03060
P12023 Q01484 P35817 P21127 P09543 P09543 Q13510 P07315
P08592 Q8C8R3 P23560 P08571 O81445 O81445 Q9Y294 P07320
Q15758 Q8IWZ3 A6H8Y1 P06126 Q15021 Q15021 P32447 P46108
P01011 Q9V4P1 O76090 P29016 Q15003 Q15003 Q9VW15 Q64010
Q2M2I8 Q9NQW6 P00722 P15813 Q9BPX3 Q9BPX3 Q9UBL3 P0ACJ8
Q9UGJ0 Q99873 P16278 P15812 P42695 P42695 P17405 P02741
Q13131 O14744 P16442 Q9NNX6 Q6IBW4 Q6IBW4 P00805 Q64735
P54646 Q96LA8 Q15582 Q5ZPR3 Q16281 Q16281 P20933 Q6UUV9
Q9NY61 P20594 P37702 P10747 Q14028 Q14028 Q8IZT6 Q53ET0
P00509 O75179 P08236 P42771 P34972 P34972 Q13625 Q6UUV7
Q9ZR72 P01008 Q9UHR4 Q8N726 P02452 P02452 P00966 Q96318
Q9C8G9 P02833 P53004 Q64364 P11087 P11087 P05023 P82279
Q94FB9 Q9H6X2 Q9Y6D5 Q9Y5K6 P02454 P02454 P16615 Q43125
Q9XIE2 P58335 O00499 O95400 P02467 P02467 P20020 O77059
Q9HC16 Q38914 P12995 P06729 P08123 P08123 O43520 Q96524
APOBEC-3G P04083 P12996 P16671 P02458 P02458 Q6PL18 P02489
O95477 P07355 P13000 P28907 P06681 P06681 P15336 P02511
P78363 P12429 O15392 P07766 P02461 P02461 P17544 O75534
O95342 P08758 Q96CA5 P20963 P01024 P01024 P53104 Q9Y2W7
Q09428 P08133 P62593 P29965 P01027 P01027 Q9Y4P1 Q9QXT8
P33897 Q16853 Q01532 P16070 P02462 P02462 P38182 P07333
Q8NE71 P21397 P43583 P15379 P02463 P02463 Q8WXF7 P09603
P45844 P27338 P54132 Q08722 P08572 P08572 Q13315 P15509
Q9UNQ0 P35631 P30043 P01730 Q01955 Q01955 P38110 Q99062
Q8IZP0 P17427 P35226 P13987 P53420 P53420 P54259 P01243
Q8CBW3 P63010 Q13873 P11912 P29400 P29400 P0AB98 P68400
A0MES8 Q96CW1 P36894 P11911 P0C0L4 P0C0L4 P00846 P67870
Q9SJN0 P84092 P41832 P40259 P0C0L5 P0C0L5 Q04656 Q8WXE0
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Table E.4: (continued)
P00519 P35632 Q8NFC6 P48960 P01029 P01029 P35670 O14936
P00520 O14727 Q14137 P21926 P20908 P20908 P00829 P41240
P42684 Q9H1A4 Q53HL2 Q96GN5 P05997 P05997 P68699 Q13098
O14639 P25054 Q00587 P32458 P01031 P01031 Q8WXE1 Q9UNS2
Q8K4G5 P27695 P50747 P32797 P12109 P12109 O75882 Q92905
P15891 Q9BZZ5 P00974 Q13042 P12110 P12110 P46100 P13611
Q13085 P02647 Q12830 Q12834 P12111 P12111 Q9VXG8 Q00657
Q5SWU9 P02652 P15056 P26309 P13671 P13671 Q13535 P00183
Q00955 P06727 P38398 Q9UJX2 Q02388 Q02388 P38111 P17927
P11310 Q6Q788 P51587 P16522 P07357 P07357 Q76LX8 P20023
P49748 P04114 P46736 P30260 P07360 P07360 P00918 P43320
Q5T8D3 P02655 O95696 P06704 P02748 P02748 P07451 P16220
P07108 P05090 P25440 Q16543 Q03692 Q03692 P22748 Q03060
P55926 P02649 Q15059 P60953 P13942 P13942 Q16790 P07315
Q96AP0 P02749 O60885 P60766 O43405 O43405 P01258 P07320
Q9BYF1 O95445 Q9NPI1 P25694 P23528 P23528 P62157 P46108
P0A9G6 Q7Z2E3 Q9H0E9 P07834 Q9H9E3 Q9H9E3 P62152 Q64010
P22303 P07741 Q5VTR2 Q99459 Q9UMD9 Q9UMD9 P62158 P0ACJ8
P04058 P29972 Q9NXR7 Q6P1J9 O04197 O04197 P62161 P02741
Q10714 P41181 O22476 O00311 P39060 P39060 P27797 Q64735
P12821 P60844 P55201 Q69YH5 P39061 P39061 P27824 Q6UUV9
P32297 P10398 Q10589 Q9H5V8 P38432 P38432 P35564 Q53ET0
P02708 P25098 Q06187 P0ABF6 P01190 P01190 Q08AD1 Q6UUV7
Q9UKV3 P63345 P06129 Q9NYV4 P01189 P01189 P20807 Q96318
Q07912 P84077 O60566 Q14004 P46946 P46946 Q86VP6 P82279
P53396 P62330 O43683 O94921 Q8N668 Q8N668 Q01518 Q43125
P21399 Q8N6T3 P47136 Q00536 P49747 P49747 P20160 O77059
P0A6A8 Q9NP61 P48524 P06493 P21964 P21964 P00864 Q96524
Q9LX29 P93022 P23293 P24941 P43254 P43254 P13773 P02489
P31224 P05089 P10845 Q00526 P53621 P53621 P0A6F1 P02511
Q01574 Q92888 P15538 P11802 P00395 P00395 P00968 O75534
P07830 Q92974 P19099 Q00535 O43303 O43303 Q9WVG6 Q9Y2W7
P62736 Q15052 Q86VB7 P50613 P05093 P05093 P02666 Q9QXT8
P60709 Q14155 Q07021 P50750 Q24478 Q24478 O15234 P07333
P12814 Q9ES28 P02746 P24100 P11511 P11511 Q8NG31 P09603
P35609 O15085 P00736 O76039 P04798 P04798 P02668 P15509
O43707 Q9NZN5 P09871 P38936 P05177 P05177 Q14511 Q99062
P05095 Q5SW96 P11586 P46527 Q16678 Q16678 P29466 P01243
P68133 O14497 Q6PHS9 Q06850 P08686 P08686 P42574 P68400
P60010 Q8NFD5 Q9NZU7 Q38872 P11509 P11509 Q14790 P67870
P37023 Q99856 O00555 Q9H211 P20813 P20813 P55211 Q8WXE0
P45381 Q4LE39 Q13936 Q9Y232 P10632 P10632 Q92851 O14936
Q13444 P36404 O60840 Q7Z7A1 P11712 P11712 P41180 P41240
P35348 Q9H0F7 Q13698 Q5SW79 P33261 P33261 P04040 Q13098
P08913 P04424 Q02641 O15078 P10635 P10635 P07858 Q9UNS2
Q13443 P77398 Q9H251 Q5VT06 P05181 P05181 P53634 Q92905
P56658 P0A4Z2 P12830 P13688 P08684 P08684 P07339 P13611
P06134 Q8LGE3 P09803 P06731 P20815 P20815 P14091 Q00657
P00813 P17870 Q9BY67 Q9XWD6 Q02928 Q02928 Q9UBX1
P03958 P49407 Q8R5M8 Q92879 Q6FI81 Q6FI81 P08311
P35611 P29066 Q13111 O95319 O43809 O43809 P43235
Q9UEY8 P32121 Q13112 P19835 P31327 P31327 P07199
P00325 P29067 Q24572 P49450 P50416 P50416 Q03188
P00330 P15289 P00915 P36012 P23786 P23786 Q02224
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Table E.5: Uniprot IDs for Allergens Independent Data Set
ID ID ID ID ID ID ID ID
O46206 O49860 O18535 P18632 AAB30829 Q9XF37 Q9U3U5 CAA59340
Q6QHU2 Q8T379 Q8GSC5 P02672 P38949 Q5TIW1 P32936 P01552
1G5U\ B BAA09633 CAA27571 P43184 P18153 O81092 Q9XG86 O97192
O23752 Q84ZX5 Q5EZB4 JC5475 Q39430 P49822 Q8GT40 Q9NAS5
JE0227 P31757 Q9HF12 AAB32842 Q94508 Q13845 2122374B Q9U1G2
Q9LLB7 P49370 Q9TWR0 Q23939 Q40280 S13614 P49455 Q42661
P02754 Q9SCI1 H44583 Q8GT39 P43237 AAA34257 S65144 P15322
Q39431 Q84RR5 P14292 CAA39880 Q8WQK5 P39675 AAA68882 AAA20067
AAB23303 AAA34258 AAA34275 Q941R0 P15252 Q9LEI9 Q5EZB0 CAA44345
P82946\ 2 P58171 AAD47382 AAB31957 Q5EZA0 Q9M7M8 AAB32652 P12993
E53240 P35775 P46075 CAA74694 P00698 Q9BIX2 CAA45777 Q84MM5
Q5EZA8 P23472 AAB35084 O18530 CAA54819 P08835 P24627 Q8MVU3
Q9JJH9 Q7M1X8 Q42499 O82015 O24172 Q6VPT9 Q9T0M8
Q90YK9 Q41260 Q6QHU1 Q40962 P35081 AAF65313 P28296
O04725 Q8TCD2 Q01940 P07380 P82616\ 2 O46212 P68436
P81241 Q5XWE1 CAA27588 P82946 P80207 P81826 Q8J1L4
AAC49648 Q9FPK2 AAT80664 Q9XF42 AAB23464 CAA54485 Q7M3Y8\ 3
Q5EZB2 P46419 P27631 Q6VPU6 Q5EZB6 Q9U5P1 Q5EZ76
Table E.6: Uniprot IDs for Non-Allergens Independent Data Set
ID ID ID ID ID ID ID ID
P02167 P37228 Q9UXR0 P81517 O59045 Q9MUM2 P68132 Q6HF98
P42269 P02601 P29293 Q8LDP4 Q83AJ2 Q4QNR3 P05087 P53686
P25871 Q8D228 P53513 Q9GKX7 Q5L0N0 P08463 Q5FVI3 Q4WT34
P33624 Q6MB26 P54108 P27491 P14652 P14243 P96377 P26448
Q5ASQ0 P68080 P80031 Q9C566 Q8GH68 Q9RWC7 P08058 P61223
Q8IUD2 Q9DGJ1 P00997 P12069 Q9L6P1 P11986 O52633 O82827
Q9SZY1 Q9L9I0 Q8K1K6 Q86RN8 Q57JA2 P08022 Q92249 Q9UBT2
P02047 P51879 P12329 Q9NSB2 Q8P550 P48419 P08217 Q8MXI4
P81660 Q7KQL8 Q25088 P51781 P81755 O83770 P69888 P29755
P16291 Q93WF1 Q37718 P67944 Q9M290 Q2MI83 Q7M3V3 Q6R2R2
P66829 P31108 Q9M8Z8 Q9LT77 Q8G2L7 Q6GEJ0 P05577 P17984
O73872 Q8G0G3 P03953 P16627 P68547 Q9PE46 P19527 P65111
P26413 Q66DP8 P22792 P09243 P17730 Q9XSB8 P23904 P66980
P08905 P10649 Q03902 Q7SXW3 Q9D168 Q8MJ47 P02059 Q90523
P68082 P35795 Q3BVB8 P42373 P35070 Q9QZ25 P06606 P03998
P29245 P42374 O51401 Q4P235 Q39011 P33968 P27522 P75275
P34930 Q02200 Q9LRM5 Q41112 P56297 Q9V726 P24722 Q8N7C0
P41148 P69753 P04727 P26456 P62143 Q5HIQ6 Q40665 P64854
Q02157 P50691 P81214 P06741 Q6L201 P37508 P07444 P35391
P49237 P04347 P30412 P19236 Q7N589 P63713 Q21355 P55549
P14841 Q9Z520 P08019 P00198 Q59060 Q89AE0 O35453 Q5UR58
Q9BN10 P27521 O60575 Q6FMG7 Q8Y7B6 P59920 P16394 Q65ZZ4
P05156 O43109 P05937 Q88AE7 P57801 Q5YY83 P09212 Q8FJB7
Q06548 P06750 P09542 Q7M8C4 P16649 P47228 P51902 Q9CG33
P19849 P19171 Q82TV8 P12411 Q83HC7 P46218 P51647 P0AG61
Q4PBY6 Q9LDI3 Q9ZEE0 Q70Q35 O14958 Q49WX5 P04988 P67630
P92133 P52013 P93447 O80327 Q28019 Q9UYR5 P17444 P56383
Q9QYM9 Q8HZ59 Q9CM49 Q8CFM6 Q8NH93 Q66G58 P82778 O43819
P06959 P10246 Q6HP91 P00762 P92564 Q8FD50 Q9C401 P57258
P20289 P11827 P82188 P55737 P03903 Q19375 Q42460 P75238
P98031 P08331 P83594 P43373 Q91605 P42748 Q8VWY6 O58687
P21783 Q4QJW4 P01090 Q9QZ76 Q9WZQ8 P23103 P01319 Q62L77
Q89KU3 Q3LI67 P48493 Q4L919 Q7SBR3 Q82XA0 P68279 Q8D2J1
Q9UBX1 P42279 P29517 Q9MZF4 Q7WME6 Q9PKX1 Q5U907 Q60FY0
Q9N2G9 P24988 Q43358 P18241 Q85FW2 Q8YXH5 O06653 Q96I25
O80995 Q9LXW3 P09006 Q5GZV7 Q4UMR5 Q91316 Q8K9B2 P37958
Q29092 P37743 Q01595 P52260 Q8YZQ3 P0A621 P98094 Q65RX0
P08144 P35174 P17505 Q09675 P31782 Q67TJ2 P04906 P25734
P22998 P49935 P09107 P17156 Q87XL0 Q720A1 P35835 Q3BAH6
P12437 Q60AK3 Q28222 P54826 Q7MM54 Q9F0R1 Q96460 P19142
P54202 P04110 Q24789 Q57H69 Q8EQZ8 Q5HF87 P05109 Q9Y6M5
Q43875 Q99405 Q42952 Q9FL76 P25600 Q8G6J8 Q24798 Q12622
P04957 Q9ZMM2 P54628 P11684 Q9I013 Q8KBF4 Q6BXM5 Q56254
P84346 O30974 Q02970 P19859 Q98A73 Q6ZLA3 P13436 P68056
Q74H59 Q7XA40 P10787 P16545 P04659 Q02193 P07171 P16519
Q9Z319 Q9XBR5 P12863 Q5R6F7 Q9VLA1 Q04372 P14750 Q571F8
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Table E.6: (continued)
P51459 Q90339 Q26563 Q9TLT1 P0AEE3 P0A0Y7 Q9W7R2 Q9I2W7
P16053 Q9UNI1 Q18688 Q05423 P64191 O54862 Q39445 P00648
P05941 Q8IWT6 P98030 O15393 Q8CP01 P67767 Q09092 Q6LU53
Q9NFZ7 P81993 P09967 Q69AB1 Q9BDN4 Q5GRY9 P78504 P08493
P55325 Q17967 Q9Z9M2 Q65VZ7 P41717 P43332 P41951 P64764
Q28944 O08800 P83578 Q8JGT9 Q99FY3 Q5WHM7 Q9SY33 Q6GJI3
P07214 P13744 P02585 Q00446 Q5RCA4 Q05587 Q8ZJK9 Q9ZGW3
P46369 P25775 P59671 Q9ES45 O95070 Q8KCS2 P82724 Q22918
O42724 Q8EPE2 P29500 P32937 Q8BHL8 Q7Z494 P36304 Q64255
Q9XSC6 O74187 Q5HV33 Q8E0H0 Q80DT0 Q732N3 P50423 Q6PI62
P32733 Q43735 P29531 Q9NY56 O42354 P12404 P28783 O48410
P08306 P05934 P23239 Q81LW0 Q5NHV4 Q06069 P17066 Q3B6M7
Q9FYF7 P41184 P15090 P25307 P0A5E2 P09915 P39451 Q24524
P05964 P34931 P29109 O96790 Q4I061 P37363 P35415 P01178
O35660 Q9NQ38 P02224 Q9LLL8 Q5RFN3 Q71UG0 Q8CX68 P02826
Q89CK8 P13601 Q83BQ3 P09856 O29548 P75109 O47428 P66635
Q8ETY8 Q7ZZN9 P30151 Q42431 Q8Y3T4 Q92JM8 P66943 Q9P378
O77811 P68390 O05700 O88181 Q944H0 P12673 P16252 Q7MAZ9
O60087 P98044 Q9FH83 O94273 Q96YA4 Q9R1T7 Q9ZRB0 Q23529
O15041 P48740 Q9NS15 Q28794 P47027 Q87QV1 P09224 O35385
P52855 Q43779 P28760 Q4UDU8 Q5WTF5 Q7LBR1 P32877 Q75AH9
Q5R8E8 Q8PPG7 Q9TSP2 O87777 Q9KP47 Q9RCA1 Q43534 O55102
P00406 P25843 O23237 Q5H186 P11292 Q7V568 Q9LF54 P39247
Q12794 O04996 Q5PK93 P21199 O51931 Q98KC1 P24789 P53252
P09653 P00984 Q9Z9C4 Q52RN5 Q88YP9 Q90660 Q01490 P37002
Q4PCH8 P27518 P31393 Q7ZT99 Q7MNN7 Q33800 Q06016 Q6GGD5
P18868 P23883 O88281 P68392 Q4FS54 Q10164 Q9ZNY3 Q6PZD9
Q46YS9 Q7N0P4 P23490 P05615 P51776 Q98FG0 P81709 Q9PJM1
Q9LHB9 P25326 P08106 P29446 Q20932 O13712 P67799 P01236
Q8DR29 P09605 O65399 P21567 Q8KER4 O35568 P19666 P0ABS6
Q8CTD5 Q9NWZ3 Q28923 P52244 Q9EQ28 Q881U0 Q24560 Q9JXF5
O77020 P09733 Q8HXS3 P30112 P57809 Q87FT1 Q8P5D8 O66772
O47675 P09655 Q37604 Q9P926 O74315 P0A966 Q10717 Q8CSX7
P39085 P0A4L1 P01034 Q6CL78 O30175 Q8RT67 Q23763 P17310
P34368 Q92044 P68508 Q8R4Y4 P96069 Q7VH57 Q9P7P7 Q06010
P35045 P36952 Q9K5Z5 Q9YGJ2 O34967 P39342 P28161 P55959
Q02844 Q29145 Q707X3 P46587 Q5LNU7 P55780 Q9CQ19 Q92JI7
Q06655 P22133 P10782 Q88VW2 Q3JWH7 P77700 Q6QNF4 Q9PH36
P83595 P01001 Q43873 P18856 P01621 Q81W16 P18172 O95922
Q4ING3 P91253 P80646 Q04432 Q692W3 Q8G8Y2 Q9Y4C1 P54484
Q03376 P91902 Q29426 P05687 P37700 P94632 P0C088 P44477
P01337 Q9Z2H4 P02204 P25765 P0A4A6 Q7TV16 Q98MZ3 P25514
P11948 P48673 P07436 P03520 Q8U261 Q49YH9 P09324 Q9RS39
Q9HTJ1 Q7VVY2 P02854 P48720 Q5KWJ2 Q9CMY2 Q9FRX4 P13591
Q9JHJ7 Q96522 P02154 P24031 O54751 Q966L8 Q8G4G9 Q9EXQ1
Q8ZL52 P27463 Q27450 O43790 Q9KP97 Q9CWM2 P32590 P60502
P32938 P15714 Q9SYQ8 Q9ZDX9 P11279 Q23280 Q9W6G6 P77234
Q9X2T1 P10974 Q65PB5 P34460 Q5XCQ3 P19807 Q95NR9 P0AG16
P26792 P46368 P20233 P05592 P75363 P68028 Q9PAZ2 P32995
Q05511 Q9SZ67 Q88VM0 Q83MH5 Q6CKU6 P57692 P28524 Q5PKK7
P30404 Q01173 P27337 Q9Y4L1 Q9Y6H1 P17673 Q04902 Q9Z2D3
Q91Z98 Q43019 Q9NYK1 P02591 P82935 Q9CRB6 P10917 P09849
Q02942 P48671 P11480 P41011 P60183 Q8F4W2 P14210 P12236
P11588 Q9Y5X9 Q5R1W3 Q862Z5 P32669 O32160 Q67LB8 P64325
P00798 Q40302 Q04736 Q6C2T9 Q43133 Q5R6P6 Q9SLY8 Q48VS4
P49223 P09871 P68530 P09466 Q5WHP3 P44903 P61184 P42851
P35336 P56202 O46427 Q5BJE1 P98175 P18670 P23286 Q710D7
Q9EQT5 Q37369 Q03975 Q9JJZ2 Q9Z7T3 P54976 P33157 P0AAN8
P32822 O24585 P81902 O24581 Q42539 Q83KD8 P16635 Q71KN3
Q6X9Z5 Q986N6 Q03044 P50291 Q4K8H3 P07471 P56626 P22485
P05167 P30842 P56625 Q9BIR7 Q8Z4R0 Q94694 Q91195 Q5UQL2
P79819 Q6BM74 P14614 Q9UBX7 Q58926 Q9K620 P98043 P46389
O35684 Q29150 Q93572 P92131 Q8BWN8 Q8YAC4 Q6GDP4 Q815J4
P01041 P08055 P30563 Q9M263 P51229 O82134 Q9JM71 Q8PZI1
Q06331 P36401 P25784 P24303 O28355 Q9D3G2 P67978 O04487
P79139 P02195 P02773 P11965 Q9F0D4 O14198 Q89A93 Q89AT8
P50343 P32589 P68407 P00986 Q6SEH4 P36547 Q8YA20 P26142
Q39799 P05611 Q8K3H7 Q8BJR6 Q8NGR8 P0A7S2 P92996 O94544
Q9K9B2 P29860 O87712 P28758 Q52562 P63294 Q9FIC6 Q71Z80
P48674 Q9LNU3 Q6CJR7 P21589 Q8YQ78 Q62GM2 Q5KAW8 P34666
P05939 Q3SB11 P16641 Q8P1W3 Q899M3 P13273 Q3SZ10 Q6BSE7
P34827 P12399 Q5JJ64 O76284 Q8Y4H1 Q822J3 P01088 P0C1B8
Q9NR96 P52269 Q91233 P35033 Q5FJP6 Q9ZHF6 P09734 Q8R6F5
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Table E.6: (continued)
P93329 P01000 Q7VDY0 P05943 P52467 Q3A6M1 P10822 O51578
O77814 Q9H4G4 P18294 P04248 Q9Y935 Q8RGF0 Q01705 P83260
Q9L8F6 Q57JA9 Q4IPB3 Q68XI2 Q6DIX1 P31085 Q9FL89 Q5LIK4
O08789 P01325 P04247 P13918 Q69ZB8 Q93JF1 P92999 Q00901
Q07663 P35034 Q9Y7S9 Q8YHF5 Q3JZ19 O15374 Q9LLR6 P11934
P52232 Q28987 Q9SM64 Q98QA8 Q9HQ97 O26147 P35590 Q8CQF4
P48871 Q5HER0 Q4P555 P0A343 Q7NWN7 O66756 Q9FRV0 P84247
P42236 P42088 Q7Z410 P61701 Q8P1E3 Q5NRQ1 Q4WIF3 Q38J84
Q38865 Q27666 P12333 P36454 Q6FD81 Q9Z7P2 P73920 P53191
Q4A0E7 P40001 Q8YFY0 Q9Y473 P84005 Q9BBR4 O04151 Q8ZH66
P34648 P02606 Q9XSM2 P66671 Q4K6V0 Q8K0W9 P02196 Q9RDV8
Q16937 Q3IYM7 Q03301 Q3ASF8 O29573 Q890Q7 P05438 P62170
P25036 P93338 P00566 P54007 P23910 P57476 Q5X3L4 O66805
O19092 P35004 P36369 Q48AW1 P46314 Q58442 Q9LXG3 P42094
Q46XI7 P26455 P29447 P36023 Q37601 P58603 P06472 P42252
P00791 P05120 P11503 Q16960 P33109 P68118 Q8KEA4 P00369
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